id,adj.P.Val.xBirA.Cre.over.NoBirA,AveExpr.xBirA.Cre.over.NoBirA,Log.P.Value.xBirA.Cre.over.NoBirA,logFC.xBirA.Cre.over.NoBirA,P.Value.xBirA.Cre.over.NoBirA,t.xBirA.Cre.over.NoBirA,Ilia_newDatabase..126.126.127.128.129.130.131..NoBirA_6.multimedian,Ilia_newDatabase..128.126.127.128.129.130.131..NoBirA_4.multimedian,Ilia_newDatabase..129.126.127.128.129.130.131..NoBirA_5.multimedian,Ilia_newDatabase..127.126.127.128.129.130.131..BirA.Cre_3.multimedian,Ilia_newDatabase..130.126.127.128.129.130.131..BirA.Cre_2.multimedian,Ilia_newDatabase..131.126.127.128.129.130.131..BirA.Cre_1.multimedian,id.query,id.mapped,id.concat,accession_number,geneSymbol,numColumnsProteinObserved,numSpectraProteinObserved,numPepsUnique,numPepsUniqueSubgroupSpecificCI,accession_numbers,species,protein_mw,percentCoverage,groupNum,subgroupNum,scoreUnique,scoreUniqueSubgroupSpecificCI,orfCategory,sequenceLength,entry_name,cellular_component,biological_process,molecular_function,Ilia_newDatabase.unique_peptides,Ilia_newDatabase.numSpectra,Ilia_newDatabase.totalIntensity,Ilia_newDatabase.pct_cov
E9Q414,0.498295882,-0.09225,6.039408093,0.320833333,0.248919655,1.272334388,-0.402,-0.3345,-0.0215,0.198,-0.219,0.2255,E9Q414,Apob,E9Q414_Apob,E9Q414,Apob,1,1119,269,269,E9Q414,MOUSE,510791.9,54.2,1,1.1,4060.64,4060.64,,4505,Apolipoprotein B-100,extracellular region|cytoplasm|endoplasmic reticulum|Golgi apparatus|plasma membrane|vesicle membrane|actin cytoskeleton|vesicle lumen|mature chylomicron|very-low-density lipoprotein particle|low-density lipoprotein particle|intermediate-density lipoprotein particle|chylomicron|neuronal cell body|extracellular exosome|,in utero embryonic development|lipid metabolic process|triglyceride mobilization|spermatogenesis|nervous system development|cholesterol metabolic process|fertilization|response to virus|response to carbohydrate|post-embryonic development|response to selenium ion|positive regulation of gene expression|positive regulation of macrophage derived foam cell differentiation|positive regulation of lipid storage|positive regulation of cholesterol storage|lipid catabolic process|triglyceride catabolic process|cholesterol transport|sperm motility|response to lipopolysaccharide|cholesterol efflux|low-density lipoprotein particle remodeling|low-density lipoprotein particle clearance|lipoprotein metabolic process|lipoprotein biosynthetic process|lipoprotein catabolic process|cholesterol homeostasis|lipoprotein transport|regulation of cholesterol biosynthetic process|artery morphogenesis|cellular response to tumor necrosis factor|cellular response to prostaglandin stimulus|,phospholipid binding|heparin binding|cholesterol transporter activity|lipase binding|low-density lipoprotein particle receptor binding|,269,1119,1.61E+12,54.2%
P01027,0.482514848,-0.147583333,6.295757192,0.4435,0.234652011,1.316369666,-0.822,-0.4015,0.1155,-0.037,-0.195,0.4545,P01027,C3,P01027_C3,P01027,C3,1,998,175,152,P01027|P01027-2|Q2UVX4|G3X7A5,MOUSE,188021,86.1,2,2.1,2794.84,2491.05,,1663,Complement C3,extracellular space|extracellular exosome|blood microparticle|,"positive regulation of type IIa hypersensitivity|positive regulation of protein phosphorylation|positive regulation of activation of membrane attack complex|tolerance induction|fatty acid metabolic process|inflammatory response|complement activation|complement activation, alternative pathway|complement activation, classical pathway|blood coagulation|positive regulation of vascular endothelial growth factor production|positive regulation of glucose transport|regulation of triglyceride biosynthetic process|positive regulation of lipid storage|negative regulation of endopeptidase activity|response to magnesium ion|response to estradiol|response to progesterone|positive regulation of G-protein coupled receptor protein signaling pathway|positive regulation of angiogenesis|positive regulation of developmental growth|positive regulation of phagocytosis|response to glucocorticoid|positive regulation of ERK1 and ERK2 cascade|positive regulation of apoptotic cell clearance|",endopeptidase inhibitor activity|protein binding|lipid binding|C5L2 anaphylatoxin chemotactic receptor binding|cofactor binding|,175,998,2.94E+12,86.1%
A0A0F6QNP7,0.958652624,0.15975,0.333257836,-0.054333333,0.926134828,-0.098466055,,0.2005,,-0.007,-0.295,0.7405,A0A0F6QNP7,NotFound,A0A0F6QNP7_NotFound,A0A0F6QNP7,C3,1,1,26,1,A0A0F6QNP7,BOVIN,188719.1,10,2,2.2,325.65,7.96,,1661,Complement component 3,,,,1,1,5950000,0.6%
Q61838,0.751865777,-0.046916667,2.474131088,0.2095,0.565700928,0.606546436,-0.74,-0.1695,0.4545,-0.016,0.128,0.0615,Q61838,NotFound,Q61838_NotFound,Q61838,Pzp,1,1999,140,135,Q61838,MOUSE,167218.8,74.9,3,3.1,2582.97,2509.87,,1495,Pregnancy zone protein,extracellular region|extracellular space|,embryo implantation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|protein complex binding|,140,1999,9.92E+13,74.9%
F1MI18,0.542413314,1.02,5.269498721,-1.69625,0.297200905,-1.162192476,1.266,2.8095,,3.09,-0.969,-1.0965,F1MI18,NotFound,F1MI18_NotFound,F1MI18,,1,3,7,2,F1MI18|F1MJK3,BOVIN,167182.2,4.3,3,3.2,86.39,13.29,,1478,Uncharacterized protein,,,,2,3,128000000,1.3%
P06684,0.291629535,-0.217083333,11.1163474,0.4945,0.077333072,2.115357491,-0.685,-0.2705,-0.4375,0.164,-0.106,0.0325,P06684,Hc,P06684_Hc,P06684,C5,1,542,124,124,P06684|A0A0J9YUU3,MOUSE,190586.2,59.9,4,4.1,1830.66,1830.66,,1680,Complement C5,membrane attack complex|extracellular space|extracellular exosome|,"in utero embryonic development|inflammatory response|complement activation, alternative pathway|complement activation, classical pathway|positive regulation of vascular endothelial growth factor production|negative regulation of macrophage chemotaxis|negative regulation of endopeptidase activity|cytolysis|positive regulation of angiogenesis|positive regulation of chemokine secretion|activation of mitophagy in response to mitochondrial depolarization|",endopeptidase inhibitor activity|,124,542,1.08E+12,59.9%
A0A087WSN6,0.766944778,0.973083333,2.305690008,-0.417166667,0.588072674,-0.571817422,2.402,0.6875,0.4555,0.957,1.705,-0.3685,A0A087WSN6,Fn1,A0A087WSN6_Fn1,A0A087WSN6,Fn1,1,515,112,112,A0A087WSN6|B9EHT6|A0A087WR50|Q3UHL6|B7ZNJ1|P11276|A0A087WS56|Q4KL80,MOUSE,256658.4,53.6,5,5.1,1815.33,1815.33,,2296,Fibronectin,fibrinogen complex|proteinaceous extracellular matrix|basement membrane|basal lamina|extracellular space|endoplasmic reticulum-Golgi intermediate compartment|apical plasma membrane|extracellular matrix|extracellular exosome|blood microparticle|extracellular matrix|,"regulation of protein phosphorylation|cell-substrate junction assembly|cell adhesion|cell-matrix adhesion|calcium-independent cell-matrix adhesion|positive regulation of cell proliferation|positive regulation of gene expression|positive regulation of peptidase activity|peptide cross-linking|integrin activation|substrate adhesion-dependent cell spreading|endodermal cell differentiation|wound healing|positive regulation of axon extension|positive regulation of fibroblast proliferation|regulation of ERK1 and ERK2 cascade|positive regulation of substrate-dependent cell migration, cell attachment to substrate|negative regulation of transforming growth factor-beta secretion|",protease binding|integrin binding|protein binding|peptidase activator activity|,112,515,5.78E+11,53.6%
P28665,0.441723111,-0.145416667,7.497403512,0.4065,0.17793429,1.519376526,-0.768,-0.1275,-0.1505,0.163,0.015,-0.0045,P28665,Mug1,P28665_Mug1,P28665,Mug1,1,649,101,48,P28665,MOUSE,166721,61.1,6,6.1,1679.22,899.67,,1476,Murinoglobulin-1,extracellular space|,embryo implantation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,101,649,1.59E+12,61.1%
P28666,0.495148757,-0.138083333,6.090782508,0.351166667,0.245992434,1.281184081,-0.386,-0.5705,0.0155,-0.148,-0.073,0.3335,P28666,Mug2,P28666_Mug2,P28666,Mug2,1,14,57,12,P28666,MOUSE,163805.4,35.8,6,6.2,809.55,142.03,,1451,Murinoglobulin-2,extracellular space|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,12,14,1110000000,9.9%
A0A0N4SVU1,0.305538902,-0.3348,10.53829245,0.804083333,0.088342718,2.093983829,-1.318,-0.3165,,-0.12,-0.05,0.1305,A0A0N4SVU1,NotFound,A0A0N4SVU1_NotFound,A0A0N4SVU1,Gm7298,1,3,36,2,A0A0N4SVU1,MOUSE,166767.7,22.4,6,6.3,491.19,11.4,,1476,Predicted gene 7298,,,,2,3,20000000,1.2%
P01029,0.964951795,0.01275,0.253172927,-0.0265,0.943371404,-0.073961548,-0.323,-0.3325,0.7335,0.083,-0.196,0.1115,P01029,C4b,P01029_C4b,P01029,C4b,1,570,111,111,P01029|E1BH06|F1MVK1|P01030,MOUSE,194566.4,60.1,7,7.1,1604.77,1604.77,,1738,Complement C4-B,extracellular space|,"inflammatory response|complement activation, classical pathway|negative regulation of endopeptidase activity|innate immune response|",endopeptidase inhibitor activity|,111,570,9.43E+11,60.1%
Q921I1,0.279130421,-0.10875,11.60435464,0.663166667,0.069113762,2.195605284,-0.837,0.0265,-0.5105,0.349,0.332,-0.0125,Q921I1,Trf,Q921I1_Trf,Q921I1,Tf,1,894,86,83,Q921I1|E9Q035|Q29443|E9Q939,MOUSE,78890.5,82.2,8,8.1,1550.92,1502.05,,697,Serotransferrin,extracellular space|endosome|early endosome|late endosome|coated pit|basal plasma membrane|cell surface|membrane|cytoplasmic membrane-bounded vesicle|apical plasma membrane|vesicle coat|endocytic vesicle|vesicle|basal part of cell|perinuclear region of cytoplasm|recycling endosome|extracellular exosome|blood microparticle|dense body|,"iron ion transport|cellular iron ion homeostasis|actin filament organization|activation of JUN kinase activity|ferric iron transport|osteoclast differentiation|positive regulation of phosphorylation|positive regulation of bone resorption|positive regulation of transcription, DNA-templated|SMAD protein signal transduction|ERK1 and ERK2 cascade|positive regulation of cell motility|",protein binding|ferric iron binding|ferric iron transmembrane transporter activity|,86,894,1.5E+13,82.2%
Q2HJF0,0.468261811,-0.51075,6.76116856,1.485166667,0.210806086,1.399676908,0.125,-0.0915,-3.7935,0.504,0.224,-0.0325,Q2HJF0,NotFound,Q2HJF0_NotFound,Q2HJF0,LOC525947,1,13,7,4,Q2HJF0,BOVIN,70893.5,4.8,8,8.2,75.58,26.71,,622,Serotransferrin-like,,,,4,13,13400000000,1.4%
E9Q8I0,0.519628152,-0.14625,5.616021965,0.360166667,0.274408654,1.198887462,-0.606,-0.4655,0.0925,-0.142,-0.138,0.3815,E9Q8I0,Cfh,E9Q8I0_Cfh,E9Q8I0,Cfh,1,483,91,73,E9Q8I0|P06909|D6RGQ0|E9Q8H9|A0A0A6YVP8,MOUSE,145947.1,74.7,9,9.1,1540.08,1270.3,,1252,Complement factor H,extracellular exosome|blood microparticle|,regulation of complement activation|,complement component C3b binding|heparin binding|heparan sulfate proteoglycan binding|,91,483,1.8E+12,74.7%
E9Q8B5,0.675762207,0.062,3.262989965,0.257083333,0.471738154,0.775708214,0.03,-0.2145,,0.253,-0.239,0.4805,E9Q8B5,Gm4788,E9Q8B5_Gm4788,E9Q8B5,Gm4788,1,12,49,4,E9Q8B5|E9Q8B6,MOUSE,102688.5,61.7,9,9.2,789.77,69.54,,879,Predicted gene 4788,,,,4,12,12600000000,6.8%
E9PUM5,0.838778687,0.1554,1.37328047,-0.118083333,0.728906718,-0.365844994,0.325,0.1275,,0.226,-0.286,0.3845,E9PUM5,NotFound,E9PUM5_NotFound,E9PUM5,Gm4788,1,1,45,1,E9PUM5,MOUSE,94467.4,61.6,9,9.3,727.88,16.01,,808,Predicted gene 4788,,,,1,1,27800000,2.5%
Q4LDF6,0.445011431,-0.0566,7.365834602,0.461083333,0.183407267,1.534142339,-0.534,-0.1325,,0.383,0.016,-0.0155,Q4LDF6,Cfhr2,Q4LDF6_Cfhr2,Q4LDF6,Cfhr2,1,11,17,5,Q4LDF6|Q61405,MOUSE,39129.7,64.7,9,9.4,286.71,74.34,,332,Complement factor H-related 2,,,,5,11,774000000,21.0%
P20918,0.484255225,0.081916667,6.257785916,0.589166667,0.236712618,1.311101827,-0.608,0.5085,-0.5385,1.054,0.122,-0.0465,P20918,Plg,P20918_Plg,P20918,Plg,1,627,83,83,P20918,MOUSE,93544.9,85.2,10,10.1,1397.85,1397.85,,812,Plasminogen,extracellular region|extracellular space|cell surface|extrinsic component of plasma membrane|extrinsic component of external side of plasma membrane|plasma lipoprotein particle|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,blood coagulation|negative regulation of cell-substrate adhesion|negative regulation of angiogenesis|extracellular matrix disassembly|tissue regeneration|fibrinolysis|myoblast differentiation|muscle cell cellular homeostasis|tissue remodeling|proteolysis involved in cellular protein catabolic process|negative regulation of fibrinolysis|positive regulation of fibrinolysis|trophoblast giant cell differentiation|labyrinthine layer blood vessel development|mononuclear cell migration|,fibronectin binding|serine-type endopeptidase activity|receptor binding|protein domain specific binding|apolipoprotein binding|,83,627,4.89E+12,85.2%
E9PZD8,0.688993262,0.033416667,3.109763882,0.268833333,0.488678927,0.735948125,-0.805,0.0715,0.4305,0.274,0.239,-0.0095,E9PZD8,Cp,E9PZD8_Cp,E9PZD8,Cp,1,524,76,1,E9PZD8|Q61147,MOUSE,125007.5,59,11,11.1,1354.8,15.24,,1086,Ceruloplasmin,extracellular space|lysosomal membrane|extracellular exosome|blood microparticle|,copper ion transport|cellular iron ion homeostasis|oxidation-reduction process|,ferroxidase activity|copper ion binding|chaperone binding|,76,524,1.93E+12,59.0%
G3X8Q5,0.544926169,0.3082,5.186574249,-0.31425,0.302930202,-1.143073553,0.453,0.5405,,0.205,0.374,-0.0315,G3X8Q5,Cp,G3X8Q5_Cp,G3X8Q5,Cp,1,6,76,1,G3X8Q5|G3X9T8,MOUSE,124936.5,58.9,11,11.2,1352.92,13.36,,1085,Ceruloplasmin,extracellular space|lysosomal membrane|extracellular exosome|blood microparticle|,copper ion transport|cellular iron ion homeostasis|oxidation-reduction process|,ferroxidase activity|copper ion binding|chaperone binding|,1,6,1590000000,1.0%
B8JJN0,0.662037385,-0.006916667,3.412145484,0.226166667,0.455811682,0.795314629,-0.461,-0.0145,0.1155,0.446,-0.138,0.0105,B8JJN0,NotFound,B8JJN0_NotFound,B8JJN0,Gm20547,1,397,87,62,B8JJN0|B8JJM5|P04186|B8JJM6|F6XQ00|Q9WTX6,MOUSE,144605,52.1,12,12.1,1322.14,935.17,,1276,Predicted gene 20547,,proteolysis|,serine-type endopeptidase activity|,87,397,7.83E+11,52.1%
P21180,0.796996071,0.0494,1.970176072,0.16025,0.635305175,0.503388882,-0.074,-0.0195,,0.476,-0.224,0.0885,P21180,C2,P21180_C2,P21180,C2,1,25,35,10,P21180|P21180-2|B8JJN2|B8JJM9,MOUSE,85995.1,46.1,12,12.2,508.49,121.52,,760,Complement C2,extracellular exosome|,"proteolysis|complement activation|complement activation, classical pathway|response to nutrient|innate immune response|positive regulation of apoptotic cell clearance|",serine-type endopeptidase activity|metal ion binding|,10,25,24500000000,15.6%
P07724,0.971784399,-0.008583333,0.190275673,-0.019833333,0.957133314,-0.055962063,-0.442,-0.2615,0.7075,-0.031,-0.108,0.0835,P07724,Alb,P07724_Alb,P07724,Alb,1,665,71,69,P07724,MOUSE,70745.2,87.5,13,13.1,1232.45,1189.55,,608,Serum albumin,extracellular region|extracellular space|nucleus|cytoplasm|myelin sheath|protein complex|extracellular exosome|blood microparticle|,retina homeostasis|transport|cellular response to starvation|hemolysis by symbiont of host erythrocytes|negative regulation of apoptotic process|maintenance of mitochondrion location|,DNA binding|fatty acid binding|drug binding|toxic substance binding|pyridoxal phosphate binding|metal ion binding|chaperone binding|oxygen binding|,71,665,1.02E+13,87.5%
P02769,0.262291975,0.613916667,12.7631855,-0.870833333,0.052927508,-2.387206892,1.009,1.1065,1.0325,0.92,-0.298,-0.0865,P02769,NotFound,P02769_NotFound,P02769,ALB,1,10,8,6,P02769,BOVIN,71289,14.9,13,13.2,96.66,53.76,,607,Serum albumin,,,,6,10,1330000000,10.5%
O88783,0.933745622,0.186583333,0.529232158,-0.046166667,0.885272114,-0.150339916,-0.204,0.1345,0.6985,0.366,0.148,-0.0235,O88783,F5,O88783_F5,O88783,F5,1,219,78,78,O88783,MOUSE,248366.9,35.3,14,14.1,1111.77,1111.77,,2183,Coagulation factor V,extracellular space|membrane|platelet alpha granule|extracellular vesicle|,blood coagulation|blood circulation|platelet activation|,copper ion binding|,78,219,71500000000,35.3%
Q80YQ1,0.606693779,0.582916667,4.104009136,-0.888166667,0.388686168,-0.928607053,3.148,0.0385,-0.1055,0.795,0.325,-0.7035,Q80YQ1,Thbs1,Q80YQ1_Thbs1,Q80YQ1,Thbs1,1,315,65,65,Q80YQ1|P35441|Q03350,MOUSE,133681.8,53.1,15,15.1,995.93,995.93,,1171,Thrombospondin-1,fibrinogen complex|extracellular space|external side of plasma membrane|cell surface|secretory granule|extracellular matrix|platelet alpha granule|extracellular exosome|extracellular matrix|,activation of MAPK activity|negative regulation of endothelial cell proliferation|negative regulation of cell-matrix adhesion|sprouting angiogenesis|chronic inflammatory response|negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II|negative regulation of dendritic cell antigen processing and presentation|outflow tract morphogenesis|endocardial cushion development|growth plate cartilage development|inflammatory response|immune response|cell cycle arrest|cell adhesion|response to glucose|positive regulation of endothelial cell migration|negative regulation of endothelial cell migration|negative regulation of plasma membrane long-chain fatty acid transport|negative regulation of nitric oxide mediated signal transduction|negative regulation of cGMP-mediated signaling|negative regulation of plasminogen activation|positive regulation of fibroblast migration|positive regulation of cell-substrate adhesion|cell migration|negative regulation of angiogenesis|peptide cross-linking|positive regulation of blood coagulation|positive regulation of cell migration|positive regulation of transforming growth factor beta receptor signaling pathway|regulation of cGMP metabolic process|response to magnesium ion|negative regulation of interleukin-12 production|negative regulation of fibroblast growth factor receptor signaling pathway|positive regulation of phosphorylation|response to drug|positive regulation of tumor necrosis factor biosynthetic process|positive regulation of macrophage activation|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of blood vessel endothelial cell migration|negative regulation of blood vessel endothelial cell migration|engulfment of apoptotic cell|positive regulation of translation|positive regulation of angiogenesis|blood vessel morphogenesis|positive regulation of chemotaxis|response to calcium ion|positive regulation of protein kinase B signaling|negative regulation of fibrinolysis|cellular response to nitric oxide|positive regulation of extrinsic apoptotic signaling pathway via death domain receptors|positive regulation of endothelial cell apoptotic process|positive regulation of reactive oxygen species metabolic process|negative regulation of endothelial cell chemotaxis|,phosphatidylserine binding|fibronectin binding|integrin binding|calcium ion binding|heparin binding|fibroblast growth factor binding|low-density lipoprotein particle binding|laminin binding|extracellular matrix binding|fibrinogen binding|collagen V binding|,66,315,4.49E+11,53.1%
Q5SWU9,0.231440112,0.992416667,14.97637251,-1.573833333,0.031795287,-2.779269369,1.481,1.8945,1.9625,1.414,-0.732,-0.0655,Q5SWU9,Acaca,Q5SWU9_Acaca,Q5SWU9,Acaca,1,159,75,63,Q5SWU9|Q5SWU9-2,MOUSE,266849.4,32.9,16,16.1,928.09,775.79,,2345,Acetyl-CoA carboxylase 1,nucleolus|cytoplasm|mitochondrion|cytosol|actin cytoskeleton|extracellular exosome|,tissue homeostasis|acetyl-CoA metabolic process|lipid metabolic process|fatty acid biosynthetic process|multicellular organismal protein metabolic process|protein homotetramerization|lipid homeostasis|cellular response to prostaglandin E stimulus|malonyl-CoA biosynthetic process|,acetyl-CoA carboxylase activity|biotin carboxylase activity|protein binding|ATP binding|metal ion binding|,75,159,27400000000,32.9%
E9Q4Z2,0.352083154,1.006916667,9.381752263,-1.198833333,0.115298796,-1.838372564,1.107,1.8355,1.8765,1.765,-0.694,0.1515,E9Q4Z2,Acacb,E9Q4Z2_Acacb,E9Q4Z2,Acacb,1,7,18,6,E9Q4Z2,MOUSE,278141.4,8.4,16,16.2,214.71,62.41,,2448,Acetyl-CoA carboxylase 2,nucleus|mitochondrion|endomembrane system|membrane|,acetyl-CoA metabolic process|fatty acid biosynthetic process|positive regulation of lipid storage|negative regulation of fatty acid oxidation|protein homotetramerization|positive regulation of heart growth|malonyl-CoA biosynthetic process|,acetyl-CoA carboxylase activity|biotin carboxylase activity|ATP binding|metal ion binding|,6,7,56400000,2.8%
Q9DBD0,0.729414454,0.076083333,2.709253301,0.202833333,0.535888787,0.655210495,-0.492,-0.0215,0.4375,0.363,0.191,-0.0215,Q9DBD0,1300017J02Rik,Q9DBD0_1300017J02Rik,Q9DBD0,Ica,1,300,58,58,Q9DBD0|D3YY36,MOUSE,78761.2,66.7,17,17.1,909.6,909.6,,700,Inhibitor of carbonic anhydrase,extracellular space|,negative regulation of catalytic activity|,enzyme inhibitor activity|iron ion binding|,58,300,6.58E+11,66.7%
A6X935,0.543702736,-0.06925,5.242164679,0.258833333,0.299077356,1.133180479,-0.179,-0.2195,-0.1975,0.303,-0.136,0.0135,A6X935,Itih4,A6X935_Itih4,A6X935,Itih4,1,258,55,1,A6X935|A6X935-2|E9Q5L2,MOUSE,104828.7,63.8,18,18.1,891.16,24.1,,942,"Inter alpha-trypsin inhibitor, heavy chain 4",cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,acute-phase response|negative regulation of endopeptidase activity|hyaluronan metabolic process|response to cytokine|,serine-type endopeptidase inhibitor activity|protein binding|calcium ion binding|hyaluronic acid binding|,55,258,5.43E+11,63.8%
E9PVD2,0.890608531,0.0472,0.917875541,0.08325,0.809491785,0.253660377,0.365,-0.3705,,0.171,0.082,-0.0115,E9PVD2,Itih4,E9PVD2_Itih4,E9PVD2,Itih4,1,9,55,1,E9PVD2|A0A0R4J1N1,MOUSE,104757.7,63.7,18,18.2,891.16,24.1,,941,"Inter alpha-trypsin inhibitor, heavy chain 4",cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|calcium ion binding|hyaluronic acid binding|,1,9,5170000000,2.2%
P21614,0.416821309,-0.05775,8.058423697,0.543166667,0.15637151,1.612724019,-0.914,0.0445,-0.1185,0.496,0.183,-0.0375,P21614,Gc,P21614_Gc,P21614,Gc,1,214,49,49,P21614,MOUSE,55196.9,89.2,19,19.1,856.16,856.16,,476,Vitamin D-binding protein,extracellular space|cytosol|axon|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|,female pregnancy|lactation|response to nutrient levels|response to estradiol|vitamin D metabolic process|vitamin transport|,actin binding|vitamin transporter activity|calcidiol binding|,49,214,2.73E+11,89.2%
P06728,0.26133403,-0.192916667,13.03437814,0.562166667,0.049723557,2.432327474,-0.713,-0.3245,-0.3845,0.028,0.216,0.0205,P06728,Apoa4,P06728_Apoa4,P06728,Apoa4,1,584,50,50,P06728,MOUSE,45028.2,85.8,20,20.1,852.77,852.77,,395,Apolipoprotein A-IV,extracellular region|extracellular space|cytosol|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|cell surface|,innate immune response in mucosa|cholesterol biosynthetic process|lipid transport|response to lipid hydroperoxide|leukocyte cell-cell adhesion|cholesterol metabolic process|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|removal of superoxide radicals|triglyceride catabolic process|regulation of intestinal cholesterol absorption|neuron projection regeneration|regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|negative regulation of plasma lipoprotein particle oxidation|response to stilbenoid|lipoprotein metabolic process|cholesterol homeostasis|hydrogen peroxide catabolic process|reverse cholesterol transport|multicellular organismal lipid catabolic process|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|positive regulation of lipoprotein lipase activity|lipid homeostasis|protein-lipid complex assembly|triglyceride homeostasis|,copper ion binding|lipid binding|cholesterol binding|antioxidant activity|cholesterol transporter activity|phosphatidylcholine binding|protein homodimerization activity|phosphatidylcholine-sterol O-acyltransferase activator activity|,50,584,1.3E+13,85.8%
Q91ZX7,0.785251911,0.001583333,2.087184117,-0.130166667,0.61841724,-0.524109647,-0.109,-0.1015,0.4105,-0.12,-0.093,0.0225,Q91ZX7,Lrp1,Q91ZX7_Lrp1,Q91ZX7,Lrp1,1,119,70,70,A0A0R4J0I9|Q91ZX7|Q3U5J2|Q9JI18|A2API5|E9Q202|D3Z5M3,MOUSE,523675.1,17.3,21,21.1,824.21,824.21,,4545,Prolow-density lipoprotein receptor-related protein 1,nucleolus|cytoplasm|lysosomal membrane|integral component of plasma membrane|coated pit|focal adhesion|membrane|receptor complex|perinuclear region of cytoplasm|,receptor-mediated endocytosis|cholesterol metabolic process|positive regulation of cholesterol efflux|negative regulation of smooth muscle cell migration|negative regulation of Wnt signaling pathway|positive regulation of lipid transport|regulation of cholesterol transport|regulation of phospholipase A2 activity|regulation of actin cytoskeleton organization|aorta morphogenesis|apoptotic cell clearance|beta-amyloid clearance|negative regulation of platelet-derived growth factor receptor-beta signaling pathway|,calcium ion binding|protein binding|protein complex binding|apolipoprotein binding|poly(A) RNA binding|,70,119,12600000000,17.3%
P32261,0.478310449,0.109583333,6.586189393,0.411166667,0.21947298,1.365911236,-0.522,0.0935,0.1405,0.468,0.512,-0.0345,P32261,Serpinc1,P32261_Serpinc1,P32261,Serpinc1,1,355,56,56,P32261|A0A0A6YX49|A0A0A6YXS8,MOUSE,52516.1,68.3,22,22.1,820.13,820.13,,465,Antithrombin-III,extracellular space|extracellular exosome|blood microparticle|,"response to nutrient|blood coagulation|negative regulation of endopeptidase activity|negative regulation of inflammatory response|regulation of blood coagulation, intrinsic pathway|",protease binding|serine-type endopeptidase inhibitor activity|heparin binding|,56,355,1.45E+12,68.3%
P19221,0.468261811,-0.11275,6.772830668,0.4445,0.210240767,1.397571538,-0.784,-0.0225,-0.1985,0.48,-0.202,0.0505,P19221,F2,P19221_F2,P19221,F2,1,271,48,48,P19221|H7BX99,MOUSE,71693.8,58.5,23,23.1,791.39,791.39,,618,Prothrombin,extracellular space|cytosol|extracellular matrix|extracellular exosome|blood microparticle|,positive regulation of protein phosphorylation|proteolysis|acute-phase response|cell surface receptor signaling pathway|positive regulation of cell proliferation|regulation of cell shape|response to wounding|regulation of gene expression|positive regulation of phosphatidylinositol 3-kinase signaling|response to inactivity|platelet activation|positive regulation of blood coagulation|positive regulation of cell growth|positive regulation of collagen biosynthetic process|fibrinolysis|negative regulation of proteolysis|negative regulation of astrocyte differentiation|positive regulation of release of sequestered calcium ion into cytosol|cytosolic calcium ion homeostasis|thrombin receptor signaling pathway|cellular response to mechanical stimulus|positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway|positive regulation of reactive oxygen species metabolic process|,serine-type endopeptidase activity|receptor binding|calcium ion binding|protein binding|peptidase activity|thrombospondin receptor activity|,48,271,8.78E+11,58.5%
Q61702,0.348496369,-0.04175,9.46880038,0.5145,0.113010803,1.845136647,-0.672,-0.0075,-0.2175,0.446,0.218,-0.0175,Q61702,Itih1,Q61702_Itih1,Q61702,Itih1,1,202,47,2,Q61702,MOUSE,101521.5,50.8,24,24.1,783.71,31.65,,907,Inter-alpha-trypsin inhibitor heavy chain H1,extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,47,202,2.96E+11,50.8%
F8WJ05,0.921035669,0.3485,0.621825888,-0.081333333,0.866597459,-0.17853159,,0.4095,,0.558,0.521,-0.0945,F8WJ05,Itih1,F8WJ05_Itih1,F8WJ05,Itih1,1,4,46,2,F8WJ05,MOUSE,102089.1,50.9,24,24.2,766.16,20.16,,911,Inter-alpha-trypsin inhibitor heavy chain H1,extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,2,4,862000000,3.4%
Q8K0E8,0.729414454,0.81475,2.704127967,-0.857166667,0.53652159,-0.655118842,3.654,-0.1055,0.1815,-0.186,2.391,-1.0465,Q8K0E8,Fgb,Q8K0E8_Fgb,Q8K0E8,Fgb,1,180,49,49,Q8K0E8|F1MAV0|P02676,MOUSE,55436.4,79.6,25,25.1,763.62,763.62,,481,Fibrinogen beta chain,fibrinogen complex|extracellular space|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|extracellular vesicle|,"cell-matrix adhesion|signal transduction|plasminogen activation|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|induction of bacterial agglutination|cellular protein complex assembly|cellular response to leptin stimulus|innate immune response|positive regulation of vasoconstriction|positive regulation of exocytosis|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to interleukin-1|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of endothelial cell apoptotic process|","structural molecule activity|protein binding, bridging|chaperone binding|receptor binding|cell adhesion molecule binding|",49,180,1.99E+11,79.6%
Q60841,0.843133985,0.024083333,1.342812356,0.1295,0.734038374,0.35545544,-0.43,-0.3485,0.6565,-0.184,0.175,0.2755,Q60841,Reln,Q60841_Reln,Q60841,Reln,1,128,56,56,Q60841|Q60841-2|Q60841-3,MOUSE,394505.8,18.1,26,26.1,762.82,762.82,,3461,Reelin,proteinaceous extracellular matrix|extracellular space|cytoplasm|dendrite|,"cell morphogenesis involved in differentiation|neuron migration|proteolysis|cell adhesion|axon guidance|central nervous system development|brain development|learning|long-term memory|associative learning|glial cell differentiation|regulation of gene expression|positive regulation of neuron projection development|positive regulation of phosphatidylinositol 3-kinase signaling|dendrite development|cell migration|peptidyl-tyrosine phosphorylation|spinal cord patterning|ventral spinal cord development|hippocampus development|cerebral cortex tangential migration|layer formation in cerebral cortex|cerebral cortex development|forebrain development|positive regulation of TOR signaling|positive regulation of CREB transcription factor activity|protein localization to synapse|reelin-mediated signaling pathway|positive regulation of protein kinase activity|response to pain|positive regulation of peptidyl-tyrosine phosphorylation|regulation of behavior|regulation of synaptic transmission|positive regulation of small GTPase mediated signal transduction|positive regulation of synaptic transmission, glutamatergic|long-term synaptic potentiation|positive regulation of dendritic spine morphogenesis|positive regulation of protein tyrosine kinase activity|positive regulation of synapse maturation|postsynaptic density assembly|N-methyl-D-aspartate receptor clustering|postsynaptic density protein 95 clustering|receptor localization to synapse|lateral motor column neuron migration|positive regulation of long-term synaptic potentiation|positive regulation of lateral motor column neuron migration|regulation of N-methyl-D-aspartate selective glutamate receptor activity|positive regulation of excitatory postsynaptic membrane potential|positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity|",protein binding|serine-type peptidase activity|metal ion binding|lipoprotein particle receptor binding|very-low-density lipoprotein particle receptor binding|,56,128,12400000000,18.1%
P26262,0.675762207,0.084083333,3.266850911,0.328833333,0.471318958,0.767301406,-0.84,-0.1195,0.7185,0.395,0.361,-0.0105,P26262,Klkb1,P26262_Klkb1,P26262,Klkb1,1,236,48,48,P26262|P04187,MOUSE,73492.3,68.1,27,27.1,758.27,758.27,,638,Plasma kallikrein,extracellular space|extracellular exosome|,inflammatory response|blood coagulation|plasminogen activation|fibrinolysis|positive regulation of fibrinolysis|liver regeneration|,serine-type endopeptidase activity|,48,236,5.06E+11,68.1%
A0A0R4J0I1,0.644486691,-0.089583333,3.620479291,0.2035,0.434462274,0.835510623,-0.469,-0.1665,0.0615,-0.109,0.113,0.0325,A0A0R4J0I1,Serpina3k,A0A0R4J0I1_Serpina3k,A0A0R4J0I1,Serpina3k,1,879,37,25,A0A0R4J0I1|P07759,MOUSE,46900.1,68.1,28,28.1,736.58,493.38,,418,MCG1051009,,,,37,879,1.01E+13,68.1%
G3X8T9,0.994215419,0.0928,0.053034545,-0.00575,0.987862604,-0.015958101,-0.235,0.4275,,0.457,-0.138,-0.0475,G3X8T9,Serpina3n,G3X8T9_Serpina3n,G3X8T9,Serpina3n,1,15,29,2,G3X8T9,MOUSE,46936.4,52.6,28,28.2,454.71,40.82,,418,"Serine (Or cysteine) peptidase inhibitor, clade A, member 3N, isoform CRA_a",extracellular region|extracellular space|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,2,15,18400000000,6.6%
Q91WP6,0.441723111,0.1342,7.497938779,-0.535916667,0.177912361,-1.557467867,0.043,0.8685,,-0.01,-0.062,-0.1685,Q91WP6,NotFound,Q91WP6_NotFound,Q91WP6,Serpina3n,1,1,29,1,Q91WP6|Q5I2A0|F2Z405,MOUSE,46888.3,53.1,28,28.3,442.7,13.01,,418,Serine protease inhibitor A3N,extracellular region|extracellular space|extracellular exosome|blood microparticle|,acute-phase response|negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,1,1,11300000,4.3%
Q03734,0.569153145,0.39825,4.696363615,-0.3235,0.339127992,-1.035554205,0.771,0.0625,0.8465,0.487,0.276,-0.0535,Q03734,Serpina3m,Q03734_Serpina3m,Q03734,Serpina3m,1,55,27,15,Q03734,MOUSE,47234.5,55.5,28,28.4,474.73,217.4,,418,Serine protease inhibitor A3M,extracellular space|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,15,55,43200000000,38.7%
P29621,0.277507267,-0.3218,11.97963935,0.637416667,0.063392235,2.35293543,-0.834,-0.5745,,-0.104,-0.185,0.0885,P29621,Serpina3c,P29621_Serpina3c,P29621,Serpina3c,1,9,13,7,P29621|Q80X76,MOUSE,46936.4,29,28,28.5,207.7,102.65,,417,Serine protease inhibitor A3C,extracellular space|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,7,9,367000000,17.7%
D3Z450,0.149102391,0.497625,18.60508468,-1.485833333,0.013787691,-4.072815063,1.612,,,0.272,0.018,0.0885,D3Z450,Serpina3i,D3Z450_Serpina3i,D3Z450,Serpina3i,1,3,5,2,D3Z450,MOUSE,45964.2,10.5,28,28.6,45.25,10.68,,408,"Serine (or cysteine) peptidase inhibitor, clade A, member 3I",extracellular space|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,serine-type endopeptidase inhibitor activity|,2,3,802000000,6.6%
P42703,0.334785174,0.139416667,9.97517336,0.7175,0.100573292,1.928183849,-0.423,-0.3215,0.0865,-0.203,0.75,0.9475,P42703,Lifr,P42703_Lifr,P42703,Lifr,1,224,49,3,P42703,MOUSE,123883.7,40.1,29,29.1,733.51,44.72,,1092,Leukemia inhibitory factor receptor,plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,positive regulation of cell proliferation|negative regulation of muscle cell apoptotic process|response to organic cyclic compound|cytokine-mediated signaling pathway|organ regeneration|response to cytokine|oncostatin-M-mediated signaling pathway|neuron projection morphogenesis|leukemia inhibitory factor signaling pathway|ciliary neurotrophic factor-mediated signaling pathway|,leukemia inhibitory factor receptor activity|ciliary neurotrophic factor receptor binding|protein binding|growth factor binding|cytokine binding|protein heterodimerization activity|ciliary neurotrophic factor receptor activity|oncostatin-M receptor activity|,49,224,5.49E+11,40.1%
P42703-2,0.23713653,0.96375,14.33442891,-1.3545,0.036860151,-2.66334239,0.827,1.5915,2.5045,-0.24,0.259,0.8405,P42703,Lifr,P42703-2_Lifr,P42703-2,Lifr,1,15,47,2,P42703-2,MOUSE,82255.7,58.4,29,29.2,702.25,28,,1092,Isoform 2 of Leukemia inhibitory factor receptor,plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,positive regulation of cell proliferation|negative regulation of muscle cell apoptotic process|response to organic cyclic compound|cytokine-mediated signaling pathway|organ regeneration|response to cytokine|oncostatin-M-mediated signaling pathway|neuron projection morphogenesis|leukemia inhibitory factor signaling pathway|ciliary neurotrophic factor-mediated signaling pathway|,leukemia inhibitory factor receptor activity|ciliary neurotrophic factor receptor binding|protein binding|growth factor binding|cytokine binding|protein heterodimerization activity|ciliary neurotrophic factor receptor activity|oncostatin-M receptor activity|,2,15,15000000000,3.7%
E9PV24,0.688095193,0.629916667,3.125220828,-0.948166667,0.486942765,-0.740186696,3.643,0.0425,-0.3735,-0.419,1.903,-1.0165,E9PV24,Fga,E9PV24_Fga,E9PV24,Fga,1,215,54,54,E9PV24|E9PV24-2|P02672|A5PJE3,MOUSE,88169.4,58.6,30,30.1,731.96,731.96,,789,Fibrinogen alpha chain,fibrinogen complex|extracellular space|rough endoplasmic reticulum|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|extracellular vesicle|,"protein complex assembly|acute-phase response|cell-matrix adhesion|signal transduction|blood coagulation|plasminogen activation|response to estradiol|response to genistein|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|induction of bacterial agglutination|response to morphine|cellular protein complex assembly|innate immune response|positive regulation of vasoconstriction|positive regulation of exocytosis|response to cycloheximide|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to interleukin-6|cellular response to organic cyclic compound|blood coagulation, common pathway|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|liver regeneration|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|cellular response to granulocyte colony-stimulating factor|negative regulation of endothelial cell apoptotic process|","structural molecule activity|protein binding, bridging|receptor binding|cell adhesion molecule binding|",54,215,4.2E+11,58.6%
Q00623,0.339465731,-0.160583333,9.714336589,0.6015,0.106798792,1.885416349,-1.045,-0.1575,-0.1815,0.32,0.079,0.0215,Q00623,Apoa1,Q00623_Apoa1,Q00623,Apoa1,1,1007,43,43,Q00623,MOUSE,30615,81.4,31,31.1,699.18,699.18,,264,Apolipoprotein A-I,extracellular region|extracellular space|nucleus|cytosol|cell surface|endocytic vesicle|cytoplasmic vesicle|very-low-density lipoprotein particle|high-density lipoprotein particle|discoidal high-density lipoprotein particle|spherical high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|extracellular vesicle|,regulation of protein phosphorylation|endothelial cell proliferation|negative regulation of cytokine secretion involved in immune response|phospholipid metabolic process|phosphatidylcholine biosynthetic process|cholesterol biosynthetic process|G-protein coupled receptor signaling pathway|integrin-mediated signaling pathway|response to nutrient|cholesterol metabolic process|glucocorticoid metabolic process|negative regulation of tumor necrosis factor-mediated signaling pathway|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|negative regulation of very-low-density lipoprotein particle remodeling|protein oxidation|peptidyl-methionine modification|triglyceride catabolic process|lipid storage|regulation of intestinal cholesterol absorption|cholesterol transport|adrenal gland development|organ regeneration|regulation of Cdc42 protein signal transduction|cholesterol efflux|phospholipid efflux|negative regulation of heterotypic cell-cell adhesion|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|positive regulation of Rho protein signal transduction|lipoprotein biosynthetic process|response to drug|cholesterol homeostasis|blood vessel endothelial cell migration|response to estrogen|reverse cholesterol transport|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|negative regulation of interleukin-1 beta secretion|negative regulation of inflammatory response|protein stabilization|negative chemotaxis|positive regulation of lipoprotein lipase activity|vitamin transport|positive regulation of hydrolase activity|negative regulation of hydrolase activity|positive regulation of stress fiber assembly|phospholipid homeostasis|negative regulation of lipase activity|negative regulation of cell adhesion molecule production|negative regulation of response to cytokine stimulus|triglyceride homeostasis|cholesterol import|positive regulation of substrate adhesion-dependent cell spreading|protein localization|axon regeneration|,beta-amyloid binding|lipid transporter activity|protein binding|phospholipid binding|phospholipid transporter activity|high-density lipoprotein particle binding|lipid binding|cholesterol binding|cholesterol transporter activity|enzyme binding|phosphatidylcholine binding|apolipoprotein receptor binding|apolipoprotein A-I receptor binding|identical protein binding|chemorepellent activity|lipase inhibitor activity|phosphatidylcholine-sterol O-acyltransferase activator activity|high-density lipoprotein particle receptor binding|lipoprotein particle binding|cholesterol transporter activity|,43,1007,1.75E+14,81.4%
A0A0R4J038,0.366645294,-0.06275,9.039486152,0.479166667,0.124753111,1.774622296,-0.67,-0.0205,-0.2165,0.375,0.156,-0.0005,A0A0R4J038,Kng1,A0A0R4J038_Kng1,A0A0R4J038,Kng1,1,281,40,7,A0A0R4J038|D3YTY9|O08677|O08677-3|B99909|P01044|P01045,MOUSE,74183.9,50.8,32,32.1,683.55,128.96,,661,Kininogen-1,,,,40,281,2.28E+12,50.8%
O08677-2,0.282360967,0.207083333,11.28864438,-0.731833333,0.07432511,-2.143668124,0.272,1.1895,0.2575,0.067,-0.433,-0.1105,O08677,Kng1,O08677-2_Kng1,O08677-2,Kng1,1,20,32,3,O08677-2,MOUSE,48981.4,64.3,32,32.2,552.37,30.95,,661,Isoform LMW of Kininogen-1,extracellular space|cytosol|extracellular exosome|blood microparticle|,inflammatory response|blood coagulation|negative regulation of endopeptidase activity|vasodilation|,cysteine-type endopeptidase inhibitor activity|receptor binding|,3,20,25700000000,6.2%
Q6S9I3,0.958652624,0.116916667,0.334103017,0.0345,0.92595461,0.096782127,-0.554,0.4195,0.4335,0.456,-0.019,-0.0345,Q6S9I3,Kng2,Q6S9I3_Kng2,Q6S9I3,Kng2,1,80,31,24,Q6S9I3|Q6S9I2|E0CYI5,MOUSE,72355.1,37.1,32,32.3,476.85,396.59,,644,HMW kininogen-II,extracellular space|cytosol|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|,cysteine-type endopeptidase inhibitor activity|receptor binding|,24,80,48500000000,35.2%
Q61129,0.594740834,-0.031916667,4.311819688,0.256833333,0.37052544,0.96534816,-0.516,-0.1775,0.2125,0.127,0.137,0.0255,Q61129,Cfi,Q61129_Cfi,Q61129,Cfi,1,207,41,41,Q61129,MOUSE,69541.5,59.7,33,33.1,676.69,676.69,,603,Complement factor I,extracellular space|membrane|extracellular exosome|,"proteolysis|receptor-mediated endocytosis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|scavenger receptor activity|metal ion binding|,41,207,4.32E+11,59.7%
P20029,0.301834969,-0.19475,10.66384778,0.555166667,0.085825279,2.041091263,-0.581,-0.0795,-0.7565,0.276,-0.002,-0.0255,P20029,Hspa5,P20029_Hspa5,P20029,Hspa5,1,160,43,40,P20029,MOUSE,72534.8,53.8,34,34.1,621.73,591.44,,655,78 kDa glucose-regulated protein,extracellular region|nucleus|mitochondrion|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|smooth endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|plasma membrane|focal adhesion|cell surface|membrane|integral component of endoplasmic reticulum membrane|midbody|endoplasmic reticulum chaperone complex|melanosome|myelin sheath|extracellular exosome|COP9 signalosome|,ER overload response|activation of signaling protein activity involved in unfolded protein response|cerebellum structural organization|cerebellar Purkinje cell layer development|substantia nigra development|positive regulation of cell migration|negative regulation of transforming growth factor beta receptor signaling pathway|positive regulation of protein ubiquitination|response to endoplasmic reticulum stress|maintenance of protein localization in endoplasmic reticulum|positive regulation of embryonic development|cellular response to glucose starvation|negative regulation of apoptotic process|proteolysis involved in cellular protein catabolic process|cellular response to antibiotic|cellular response to interleukin-4|toxin transport|,glycoprotein binding|protein binding|ATP binding|ATPase activity|enzyme binding|protein domain specific binding|ubiquitin protein ligase binding|ribosome binding|unfolded protein binding|misfolded protein binding|,43,160,1.33E+11,53.8%
P63017,0.812519126,-0.0604,1.690702378,0.123083333,0.677531923,0.440160928,-0.035,-0.2335,,0.179,-0.227,0.0145,P63017,Hspa8,P63017_Hspa8,P63017,Hspa8,1,27,21,18,P63017|Q504P4|P17156|P16627|P17879|Q61696,MOUSE,71098,31.5,34,34.2,247.93,217.64,,646,Heat shock cognate 71 kDa protein,Prp19 complex|extracellular space|intracellular|nucleus|spliceosomal complex|nucleolus|cytosol|plasma membrane|focal adhesion|membrane|ribonucleoprotein complex|melanosome|myelin sheath|extracellular exosome|blood microparticle|ubiquitin ligase complex|,"transcription, DNA-templated|mRNA processing|protein folding|RNA splicing|protein refolding|negative regulation of transcription, DNA-templated|ATP metabolic process|positive regulation of mRNA splicing, via spliceosome|chaperone mediated protein folding requiring cofactor|regulation of cell cycle|clathrin coat disassembly|negative regulation of fibril organization|","G-protein coupled receptor binding|protein binding|ATP binding|ATPase activity|enzyme binding|MHC class II protein complex binding|heat shock protein binding|ubiquitin protein ligase binding|ATPase activity, coupled|poly(A) RNA binding|unfolded protein binding|C3HC4-type RING finger domain binding|",18,27,662000000,28.7%
Q07968,0.612008945,-0.010583333,3.959747419,0.284833333,0.401814179,0.899862714,-0.603,-0.2345,0.3785,0.069,0.32,0.0065,Q07968,F13b,Q07968_F13b,Q07968,F13b,1,203,40,40,Q07968,MOUSE,78476.1,53.9,35,35.1,618.42,618.42,,669,Coagulation factor XIII B chain,extracellular region|,blood coagulation|,,40,203,1.91E+11,53.9%
P01872,0.419442327,0.085583333,8.009900757,0.575833333,0.158128417,1.604677083,-0.271,-0.1575,-0.1785,-0.002,1.106,0.0165,P01872,NotFound,P01872_NotFound,P01872,Ighm,1,234,37,37,P01872|P01872-2|P04221|P03988,MOUSE,50655.7,56.1,36,36.1,613.87,613.87,,454,Ig mu chain C region,"extracellular space|plasma membrane|external side of plasma membrane|integral component of membrane|B cell receptor complex|immunoglobulin complex, circulating|perinuclear region of cytoplasm|",activation of MAPK activity|humoral immune response mediated by circulating immunoglobulin|immunoglobulin mediated immune response|antigen processing and presentation|positive regulation of B cell proliferation|positive regulation of MAPK cascade|early endosome to late endosome transport|positive regulation of endocytosis|positive regulation of peptidyl-tyrosine phosphorylation|defense response to Gram-negative bacterium|B cell receptor signaling pathway|positive regulation of B cell activation|,antigen binding|transmembrane signaling receptor activity|protein binding|immunoglobulin receptor binding|identical protein binding|,37,234,1E+12,56.1%
E9Q6D8,0.231846274,-0.141416667,14.70412853,0.703833333,0.033852219,2.713335634,-0.548,-0.5775,-0.3545,0.017,0.586,0.0285,E9Q6D8,NotFound,E9Q6D8_NotFound,E9Q6D8,C6,1,108,37,37,E9Q6D8|Q91X70,MOUSE,108049.4,48,37,37.1,596.87,596.87,,931,Complement component 6,membrane attack complex|extracellular exosome|,in utero embryonic development|immune response|,,37,108,35900000000,48.0%
Q8K182,0.966340291,0.075916667,0.239837712,-0.0355,0.946272521,-0.070216463,-0.47,-0.4445,1.1955,0.033,-0.199,0.3405,Q8K182,C8a,Q8K182_C8a,Q8K182,C8a,1,191,38,38,Q8K182|A2A997|A2A998,MOUSE,67733.7,52.4,38,38.1,590.63,590.63,,587,Complement component C8 alpha chain,membrane attack complex|extracellular exosome|blood microparticle|,"complement activation|complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",complement binding|protein complex binding|,38,191,2.86E+11,52.4%
P08113,0.339465731,-0.230583333,9.690490882,0.462166667,0.107386803,1.881505602,-0.725,-0.4915,-0.1685,-0.11,0.086,0.0255,P08113,Hsp90b1,P08113_Hsp90b1,P08113,Hsp90b1,1,98,45,45,P08113|P11499|E9PX27,MOUSE,92759.4,46.8,39,39.1,583.98,583.98,,802,Endoplasmin,extracellular region|nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum membrane|cytosol|plasma membrane|focal adhesion|membrane|midbody|extracellular matrix|endoplasmic reticulum chaperone complex|melanosome|perinuclear region of cytoplasm|extracellular exosome|,"response to hypoxia|protein folding|ER-associated ubiquitin-dependent protein catabolic process|retrograde protein transport, ER to cytosol|actin rod assembly|negative regulation of apoptotic process|regulation of phosphoprotein phosphatase activity|cellular response to ATP|",RNA binding|protein binding|ATP binding|protein phosphatase binding|virion binding|low-density lipoprotein particle receptor binding|unfolded protein binding|,45,98,24400000000,46.8%
Q8BH35,0.246733887,-0.298083333,13.65996915,0.681833333,0.043052967,2.536919166,-0.516,-0.4185,-0.9825,0.068,-0.198,0.2585,Q8BH35,C8b,Q8BH35_C8b,Q8BH35,C8b,1,143,36,36,Q8BH35|Q8BH35-2,MOUSE,68053.9,56.7,40,40.1,578.32,578.32,,589,Complement component C8 beta chain,membrane attack complex|extracellular space|extracellular exosome|extracellular vesicle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",protein complex binding|,36,143,1.05E+11,56.7%
D3YXF5,0.424393882,-0.18275,7.922282618,0.4645,0.161351029,1.590134855,-0.894,-0.2795,-0.0715,-0.069,0.213,0.0045,D3YXF5,C7,D3YXF5_C7,D3YXF5,C7,1,105,38,38,D3YXF5,MOUSE,96587.9,43.6,41,41.1,573.04,573.04,,845,Complement component 7,membrane attack complex|extracellular exosome|,immune response|,,38,105,28400000000,43.6%
E9PUU8,0.549465437,-0.132916667,5.00062501,0.2835,0.31618226,1.090244939,-0.114,-0.0415,-0.6685,-0.046,0.082,-0.0095,E9PUU8,NotFound,E9PUU8_NotFound,E9PUU8,Pkhd1l1,1,75,45,45,E9PUU8|Q80ZA4|F8WH29|Q80ZA4-2,MOUSE,469488.1,13.2,42,42.1,572.37,572.37,,4249,Fibrocystin-L,cilium|,,protein binding|,45,75,5600000000,13.2%
Q91WP0,0.482514848,-0.105583333,6.369884838,0.3375,0.230680836,1.329047896,-0.607,-0.2535,0.0375,0.124,0.055,0.0105,Q91WP0,Masp2,Q91WP0_Masp2,Q91WP0,Masp2,1,186,41,41,Q91WP0|Q91WP0-2,MOUSE,76998.6,55.3,43,43.1,571.06,571.06,,685,Mannan-binding lectin serine protease 2,extracellular exosome|,"complement activation, lectin pathway|proteolysis|complement activation, classical pathway|",complement component C4b binding|serine-type endopeptidase activity|calcium ion binding|protein binding|peptidase activity|calcium-dependent protein binding|,42,186,2.59E+11,55.3%
P06683,0.684540349,-0.064083333,3.15753012,0.221833333,0.483333601,0.745411705,-0.522,-0.3495,0.3465,-0.023,0.147,0.0165,P06683,C9,P06683_C9,P06683,C9,1,169,36,36,A0A0R4J032|P06683,MOUSE,63256.4,60.5,44,44.1,570.53,570.53,,548,Complement component C9,membrane attack complex|cytoplasm|plasma membrane|extracellular exosome|blood microparticle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",,36,169,3.58E+11,60.5%
G3X977,0.441723111,-0.042083333,7.598163253,0.4465,0.173853595,1.536195505,-0.67,0.0605,-0.1865,0.458,0.112,-0.0265,G3X977,Itih2,G3X977_Itih2,G3X977,Itih2,1,202,36,36,G3X977|Q61703,MOUSE,106758.8,36.7,45,45.1,565.79,565.79,,950,"Inter-alpha trypsin inhibitor, heavy chain 2",extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,36,202,7.12E+11,36.7%
P09103,0.23713653,-0.403416667,14.10757683,1.0445,0.0388367,2.617039094,-0.776,-0.2815,-1.7195,0.208,0.157,-0.0085,P09103,P4hb,P09103_P4hb,P09103,P4hb,1,104,40,40,P09103|P05307|A6H7J6|E9Q8G8,MOUSE,57456.8,64.8,46,46.1,562.52,562.52,,509,Protein disulfide-isomerase,endoplasmic reticulum|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|focal adhesion|external side of plasma membrane|procollagen-proline 4-dioxygenase complex|endoplasmic reticulum chaperone complex|melanosome|extracellular exosome|,protein folding|peptidyl-proline hydroxylation to 4-hydroxy-L-proline|response to endoplasmic reticulum stress|cell redox homeostasis|cellular response to hypoxia|regulation of oxidative stress-induced intrinsic apoptotic signaling pathway|,protein disulfide isomerase activity|integrin binding|protein binding|enzyme binding|poly(A) RNA binding|protein heterodimerization activity|procollagen-proline 4-dioxygenase activity|peptidyl-proline 4-dioxygenase activity|,40,104,43200000000,64.8%
Q91X72,0.890608531,0.342583333,0.917752162,-0.104833333,0.809514783,-0.251642013,1.03,-0.1905,0.3455,0.108,0.843,-0.0805,Q91X72,Hpx,Q91X72_Hpx,Q91X72,Hpx,1,152,36,36,Q91X72,MOUSE,52058.5,53,47,47.1,561.9,561.9,,460,Hemopexin,extracellular space|extracellular exosome|blood microparticle|,positive regulation of immunoglobulin production|positive regulation of humoral immune response mediated by circulating immunoglobulin|transport|hemoglobin metabolic process|heme metabolic process|positive regulation of tyrosine phosphorylation of Stat1 protein|regulation of protein metabolic process|positive regulation of response to interferon-gamma|positive regulation of interferon-gamma-mediated signaling pathway|,heme binding|metal ion binding|,36,152,1.57E+11,53.0%
E9Q6C2,0.785251911,0.18425,2.090205892,-0.320166667,0.617987102,-0.525451524,-0.643,-0.0195,1.6955,0.206,-0.178,0.0445,E9Q6C2,C1s1,E9Q6C2_C1s1,E9Q6C2,C1s1,1,120,33,2,E9Q6C2,MOUSE,79039.3,51.4,48,48.1,540.31,17.67,,694,"Complement component 1, s subcomponent 1",extracellular exosome|blood microparticle|,proteolysis|complement activation|,serine-type endopeptidase activity|calcium ion binding|identical protein binding|,33,120,42500000000,51.4%
Q8CG14,0.852172906,-0.034583333,1.288236327,0.134166667,0.74332094,0.342575324,-0.309,0.6975,-0.6935,0.036,-0.027,0.0885,Q8CG14,C1s1,Q8CG14_C1s1,Q8CG14,C1sa,1,9,32,2,Q8CG14,MOUSE,78396.6,51.7,48,48.2,529.32,27.07,,688,Complement C1s-A subcomponent,extracellular exosome|blood microparticle|,"proteolysis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|calcium ion binding|identical protein binding|,2,9,1480000000,3.9%
Q00897,0.339733714,-0.05875,9.622396286,0.447166667,0.109083828,1.870336781,-0.492,-0.0645,-0.2905,0.334,0.159,0.0015,Q00897,Serpina1d,Q00897_Serpina1d,Q00897,Serpina1d,1,231,31,9,Q00897,MOUSE,46168.7,61,49,49.1,536.97,165.58,,413,Alpha-1-antitrypsin 1-4,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|identical protein binding|,31,231,2.1E+12,61.0%
P22599,0.363669711,-0.249416667,9.198968569,0.747833333,0.120255,1.802881044,-1.404,0.1165,-0.5825,0.282,0.133,-0.0415,P22599,Serpina1b,P22599_Serpina1b,P22599,Serpina1b,1,40,29,8,P22599,MOUSE,46145,60.5,49,49.2,519.2,151.37,,413,Alpha-1-antitrypsin 1-2,extracellular region|extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,in utero embryonic development|protein N-linked glycosylation|acute-phase response|negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|protein binding|identical protein binding|,8,40,1.55E+11,21.7%
A0A0R4J0X5,0.830935436,0.17325,1.487887457,-0.094833333,0.709923013,-0.389529969,-0.079,0.3285,0.4125,0.255,0.101,0.0215,A0A0R4J0X5,Serpina1c,A0A0R4J0X5_Serpina1c,A0A0R4J0X5,Serpina1c,1,112,28,9,A0A0R4J0X5,MOUSE,46024.7,59.3,49,49.3,489.12,168.56,,413,Alpha-1-antitrypsin 1-3,,,,9,112,1.97E+12,27.8%
Q00898,0.579053364,0.48125,4.483950144,-0.330166667,0.356127069,-0.996933366,0.73,0.5325,0.6765,-0.315,0.541,0.7225,Q00898,Serpina1e,Q00898_Serpina1e,Q00898,Serpina1e,1,14,22,4,Q00898,MOUSE,46118.8,34.3,49,49.4,336.31,54.33,,413,Alpha-1-antitrypsin 1-5,extracellular space|endoplasmic reticulum|Golgi apparatus|extracellular exosome|,negative regulation of endopeptidase activity|response to cytokine|response to peptide hormone|,glycoprotein binding|protease binding|serine-type endopeptidase inhibitor activity|identical protein binding|,4,14,1630000000,9.9%
Q06890,0.459548232,0.407916667,7.04490954,-0.580833333,0.197473601,-1.444732115,1.455,0.2135,0.4265,0.51,-0.046,-0.1115,Q06890,Clu,Q06890_Clu,Q06890,Clu,1,189,33,33,Q06890,MOUSE,52282.3,48.4,50,50.1,520.7,520.7,,448,Clusterin,extracellular space|intracellular|nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|cytosol|extracellular matrix|mitochondrial membrane|spherical high-density lipoprotein particle|chromaffin granule|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|neurofibrillary tangle|apical dendrite|extracellular matrix|,cell morphogenesis|microglial cell activation|response to virus|protein import|central nervous system myelin maintenance|positive regulation of proteasomal ubiquitin-dependent protein catabolic process|negative regulation of protein homooligomerization|positive regulation of tumor necrosis factor production|positive regulation of apoptotic process|positive regulation of nitric oxide biosynthetic process|protein stabilization|positive regulation of NF-kappaB transcription factor activity|chaperone-mediated protein complex assembly|response to misfolded protein|chaperone-mediated protein folding|microglial cell proliferation|intrinsic apoptotic signaling pathway|regulation of beta-amyloid clearance|regulation of neuron death|positive regulation of neuron death|positive regulation of beta-amyloid formation|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage|negative regulation of beta-amyloid formation|regulation of neuronal signal transduction|positive regulation of tau-protein kinase activity|positive regulation of neurofibrillary tangle assembly|positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process|positive regulation of intrinsic apoptotic signaling pathway|,protein binding|ubiquitin protein ligase binding|misfolded protein binding|ATPase activity|,33,189,6.29E+11,48.4%
P98064,0.491960375,-0.15025,6.160934931,0.304833333,0.242050791,1.293248122,-0.524,-0.3245,-0.0595,-0.12,0.085,0.0415,P98064,Masp1,P98064_Masp1,P98064,Masp1,1,118,37,19,P98064,MOUSE,81621.4,52.2,51,51.1,520.33,239.78,,704,Mannan-binding lectin serine protease 1,extracellular space|,"complement activation, lectin pathway|proteolysis|",serine-type endopeptidase activity|calcium ion binding|protein homodimerization activity|calcium-dependent protein binding|,37,118,52500000000,52.2%
P98064-2,0.298450194,-0.37575,10.79149985,0.837833333,0.083339332,2.064802349,-1.231,-1.2155,0.0625,-0.12,0.139,0.1105,P98064,Masp1,P98064-2_Masp1,P98064-2,Masp1,1,21,26,8,P98064-2,MOUSE,83984.9,37.6,51,51.2,387.86,107.31,,704,Isoform 2 of Mannan-binding lectin serine protease 1,extracellular space|,"complement activation, lectin pathway|proteolysis|",serine-type endopeptidase activity|calcium ion binding|protein homodimerization activity|calcium-dependent protein binding|,8,21,4900000000,10.2%
E9QPD7,0.149102391,1.117583333,18.65909862,-1.756833333,0.013617273,-3.434354132,2.11,1.7285,2.1495,1.29,-0.645,0.0725,E9QPD7,Pcx,E9QPD7_Pcx,E9QPD7,Pcx,1,83,38,38,E9QPD7|G5E8R3|Q05920,MOUSE,130571.1,33.5,52,52.1,505.71,505.71,,1179,Pyruvate carboxylase,mitochondrion|,pyruvate metabolic process|gluconeogenesis|negative regulation of gene expression|viral RNA genome packaging|positive regulation by host of viral release from host cell|,DNA binding|biotin carboxylase activity|pyruvate carboxylase activity|ATP binding|biotin binding|metal ion binding|,38,83,13700000000,33.5%
Q8CG16,0.91535326,-0.016583333,0.740907965,0.076833333,0.843158463,0.206315093,-0.56,-0.2675,0.6625,0.234,-0.189,0.0205,Q8CG16,C1ra,Q8CG16_C1ra,Q8CG16,C1ra,1,95,33,30,Q8CG16|Q8CFG9,MOUSE,81555.2,54.8,53,53.1,492.93,454.53,,707,Complement C1r-A subcomponent,extracellular exosome|blood microparticle|,"proteolysis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|calcium ion binding|,33,95,42600000000,54.8%
Q3UZ09,0.762754224,0.060083333,2.355941031,-0.145833333,0.581307461,-0.581692252,0.379,-0.1625,0.1825,0.132,-0.18,0.0095,Q3UZ09,C1rl,Q3UZ09_C1rl,Q3UZ09,C1rl,1,24,18,15,Q3UZ09,MOUSE,54233.1,35.2,53,53.2,202.7,164.3,,482,Complement C1r subcomponent-like protein,extracellular space|extracellular exosome|,"proteolysis|complement activation, classical pathway|innate immune response|",serine-type endopeptidase activity|,15,24,1830000000,30.9%
Q19LI2,0.812519126,0.71325,1.693366334,0.361166667,0.677116453,0.437264553,0.138,0.1725,1.2875,-0.12,2.71,0.0915,Q19LI2,A1bg,Q19LI2_A1bg,Q19LI2,A1bg,1,177,30,30,Q19LI2,MOUSE,57237.7,66,54,54.1,481.43,481.43,,512,Alpha-1B-glycoprotein,extracellular region|extracellular space|extracellular exosome|blood microparticle|,,,30,177,8.23E+11,66.0%
Q01339,0.507014901,0.037916667,5.891264899,0.375833333,0.25755709,1.246742405,-0.632,0.0725,0.1095,0.446,0.254,-0.0225,Q01339,Apoh,Q01339_Apoh,Q01339,Apoh,1,190,31,31,Q01339,MOUSE,39930.4,70.7,55,55.1,479.13,479.13,,345,Beta-2-glycoprotein 1,extracellular space|cell surface|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|extracellular matrix|,"negative regulation of endothelial cell proliferation|triglyceride metabolic process|blood coagulation, intrinsic pathway|negative regulation of endothelial cell migration|negative regulation of angiogenesis|regulation of blood coagulation|negative regulation of blood coagulation|organ regeneration|plasminogen activation|negative regulation of myeloid cell apoptotic process|negative regulation of smooth muscle cell apoptotic process|positive regulation of lipoprotein lipase activity|regulation of fibrinolysis|negative regulation of fibrinolysis|",glycoprotein binding|phospholipid binding|heparin binding|lipid binding|identical protein binding|lipoprotein lipase activator activity|,31,190,1.25E+12,70.7%
O89020,0.441723111,-0.117416667,7.414910877,0.365833333,0.181346389,1.505587208,-0.57,-0.3005,-0.0305,0.176,0.025,-0.0045,O89020,Afm,O89020_Afm,O89020,Afm,1,133,34,34,O89020|O89020-3|O89020-2,MOUSE,71317.7,49.8,56,56.1,477.33,477.33,,608,Afamin,extracellular space|extracellular exosome|blood microparticle|,vitamin transport|,vitamin E binding|,34,133,96000000000,49.8%
J3QQ16,0.606693779,0.045083333,4.050787579,-0.205833333,0.393478713,-0.916915922,0.121,0.0225,0.3005,-0.2,-0.07,0.0965,J3QQ16,Col6a3,J3QQ16_Col6a3,J3QQ16,Col6a3,1,60,43,43,J3QQ16|E9PWQ3|A0A087WS16,MOUSE,290173.5,16.9,57,57.1,477.11,477.11,,2677,"Collagen, type VI, alpha 3",proteinaceous extracellular matrix|collagen trimer|extracellular space|extracellular matrix|sarcolemma|extracellular exosome|extracellular vesicle|extracellular matrix|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,43,60,1830000000,16.9%
B2RPV6,0.936111423,0.165583333,0.500005285,0.063833333,0.891249854,0.142494606,1.063,-0.1965,-0.4655,0.227,0.448,-0.0825,B2RPV6,Mmrn1,B2RPV6_Mmrn1,B2RPV6,Mmrn1,1,71,34,34,B2RPV6|G3UVV6|A0A0N4SVL8,MOUSE,137358.3,29,58,58.1,467.98,467.98,,1210,Multimerin-1,extracellular region|,,,34,71,7570000000,29.0%
P13020,0.881241581,0.06025,0.99387243,-0.086833333,0.795449763,-0.270652765,-0.394,0.0395,0.6655,-0.002,0.072,-0.0195,P13020,Gsn,P13020_Gsn,P13020,Gsn,1,84,33,33,P13020|P13020-2,MOUSE,86339.4,37.4,59,59.1,465.9,465.9,,780,Gelsolin,ruffle|podosome|extracellular region|extracellular space|cytoplasm|cytosol|plasma membrane|focal adhesion|sarcoplasm|lamellipodium|actin cap|cortical actin cytoskeleton|myelin sheath|perinuclear region of cytoplasm|extracellular exosome|blood microparticle|nucleus|focal adhesion|cortical actin cytoskeleton|,"phagocytosis, engulfment|aging|positive regulation of gene expression|oligodendrocyte development|striated muscle atrophy|vesicle-mediated transport|actin filament polymerization|protein destabilization|tissue regeneration|sequestering of actin monomers|actin nucleation|response to ethanol|negative regulation of viral entry into host cell|phosphatidylinositol-mediated signaling|actin filament severing|barbed-end actin filament capping|positive regulation of actin nucleation|response to folic acid|actin filament capping|cilium morphogenesis|cellular response to cadmium ion|regulation of podosome assembly|actin filament reorganization|renal protein absorption|hepatocyte apoptotic process|positive regulation of keratinocyte apoptotic process|regulation of wound healing, spreading of epidermal cells|regulation of establishment of T cell polarity|regulation of plasma membrane raft polarization|regulation of receptor clustering|positive regulation of protein processing in phagocytic vesicle|amyloid fibril formation|positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway|",actin binding|calcium ion binding|protein binding|protein domain specific binding|myosin II binding|,33,84,73100000000,37.4%
Q61508,0.654180643,0.492916667,3.52487714,0.4585,0.444132226,0.818530011,0.79,0.2595,-0.2585,0.423,1.821,-0.0775,Q61508,Ecm1,Q61508_Ecm1,Q61508,Ecm1,1,97,31,31,Q61508|F8WI14|Q61508-2,MOUSE,64485.6,55.4,60,60.1,443.12,443.12,,559,Extracellular matrix protein 1,proteinaceous extracellular matrix|extracellular space|extracellular matrix|extracellular exosome|,ossification|angiogenesis|positive regulation of endothelial cell proliferation|negative regulation of cytokine-mediated signaling pathway|regulation of type 2 immune response|regulation of transcription from RNA polymerase II promoter|inflammatory response|signal transduction|negative regulation of peptidase activity|negative regulation of bone mineralization|biomineral tissue development|positive regulation of I-kappaB kinase/NF-kappaB signaling|positive regulation of angiogenesis|regulation of T cell migration|,protease binding|signal transducer activity|interleukin-2 receptor binding|protein C-terminus binding|enzyme binding|laminin binding|,31,97,52500000000,55.4%
O08601-2,0.87051184,0.108916667,1.07903507,-0.0755,0.780003395,-0.291746865,-0.136,0.2265,0.3495,0.34,-0.096,-0.0305,O08601,Mttp,O08601-2_Mttp,O08601-2,Mttp,1,55,30,30,O08601-2|O08601,MOUSE,101433.7,32.5,61,61.1,425.25,425.25,,894,Isoform 2 of Microsomal triglyceride transfer protein large subunit,endoplasmic reticulum|rough endoplasmic reticulum|Golgi apparatus|basolateral plasma membrane|brush border membrane|microvillus membrane|membrane-bounded vesicle|receptor complex|,protein lipidation|lipid metabolic process|triglyceride metabolic process|lipid transport|circadian rhythm|cholesterol metabolic process|lipoprotein metabolic process|cholesterol homeostasis|lipoprotein transport|response to calcium ion|,lipid transporter activity|protein binding|lipid binding|apolipoprotein binding|protein heterodimerization activity|,30,55,8170000000,32.5%
Q8BPB5,0.365800695,-0.117583333,9.090473518,0.416833333,0.123297039,1.783004388,-0.559,-0.1175,-0.3015,0.034,0.22,0.0185,Q8BPB5,Efemp1,Q8BPB5_Efemp1,Q8BPB5,Efemp1,1,96,26,26,Q8BPB5,MOUSE,57234.1,59.2,62,62.1,414.01,414.01,,493,EGF-containing fibulin-like extracellular matrix protein 1,proteinaceous extracellular matrix|extracellular space|extracellular exosome|extracellular matrix|,"regulation of transcription, DNA-templated|epidermal growth factor receptor signaling pathway|peptidyl-tyrosine phosphorylation|negative regulation of chondrocyte differentiation|",epidermal growth factor-activated receptor activity|epidermal growth factor receptor binding|calcium ion binding|growth factor activity|,26,96,69000000000,59.2%
Q9ESB3,0.43656,-0.259416667,7.745133497,1.1745,0.168068626,1.565913186,-0.439,0.2995,-2.4005,1.079,-0.038,-0.0575,Q9ESB3,Hrg,Q9ESB3_Hrg,Q9ESB3,Hrg,1,133,25,25,A0A0R4J039|Q9ESB3,MOUSE,60131.6,38.8,63,63.1,395.06,395.06,,525,Histidine-rich glycoprotein,extracellular region|vesicle|endolysosome|phagolysosome membrane|,angiogenesis|positive regulation of immune response to tumor cell|chemotaxis|negative regulation of cell adhesion|negative regulation of cell proliferation|regulation of gene expression|regulation of platelet activation|negative regulation of lamellipodium assembly|negative regulation of endopeptidase activity|response to organic cyclic compound|heme transport|negative regulation of angiogenesis|platelet activation|regulation of blood coagulation|negative regulation of cell growth|regulation of actin cytoskeleton organization|negative regulation of cell adhesion mediated by integrin|regulation of transcription from RNA polymerase II promoter in response to iron|fibrinolysis|positive regulation of apoptotic process|regulation of protein complex assembly|negative regulation of blood vessel endothelial cell migration|regulation of peptidyl-tyrosine phosphorylation|defense response to fungus|positive regulation of focal adhesion assembly|negative regulation of fibrinolysis|heme export|negative regulation of vascular endothelial growth factor signaling pathway|positive regulation of blood vessel remodeling|negative regulation of endothelial cell chemotaxis|,serine-type endopeptidase inhibitor activity|cysteine-type endopeptidase inhibitor activity|receptor binding|protein binding|heparin binding|zinc ion binding|immunoglobulin binding|heme binding|heparan sulfate proteoglycan binding|metal ion binding|,25,133,2.62E+11,38.8%
Q5XQN5,0.231846274,0.415416667,14.6936444,-2.3025,0.033934039,-2.730277495,1.411,3.3055,-0.0165,-0.756,-1.242,-0.2095,Q5XQN5,NotFound,Q5XQN5_NotFound,Q5XQN5,KRT5,1,93,35,20,Q5XQN5|Q922U2|P07744|P11679|Q99M73|Q9DCV7|P19246,BOVIN,63107,39.7,64,64.1,386.39,218.8,,601,"Keratin, type II cytoskeletal 5",,,,36,93,28300000000,39.7%
P50446,0.296807957,0.407416667,10.89506753,-2.7945,0.081375421,-2.089124625,1.791,4.5855,-0.9625,-0.765,-1.545,-0.6595,P50446,Krt6a,P50446_Krt6a,P50446,Krt6a,1,5,19,3,P50446|Q9Z331|Q3UV11|E9Q1Z0|Q6IFZ8,MOUSE,59676.4,24.5,64,64.2,215.09,28.73,,553,"Keratin, type II cytoskeletal 6A",keratin filament|extracellular exosome|,morphogenesis of an epithelium|Wnt signaling pathway|keratinization|wound healing|intermediate filament organization|,structural molecule activity|,3,5,1920000000,4.8%
Q3TTY5,0.282360967,0.291916667,11.30122177,-1.880166667,0.074110172,-2.15660322,1.312,2.9845,-0.6005,-0.504,-0.899,-0.5415,Q3TTY5,Krt2,Q3TTY5_Krt2,Q3TTY5,Krt2,1,32,14,8,Q3TTY5,MOUSE,71377.9,10.8,64,64.3,159.48,92.3,,707,"Keratin, type II cytoskeletal 2 epidermal",extracellular space|nucleus|Golgi apparatus|membrane|keratin filament|extracellular exosome|,keratinization|keratinocyte activation|keratinocyte proliferation|keratinocyte migration|,structural molecule activity|,8,32,11600000000,7.6%
Q8VED5,0.23713653,0.43025,14.25753912,-2.708166667,0.037518554,-2.655138669,1.64,3.9275,-0.2145,-0.8,-1.454,-0.5175,Q8VED5,Krt79,Q8VED5_Krt79,Q8VED5,Krt79,1,4,10,1,Q8VED5,MOUSE,57836.6,10.3,64,64.4,114.36,19.23,,531,"Keratin, type II cytoskeletal 79",keratin filament|extracellular exosome|,,structural molecule activity|enzyme binding|,1,4,1600000000,2.2%
Q3UV17,0.312629895,0.483416667,10.39092738,-2.507166667,0.091391806,-2.005527908,2.752,3.5975,-1.1385,-0.796,-1.48,-0.0345,Q3UV17,Krt76,Q3UV17_Krt76,Q3UV17,Krt76,1,5,9,1,Q3UV17,MOUSE,63357,9.7,64,64.5,99.89,15.67,,594,"Keratin, type II cytoskeletal 2 oral",nucleus|keratin filament|extracellular exosome|,epidermis development|sebaceous gland development|,structural molecule activity|,1,5,8760000000,1.5%
Q6IFZ6,0.339465731,0.60375,9.647483993,-1.1385,0.108455505,-1.88239456,1.941,1.4515,0.1265,0.927,-0.4,-0.4235,Q6IFZ6,Krt77,Q6IFZ6_Krt77,Q6IFZ6,Krt77,1,4,9,4,Q6IFZ6|Q6IFZ9|Q9R0H5,MOUSE,61414.7,9.9,64,64.6,97.36,33.18,,572,"Keratin, type II cytoskeletal 1b",cytoskeleton|keratin filament|extracellular exosome|,,structural molecule activity|,4,4,858000000,3.6%
Q6NXH9,0.551970504,0.068083333,4.935570788,-1.567833333,0.320954095,-1.080980165,2.219,2.8835,-2.5465,-0.945,-1.337,0.1345,Q6NXH9,Krt73,Q6NXH9_Krt73,Q6NXH9,Krt73,1,3,8,2,Q6NXH9,MOUSE,59538,8.9,64,64.7,76.69,9.67,,539,"Keratin, type II cytoskeletal 73",nucleus|keratin filament|extracellular exosome|,activation of mitophagy in response to mitochondrial depolarization|,structural molecule activity|,2,3,1920000000,1.8%
P04104,0.549465437,0.086916667,5.01685693,-1.726833333,0.315002722,-1.095577825,1.896,3.5835,-2.6285,-0.728,-1.672,0.0705,P04104,Krt1,P04104_Krt1,P04104,Krt1,1,11,7,3,P04104,MOUSE,66118.3,7.2,64,64.8,89.24,44.88,,637,"Keratin, type II cytoskeletal 1",extracellular space|nucleus|plasma membrane|membrane|extracellular matrix|keratin filament|extracellular exosome|blood microparticle|,"complement activation, lectin pathway|retina homeostasis|negative regulation of inflammatory response|establishment of skin barrier|",structural molecule activity|carbohydrate binding|,3,11,27900000000,3.7%
Q6IME9,0.218611325,0.2472,15.54213477,-1.38675,0.027911715,-3.03260984,0.466,1.6925,,-0.204,-0.631,-0.0875,Q6IME9,Krt72,Q6IME9_Krt72,Q6IME9,Krt72,1,1,5,1,Q6IME9,MOUSE,57262.8,7.3,64,64.9,48.01,5.45,,520,"Keratin, type II cytoskeletal 72",keratin filament|extracellular exosome|,,structural molecule activity|,1,1,884000000,2.3%
Q61247,0.251180411,-0.139416667,13.39683714,0.779833333,0.04574212,2.492835348,-0.727,-0.0075,-0.8535,0.38,0.39,-0.0185,Q61247,Serpinf2,Q61247_Serpinf2,Q61247,Serpinf2,1,138,24,24,Q61247,MOUSE,55199.1,41.1,65,65.1,378.44,378.44,,491,Alpha-2-antiplasmin,fibrinogen complex|extracellular space|cell surface|extracellular exosome|blood microparticle|,regulation of blood vessel size by renin-angiotensin|acute-phase response|response to organic substance|negative regulation of plasminogen activation|negative regulation of endopeptidase activity|collagen fibril organization|positive regulation of collagen biosynthetic process|positive regulation of cell differentiation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of JNK cascade|blood vessel morphogenesis|positive regulation of smooth muscle cell proliferation|positive regulation of stress fiber assembly|negative regulation of fibrinolysis|positive regulation of ERK1 and ERK2 cascade|positive regulation of transforming growth factor beta production|,protease binding|serine-type endopeptidase inhibitor activity|protein homodimerization activity|,24,138,5.31E+11,41.1%
Q01279,0.836083189,0.09575,1.432477728,0.134833333,0.719038636,0.376591749,-0.437,-0.0995,0.6215,-0.199,0.457,0.2315,Q01279,Egfr,Q01279_Egfr,Q01279,Egfr,1,82,28,28,Q01279|Q9WVF5,MOUSE,138274.2,23.1,66,66.1,375.09,375.09,,1210,Epidermal growth factor receptor,"Golgi membrane|intracellular|nucleus|cytoplasm|endosome|endoplasmic reticulum membrane|plasma membrane|focal adhesion|cell surface|endosome membrane|membrane|integral component of membrane|basolateral plasma membrane|endocytic vesicle|early endosome membrane|nuclear membrane|receptor complex|membrane raft|perinuclear region of cytoplasm|multivesicular body, internal vesicle lumen|",cell morphogenesis|embryonic placenta development|positive regulation of protein phosphorylation|hair follicle development|signal transduction|cell surface receptor signaling pathway|epidermal growth factor receptor signaling pathway|salivary gland morphogenesis|learning or memory|cell proliferation|positive regulation of cell proliferation|epidermis development|single organismal cell-cell adhesion|peptidyl-tyrosine phosphorylation|cerebral cortex cell migration|signal transduction by protein phosphorylation|positive regulation of cell migration|positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle|positive regulation of catenin import into nucleus|regulation of cell proliferation|negative regulation of protein catabolic process|positive regulation of phosphorylation|negative regulation of apoptotic process|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of DNA repair|positive regulation of DNA replication|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|positive regulation of fibroblast proliferation|digestive tract morphogenesis|positive regulation of epithelial cell proliferation|regulation of peptidyl-tyrosine phosphorylation|regulation of nitric-oxide synthase activity|positive regulation of protein kinase B signaling|morphogenesis of an epithelial fold|response to UV-A|positive regulation of ERK1 and ERK2 cascade|cellular response to amino acid stimulus|cellular response to epidermal growth factor stimulus|cellular response to estradiol stimulus|,chromatin binding|protein tyrosine kinase activity|receptor signaling protein tyrosine kinase activity|signal transducer activity|transmembrane signaling receptor activity|epidermal growth factor-activated receptor activity|protein binding|ATP binding|kinase activity|enzyme binding|protein phosphatase binding|ubiquitin protein ligase binding|identical protein binding|protein heterodimerization activity|actin filament binding|nitric-oxide synthase regulator activity|,28,82,29400000000,23.1%
P97290,0.91535326,0.149583333,0.70355304,-0.1215,0.850441992,-0.19679387,-0.674,-0.3165,1.6215,0.264,0.004,-0.0015,P97290,Serping1,P97290_Serping1,P97290,Serping1,1,124,26,26,P97290|A2ATR8,MOUSE,55868.8,38,67,67.1,369.92,369.92,,504,Plasma protease C1 inhibitor,extracellular space|extracellular exosome|blood microparticle|,"negative regulation of complement activation, lectin pathway|complement activation, classical pathway|aging|blood coagulation|negative regulation of endopeptidase activity|fibrinolysis|innate immune response|",serine-type endopeptidase inhibitor activity|,26,124,1.3E+11,38.0%
Q9QWK4,0.881241581,0.29575,0.998197315,-0.1005,0.794658016,-0.271730559,0.27,-0.0525,0.8205,-0.093,0.818,0.0115,Q9QWK4,Cd5l,Q9QWK4_Cd5l,Q9QWK4,Cd5l,1,108,25,25,Q9QWK4,MOUSE,40345.4,60.5,68,68.1,367.63,367.63,,352,CD5 antigen-like,membrane|extracellular exosome|blood microparticle|,receptor-mediated endocytosis|apoptotic process|,scavenger receptor activity|,25,108,2.75E+11,60.5%
Q9JKR6,0.482514848,-0.204583333,6.390791299,0.308166667,0.229573032,1.332619301,-0.405,-0.1225,-0.5485,-0.159,-0.018,0.0255,Q9JKR6,Hyou1,Q9JKR6_Hyou1,Q9JKR6,Hyou1,1,62,26,26,Q9JKR6|E0CYZ2,MOUSE,111407.3,29.6,69,69.1,366.11,366.11,,999,Hypoxia up-regulated protein 1,extracellular region|endoplasmic reticulum lumen|focal adhesion|membrane|endoplasmic reticulum chaperone complex|extracellular exosome|,response to ischemia|response to endoplasmic reticulum stress|negative regulation of apoptotic process|cellular response to hypoxia|negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway|negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway|,ATP binding|,26,62,8240000000,29.6%
Q8R121,0.729414454,0.026416667,2.722256461,0.166833333,0.534286688,0.657873019,-0.352,-0.0735,0.2545,0.11,0.23,-0.0105,Q8R121,Serpina10,Q8R121_Serpina10,Q8R121,Serpina10,1,76,24,24,Q8R121|Q8R121-2,MOUSE,51910.6,47.7,70,70.1,363.6,363.6,,448,Protein Z-dependent protease inhibitor,extracellular space|extracellular exosome|,blood coagulation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|heparin binding|,24,76,46500000000,47.7%
Q8VCU2,0.953312195,-0.012083333,0.384647125,0.0665,0.915240622,0.110962339,-0.852,-0.6095,1.3255,0.176,-0.138,0.0255,Q8VCU2,Gpld1,Q8VCU2_Gpld1,Q8VCU2,Gpld1,1,86,26,26,Q8VCU2|O70362,MOUSE,94192.4,29,71,71.1,358.4,358.4,,842,Glycosylphosphatidylinositol specific phospholipase D1,proteinaceous extracellular matrix|extracellular space|intracellular|cytoplasm|lysosomal membrane|intracellular membrane-bounded organelle|extracellular exosome|,cell migration involved in sprouting angiogenesis|complement receptor mediated signaling pathway|GPI anchor release|negative regulation of cell proliferation|insulin receptor signaling pathway|response to glucose|positive regulation of endothelial cell migration|cellular response to insulin stimulus|cellular response to drug|positive regulation of apoptotic process|positive regulation of cytolysis|positive regulation of membrane protein ectodomain proteolysis|cellular response to calcium ion|cellular response to cholesterol|cellular response to triglyceride|cellular response to pH|regulation of cellular response to insulin stimulus|,glycosylphosphatidylinositol phospholipase D activity|phospholipase D activity|protein binding|,26,86,35800000000,29.0%
Q8BH61,0.859645788,0.967583333,1.186922027,0.283833333,0.760865334,0.318448726,1.498,1.1145,-0.1355,0.609,2.942,-0.2225,Q8BH61,F13a1,Q8BH61_F13a1,Q8BH61,F13a1,1,74,26,26,Q8BH61,MOUSE,83719.2,32.9,72,72.1,353.61,353.61,,732,Coagulation factor XIII A chain,cytoplasm|blood microparticle|,blood coagulation|peptide cross-linking|,protein-glutamine gamma-glutamyltransferase activity|metal ion binding|,26,74,15500000000,32.9%
P49182,0.298450194,-0.210416667,10.78664419,0.679166667,0.083432562,2.061235148,-0.154,-0.3785,-1.1175,0.407,-0.025,0.0055,P49182,Serpind1,P49182_Serpind1,P49182,Serpind1,1,102,24,24,P49182,MOUSE,54781,43.7,73,73.1,341.25,341.25,,478,Heparin cofactor 2,extracellular space|extracellular exosome|,blood coagulation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|heparin binding|,24,102,1.05E+11,43.7%
P14211,0.133471994,-0.45175,19.55180839,0.9405,0.011087131,3.575601962,-1.156,-0.5245,-1.0855,0.119,-0.076,0.0125,P14211,Calr,P14211_Calr,P14211,Calr,1,72,24,24,P14211,MOUSE,48164.8,52.8,74,74.1,338.1,338.1,,416,Calreticulin,acrosomal vesicle|extracellular region|extracellular space|nucleus|cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|Golgi apparatus|cytosol|polysome|focal adhesion|external side of plasma membrane|membrane|extracellular matrix|sarcoplasmic reticulum lumen|MHC class I peptide loading complex|phagocytic vesicle|perinuclear region of cytoplasm|extracellular exosome|,"negative regulation of transcription from RNA polymerase II promoter|peptide antigen assembly with MHC class I protein complex|protein export from nucleus|cell cycle arrest|spermatogenesis|positive regulation of cell proliferation|positive regulation of gene expression|negative regulation of translation|cortical actin cytoskeleton organization|response to estradiol|negative regulation of intracellular steroid hormone receptor signaling pathway|response to testosterone|protein localization to nucleus|regulation of meiotic nuclear division|response to drug|negative regulation of neuron differentiation|positive regulation of DNA replication|positive regulation of cell cycle|negative regulation of transcription, DNA-templated|negative regulation of retinoic acid receptor signaling pathway|positive regulation of phagocytosis|protein stabilization|cardiac muscle cell differentiation|chaperone-mediated protein folding|cellular response to lithium ion|cellular response to organic substance|cellular senescence|positive regulation of substrate adhesion-dependent cell spreading|positive regulation of dendritic cell chemotaxis|",glycoprotein binding|mRNA binding|integrin binding|iron ion binding|calcium ion binding|protein binding|carbohydrate binding|ubiquitin protein ligase binding|peptide binding|hormone binding|poly(A) RNA binding|androgen receptor binding|unfolded protein binding|,24,72,47500000000,52.8%
Q3UER8,0.705987939,1.05525,2.94564538,-0.8175,0.507499317,-0.7042508,3.341,0.1915,0.8595,-0.035,2.668,-0.6935,Q3UER8,Fgg,Q3UER8_Fgg,Q3UER8,Fgg,1,106,24,24,Q3UER8|Q8VCM7|P12799|F1MGU7|Q3SZZ9,MOUSE,51033.2,54.4,75,75.1,336.53,336.53,,443,Fibrinogen gamma chain,fibrinogen complex|extracellular space|cell cortex|external side of plasma membrane|cell surface|platelet alpha granule|extracellular exosome|blood microparticle|,"cell-matrix adhesion|signal transduction|protein secretion|plasminogen activation|positive regulation of heterotypic cell-cell adhesion|fibrinolysis|cellular protein complex assembly|positive regulation of vasoconstriction|positive regulation of exocytosis|positive regulation of protein secretion|protein polymerization|response to calcium ion|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|blood coagulation, fibrin clot formation|positive regulation of peptide hormone secretion|negative regulation of extrinsic apoptotic signaling pathway via death domain receptors|negative regulation of endothelial cell apoptotic process|","receptor binding|structural molecule activity|protein binding, bridging|cell adhesion molecule binding|",24,106,1.23E+11,54.4%
P26928,0.279286999,-0.30875,11.57399016,0.7225,0.069598677,2.19060617,-0.317,-0.3855,-1.3075,0.151,0.002,0.0045,P26928,Mst1,P26928_Mst1,P26928,Mst1,1,71,26,26,P26928|E0CXN0,MOUSE,83185.1,37.4,76,76.1,330.64,330.64,,716,Hepatocyte growth factor-like protein,extracellular exosome|,proteolysis|spermatogenesis|embryo implantation|sperm motility|,serine-type endopeptidase activity|,26,71,17900000000,37.4%
Q8BK48,0.998370587,0.094083333,0.007082223,0.000833333,0.998370587,0.002126502,-0.37,-0.2665,0.9175,0.108,0.179,-0.0035,Q8BK48,Ces2e,Q8BK48_Ces2e,Q8BK48,Ces2e,1,70,22,17,Q8BK48|F6Z9B9|Q08ED5|Q149K3,MOUSE,62716,40.6,77,77.1,328.85,258.69,,559,Pyrethroid hydrolase Ces2e,endoplasmic reticulum|,metabolic process|,carboxylic ester hydrolase activity|,22,70,18300000000,40.6%
Q91WG0,0.853173903,0.009916667,1.22811639,0.097833333,0.753682378,0.328043861,-0.474,0.0265,0.3305,0.326,-0.125,-0.0245,Q91WG0,Ces2c,Q91WG0_Ces2c,Q91WG0,Ces2c,1,15,15,8,Q91WG0|Q6PDB7,MOUSE,62753.8,29.9,77,77.2,225.65,122.3,,561,Acylcarnitine hydrolase,endoplasmic reticulum|intracellular membrane-bounded organelle|,metabolic process|,acylcarnitine hydrolase activity|,8,15,491000000,14.7%
Q8QZR3,0.524685888,-0.224916667,5.470373396,0.3055,0.283767504,1.173391086,-0.551,0.0095,-0.5915,0.004,-0.185,-0.0355,Q8QZR3,Ces2a,Q8QZR3_Ces2a,Q8QZR3,Ces2a,1,11,10,5,Q8QZR3|Q8QZR3-2,MOUSE,62395.6,17.7,77,77.3,139.71,70.99,,558,Pyrethroid hydrolase Ces2a,,,carboxylic ester hydrolase activity|,5,11,545000000,10.2%
E9PV38,0.853173903,-0.0336,1.233596138,-0.093083333,0.752732012,-0.33218843,-0.178,0.2225,,0.044,-0.179,-0.0775,E9PV38,Ces2g,E9PV38_Ces2g,E9PV38,Ces2g,1,2,8,2,E9PV38,MOUSE,63005,17.1,77,77.4,104,16.61,,560,Carboxylic ester hydrolase,,metabolic process|,hydrolase activity|,2,2,317000000,4.6%
P39039,0.44969573,-0.11175,7.18023877,0.347833333,0.191415068,1.466256969,-0.577,-0.0725,-0.2075,0.098,0.055,0.0335,P39039,Mbl1,P39039_Mbl1,P39039,Mbl1,1,107,21,21,P39039|P39039-2|A0A2C9F2B6,MOUSE,25852,64,78,78.1,326.15,326.15,,239,Mannose-binding protein A,collagen trimer|extracellular space|,"complement activation, lectin pathway|complement activation, classical pathway|negative regulation of growth of symbiont in host|positive regulation of phagocytosis|defense response to Gram-positive bacterium|protein homotetramerization|killing by host of symbiont cells|protein homotrimerization|",protease binding|calcium ion binding|mannose binding|polysaccharide binding|protein homodimerization activity|calcium-dependent protein binding|phosphatidylinositol-4-phosphate binding|,21,107,8E+11,64.0%
A2A7A7,0.754501111,0.005583333,2.449724512,-0.136833333,0.568889016,-0.601436246,0.139,0.1575,-0.0745,-0.074,-0.235,0.1205,A2A7A7,H6pd,A2A7A7_H6pd,A2A7A7,H6pd,1,59,25,25,A2A7A7|Q8CFX1,MOUSE,90478.8,31.6,79,79.1,325.26,325.26,,797,GDH/6PGL endoplasmic bifunctional protein,mitochondrion|,glucose metabolic process|pentose-phosphate shunt|oxidation-reduction process|response to alcohol|,glucose-6-phosphate dehydrogenase activity|6-phosphogluconolactonase activity|carbohydrate binding|NADP binding|,25,59,20300000000,31.6%
F8VQ07,0.339465731,-0.09225,9.702309196,0.442166667,0.107094972,1.883443855,-0.441,-0.3255,-0.1735,0.376,0.014,-0.0035,F8VQ07,5830473C10Rik,F8VQ07_5830473C10Rik,F8VQ07,5830473C10Rik,1,57,26,26,F8VQ07|A0A0J9YV75,MOUSE,72340.4,34.3,80,80.1,324.4,324.4,,620,RIKEN cDNA 5830473C10 gene,extracellular space|,transport|,,26,57,9410000000,34.3%
P00920,0.917768271,0.012416667,0.655709086,-0.0525,0.859862663,-0.184034658,-0.129,-0.2525,0.4975,0.031,-0.187,0.1145,P00920,Car2,P00920_Car2,P00920,Ca2,1,57,18,18,P00920|A0A0A6YX78|P00921,MOUSE,29146.1,57.6,81,81.1,321.76,321.76,,260,Carbonic anhydrase 2,extracellular space|cytoplasm|cytosol|plasma membrane|microvillus|basolateral plasma membrane|axon|myelin sheath|apical part of cell|extracellular exosome|,"kidney development|morphogenesis of an epithelium|one-carbon metabolic process|regulation of pH|response to pH|response to zinc ion|carbon dioxide transport|positive regulation of synaptic transmission, GABAergic|positive regulation of cellular pH reduction|angiotensin-activated signaling pathway|odontogenesis of dentin-containing tooth|response to estrogen|regulation of anion transport|positive regulation of osteoclast differentiation|positive regulation of bone resorption|secretion|regulation of intracellular pH|cellular response to fluid shear stress|positive regulation of dipeptide transmembrane transport|regulation of chloride transport|",arylesterase activity|carbonate dehydratase activity|zinc ion binding|,18,57,17800000000,57.6%
A2AS37,0.852172906,0.277416667,1.280592847,-0.1725,0.744630319,-0.340917815,-0.43,0.0965,1.4245,0.487,0.126,-0.0395,A2AS37,AI182371,A2AS37_AI182371,A2AS37,AI182371,1,76,20,20,A2AS37,MOUSE,40887.3,50.8,82,82.1,312.65,312.65,,356,Expressed sequence AI182371,extracellular region|,inflammatory response|complement activation|negative regulation of endopeptidase activity|,endopeptidase inhibitor activity|,20,76,83800000000,50.8%
Q8BHN3-2,0.762754224,-0.09475,2.352362987,0.127166667,0.581786583,0.580935529,-0.132,-0.0015,-0.3415,-0.005,-0.067,-0.0215,Q8BHN3,Ganab,Q8BHN3-2_Ganab,Q8BHN3-2,Ganab,1,58,28,28,Q8BHN3-2|Q8BHN3|Q8BHN3-3,MOUSE,109858.4,28.7,83,83.1,303.22,303.22,,944,Isoform 2 of Neutral alpha-glucosidase AB,endoplasmic reticulum|Golgi apparatus|membrane|glucosidase II complex|melanosome|extracellular exosome|,N-glycan processing|,"protein binding|glucosidase activity|carbohydrate binding|glucan 1,3-alpha-glucosidase activity|poly(A) RNA binding|",28,58,9730000000,28.7%
Q61704,0.573841572,-0.23025,4.621025044,0.6235,0.345062286,1.024027184,0.331,-0.0355,-1.9215,0.313,-0.044,-0.0245,Q61704,Itih3,Q61704_Itih3,Q61704,Itih3,1,68,22,22,Q61704,MOUSE,99698.3,25.1,84,84.1,296.38,296.38,,889,Inter-alpha-trypsin inhibitor heavy chain H3,extracellular exosome|,negative regulation of endopeptidase activity|hyaluronan metabolic process|,serine-type endopeptidase inhibitor activity|,22,68,28500000000,25.1%
Q07456,0.255097963,-0.242416667,13.21681481,0.789166667,0.047678054,2.462752729,-0.443,-0.2585,-1.2095,0.342,0.117,-0.0025,Q07456,Ambp,Q07456_Ambp,Q07456,Ambp,1,64,18,18,Q07456,MOUSE,39941.4,48.4,85,85.1,296.14,296.14,,349,Protein AMBP,extracellular space|plasma membrane|cell surface|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,negative regulation of endopeptidase activity|protein-chromophore linkage|protein catabolic process|protein maturation|,serine-type endopeptidase inhibitor activity|IgA binding|heme binding|small molecule binding|protein homodimerization activity|,18,64,79300000000,48.4%
O70570,0.756676622,-0.151083333,2.428028761,0.1405,0.571738087,0.59688401,-0.266,0.0115,-0.4095,0.02,-0.24,-0.0225,O70570,Pigr,O70570_Pigr,O70570,Pigr,1,42,21,21,O70570,MOUSE,86309.5,30,86,86.1,293.74,293.74,,771,Polymeric immunoglobulin receptor,extracellular space|plasma membrane|integral component of membrane|receptor complex|extracellular exosome|,detection of chemical stimulus involved in sensory perception of bitter taste|retina homeostasis|immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor|epidermal growth factor receptor signaling pathway|Fc receptor signaling pathway|receptor clustering|,polymeric immunoglobulin receptor activity|,21,42,10400000000,30.0%
P23953,0.441723111,-0.187916667,7.504939569,0.438166667,0.177625798,1.52063535,-0.871,-0.1845,-0.1655,0.222,-0.133,0.0045,P23953,Ces1c,P23953_Ces1c,P23953,Ces1c,1,57,21,13,P23953|Q8VCT4|E9PYP1,MOUSE,61339.9,35.3,87,87.1,292.8,192.44,,554,Carboxylesterase 1C,extracellular space|endoplasmic reticulum lumen|,metabolic process|,"hydrolase activity, acting on ester bonds|carboxylic ester hydrolase activity|",21,57,24900000000,35.3%
D3Z5G7,0.881241581,0.053916667,0.986629208,-0.0875,0.796777532,-0.268846101,0.076,-0.4065,0.6235,0.198,-0.173,0.0055,D3Z5G7,Ces1b,D3Z5G7_Ces1b,D3Z5G7,Ces1b,1,21,17,9,D3Z5G7|Q8VCC2,MOUSE,62538.2,33.1,87,87.2,237.99,137.63,,567,Carboxylic ester hydrolase,,metabolic process|,hydrolase activity|,9,21,1390000000,21.8%
P35917,0.933745622,0.02375,0.521945747,0.036833333,0.886758633,0.148375212,0.081,-0.2915,0.2265,-0.073,0.213,-0.0135,P35917,Flt4,P35917_Flt4,P35917,Flt4,1,35,23,23,P35917,MOUSE,155124.7,17.8,88,88.1,292.48,292.48,,1363,Vascular endothelial growth factor receptor 3,nucleus|cytoplasm|plasma membrane|integral component of plasma membrane|receptor complex|,positive regulation of protein phosphorylation|positive regulation of endothelial cell proliferation|vasculature development|lymph vessel development|lymphangiogenesis|sprouting angiogenesis|positive regulation of cell proliferation|positive regulation of vascular endothelial growth factor production|positive regulation of endothelial cell migration|peptidyl-tyrosine phosphorylation|cellular response to vascular endothelial growth factor stimulus|vascular endothelial growth factor signaling pathway|negative regulation of apoptotic process|positive regulation of MAPK cascade|positive regulation of JNK cascade|protein autophosphorylation|vascular endothelial growth factor receptor signaling pathway|blood vessel morphogenesis|regulation of blood vessel remodeling|positive regulation of ERK1 and ERK2 cascade|positive regulation of protein kinase C signaling|,transmembrane receptor protein tyrosine kinase activity|vascular endothelial growth factor-activated receptor activity|protein binding|ATP binding|growth factor binding|protein phosphatase binding|,23,35,4470000000,17.8%
Q9DBB9,0.46334768,-0.21475,6.893077715,0.409833333,0.20449949,1.417901942,-0.894,-0.3415,-0.0235,-0.019,-0.049,0.0385,Q9DBB9,Cpn2,Q9DBB9_Cpn2,Q9DBB9,Cpn2,1,74,18,18,Q9DBB9,MOUSE,61333.9,43.6,89,89.1,288.7,288.7,,547,Carboxypeptidase N subunit 2,extracellular exosome|blood microparticle|,,,18,74,66500000000,43.6%
Q8CG19,0.519628152,0.42075,5.696264914,-0.447166667,0.269385061,-1.212881816,1.083,-0.0405,0.8905,0.174,0.488,-0.0705,Q8CG19,Ltbp1,Q8CG19_Ltbp1,Q8CG19,Ltbp1,1,35,20,20,Q8CG19|Q8CG19-2|Q8CG19-3|Q61810|F8VQ06|Q61810-2,MOUSE,195158.2,14.4,90,90.1,287.91,287.91,,1712,Latent-transforming growth factor beta-binding protein 1,microfibril|proteinaceous extracellular matrix|extracellular matrix|protein complex|extracellular matrix|,transforming growth factor beta receptor signaling pathway|,calcium ion binding|transforming growth factor beta binding|microfibril binding|,20,35,2720000000,14.4%
A11111,0.339465731,-0.292,9.648024033,0.667916667,0.108442019,1.936171356,-1.103,-0.2825,,0.061,-0.138,0.0025,A11111,NotFound,A11111_NotFound,A11111,,1,53,18,18,A11111|P06709,MOUSE,39099.5,57,91,91.1,287.06,287.06,,,BirAG3ER,,,,18,53,2.21E+11,57.0%
P60710,0.608254328,-0.28725,4.028947162,0.5915,0.395462478,0.914544456,0.057,0.2525,-2.0585,0.099,-0.298,0.2245,P60710,Actb,P60710_Actb,P60710,Actb,1,57,20,1,P60710|E9Q1F2|V9GXQ2,MOUSE,42078.3,51.4,92,92.1,285.76,21.03,,375,"Actin, cytoplasmic 1",nuclear chromatin|extracellular space|cytosol|plasma membrane|focal adhesion|membrane|ribonucleoprotein complex|cortical cytoskeleton|NuA4 histone acetyltransferase complex|cytoplasmic ribonucleoprotein granule|myelin sheath|protein complex|extracellular exosome|MLL5-L complex|blood microparticle|dense body|,retina homeostasis|substantia nigra development|ATP-dependent chromatin remodeling|platelet aggregation|,protein binding|ATP binding|kinesin binding|Tat protein binding|identical protein binding|nitric-oxide synthase binding|RNA polymerase II core promoter proximal region sequence-specific DNA binding|RNA polymerase II distal enhancer sequence-specific DNA binding|nucleosomal DNA binding|,20,57,21900000000,51.4%
P63260,0.500924078,0.285,5.98491872,-0.587333333,0.252062435,-1.327205152,,0.7255,,0.358,-0.254,0.3105,P63260,Actg1,P63260_Actg1,P63260,Actg1,1,2,20,1,P63260|G3UYG0|B1ATY1,MOUSE,42134.4,51.4,92,92.2,285.65,20.92,,375,"Actin, cytoplasmic 2",extracellular space|nucleus|cytosol|plasma membrane|focal adhesion|actin cytoskeleton|membrane|myofibril|filamentous actin|costamere|myelin sheath|extracellular exosome|blood microparticle|dense body|,retina homeostasis|sarcomere organization|response to calcium ion|platelet aggregation|,structural constituent of cytoskeleton|protein binding|ATP binding|ubiquitin protein ligase binding|identical protein binding|,1,2,20200000,4.5%
P68134,0.642142641,-0.06225,3.677665417,0.355,0.428778952,0.875067192,,-0.3285,,0.203,-0.27,0.1465,P68134,Acta1,P68134_Acta1,P68134,Acta1,1,2,16,1,P68134|P68033|P62737|P63268,MOUSE,42392.6,33.9,92,92.3,208.68,11.26,,377,"Actin, alpha skeletal muscle",stress fiber|extracellular space|cytoplasm|striated muscle thin filament|actin filament|actin cytoskeleton|sarcomere|lamellipodium|filopodium|protein complex|cell body|extracellular exosome|blood microparticle|,response to mechanical stimulus|response to extracellular stimulus|response to lithium ion|positive regulation of gene expression|cell growth|skeletal muscle thin filament assembly|skeletal muscle fiber adaptation|response to steroid hormone|skeletal muscle fiber development|mesenchyme migration|,protein binding|ATP binding|,1,2,714000000,4.2%
Q8BFZ3,0.662037385,0.1132,3.444982829,0.35075,0.452378251,0.812546148,-0.626,0.4315,,0.304,0.554,-0.0975,Q8BFZ3,Actbl2,Q8BFZ3_Actbl2,Q8BFZ3,Actbl2,1,1,9,1,Q8BFZ3,MOUSE,42345.8,18.8,92,92.4,101.11,4.65,,376,Beta-actin-like protein 2,extracellular space|cytoplasm|cytoskeleton|extracellular exosome|,,ATP binding|,1,1,11900000,3.7%
P41317,0.23713653,-0.55325,14.08738647,1.2495,0.039017672,2.620795981,-1.241,-0.2315,-2.0615,0.212,0.001,0.0015,P41317,Mbl2,P41317_Mbl2,P41317,Mbl2,1,91,17,17,P41317,MOUSE,26356,60.2,93,93.1,285.71,285.71,,244,Mannose-binding protein C,collagen trimer|extracellular space|,"complement activation, lectin pathway|complement activation, classical pathway|negative regulation of growth of symbiont in host|innate immune response|negative regulation of viral process|positive regulation of phagocytosis|defense response to Gram-positive bacterium|killing by host of symbiont cells|",receptor binding|calcium ion binding|mannose binding|calcium-dependent protein binding|,17,91,2.49E+11,60.2%
Q02819,0.376897582,-0.341583333,8.864333911,0.742166667,0.129887276,1.74771653,-0.443,-0.1045,-1.5905,-0.191,0.163,0.1165,Q02819,Nucb1,Q02819_Nucb1,Q02819,Nucb1,1,39,23,23,Q02819|A0A1C7CYU3,MOUSE,53407.7,48.1,94,94.1,284.14,284.14,,459,Nucleobindin-1,extracellular space|nucleus|early endosome|rough endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|Golgi-associated vesicle|cis-Golgi network|trans-Golgi network|microtubule cytoskeleton|membrane|Golgi cisterna membrane|extracellular exosome|extrinsic component of Golgi membrane|lumenal side of Golgi membrane|,response to cisplatin|regulation of protein targeting|,G-protein alpha-subunit binding|DNA binding|calcium ion binding|,23,39,4890000000,48.1%
P16294,0.295352914,-0.177,10.98346369,0.66375,0.079735851,2.173431437,-0.854,-0.2965,,0.255,-0.001,0.0115,P16294,F9,P16294_F9,P16294,F9,1,58,18,18,P16294,MOUSE,54289.1,43.7,95,95.1,283.53,283.53,,471,Coagulation factor IX,extracellular space|extracellular exosome|,proteolysis|blood coagulation|zymogen activation|,endopeptidase activity|serine-type endopeptidase activity|calcium ion binding|peptidase activity|,18,58,45300000000,43.7%
Q64726,0.519628152,0.029583333,5.650549573,0.429166667,0.272235679,1.204913538,-0.056,0.2845,-0.7835,0.587,0.18,-0.0345,Q64726,Azgp1,Q64726_Azgp1,Q64726,Azgp1,1,62,20,20,Q64726,MOUSE,35559.5,53.7,96,96.1,281.83,281.83,,307,Zinc-alpha-2-glycoprotein,extracellular space|nucleus|plasma membrane|MHC class I protein complex|extracellular exosome|,detection of chemical stimulus involved in sensory perception of bitter taste|retina homeostasis|antigen processing and presentation of peptide antigen via MHC class I|immune response|cell adhesion|regulation of multicellular organism growth|,glycoprotein binding|peptide antigen binding|,20,62,32000000000,53.7%
P29699,0.339465731,-0.20225,9.769483165,0.558833333,0.105451238,1.894459783,-0.989,-0.1885,-0.2675,0.23,0.003,-0.0015,P29699,Ahsg,P29699_Ahsg,P29699,Ahsg,1,81,17,17,P29699,MOUSE,38123.7,62,97,97.1,277.39,277.39,,345,Alpha-2-HS-glycoprotein,extracellular space|extracellular exosome|blood microparticle|,ossification|acute-phase response|negative regulation of endopeptidase activity|negative regulation of bone mineralization|regulation of inflammatory response|positive regulation of phagocytosis|,cysteine-type endopeptidase inhibitor activity|,17,81,2.69E+11,62.0%
P97298,0.246733887,-0.27525,13.62952847,0.726166667,0.043355795,2.531812178,-0.586,-0.2485,-1.0805,0.228,0.032,0.0035,P97298,Serpinf1,P97298_Serpinf1,P97298,Serpinf1,1,61,17,17,P97298|E9PWS2,MOUSE,46290.3,48.2,98,98.1,276.78,276.78,,417,Pigment epithelium-derived factor,extracellular region|basement membrane|extracellular space|melanosome|axon hillock|perinuclear region of cytoplasm|extracellular exosome|extracellular matrix|,kidney development|aging|short-term memory|response to acidic pH|negative regulation of endothelial cell migration|negative regulation of gene expression|negative regulation of endopeptidase activity|positive regulation of neuron projection development|negative regulation of angiogenesis|ovulation cycle|response to arsenic-containing substance|negative regulation of inflammatory response|positive regulation of neurogenesis|retina development in camera-type eye|negative regulation of epithelial cell proliferation involved in prostate gland development|cellular response to cobalt ion|cellular response to retinoic acid|cellular response to glucose stimulus|cellular response to dexamethasone stimulus|negative regulation of neuron death|,serine-type endopeptidase inhibitor activity|,17,61,17600000000,48.2%
P70375,0.339465731,-0.21425,9.697377483,0.5295,0.107216654,1.88263504,-0.927,-0.4095,-0.1005,0.061,0.075,0.0155,P70375,F7,P70375_F7,P70375,F7,1,64,20,20,P70375,MOUSE,51701.8,40.3,99,99.1,273.76,273.76,,446,Coagulation factor VII,extracellular region|extracellular space|vesicle|,positive regulation of leukocyte chemotaxis|proteolysis|blood coagulation|circadian rhythm|positive regulation of platelet-derived growth factor receptor signaling pathway|positive regulation of blood coagulation|organ regeneration|response to vitamin K|response to estrogen|positive regulation of positive chemotaxis|positive regulation of protein kinase B signaling|response to growth hormone|,glycoprotein binding|serine-type endopeptidase activity|receptor binding|calcium ion binding|,20,64,51100000000,40.3%
Q06194,0.363785285,-0.333583333,9.167824502,0.636166667,0.121120471,1.795716248,-0.305,-0.2885,-1.3615,-0.132,0.096,-0.0105,Q06194,F8,Q06194_F8,Q06194,F8,1,36,21,21,Q06194|B2RRC9,MOUSE,267560.2,8.3,100,100.1,270.95,270.95,,2319,Coagulation factor VIII,extracellular space|,acute-phase response|platelet activation|oxidation-reduction process|,copper ion binding|oxidoreductase activity|,21,36,2610000000,8.3%
P08226,0.279130421,-0.18625,11.86288896,0.5475,0.065119507,2.238207356,-0.502,-0.2815,-0.5965,-0.188,0.278,0.1725,P08226,Apoe,P08226_Apoe,P08226,Apoe,1,74,20,20,P08226,MOUSE,35923,52.4,101,101.1,267.28,267.28,,311,Apolipoprotein E,extracellular region|extracellular space|nucleus|endoplasmic reticulum|Golgi apparatus|cytosol|membrane|extracellular matrix|very-low-density lipoprotein particle|low-density lipoprotein particle|intermediate-density lipoprotein particle|high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|extracellular vesicle|,negative regulation of endothelial cell proliferation|response to dietary excess|lipid metabolic process|triglyceride metabolic process|cholesterol biosynthetic process|cholesterol catabolic process|cellular calcium ion homeostasis|receptor-mediated endocytosis|response to oxidative stress|G-protein coupled receptor signaling pathway|nitric oxide mediated signal transduction|cholesterol metabolic process|regulation of gene expression|negative regulation of platelet activation|positive regulation of cholesterol esterification|positive regulation of cholesterol efflux|long-chain fatty acid transport|protein import|virion assembly|triglyceride catabolic process|cGMP-mediated signaling|negative regulation of blood coagulation|regulation of axon extension|positive regulation of cGMP biosynthetic process|regulation of cholesterol transport|regulation of Cdc42 protein signal transduction|positive regulation of low-density lipoprotein particle receptor catabolic process|cholesterol efflux|phospholipid efflux|very-low-density lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|chylomicron remnant clearance|high-density lipoprotein particle clearance|very-low-density lipoprotein particle clearance|lipoprotein metabolic process|lipoprotein biosynthetic process|lipoprotein catabolic process|vasodilation|cholesterol homeostasis|negative regulation of MAP kinase activity|negative regulation of neuron apoptotic process|negative regulation of blood vessel endothelial cell migration|reverse cholesterol transport|positive regulation by host of viral process|negative regulation of cholesterol biosynthetic process|positive regulation of lipid biosynthetic process|artery morphogenesis|negative regulation of inflammatory response|positive regulation of nitric-oxide synthase activity|positive regulation of membrane protein ectodomain proteolysis|negative regulation of lipid biosynthetic process|maintenance of location in cell|lipid homeostasis|fatty acid homeostasis|positive regulation of dendritic spine development|negative regulation of dendritic spine development|cardiovascular system development|negative regulation of cholesterol efflux|alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering|N-methyl-D-aspartate receptor clustering|regulation of beta-amyloid clearance|regulation of neuron death|negative regulation of neuron death|positive regulation of neuron death|negative regulation of postsynaptic membrane organization|positive regulation of postsynaptic membrane organization|negative regulation of presynaptic membrane organization|positive regulation of presynaptic membrane organization|positive regulation of beta-amyloid formation|negative regulation of beta-amyloid formation|regulation of tau-protein kinase activity|negative regulation of dendritic spine maintenance|positive regulation of dendritic spine maintenance|positive regulation of phospholipid efflux|positive regulation of neurofibrillary tangle assembly|negative regulation of phospholipid efflux|negative regulation of lipid transport across blood brain barrier|positive regulation of lipid transport across blood brain barrier|protein localization|axon regeneration|,beta-amyloid binding|lipid transporter activity|protein binding|phospholipid binding|heparin binding|lipid binding|cholesterol binding|antioxidant activity|cholesterol transporter activity|identical protein binding|protein homodimerization activity|metal chelating activity|tau protein binding|low-density lipoprotein particle receptor binding|phosphatidylcholine-sterol O-acyltransferase activator activity|very-low-density lipoprotein particle receptor binding|lipoprotein particle binding|,20,74,52500000000,52.4%
Q03311,0.482514848,-0.093416667,6.40781469,0.357166667,0.228674917,1.335526,-0.667,-0.1785,0.0295,0.212,0.037,0.0065,Q03311,Bche,Q03311_Bche,Q03311,Bche,1,53,17,17,Q03311,MOUSE,68974.5,27.3,102,102.1,264.82,264.82,,603,Cholinesterase,nuclear envelope lumen|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|blood microparticle|,learning|negative regulation of cell proliferation|neuroblast differentiation|choline metabolic process|response to drug|response to alkaloid|negative regulation of synaptic transmission|response to glucocorticoid|response to folic acid|,acetylcholinesterase activity|cholinesterase activity|choline binding|identical protein binding|,17,53,25900000000,27.3%
A0A0A6YXW6,0.347078132,-0.295916667,9.507957128,1.154833333,0.111996458,1.859282841,-0.058,-0.5425,-2.0195,-0.134,-0.14,1.1185,A0A0A6YXW6,NotFound,A0A0A6YXW6_NotFound,A0A0A6YXW6,Igha,1,61,14,4,A0A0A6YXW6,MOUSE,42869.8,43.7,103,103.1,263.94,67.41,,389,Immunoglobulin heavy constant alpha (Fragment),,,,14,61,1.14E+11,43.7%
P01878,0.23713653,-0.3484,14.09506951,0.981416667,0.038948707,2.744669281,-1.293,-0.5815,,-0.183,-0.045,0.3605,P01878,NotFound,P01878_NotFound,P01878,,1,2,11,1,P01878,MOUSE,37616.9,40.9,103,103.2,203.02,6.49,,344,Ig alpha chain C region,,,antigen binding|immunoglobulin receptor binding|,1,2,29100000,6.3%
P08607,0.319347131,-0.25275,10.27493491,0.469166667,0.09386561,1.977323001,-0.629,-0.5015,-0.3315,-0.065,-0.208,0.2185,P08607,C4bp,P08607_C4bp,P08607,C4bpa,1,75,16,16,P08607|E9PUZ8,MOUSE,53006.2,33.9,104,104.1,263.41,263.41,,469,C4b-binding protein,extracellular region|,"complement activation, classical pathway|innate immune response|",protein binding|,16,75,44800000000,33.9%
Q3U3V1,0.16997749,-0.33175,17.08842685,0.831166667,0.019550475,3.127233404,-0.696,-0.4595,-1.0865,0.301,-0.045,-0.0045,Q3U3V1,F10,Q3U3V1_F10,Q3U3V1,F10,1,69,20,20,Q3U3V1|O88947|D3Z215|D3Z521,MOUSE,56680.8,37.1,105,105.1,260.72,260.72,,493,Coagulation factor X,extracellular region|membrane|intracellular membrane-bounded organelle|,proteolysis|blood coagulation|positive regulation of protein kinase B signaling|,serine-type endopeptidase activity|calcium ion binding|phospholipid binding|,20,69,73400000000,37.1%
P70389,0.149102391,0.302416667,18.62143712,-0.7425,0.013735874,-3.40344295,0.804,0.5745,0.6425,-0.177,-0.094,0.0645,P70389,Igfals,P70389_Igfals,P70389,Igfals,1,41,18,18,A0A0R4J0S2|P70389,MOUSE,67757.5,34.4,106,106.1,258.86,258.86,,603,Insulin-like growth factor-binding protein complex acid labile subunit,nucleoplasm|insulin-like growth factor ternary complex|extracellular exosome|,cell adhesion|,,18,41,5440000000,34.4%
P00761,0.011676506,0.843416667,40.37649486,-2.743166667,9.1696E-05,-8.931051678,2.732,1.7835,2.1295,-0.592,-0.609,-0.3835,P00761,NotFound,P00761_NotFound,P00761,,1,296,14,13,P00761,PIG,25093.7,64,107,107.1,253.07,237.55,,231,Trypsin,,,,14,296,4.47E+13,64.0%
B99907,0.105134073,0.53275,22.0567297,-1.523833333,0.006227691,-4.058586433,2.056,1.0815,0.7465,-0.237,-0.228,-0.2225,B99907,NotFound,B99907_NotFound,B99907,,1,55,5,4,B99907,PromTArt7,5560.1,98,107,107.2,104.28,88.76,,50,"Promega trypsin artifact 2 K to R mods +28 (2239.1, 2914)(1987, 2003) [Sus scrofa]",,,,4,55,44100000000,98.0%
B99908,0.262291975,1.176916667,12.89514918,-1.8155,0.051343454,-2.423378256,2.585,1.6885,1.9805,-0.626,-0.53,1.9635,B99908,NotFound,B99908_NotFound,B99908,,1,1,2,1,B99908,PromTArt8,3352.7,96.7,107,107.3,24.26,8.74,,31,Promega trypsin artifact LIK -> GNPK +42 [Sus scrofa],,,,1,1,17500000,64.5%
Q08761,0.900997634,0.115583333,0.836805502,-0.112166667,0.824744541,-0.231192184,-0.404,-0.3265,1.2455,0.239,-0.064,0.0035,Q08761,Pros1,Q08761_Pros1,Q08761,Pros1,1,43,21,21,Q08761,MOUSE,76987.1,26.9,108,108.1,248.7,248.7,,675,Vitamin K-dependent protein S,extracellular space|protein complex|extracellular exosome|blood microparticle|,blood coagulation|response to lipopolysaccharide|fibrinolysis|positive regulation of phagocytosis|,calcium ion binding|protein complex binding|,21,43,11600000000,26.9%
P82198,0.637148916,-0.097916667,3.721973295,0.258833333,0.424426674,0.854900042,-0.371,-0.4725,0.1615,-0.179,-0.154,0.4275,P82198,Tgfbi,P82198_Tgfbi,P82198,Tgfbi,1,33,19,19,P82198|Q3UXJ2,MOUSE,75223.3,25.7,109,109.1,245.9,245.9,,683,Transforming growth factor-beta-induced protein ig-h3,proteinaceous extracellular matrix|basement membrane|extracellular space|trans-Golgi network|extracellular exosome|extracellular matrix|,angiogenesis|chondrocyte differentiation|cell adhesion|extracellular matrix organization|,collagen binding|cell adhesion molecule binding|extracellular matrix binding|,19,33,2040000000,25.7%
O70165,0.884037397,0.006583333,0.965206374,0.193833333,0.800717578,0.263777691,-1.509,-0.2465,1.4845,0.141,0.177,-0.0075,O70165,Fcna,O70165_Fcna,O70165,Fcn1,1,66,15,15,O70165,MOUSE,36868.4,33.2,110,110.1,243.87,243.87,,334,Ficolin-1,collagen trimer|extrinsic component of external side of plasma membrane|blood microparticle|,cell surface pattern recognition receptor signaling pathway|G-protein coupled receptor signaling pathway|recognition of apoptotic cell|negative regulation of viral entry into host cell|defense response to virus|negative regulation of RNA biosynthetic process|positive regulation of interleukin-8 secretion|,antigen binding|protein binding|signaling pattern recognition receptor activity|carbohydrate binding|metal ion binding|carbohydrate derivative binding|,15,66,67400000000,33.2%
P27773,0.279130421,-0.22975,11.78540604,0.477833333,0.066291737,2.225432096,-0.321,-0.6175,-0.4675,0.014,0.002,0.0115,P27773,Pdia3,P27773_Pdia3,P27773,Pdia3,1,27,19,19,P27773|A5D7E8|P38657,MOUSE,57133.7,36.8,111,111.1,237.47,237.47,,505,Protein disulfide-isomerase A3,nucleus|endoplasmic reticulum|endoplasmic reticulum lumen|smooth endoplasmic reticulum|focal adhesion|cell surface|melanosome|myelin sheath|extracellular exosome|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|positive regulation of extrinsic apoptotic signaling pathway|,protein disulfide isomerase activity|protein binding|poly(A) RNA binding|,19,27,2510000000,36.8%
Q9R1E6-2,0.507080972,-0.59825,5.87706336,1.5375,0.258400687,1.247468381,-0.377,0.5365,-4.2605,0.706,-0.138,-0.0565,Q9R1E6,Enpp2,Q9R1E6-2_Enpp2,Q9R1E6-2,Enpp2,1,28,18,18,Q9R1E6-2|G3UXY9|Q9R1E6-3|Q9R1E6,MOUSE,106969.5,22.8,112,112.1,237.47,237.47,,862,Isoform 2 of Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,extracellular space|integral component of plasma membrane|,receptor-mediated endocytosis|chemotaxis|immune response|phospholipid catabolic process|positive regulation of epithelial cell migration|regulation of cell migration|phosphatidylcholine catabolic process|regulation of angiogenesis|positive regulation of peptidyl-tyrosine phosphorylation|nucleic acid phosphodiester bond hydrolysis|positive regulation of lamellipodium morphogenesis|,nucleic acid binding|phosphodiesterase I activity|nucleotide diphosphatase activity|lysophospholipase activity|scavenger receptor activity|calcium ion binding|zinc ion binding|polysaccharide binding|alkylglycerophosphoethanolamine phosphodiesterase activity|,18,28,3580000000,22.8%
P01898,0.793370666,0.317083333,1.998688517,-0.397833333,0.63114791,-0.505450848,-0.395,-0.4365,2.3795,0.292,0.061,0.0015,P01898,H2-Q10,P01898_H2-Q10,P01898,H2-Q10,1,64,15,9,P01898|G3UXE9|E9Q0G4|A7VMS6|V9GXR0|V9GXI4|Q05A75|G3UZL7|A0A0B4J1G3,MOUSE,37478.5,40.6,113,113.1,235.92,151.99,,325,"H-2 class I histocompatibility antigen, Q10 alpha chain",endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|plasma membrane|cell surface|membrane|phagocytic vesicle membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|integral component of lumenal side of endoplasmic reticulum membrane|,antigen processing and presentation of peptide antigen via MHC class I|immune response|,receptor binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,15,64,25200000000,40.6%
Q8HWB2,0.35590614,-0.49575,9.313716325,1.109166667,0.117119273,1.827097317,-0.283,-0.4135,-2.4545,0.163,0.012,0.0015,Q8HWB2,H2-Q4,Q8HWB2_H2-Q4,Q8HWB2,H2-Q4,1,14,15,8,Q8HWB2|P01899|P79568|O19441|E9PX63|P04223|P04223-2|P14426|P01900|P14429|E9QJR9|E9PWT4|P14431|P14427|P01895-2|L7N260|P03991,MOUSE,39902.4,37,113,113.2,193.04,94.48,,354,"Histocompatibility 2, Q region locus 4",endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|plasma membrane|cell surface|membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|,antigen processing and presentation of peptide antigen via MHC class I|immune response|,receptor binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,8,14,544000000,19.7%
P01901,0.075127129,0.51975,24.29415845,-1.5745,0.003720353,-4.51735574,0.656,1.4315,1.8335,-0.216,-0.403,-0.1835,P01901,H2-K1,P01901_H2-K1,P01901,H2-K1,1,2,5,2,P01901|Q3TH01,MOUSE,41700.5,12.1,113,113.3,52.6,17.17,,369,"H-2 class I histocompatibility antigen, K-B alpha chain",endoplasmic reticulum|Golgi apparatus|Golgi medial cisterna|external side of plasma membrane|cell surface|membrane|phagocytic vesicle membrane|MHC class I protein complex|extracellular exosome|endoplasmic reticulum exit site|integral component of lumenal side of endoplasmic reticulum membrane|,"positive regulation of T cell mediated cytotoxicity|antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent|immune response|antigen processing and presentation of exogenous peptide antigen via MHC class I|defense response to bacterium|inner ear development|",receptor binding|protein binding|beta-2-microglobulin binding|peptide antigen binding|T cell receptor binding|poly(A) RNA binding|TAP binding|,2,2,29400000,7.0%
P29788,0.617651522,0.200583333,3.90933601,-0.2815,0.406505475,-0.890382128,0.441,-0.1775,0.7605,0.3,-0.1,-0.0205,P29788,Vtn,P29788_Vtn,P29788,Vtn,1,98,15,15,P29788,MOUSE,55646.8,28.6,114,114.1,235.56,235.56,,478,Vitronectin,proteinaceous extracellular matrix|extracellular space|extracellular matrix|extracellular exosome|blood microparticle|extracellular matrix|,receptor-mediated endocytosis|immune response|cell-matrix adhesion|positive regulation of cell-substrate adhesion|negative regulation of endopeptidase activity|positive regulation of smooth muscle cell migration|extracellular matrix organization|positive regulation of protein binding|cell adhesion mediated by integrin|endodermal cell differentiation|positive regulation of receptor-mediated endocytosis|oligodendrocyte differentiation|positive regulation of peptidyl-tyrosine phosphorylation|smooth muscle cell-matrix adhesion|,scavenger receptor activity|integrin binding|heparin binding|polysaccharide binding|extracellular matrix binding|,15,98,2.61E+11,28.6%
Q06770,0.91535326,0.183083333,0.714550124,-0.1205,0.848291251,-0.199667641,-0.734,-0.1085,1.5725,0.377,0.015,-0.0235,Q06770,Serpina6,Q06770_Serpina6,Q06770,Serpina6,1,52,15,15,Q06770,MOUSE,44939.5,35,115,115.1,234.35,234.35,,397,Corticosteroid-binding globulin,extracellular space|extracellular exosome|,transport|glucocorticoid metabolic process|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|steroid binding|,15,52,68600000000,35.0%
Q6GQT1,0.262291975,-0.361583333,12.77239378,0.8835,0.052815406,2.388736948,-0.332,-0.5425,-1.5355,-0.12,0.164,0.1965,Q6GQT1,A2m,Q6GQT1_A2m,Q6GQT1,A2m,1,72,22,22,Q6GQT1|Q7SIH1|K4JBR5|K4JR81|K4JDS3|K4JDR8|K4JF13|K4JBA2|K4JB97,MOUSE,165776,16.2,116,116.1,232.37,232.37,,1474,Alpha-2-macroglobulin-P,extracellular exosome|blood microparticle|,"negative regulation of complement activation, lectin pathway|female pregnancy|negative regulation of endopeptidase activity|stem cell differentiation|",protease binding|serine-type endopeptidase inhibitor activity|receptor binding|protein binding|growth factor binding|enzyme binding|interleukin-8 binding|interleukin-1 binding|peptidase inhibitor activity|tumor necrosis factor binding|calcium-dependent protein binding|,24,72,7.22E+12,16.2%
Q61730-2,0.729414454,-0.037916667,2.703231022,0.2035,0.536632409,0.653976384,-0.491,-0.2535,0.3255,0.355,-0.215,0.0515,Q61730,Il1rap,Q61730-2_Il1rap,Q61730-2,Il1rap,1,37,18,18,Q61730-2|Q61730-3|E9Q6I2|Q61730|G3UY13,MOUSE,42194.2,43.8,117,117.1,232.35,232.35,,570,Isoform 2 of Interleukin-1 receptor accessory protein,extracellular region|plasma membrane|membrane|integral component of membrane|,inflammatory response|cytokine-mediated signaling pathway|interleukin-2 biosynthetic process|innate immune response|,signal transducer activity|interleukin-1 receptor activity|protein binding|,18,37,7950000000,43.8%
Q3U9N4,0.729414454,0.082083333,2.759581449,-0.147166667,0.529714493,-0.665499562,0.024,0.3505,0.0925,-0.039,0.093,-0.0285,Q3U9N4,Grn,Q3U9N4_Grn,Q3U9N4,Grn,1,37,17,17,Q3U9N4|P28798,MOUSE,70037.8,28.2,118,118.1,229.4,229.4,,602,Granulins,extracellular space|mitochondrion|cell surface|intracellular membrane-bounded organelle|extracellular exosome|,blastocyst hatching|embryo implantation|response to estradiol|chondrocyte proliferation|synaptic vesicle endocytosis|positive regulation of epithelial cell proliferation|male mating behavior|positive regulation of dendritic spine development|neural precursor cell proliferation|,poly(A) RNA binding|,17,37,2170000000,28.2%
Q9JHH6,0.449503035,-0.428416667,7.235109351,1.3705,0.189011864,1.480080237,0.006,-0.0295,-3.3175,0.337,0.459,-0.0255,Q9JHH6,Cpb2,Q9JHH6_Cpb2,Q9JHH6,Cpb2,1,59,16,16,Q9JHH6,MOUSE,49269,26.5,119,119.1,226.93,226.93,,422,Carboxypeptidase B2,extracellular space|cell|extracellular exosome|,positive regulation of extracellular matrix constituent secretion|proteolysis|blood coagulation|response to heat|negative regulation of plasminogen activation|response to drug|fibrinolysis|negative regulation of fibrinolysis|cellular response to glucose stimulus|liver regeneration|negative regulation of hepatocyte proliferation|,carboxypeptidase activity|metallocarboxypeptidase activity|zinc ion binding|,16,59,32900000000,26.5%
Q9CQF9,0.482514848,-0.120083333,6.326195135,0.2785,0.23301318,1.321578429,-0.175,-0.2285,-0.3745,-0.009,0.087,-0.0205,Q9CQF9,Pcyox1,Q9CQF9_Pcyox1,Q9CQF9,Pcyox1,1,33,15,15,Q9CQF9|A0A0N4SWD3,MOUSE,56721.9,35,120,120.1,222.98,222.98,,505,Prenylcysteine oxidase,lysosome|vacuolar membrane|plasma membrane|very-low-density lipoprotein particle|extracellular exosome|,prenylated protein catabolic process|prenylcysteine catabolic process|oxidation-reduction process|chloride transmembrane transport|,prenylcysteine oxidase activity|chloride-transporting ATPase activity|,15,33,3960000000,35.0%
P29533,0.482514848,-0.197083333,6.306277985,0.2745,0.234084254,1.31817052,-0.292,-0.3545,-0.3565,-0.162,-0.02,0.0025,P29533,NotFound,P29533_NotFound,P29533,Vcam1,1,33,17,17,P29533|Q3UPN1|P29533-2,MOUSE,82457.1,24.2,121,121.1,222.7,222.7,,739,Vascular cell adhesion protein 1,podosome|extracellular space|early endosome|endoplasmic reticulum|Golgi apparatus|microvillus|external side of plasma membrane|cell surface|integral component of membrane|filopodium|anchored component of membrane|apical part of cell|extracellular exosome|alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex|cell periphery|,cell adhesion|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|leukocyte cell-cell adhesion|cell-matrix adhesion|heart development|amine metabolic process|viral process|positive regulation of T cell proliferation|leukocyte tethering or rolling|oxidation-reduction process|embryonic placenta morphogenesis|chorio-allantoic fusion|visceral serous pericardium development|cellular response to glucose stimulus|,integrin binding|primary amine oxidase activity|cell adhesion molecule binding|,17,33,7330000000,24.2%
A0A0A6YVP0,0.799195719,-0.064416667,1.91971802,0.2545,0.642729447,0.488022304,0.851,-0.2315,-1.1945,0.083,0.133,-0.0275,A0A0A6YVP0,NotFound,A0A0A6YVP0_NotFound,A0A0A6YVP0,Ighg2b,1,41,17,15,A0A0A6YVP0|P01867|P01867-2|P01865|P01863,MOUSE,45094.4,42.4,122,122.1,222.38,182.23,,405,Immunoglobulin heavy constant gamma 2B (Fragment),"extracellular space|immunoglobulin complex, circulating|","positive regulation of type IIa hypersensitivity|positive regulation of type I hypersensitivity|humoral immune response mediated by circulating immunoglobulin|phagocytosis, recognition|phagocytosis, engulfment|complement activation, classical pathway|immunoglobulin mediated immune response|positive regulation of phagocytosis|positive regulation of immune response|",antigen binding|,17,41,10500000000,42.4%
F6TQW2,0.477326119,-0.977916667,6.629142738,2.1475,0.217313009,1.377147249,-0.185,-0.1185,-5.8515,0.136,0.169,-0.0175,F6TQW2,NotFound,F6TQW2_NotFound,F6TQW2,Ighg2c,1,30,13,11,F6TQW2|P01864,MOUSE,44892.5,32.9,122,122.2,221.89,181.74,,404,Immunoglobulin heavy constant gamma 2C (Fragment),"extracellular space|immunoglobulin complex, circulating|",humoral immune response mediated by circulating immunoglobulin|immunoglobulin mediated immune response|antibacterial humoral response|defense response to bacterium|,antigen binding|,11,30,9360000000,28.2%
Q9Z0Z4,0.482514848,-0.549083333,6.34846958,1.1525,0.231821143,1.329033922,-0.131,-0.0475,-3.1975,0.12,-0.032,-0.0065,Q9Z0Z4,Heph,Q9Z0Z4_Heph,Q9Z0Z4,Heph,1,33,18,18,Q9Z0Z4|Q9Z0Z4-2|A2AI62,MOUSE,130576.7,19.1,123,123.1,221.24,221.24,,1157,Hephaestin,intracellular|integral component of membrane|basolateral plasma membrane|perinuclear region of cytoplasm|,copper ion transport|iron ion transport|cellular iron ion homeostasis|oxidation-reduction process|,ferroxidase activity|copper ion binding|ferrous iron binding|,18,33,3830000000,19.1%
P07309,0.156459648,-0.221083333,18.1293856,1.0345,0.015383723,3.31381839,-1.006,-0.2315,-0.9775,0.475,0.416,-0.0025,P07309,Ttr,P07309_Ttr,P07309,Ttr,1,58,15,15,P07309,MOUSE,15889.7,77.5,124,124.1,213.72,213.72,,147,Transthyretin,extracellular space|protein complex|extracellular exosome|,retinol metabolic process|thyroid hormone transport|,hormone activity|protein binding|identical protein binding|protein heterodimerization activity|thyroid hormone binding|,15,58,81000000000,77.5%
P70663,0.524685888,0.116583333,5.493713629,-0.302833333,0.282246547,-1.177485372,0.593,0.2945,-0.0835,-0.022,-0.032,-0.0505,P70663,Sparcl1,P70663_Sparcl1,P70663,Sparcl1,1,27,16,16,P70663,MOUSE,73141.8,31.3,125,125.1,213.33,213.33,,650,SPARC-like protein 1,proteinaceous extracellular matrix|extracellular space|extracellular exosome|,signal transduction|,calcium ion binding|,16,27,6870000000,31.3%
P02534,0.399101763,0.755083333,8.449123021,-1.735833333,0.142918253,-1.683519513,0.495,3.4745,0.8995,1.518,-1.107,-0.7495,P02534,NotFound,P02534_NotFound,P02534,,1,52,16,8,P02534|Q61765|Q61897|B0LKP1|Q9D646,SHEEP,48099.9,27.4,126,126.1,211.17,116.04,,412,"Keratin, type I microfibrillar 48 kDa, component 8C-1",,,,17,52,58200000000,27.4%
P25690,0.250985566,0.8012,13.48177986,-2.30675,0.044856152,-2.653600267,1.51,2.8605,,1.312,-1.17,-0.5065,P25690,NotFound,P25690_NotFound,P25690,,1,9,13,5,P25690|B1AQ75,SHEEP,47374.2,25.4,126,126.2,138.55,47.11,,404,"Keratin, type I microfibrillar, 47.6 kDa",,,,5,9,2010000000,8.6%
Q61207,0.234839496,-0.2966,14.57320246,0.92775,0.034888296,2.835658377,-1.155,-0.5515,,-0.147,0.302,0.0685,Q61207,Psap,Q61207_Psap,Q61207,Psap,1,35,14,14,Q61207|J3QPG5|K3W4L3|Q8BFQ1|E9PZ00,MOUSE,63303.9,32.1,127,127.1,210.17,210.17,,557,Prosaposin,extracellular space|nucleoplasm|nucleolus|mitochondrion|lysosome|Golgi apparatus|intracellular membrane-bounded organelle|extracellular exosome|,sphingolipid metabolic process|adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway|regulation of lipid metabolic process|regulation of MAPK cascade|positive regulation of MAPK cascade|developmental growth|prostate gland growth|epithelial cell differentiation involved in prostate gland development|cellular response to organic substance|negative regulation of hydrogen peroxide-induced cell death|,G-protein coupled receptor binding|,14,35,16000000000,32.1%
P25691,0.391017748,0.728916667,8.58024889,-1.656166667,0.138667636,-1.705341907,0.842,3.2055,0.6235,1.531,-1.142,-0.6865,P25691,NotFound,P25691_NotFound,P25691,,1,36,17,8,P25691|Q9Z2T6|Q6IMF0|Q99M74|Q9CPR6,SHEEP,56452.4,28.6,128,128.1,209.26,103.27,,502,"Keratin, type II microfibrillar, component 5",,,,18,36,14600000000,28.6%
P15241,0.97245788,-0.25375,0.177150584,0.093166667,0.960030303,0.052228992,0.257,2.9535,-4.1115,1.2,-1.119,-0.7025,P15241,NotFound,P15241_NotFound,P15241,,1,13,16,4,P15241,SHEEP,55506.6,23.4,128,128.2,205.54,56.9,,491,"Keratin, type II microfibrillar, component 7C",,,,4,13,4520000000,9.1%
P02539,0.705762664,0.1916,2.966376397,-0.89025,0.505082545,-0.717222549,-1.021,2.4725,,1.202,-1.022,-0.6735,P02539,NotFound,P02539_NotFound,P02539,,1,2,4,2,P02539,SHEEP,12911.1,35.7,128,128.3,51.8,14.4,,109,"Keratin, type II microfibrillar (Fragment)",,,,2,2,549000000,24.7%
O35930,0.598309776,-0.043083333,4.24277405,0.2125,0.376463257,0.952601815,0.017,-0.1235,-0.3415,0.127,0.089,-0.0265,O35930,Gp1ba,O35930_Gp1ba,O35930,Gp1ba,1,31,14,14,O35930,MOUSE,80567.4,20.2,129,129.1,204.73,204.73,,734,Platelet glycoprotein Ib alpha chain,plasma membrane|integral component of plasma membrane|cell surface|membrane|extracellular exosome|anchored component of external side of plasma membrane|,cell morphogenesis|cell adhesion|blood coagulation|hemostasis|fibrinolysis|,,14,31,4740000000,20.2%
G3X8T3,0.445312347,-0.275916667,7.329362486,0.710833333,0.18495401,1.494570147,-0.439,0.1755,-1.6305,0.154,0.094,-0.0095,G3X8T3,Ctsa,G3X8T3_Ctsa,G3X8T3,Ctsa,1,42,15,15,G3X8T3|P16675,MOUSE,56352.8,29.6,130,130.1,200.62,200.62,,492,Carboxypeptidase,nucleoplasm|mitochondrion|membrane|intracellular membrane-bounded organelle|extracellular exosome|,proteolysis|,serine-type carboxypeptidase activity|protein binding|,15,42,4.29E+11,29.6%
P02088,0.549465437,0.108916667,5.045566472,-0.386166667,0.312927228,-1.098264485,-0.247,0.2095,0.9435,-0.053,-0.244,0.0445,P02088,Hbb-b1,P02088_Hbb-b1,P02088,Hbb-b1,1,49,11,2,P02088|P02081|P02104|D4QBB3|P02070|P06642|P06643,MOUSE,15954,78.9,131,131.1,198.03,34.22,,147,Hemoglobin subunit beta-1,hemoglobin complex|myelin sheath|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,12,49,26000000000,78.9%
A8DUK4,0.603688637,0.397416667,4.180661456,-0.571166667,0.381886103,-0.942909794,-0.272,0.4335,1.8875,0.263,-0.468,0.5405,A8DUK4,Hbb-bs,A8DUK4_Hbb-bs,A8DUK4,Hbb-bs,1,24,11,5,A8DUK4,MOUSE,15804.8,78.9,131,131.2,190.12,74.57,,147,Beta-globin,hemoglobin complex|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,5,24,25800000000,37.4%
P02089,0.767593159,0.7926,2.274961071,0.453916667,0.592248396,0.571414458,0.489,0.5515,,0.613,2.432,-0.1225,P02089,Hbb-b2,P02089_Hbb-b2,P02089,Hbb-b2,1,10,11,4,P02089,MOUSE,15992.1,70,131,131.3,171.49,69.79,,147,Hemoglobin subunit beta-2,hemoglobin complex|,oxygen transport|positive regulation of myeloid cell differentiation|regulation of erythrocyte differentiation|erythrocyte development|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,4,10,371000000,26.5%
Q8VCG4,0.221504253,-0.441916667,15.36914691,0.926833333,0.029045931,2.8270961,-0.916,-0.3855,-1.4145,0.052,-0.198,0.2105,Q8VCG4,C8g,Q8VCG4_C8g,Q8VCG4,C8g,1,58,12,12,Q8VCG4|Q9DAC2,MOUSE,22678.7,63.3,132,132.1,197.03,197.03,,202,Complement component C8 gamma chain,membrane attack complex|extracellular exosome|blood microparticle|,"complement activation, alternative pathway|complement activation, classical pathway|cytolysis|",complement binding|retinol binding|protein complex binding|,12,58,40300000000,63.3%
Q9EQH2,0.405691318,-0.273416667,8.247666392,0.493833333,0.149703985,1.644065724,-0.191,-0.3445,-1.0255,0.114,-0.219,0.0255,Q9EQH2,Erap1,Q9EQH2_Erap1,Q9EQH2,Erap1,1,26,18,18,Q9EQH2,MOUSE,107167.8,20.6,133,133.1,194.41,194.41,,930,Endoplasmic reticulum aminopeptidase 1,extracellular region|extracellular space|cytoplasm|endoplasmic reticulum lumen|endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,immune system process|proteolysis|membrane protein ectodomain proteolysis|positive regulation of angiogenesis|,aminopeptidase activity|interleukin-6 receptor binding|tumor necrosis factor receptor binding|peptidase activity|metalloexopeptidase activity|zinc ion binding|,18,26,1720000000,20.6%
Q9R0E2,0.675762207,0.04525,3.270671631,-0.216166667,0.470904496,-0.767697064,-0.09,-0.0845,0.6345,-0.118,-0.052,-0.0185,Q9R0E2,Plod1,Q9R0E2_Plod1,Q9R0E2,Plod1,1,29,17,16,Q9R0E2|A8Y5E6,MOUSE,84164,24.1,134,134.1,194.02,181.51,,728,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",rough endoplasmic reticulum membrane|extracellular exosome|,response to hypoxia|epidermis development|peptidyl-lysine hydroxylation|cellular response to hormone stimulus|oxidation-reduction process|,ferrous iron binding|procollagen-lysine 5-dioxygenase activity|L-ascorbic acid binding|peptide binding|,17,29,1510000000,24.1%
Q9R0E1,0.155049195,-0.34225,18.35252806,0.8535,0.014613263,3.35434452,-0.864,-0.9915,-0.4515,-0.046,0.277,0.0225,Q9R0E1,Plod3,Q9R0E1_Plod3,Q9R0E1,Plod3,1,9,5,4,Q9R0E1,MOUSE,85491.3,6.7,134,134.2,46.59,34.08,,741,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",rough endoplasmic reticulum membrane|extracellular exosome|,in utero embryonic development|endothelial cell morphogenesis|protein localization|neural tube development|collagen fibril organization|cellular response to hormone stimulus|vasodilation|epidermis morphogenesis|oxidation-reduction process|lung morphogenesis|basement membrane assembly|,iron ion binding|procollagen-lysine 5-dioxygenase activity|L-ascorbic acid binding|procollagen glucosyltransferase activity|,4,9,1640000000,5.3%
P03987,0.838778687,0.08225,1.379809382,0.1345,0.727811749,0.364206933,0.702,-0.3115,-0.3455,-0.004,0.49,-0.0375,P03987,NotFound,P03987_NotFound,P03987,,1,54,13,13,A0A1Y7VJN6|P03987|P03987-2,MOUSE,44498.8,29.8,135,135.1,192.99,192.99,,398,Ig gamma-3 chain C region,extracellular region|plasma membrane|integral component of membrane|,,antigen binding|immunoglobulin receptor binding|,13,54,20800000000,29.8%
Q9JJN5,0.562782873,0.496416667,4.768595517,-0.8765,0.333534258,-1.050841998,-0.077,-0.0435,2.9245,0.13,0.029,0.0155,Q9JJN5,Cpn1,Q9JJN5_Cpn1,Q9JJN5,Cpn1,1,40,14,14,Q9JJN5|Q2KJ83,MOUSE,52129.7,32.6,136,136.1,191.88,191.88,,457,Carboxypeptidase N catalytic chain,extracellular space|,proteolysis|bradykinin catabolic process|response to glucocorticoid|,carboxypeptidase activity|metallocarboxypeptidase activity|zinc ion binding|,14,40,7590000000,32.6%
O09164,0.701522315,-0.190583333,3.021728321,0.382166667,0.498685991,0.719535558,0.094,0.3405,-1.5795,0.103,-0.07,-0.0315,O09164,Sod3,O09164_Sod3,O09164,Sod3,1,28,13,13,O09164,MOUSE,27733.7,43.8,137,137.1,191.86,191.86,,251,Extracellular superoxide dismutase [Cu-Zn],extracellular space|nucleus|cytoplasm|Golgi lumen|trans-Golgi network|extracellular exosome|extracellular matrix|,response to hypoxia|removal of superoxide radicals|response to copper ion|oxidation-reduction process|,superoxide dismutase activity|copper ion binding|protein binding|zinc ion binding|,13,28,12500000000,43.8%
Q9R097,0.961089316,0.172083333,0.291932911,-0.0325,0.934989446,-0.084947415,-0.227,-0.1745,0.9665,0.333,0.163,-0.0285,Q9R097,Spint1,Q9R097_Spint1,Q9R097,Spint1,1,26,15,15,Q9R097,MOUSE,58358.6,32.5,138,138.1,190.51,190.51,,507,Kunitz-type protease inhibitor 1,extracellular space|plasma membrane|extracellular exosome|,neural tube closure|embryonic placenta development|negative regulation of endopeptidase activity|extracellular matrix organization|branching involved in labyrinthine layer morphogenesis|placenta blood vessel development|,serine-type endopeptidase inhibitor activity|,15,26,1830000000,32.5%
P11680,0.310263903,-0.089583333,10.44771693,0.808833333,0.090204521,2.008247118,-0.125,-0.0665,-1.2905,0.354,0.582,0.0085,P11680,Cfp,P11680_Cfp,P11680,Cfp,1,62,14,14,P11680,MOUSE,52836.7,34.6,139,139.1,189.43,189.43,,464,Properdin,extracellular region|extracellular matrix|,"complement activation, alternative pathway|",,14,62,1.15E+11,34.6%
Q63880,0.933745622,-0.031416667,0.51828789,-0.052833333,0.887505823,-0.147387917,-0.468,-0.2255,0.6785,-0.175,-0.171,0.1725,Q63880,Ces3a,Q63880_Ces3a,Q63880,Ces3a,1,44,14,7,Q63880|Q63880-2,MOUSE,63715.9,26.7,140,140.1,187.48,99.39,,571,Carboxylesterase 3A,endoplasmic reticulum lumen|extracellular exosome|,metabolic process|,carboxylic ester hydrolase activity|,14,44,12800000000,26.7%
Q8VCU1,0.489163288,-0.1962,6.199821022,0.360083333,0.239893178,1.32681771,-0.265,-0.5595,,-0.152,-0.093,0.0885,Q8VCU1,Ces3b,Q8VCU1_Ces3b,Q8VCU1,Ces3b,1,5,10,3,Q8VCU1|Q8VCU1-2,MOUSE,63751.2,16.2,140,140.2,117.93,29.84,,571,Carboxylesterase 3B,endoplasmic reticulum lumen|extracellular exosome|,metabolic process|,carboxylic ester hydrolase activity|,3,5,343000000,5.7%
P33587,0.46334768,-0.132416667,6.944698267,0.507833333,0.202083183,1.426614161,-0.037,-0.0545,-1.0675,0.375,0.013,-0.0235,P33587,Proc,P33587_Proc,P33587,Proc,1,28,13,13,P33587,MOUSE,53186.4,29.1,141,141.1,186.51,186.51,,460,Vitamin K-dependent protein C,extracellular space|,proteolysis|blood coagulation|negative regulation of blood coagulation|negative regulation of apoptotic process|,calcium ion binding|peptidase activity|,13,28,4500000000,29.1%
P00687,0.519628152,-0.116916667,5.625829276,0.446166667,0.273789679,1.200599817,-0.303,0.3005,-1.0175,0.216,0.123,-0.0205,P00687,Amy1,P00687_Amy1,P00687,Amy1,1,25,15,15,P00687|P00688|E9PV85|Q3MHH8,MOUSE,58327.3,33.6,142,142.1,186.04,186.04,,511,Alpha-amylase 1,extracellular space|extracellular exosome|,carbohydrate catabolic process|,alpha-amylase activity|calcium ion binding|amylase activity|chloride ion binding|,15,25,6910000000,33.6%
Q9R098,0.91535326,0.025083333,0.700626159,0.044166667,0.851015331,0.19582148,-0.2,0.1455,0.0635,0.012,0.168,-0.0385,Q9R098,Hgfac,Q9R098_Hgfac,Q9R098,Hgfac,1,32,15,15,Q9R098,MOUSE,72905.8,25.5,143,143.1,185.96,185.96,,653,Hepatocyte growth factor activator,extracellular space|cytoplasm|rough endoplasmic reticulum|,proteolysis|,serine-type endopeptidase activity|,15,32,10500000000,25.5%
E9Q557,0.279130421,0.479583333,11.64565147,-2.500166667,0.068459678,-2.213953269,1.204,4.2245,-0.2395,-0.931,-1.316,-0.0645,E9Q557,Dsp,E9Q557_Dsp,E9Q557,Dsp,1,26,21,21,E9Q557|E9PZW0,MOUSE,335359.7,6.1,144,144.1,185.79,185.79,,2883,Desmoplakin,cornified envelope|nucleus|cytoplasm|plasma membrane|cell-cell junction|fascia adherens|intercalated disc|membrane|basolateral plasma membrane|desmosome|extracellular exosome|intermediate filament|,desmosome organization|ventricular compact myocardium morphogenesis|single organismal cell-cell adhesion|peptide cross-linking|keratinocyte differentiation|adherens junction organization|wound healing|skin development|intermediate filament cytoskeleton organization|intermediate filament organization|protein localization to adherens junction|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|regulation of ventricular cardiac muscle cell action potential|,"protein kinase C binding|structural molecule activity|protein binding|protein binding, bridging|poly(A) RNA binding|cell adhesion molecule binding|scaffold protein binding|",21,26,827000000,6.1%
Q91Y47,0.298904745,-0.066583333,10.75528856,0.620833333,0.084037117,2.056090884,-0.436,-0.1325,-0.5625,-0.209,0.64,0.3005,Q91Y47,F11,Q91Y47_F11,Q91Y47,F11,1,36,15,15,Q91Y47,MOUSE,71784.4,24.1,145,145.1,185.55,185.55,,624,Coagulation factor XI,extracellular space|extracellular exosome|,blood coagulation|regulation of blood coagulation|plasminogen activation|positive regulation of fibrinolysis|,serine-type endopeptidase activity|heparin binding|,15,36,12800000000,24.1%
P28654,0.103361882,0.617583333,22.3814588,-2.260166667,0.005779019,-4.17165833,2.936,0.8725,1.4345,-0.614,-0.387,-0.5365,P28654,Dcn,P28654_Dcn,P28654,Dcn,1,34,14,14,P28654,MOUSE,40150.6,30.7,146,146.1,183.24,183.24,,354,Decorin,collagen type VI trimer|extracellular space|extracellular matrix|,kidney development|placenta development|skeletal muscle tissue development|aging|response to mechanical stimulus|positive regulation of autophagy|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|response to lipopolysaccharide|wound healing|,collagen binding|glycosaminoglycan binding|poly(A) RNA binding|protein N-terminus binding|extracellular matrix binding|,14,34,9390000000,30.7%
E0CZ58,0.677925707,-0.48975,3.233406932,0.947833333,0.474962484,0.761608259,1.131,-0.1395,-3.8825,0.225,-0.189,-0.0835,E0CZ58,Prg4,E0CZ58_Prg4,E0CZ58,Prg4,1,25,15,15,E0CZ58|Q9JM99|Q9JM99-2|E9QQ17|Q9JM99-3|E9QQ18|Q9JM99-4|A0A0R4J207|Q9JM99-5,MOUSE,135831.6,12.2,147,147.1,182.88,182.88,,1221,Proteoglycan 4,extracellular space|cytoplasm|,receptor-mediated endocytosis|immune response|peptide cross-linking|regulation of cell proliferation|negative regulation of interleukin-6 biosynthetic process|hematopoietic stem cell proliferation|,scavenger receptor activity|polysaccharide binding|,15,25,3470000000,12.2%
P16301,0.573276051,-0.00625,4.64179266,0.388833333,0.343416165,1.02579876,-0.807,-0.2695,0.4745,0.464,0.114,-0.0135,P16301,Lcat,P16301_Lcat,P16301,Lcat,1,50,11,11,P16301,MOUSE,50088.2,27.3,148,148.1,182.49,182.49,,438,Phosphatidylcholine-sterol acyltransferase,extracellular space|high-density lipoprotein particle|extracellular exosome|,phospholipid metabolic process|phosphatidylcholine biosynthetic process|cholesterol metabolic process|cholesterol transport|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|cholesterol esterification|lipoprotein biosynthetic process|cholesterol homeostasis|reverse cholesterol transport|response to copper ion|response to glucocorticoid|regulation of high-density lipoprotein particle assembly|,phosphatidylcholine-sterol O-acyltransferase activity|phospholipase A2 activity|apolipoprotein A-I binding|,11,50,75100000000,27.3%
Q8CIF4,0.836932698,0.242416667,1.414900377,-0.253833333,0.721954724,-0.372900989,-0.663,-0.1665,1.9375,0.233,0.124,-0.0105,Q8CIF4,Btd,Q8CIF4_Btd,Q8CIF4,Btd,1,44,12,12,A0A0R4J131|Q8CIF4,MOUSE,58952,26.1,149,149.1,182.21,182.21,,520,Biotinidase,extracellular space|nucleolus|perikaryon|apical part of cell|extracellular exosome|,biotin metabolic process|,biotinidase activity|,12,44,12800000000,26.1%
P45700,0.23713653,-0.26375,14.12090769,0.585833333,0.038717671,2.614490276,-0.716,-0.3635,-0.5905,-0.037,0.139,-0.0145,P45700,Man1a,P45700_Man1a,P45700,Man1a1,1,22,16,16,P45700|A0A1W2P6N0,MOUSE,73502.6,28.7,150,150.1,180.91,180.91,,655,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA",Golgi membrane|cytoplasm|endoplasmic reticulum|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|membrane|integral component of membrane|extracellular exosome|,N-glycan processing|,"mannosyl-oligosaccharide 1,2-alpha-mannosidase activity|calcium ion binding|",16,22,1330000000,28.7%
Q5I012-3,0.87051184,0.015083333,1.070885196,-0.061166667,0.781468506,-0.289739826,-0.081,0.1015,0.1165,0.031,-0.073,-0.0045,Q5I012,Slc38a10,Q5I012-3_Slc38a10,Q5I012-3,Slc38a10,1,25,14,14,Q5I012-3|Q5I012-4|Q5I012|J3QNE8|Q5I012-2,MOUSE,116909.1,19.2,151,151.1,178.74,178.74,,1090,Isoform 3 of Putative sodium-coupled neutral amino acid transporter 10,Golgi apparatus|integral component of membrane|,amino acid transmembrane transport|sodium ion transport|bone development|,amino acid transmembrane transporter activity|,14,25,15700000000,19.2%
P01837,0.648286631,0.07525,3.574895572,0.283166667,0.439046423,0.826762038,0.065,-0.5105,0.2465,-0.194,0.687,0.1575,P01837,NotFound,P01837_NotFound,P01837,,1,55,11,11,P01837|A0A075B5P2,MOUSE,11948.8,94.3,152,152.1,178.32,178.32,,106,Ig kappa chain C region,plasma membrane|,,antigen binding|,11,55,1.93E+11,94.3%
P55065,0.99160876,0.138083333,0.071423785,-0.0105,0.983688562,-0.021298926,-0.402,-0.4095,1.2415,0.111,0.291,-0.0035,P55065,Pltp,P55065_Pltp,P55065,Pltp,1,37,12,12,P55065|A2A5K2,MOUSE,54680.3,32.4,153,153.1,177.91,177.91,,493,Phospholipid transfer protein,extracellular space|,lipid metabolic process|lipid transport|vitamin E biosynthetic process|positive regulation of cholesterol efflux|sperm motility|high-density lipoprotein particle remodeling|,lipid binding|,12,37,6390000000,32.4%
Q9QXC1,0.729414454,0.289583333,2.712697611,-0.432833333,0.535463952,-0.656878777,-0.478,0.0025,1.9935,0.348,-0.186,0.0575,Q9QXC1,Fetub,Q9QXC1_Fetub,Q9QXC1,Fetub,1,48,12,12,Q9QXC1|Q6YJU1,MOUSE,43567.8,23.4,154,154.1,176.74,176.74,,388,Fetuin-B,extracellular region|extracellular space|extracellular exosome|,single fertilization|binding of sperm to zona pellucida|negative regulation of endopeptidase activity|,cysteine-type endopeptidase inhibitor activity|metalloendopeptidase inhibitor activity|,12,48,27900000000,23.4%
P98086,0.729414454,0.40675,2.731435395,0.3875,0.533158651,0.660722545,1.205,0.1725,-0.7385,0.692,1.209,-0.0995,P98086,C1qa,P98086_C1qa,P98086,C1qa,1,52,12,12,P98086,MOUSE,26202.1,41.6,155,155.1,175.59,175.59,,245,Complement C1q subcomponent subunit A,collagen trimer|extracellular exosome|,"complement activation, classical pathway|innate immune response|",protein binding|,12,52,1.18E+11,41.6%
P46412,0.132527215,-0.28775,19.66699087,0.835166667,0.010796946,3.597171839,-0.537,-0.6705,-0.9085,0.301,0.074,0.0145,P46412,Gpx3,P46412_Gpx3,P46412,Gpx3,1,61,12,12,P46412|P21765,MOUSE,25581.2,43.3,156,156.1,174.84,174.84,,226,Glutathione peroxidase 3,extracellular space|extracellular exosome|,response to oxidative stress|hydrogen peroxide catabolic process|protein homotetramerization|oxidation-reduction process|,glutathione peroxidase activity|selenium binding|,12,61,45300000000,43.3%
Q3UTR7,0.623481262,-0.00325,3.84895041,0.264833333,0.412197126,0.878989419,-0.322,0.2485,-0.3335,0.52,-0.132,-0.0005,Q3UTR7,Agt,Q3UTR7_Agt,Q3UTR7,Agt,1,37,11,11,Q3UTR7|P11859,MOUSE,52954.5,32.3,157,157.1,172.59,172.59,,482,Angiotensinogen,extracellular space|cytoplasm|extracellular exosome|blood microparticle|,"ovarian follicle rupture|blood vessel development|branching involved in ureteric bud morphogenesis|kidney development|regulation of systemic arterial blood pressure by circulatory renin-angiotensin|angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure|renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure|renin-angiotensin regulation of aldosterone production|regulation of renal output by angiotensin|regulation of heart rate|brain renin-angiotensin system|renal system process|angiotensin-mediated drinking behavior|positive regulation of extracellular matrix constituent secretion|cellular sodium ion homeostasis|cell-matrix adhesion|G-protein coupled receptor signaling pathway|activation of phospholipase C activity|activation of NF-kappaB-inducing kinase activity|female pregnancy|aging|excretion|establishment of blood-nerve barrier|regulation of blood pressure|negative regulation of cell proliferation|response to cold|response to salt stress|regulation of gene expression|positive regulation of activation of JAK2 kinase activity|positive regulation of endothelial cell migration|positive regulation of cardiac muscle hypertrophy|positive regulation of gene expression|positive regulation of cholesterol esterification|negative regulation of endopeptidase activity|regulation of norepinephrine secretion|positive regulation of phosphatidylinositol 3-kinase signaling|artery smooth muscle contraction|response to muscle activity involved in regulation of muscle adaptation|negative regulation of angiogenesis|extracellular matrix organization|negative regulation of cell growth|peristalsis|positive regulation of cellular protein metabolic process|positive regulation of superoxide anion generation|positive regulation of peptidyl-serine phosphorylation|negative regulation of tissue remodeling|catenin import into nucleus|positive regulation of renal sodium excretion|positive regulation of multicellular organism growth|vasodilation|hormone metabolic process|drinking behavior|regulation of apoptotic process|positive regulation of MAPK cascade|negative regulation of neuron apoptotic process|positive regulation of nitric oxide biosynthetic process|positive regulation of fatty acid biosynthetic process|positive regulation of epidermal growth factor receptor signaling pathway|positive regulation of transcription, DNA-templated|positive regulation of vasodilation|positive regulation of organ growth|astrocyte activation|fibroblast proliferation|positive regulation of fibroblast proliferation|regulation of long-term neuronal synaptic plasticity|smooth muscle cell proliferation|cytokine secretion|regulation of inflammatory response|positive regulation of peptidyl-tyrosine phosphorylation|smooth muscle cell differentiation|negative regulation of neurotrophin TRK receptor signaling pathway|stress-activated MAPK cascade|regulation of calcium ion transport|regulation of transmission of nerve impulse|cell growth involved in cardiac muscle cell development|positive regulation of protein tyrosine kinase activity|ERK1 and ERK2 cascade|uterine smooth muscle contraction|cellular response to mechanical stimulus|positive regulation of branching involved in ureteric bud morphogenesis|positive regulation of protein kinase C activity|regulation of extracellular matrix assembly|positive regulation of membrane hyperpolarization|positive regulation of gap junction assembly|regulation of cardiac conduction|positive regulation of extrinsic apoptotic signaling pathway|",serine-type endopeptidase inhibitor activity|hormone activity|sodium channel regulator activity|type 1 angiotensin receptor binding|type 2 angiotensin receptor binding|,11,37,18000000000,32.3%
P00760,0.011676506,0.827083333,40.08832153,-2.859166667,9.79869E-05,-8.829433509,2.805,1.7665,2.1985,-0.703,-0.676,-0.4285,P00760,NotFound,P00760_NotFound,P00760,,1,30,11,11,P00760,BOVIN,26469.4,51.6,158,158.1,171.87,171.87,,246,Cationic trypsin,,,,11,30,15800000000,51.6%
G5E8J0,0.482514848,-0.156083333,6.287638118,0.297833333,0.2350911,1.314979584,-0.525,-0.2825,-0.1075,-0.027,-0.041,0.0465,G5E8J0,Notch2,G5E8J0_Notch2,G5E8J0,Notch2,1,24,15,15,G5E8J0|O35516|O35516-2,MOUSE,279492.6,6.5,159,159.1,170.89,170.89,,2473,Neurogenic locus notch homolog protein 2,nucleus|integral component of plasma membrane|cell surface|receptor complex|,pulmonary valve morphogenesis|cell cycle arrest|Notch signaling pathway|negative regulation of cell proliferation|cell growth|cell differentiation|positive regulation of Ras protein signal transduction|bone remodeling|regulation of developmental process|atrial septum morphogenesis|,calcium ion binding|,15,24,644000000,6.5%
P16882-2,0.18181008,-0.28375,16.44861773,0.741166667,0.022653652,3.014445159,-0.657,-0.3855,-0.9205,0.011,0.238,0.0115,P16882,Ghr,P16882-2_Ghr,P16882-2,Ghr,1,41,10,10,P16882-2|P16882|Q3UP14,MOUSE,34617.4,36.7,160,160.1,170.74,170.74,,650,Isoform 2 of Growth hormone receptor,extracellular region|extracellular space|nucleus|plasma membrane|integral component of plasma membrane|cell surface|integral component of membrane|extrinsic component of membrane|receptor complex|growth hormone receptor complex|,allantoin metabolic process|citrate metabolic process|2-oxoglutarate metabolic process|succinate metabolic process|oxaloacetate metabolic process|isoleucine metabolic process|valine metabolic process|creatine metabolic process|fatty acid metabolic process|endocytosis|cytokine-mediated signaling pathway|taurine metabolic process|response to estradiol|cellular response to hormone stimulus|regulation of multicellular organism growth|positive regulation of multicellular organism growth|multicellular organismal metabolic process|creatinine metabolic process|insulin-like growth factor receptor signaling pathway|positive regulation of peptidyl-tyrosine phosphorylation|growth hormone receptor signaling pathway|,growth hormone receptor activity|protein binding|peptide hormone binding|growth factor binding|protein homodimerization activity|,10,41,35700000000,36.7%
Q61781,0.23713653,0.26275,14.30347142,-2.121166667,0.037123837,-2.663028866,0.872,3.0245,0.0735,-0.723,-1.437,-0.2335,Q61781,Krt14,Q61781_Krt14,Q61781,Krt14,1,46,15,1,Q61781|Q9D312|Q9Z320|Q8VCW2|Q8CCX5|Q8CCX5-2,MOUSE,53208.4,25.8,161,161.1,168.8,11.35,,484,"Keratin, type I cytoskeletal 14",intracellular|nucleus|cytoplasm|intermediate filament|keratin filament|extracellular exosome|cell periphery|,aging|response to zinc ion|response to ionizing radiation|epithelial cell differentiation|hair cycle|intermediate filament bundle assembly|,structural molecule activity|protein binding|keratin filament binding|,16,46,2.97E+11,25.8%
Q6IFX2,0.522086579,-0.122083333,5.562181696,-1.388166667,0.277831722,-1.192374084,0.498,2.9485,-1.7305,-0.828,-1.507,-0.1135,Q6IFX2,Krt42,Q6IFX2_Krt42,Q6IFX2,Krt42,1,4,13,3,Q6IFX2,MOUSE,50474.5,25.2,161,161.2,151.31,34.72,,452,"Keratin, type I cytoskeletal 42",cytoplasm|intermediate filament|,,structural molecule activity|,3,4,190000000,5.7%
Q9QWL7,0.01315234,0.981583333,34.48230007,-4.1995,0.000356262,-7.184492944,3.283,3.7655,2.1955,-1.062,-1.995,-0.2975,Q9QWL7,Krt17,Q9QWL7_Krt17,Q9QWL7,Krt17,1,2,13,1,Q9QWL7|Q99PS0,MOUSE,48446.3,21.7,161,161.3,151.24,6.79,,433,"Keratin, type I cytoskeletal 17",cytoplasm|intermediate filament|extracellular exosome|cell periphery|,morphogenesis of an epithelium|signal transduction|positive regulation of cell growth|hair follicle morphogenesis|keratinization|intermediate filament organization|positive regulation of translation|positive regulation of hair follicle development|,structural molecule activity|protein binding|MHC class II receptor activity|MHC class II protein binding|,1,2,15300000,2.0%
B1AQ77,0.218611325,0.7108,15.5381169,-3.739916667,0.027937549,-3.055669849,0.876,5.0335,,-0.792,-0.604,-0.9595,B1AQ77,Krt15,B1AQ77_Krt15,B1AQ77,Krt15,1,4,11,2,B1AQ77|Q61414|A6BLY7,MOUSE,49664.3,13.5,161,161.4,129.01,21.98,,456,"Keratin 15, isoform CRA_a",nucleus|intermediate filament|extracellular exosome|,activation of mitophagy in response to mitochondrial depolarization|,structural molecule activity|scaffold protein binding|,2,4,1370000000,5.7%
P02535,0.296807957,0.151583333,10.92839476,-1.642833333,0.080753346,-2.094656504,0.727,2.6115,-0.4195,-0.279,-1.255,-0.4755,P02535,Krt10,P02535_Krt10,P02535,Krt10,1,24,10,5,P02535|P02535-2|A2A513|P02535-3,MOUSE,57940,13.8,161,161.5,131.67,70.41,,570,"Keratin, type I cytoskeletal 10",keratin filament|,epithelial cell differentiation|cellular response to calcium ion|,structural molecule activity|protein binding|,5,24,37900000000,8.5%
O77727,0.441723111,0.34525,7.509676017,-1.250166667,0.177432184,-1.526365768,1.319,2.3365,-0.7445,0.097,-1.007,0.0705,O77727,NotFound,O77727_NotFound,O77727,KRT15,1,6,10,2,O77727,SHEEP,48769.2,15.4,161,161.6,116.7,25.71,,453,"Keratin, type I cytoskeletal 15",,,,2,6,2630000000,3.5%
Q9Z2K1,0.643086642,0.436416667,3.652022358,-0.787166667,0.43131818,-0.843022864,0.89,2.4465,-0.8465,0.348,-1.104,0.8845,Q9Z2K1,Krt16,Q9Z2K1_Krt16,Q9Z2K1,Krt16,1,1,9,1,Q9Z2K1,MOUSE,52004.9,14.2,161,161.7,96.09,13.88,,469,"Keratin, type I cytoskeletal 16",nucleus|cytoskeleton|intermediate filament|extracellular exosome|,morphogenesis of an epithelium|inflammatory response|aging|keratinocyte differentiation|negative regulation of cell migration|keratinization|hair cycle|innate immune response|intermediate filament cytoskeleton organization|keratinocyte migration|establishment of skin barrier|,structural constituent of cytoskeleton|protein binding|,1,1,251000000,2.3%
P19001,0.011676506,0.566416667,38.81593827,-2.1605,0.000131343,-8.392660609,1.705,1.8905,1.3445,-0.493,-0.72,-0.3285,P19001,Krt19,P19001_Krt19,P19001,Krt19,1,1,6,1,P19001,MOUSE,44541,11.4,161,161.8,67.68,4.52,,403,"Keratin, type I cytoskeletal 19",intermediate filament|plasma membrane|dystrophin-associated glycoprotein complex|Z disc|sarcolemma|costamere|extracellular exosome|cell periphery|terminal web|,Notch signaling pathway|response to estrogen|sarcomere organization|cell differentiation involved in embryonic placenta development|,protein binding|structural constituent of muscle|protein complex binding|,1,1,10900000,2.9%
Q9BGM5,0.449503035,0.139083333,7.25345947,-1.9885,0.188214922,-1.483179831,1.567,3.6935,-1.8605,-0.596,-1.236,-0.7335,Q9BGM5,NotFound,Q9BGM5_NotFound,Q9BGM5,KRT25,1,4,2,1,Q9BGM5,SHEEP,49883,4,161,161.9,33.78,17.51,,450,"Keratin, type I cytoskeletal 25",,,,1,4,9030000000,2.0%
Q8K0D2,0.549465437,-0.04075,5.127578679,0.333833333,0.307073354,1.112862218,-0.593,-0.2825,0.2525,0.365,0.022,-0.0085,Q8K0D2,Habp2,Q8K0D2_Habp2,Q8K0D2,Habp2,1,32,15,15,Q8K0D2|E9QM92|E9Q092|Q8K0D2-2|Q3V1J8|E9Q0C5,MOUSE,64409.4,21.6,162,162.1,168.11,168.11,,558,Hyaluronan-binding protein 2,extracellular region|,proteolysis|,serine-type endopeptidase activity|peptidase activity|,15,32,3620000000,21.6%
P28653,0.253802285,0.36875,13.30881675,-1.173166667,0.046678654,-2.488736537,1.997,0.5465,0.3225,-0.291,-0.144,-0.2185,P28653,Bgn,P28653_Bgn,P28653,Bgn,1,23,12,12,P28653,MOUSE,42094.9,42,163,163.1,168.09,168.09,,369,Biglycan,proteinaceous extracellular matrix|intracellular|cell surface|transport vesicle|sarcolemma|extracellular exosome|extracellular matrix|,blood vessel remodeling|peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|,glycosaminoglycan binding|extracellular matrix binding|,12,23,6600000000,42.0%
A0A075B5T3,0.279130421,-0.097583333,11.68151279,0.6875,0.067896709,2.20831241,-0.457,-0.1185,-0.7485,0.046,0.705,-0.0125,A0A075B5T3,NotFound,A0A075B5T3_NotFound,A0A075B5T3,Ighv6-6,1,46,12,7,A0A075B5T3,MOUSE,13464,81.5,164,164.1,166.21,108.83,,119,Immunoglobulin heavy variable 6-6 (Fragment),,,,12,46,78700000000,81.5%
A0A075B5T2,0.262291975,-0.429916667,12.73985609,1.3355,0.053212589,2.397209513,-0.89,-0.1545,-2.2485,-0.12,0.472,0.3615,A0A075B5T2,NotFound,A0A075B5T2_NotFound,A0A075B5T2,Ighv6-3,1,18,10,5,A0A075B5T2,MOUSE,13430,56.7,164,164.2,140.01,78.14,,118,Immunoglobulin heavy variable 6-3 (Fragment),,,,5,18,19200000000,26.2%
P01801,0.262291975,-0.229,12.82156266,1.23125,0.052220826,2.515447679,-1.626,-0.3095,,0.151,0.649,-0.0095,P01801,NotFound,P01801_NotFound,P01801,,1,10,8,3,P01801|P01799|P01798|P01802|P01800|P01803,MOUSE,12924.2,45.2,164,164.3,107.64,47.18,,115,Ig heavy chain V-III region J606,,,antigen binding|,3,10,4190000000,15.6%
A0A0A6YWU3,0.426680179,0.3284,7.862606229,1.208583333,0.163583455,1.629822737,-0.271,-0.5225,,0.525,-0.231,2.1415,A0A0A6YWU3,NotFound,A0A0A6YWU3_NotFound,A0A0A6YWU3,Ighv6-7,1,1,4,1,A0A0A6YWU3,MOUSE,13943.6,24.3,164,164.4,51.62,14.63,,119,Immunoglobulin heavy variable V6-7 (Fragment),,,,1,1,20200000,7.5%
P03953,0.91535326,0.044416667,0.741374564,-0.047833333,0.84306788,-0.206436226,-0.144,0.2675,0.0815,-0.12,0.093,0.0885,P03953,Cfd,P03953_Cfd,P03953,Cfd,1,39,8,8,P03953|P03953-2,MOUSE,28569.8,43.6,165,165.1,165.79,165.79,,259,Complement factor D,extracellular space|extracellular exosome|,"proteolysis|complement activation, alternative pathway|",serine-type endopeptidase activity|,8,39,45700000000,43.6%
Q3TQC7,0.960183899,0.01325,0.30525147,0.025833333,0.932126496,0.088689357,-0.363,-0.0015,0.3655,0.297,-0.229,0.0105,Q3TQC7,Entpd5,Q3TQC7_Entpd5,Q3TQC7,Entpd5,1,26,12,12,Q3TQC7|Q9WUZ9,MOUSE,50293.2,32.5,166,166.1,165.26,165.26,,452,Ectonucleoside triphosphate diphosphohydrolase 5,extracellular exosome|,metabolic process|,hydrolase activity|,12,26,2800000000,32.5%
E9QN70,0.241404541,-0.38575,13.96795558,1.055833333,0.040105547,2.593398133,-0.638,-0.4205,-1.6825,-0.196,0.123,0.4995,E9QN70,Lamb1,E9QN70_Lamb1,E9QN70,Lamb1,1,20,14,14,E9QN70|P02469,MOUSE,209741,9.2,167,167.1,164.23,164.23,,1834,Laminin subunit beta-1,proteinaceous extracellular matrix|basement membrane|basal lamina|laminin-1 complex|laminin-2 complex|extracellular space|extracellular matrix|laminin complex|laminin-8 complex|laminin-10 complex|extracellular exosome|basement membrane|,embryo implantation|cell migration|neuronal-glial interaction involved in cerebral cortex radial glia guided migration|positive regulation of cell migration|neuron projection development|substrate adhesion-dependent cell spreading|endodermal cell differentiation|odontogenesis|,integrin binding|extracellular matrix structural constituent|protein binding|enzyme binding|glycosphingolipid binding|,14,20,645000000,9.2%
Q80YC5,0.246130185,-0.133416667,13.80103591,0.625833333,0.041676996,2.560610775,-0.635,-0.2505,-0.4535,0.425,0.113,0.0005,Q80YC5,F12,Q80YC5_F12,Q80YC5,F12,1,31,11,11,Q80YC5|E9Q698,MOUSE,67982.3,18.7,168,168.1,163.11,163.11,,597,Coagulation factor XII,extracellular space|extracellular exosome|,plasma kallikrein-kinin cascade|Factor XII activation|blood coagulation|positive regulation of plasminogen activation|protein processing|protein autoprocessing|regulation of blood coagulation|positive regulation of blood coagulation|zymogen activation|fibrinolysis|response to misfolded protein|positive regulation of fibrinolysis|,serine-type endopeptidase activity|peptidase activity|serine-type aminopeptidase activity|,11,31,8600000000,18.7%
Q8BND5,0.606693779,0.468916667,4.060890433,-0.738833333,0.39256444,-0.920535866,0.011,-0.2355,2.7395,0.076,0.229,-0.0065,Q8BND5,Qsox1,Q8BND5_Qsox1,Q8BND5,Qsox1,1,23,15,2,Q8BND5|Q8BND5-2,MOUSE,83582.5,19.6,169,169.1,162.72,28.56,,748,Sulfhydryl oxidase 1,extracellular space|endoplasmic reticulum|Golgi apparatus|integral component of Golgi membrane|intracellular membrane-bounded organelle|intercellular bridge|extracellular exosome|,protein folding|negative regulation of macroautophagy|cell redox homeostasis|oxidation-reduction process|,protein disulfide isomerase activity|flavin-linked sulfhydryl oxidase activity|,15,23,1700000000,19.6%
Q8BND5-3,0.178061338,0.604083333,16.65191109,-1.2205,0.02161767,-3.056988367,1.964,0.5025,1.1765,0.078,-0.13,0.0335,Q8BND5,Qsox1,Q8BND5-3_Qsox1,Q8BND5-3,Qsox1,1,2,14,2,Q8BND5-3,MOUSE,64076.9,22.8,169,169.2,143.47,20.41,,748,Isoform 3 of Sulfhydryl oxidase 1,extracellular space|endoplasmic reticulum|Golgi apparatus|integral component of Golgi membrane|intracellular membrane-bounded organelle|intercellular bridge|extracellular exosome|,protein folding|negative regulation of macroautophagy|cell redox homeostasis|oxidation-reduction process|,protein disulfide isomerase activity|flavin-linked sulfhydryl oxidase activity|,2,2,56500000,3.6%
P18242,0.606693779,-0.04575,4.092108716,0.205833333,0.389752696,0.92462769,-0.007,-0.2825,-0.1565,-0.08,0.196,0.0555,P18242,Ctsd,P18242_Ctsd,P18242,Ctsd,1,21,11,11,P18242|F8WIR1,MOUSE,45409.4,32.6,170,170.1,162.24,162.24,,410,Cathepsin D,extracellular space|mitochondrion|lysosome|melanosome|membrane raft|extracellular exosome|extracellular matrix|,autophagosome assembly|proteolysis|autophagy|protein catabolic process|epithelial tube branching involved in lung morphogenesis|,aspartic-type endopeptidase activity|peptidase activity|peptide binding|,11,21,605000000,32.6%
Q3UEL9,0.606693779,0.06075,4.10637804,0.6995,0.388474213,0.929049939,1.051,-0.1705,-1.7475,0.971,-0.301,0.5615,Q3UEL9,Serpina7,Q3UEL9_Serpina7,Q3UEL9,Serpina7,1,27,14,14,Q3UEL9|P61939|Q8BII9,MOUSE,48364.8,31.4,171,171.1,160.1,160.1,,426,Thyroxine-binding globulin,extracellular space|extracellular exosome|,aging|post-embryonic development|negative regulation of endopeptidase activity|response to vitamin A|response to prostaglandin E|response to drug|response to peptide hormone|response to corticosterone|thyroid hormone transport|,serine-type endopeptidase inhibitor activity|hormone binding|,14,27,9290000000,31.4%
O55111,0.301834969,-0.327583333,10.67271371,0.502166667,0.085650249,2.042545457,-0.434,-0.3965,-0.9055,-0.063,-0.173,0.0065,O55111,Dsg2,O55111_Dsg2,O55111,Dsg2,1,21,13,13,O55111|Q811I1|Q8VCE3,MOUSE,123181.5,15,172,172.1,159.95,159.95,,1122,Desmoglein-2,plasma membrane|cell surface|intercalated disc|integral component of membrane|apical plasma membrane|lateral plasma membrane|desmosome|extracellular exosome|,desmosome organization|Purkinje myocyte development|cell adhesion|homophilic cell adhesion via plasma membrane adhesion molecules|response to progesterone|maternal process involved in female pregnancy|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|regulation of ventricular cardiac muscle cell action potential|,calcium ion binding|cell adhesion molecule binding|,13,21,489000000,15.0%
P12399,0.416821309,-0.709916667,8.067859052,1.270833333,0.156032151,1.619931634,-0.322,-0.5115,-3.2025,-0.097,-0.181,0.0545,P12399,Ctla2a,P12399_Ctla2a,P12399,Ctla2a,1,47,11,11,P12399|A0A286YDF0|A0A286YD17|P12400|A0A0R4J245,MOUSE,16053.8,59.8,173,173.1,156.3,156.3,,137,Protein CTLA-2-alpha,extracellular space|lysosome|dendrite|,negative regulation of protein processing|regulation of regulatory T cell differentiation|negative regulation of inflammatory response|proteolysis involved in cellular protein catabolic process|,cysteine-type endopeptidase activity|,11,47,38800000000,59.8%
O08795-2,0.441723111,-0.0458,7.437060818,0.44575,0.180423838,1.546721492,-0.524,-0.1025,,0.253,0.179,-0.0345,O08795,Prkcsh,O08795-2_Prkcsh,O08795-2,Prkcsh,1,26,13,13,O08795-2|O08795,MOUSE,60528.5,17.2,174,174.1,156.23,156.23,,521,Isoform 2 of Glucosidase 2 subunit beta,endoplasmic reticulum|,in utero embryonic development|liver development|N-glycan processing|nitrogen compound metabolic process|negative regulation of neuron projection development|protein heterooligomerization|renal system development|,RNA binding|protein kinase C binding|calcium ion binding|protein binding|ion channel binding|phosphoprotein binding|,13,26,3870000000,17.2%
G5E8Q8,0.384794075,-0.534583333,8.708947362,0.992833333,0.13461866,1.726740654,-0.403,-0.3355,-2.3545,-0.115,0.001,-0.0005,G5E8Q8,Adgrf5,G5E8Q8_Adgrf5,G5E8Q8,Adgrf5,1,23,13,13,G5E8Q8,MOUSE,151723.4,10.6,175,175.1,155.92,155.92,,1348,Adhesion G protein-coupled receptor F5,,,,13,23,1310000000,10.6%
Q3SXB8-2,0.958049938,0.119583333,0.35589695,0.041166667,0.921319589,0.102894096,-0.216,-0.3955,0.9085,0.01,0.4,0.0105,Q3SXB8,Colec11,Q3SXB8-2_Colec11,Q3SXB8-2,Colec11,1,20,11,11,Q3SXB8-2|A0A1Y7VKG6|Q3SXB8|A0A0R4J0M6,MOUSE,29981.5,33,176,176.1,153.96,153.96,,272,Isoform 2 of Collectin-11,extracellular region|collagen trimer|,multicellular organismal development|developmental process|,mannose binding|,11,20,1810000000,33.0%
Q9D154,0.298450194,-0.2504,10.82816835,0.598083333,0.082638641,2.145669051,-0.771,-0.4475,,-0.185,0.11,0.0415,Q9D154,Serpinb1a,Q9D154_Serpinb1a,Q9D154,Serpinb1a,1,21,15,15,Q9D154|Q8VHP7|Q5SV42|Q9JK88|I7HJI5|Q9DAV6|Q9D6A7,MOUSE,42745.3,35.3,177,177.1,153.61,153.61,,379,Leukocyte elastase inhibitor A,extracellular space|cytoplasm|membrane|extracellular exosome|,negative regulation of endopeptidase activity|regulation of protein catabolic process|,serine-type endopeptidase inhibitor activity|,15,21,1070000000,35.3%
P11627,0.837431974,0.035583333,1.404275297,-0.086166667,0.723723159,-0.36997068,0.357,-0.0985,-0.0225,0.009,-0.006,-0.0255,P11627,NotFound,P11627_NotFound,P11627,L1cam,1,19,14,14,P11627|Q6PGJ3|A2AFG8|A2AFG7,MOUSE,141935.8,10.5,178,178.1,152.85,152.85,,1260,Neural cell adhesion molecule L1,plasma membrane|focal adhesion|external side of plasma membrane|cell surface|membrane|integral component of membrane|presynaptic membrane|terminal bouton|,homophilic cell adhesion via plasma membrane adhesion molecules|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|leukocyte cell-cell adhesion|cell surface receptor signaling pathway|axon guidance|positive regulation of cell-cell adhesion|neuron projection development|cell-cell adhesion mediated by integrin|homotypic cell-cell adhesion|positive regulation of calcium-mediated signaling|,integrin binding|protein binding|sialic acid binding|identical protein binding|protein self-association|,14,19,632000000,10.5%
Q9CQW3,0.441723111,-0.042083333,7.457049279,0.367833333,0.179595343,1.512633233,-0.287,0.0365,-0.4275,0.17,0.287,-0.0315,Q9CQW3,Proz,Q9CQW3_Proz,Q9CQW3,Proz,1,43,8,8,Q9CQW3|Q8CI01,MOUSE,45615.9,32,179,179.1,152.1,152.1,,399,Vitamin K-dependent protein Z,extracellular region|extracellular exosome|,proteolysis|blood coagulation|,serine-type endopeptidase activity|calcium ion binding|,8,43,22700000000,32.0%
Q60994,0.115560135,-0.300583333,20.90313615,1.242166667,0.008122438,3.832430564,-0.732,-1.0415,-0.9915,-0.135,0.884,0.2125,Q60994,Adipoq,Q60994_Adipoq,Q60994,Adipoq,1,53,9,9,Q60994,MOUSE,26922.6,30.3,180,180.1,150.71,150.71,,247,Adiponectin,collagen trimer|extracellular space|endoplasmic reticulum|cell surface|perinuclear region of cytoplasm|extracellular exosome|cell periphery|,"response to hypoxia|positive regulation of protein phosphorylation|glucose metabolic process|fatty acid beta-oxidation|response to nutrient|circadian rhythm|response to sucrose|response to glucose|positive regulation of signal transduction|negative regulation of platelet-derived growth factor receptor signaling pathway|positive regulation of protein kinase A signaling|negative regulation of macrophage derived foam cell differentiation|negative regulation of tumor necrosis factor-mediated signaling pathway|positive regulation of cholesterol efflux|regulation of glucose metabolic process|response to activity|negative regulation of smooth muscle cell migration|fatty acid oxidation|negative regulation of cell migration|negative regulation of granulocyte differentiation|negative regulation of protein autophosphorylation|positive regulation of cellular protein metabolic process|negative regulation of tumor necrosis factor production|positive regulation of interleukin-8 production|cellular response to insulin stimulus|positive regulation of myeloid cell apoptotic process|adiponectin-activated signaling pathway|negative regulation of heterotypic cell-cell adhesion|low-density lipoprotein particle clearance|response to tumor necrosis factor|cellular response to drug|glucose homeostasis|positive regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of I-kappaB kinase/NF-kappaB signaling|negative regulation of MAP kinase activity|response to ethanol|negative regulation of fat cell differentiation|negative regulation of macrophage differentiation|negative regulation of low-density lipoprotein particle receptor biosynthetic process|negative regulation of gluconeogenesis|negative regulation of blood pressure|positive regulation of blood pressure|negative regulation of transcription, DNA-templated|positive regulation of fatty acid metabolic process|positive regulation of glucose import|negative regulation of hormone secretion|negative regulation of smooth muscle cell proliferation|negative regulation of inflammatory response|positive regulation of peptidyl-tyrosine phosphorylation|negative regulation of phagocytosis|negative regulation of synaptic transmission|brown fat cell differentiation|protein homooligomerization|response to glucocorticoid|membrane depolarization|membrane hyperpolarization|protein heterotrimerization|negative regulation of ERK1 and ERK2 cascade|response to linoleic acid|detection of oxidative stress|cellular response to cAMP|positive regulation of monocyte chemotactic protein-1 production|cellular response to epinephrine stimulus|protein localization to plasma membrane|negative regulation of intracellular protein transport|negative regulation of receptor binding|negative regulation of DNA biosynthetic process|positive regulation of glycogen (starch) synthase activity|positive regulation of metanephric glomerular visceral epithelial cell development|positive regulation of cAMP-dependent protein kinase activity|positive regulation of renal albumin absorption|negative regulation of platelet-derived growth factor receptor-alpha signaling pathway|negative regulation of metanephric mesenchymal cell migration|",receptor binding|hormone activity|protein binding|sialic acid binding|identical protein binding|protein homodimerization activity|,9,53,1.72E+11,30.3%
P52430,0.737300429,0.094416667,2.633488556,0.1695,0.545319646,0.639638232,-0.304,0.0215,0.3115,0.342,0.237,-0.0415,P52430,Pon1,P52430_Pon1,P52430,Pon1,1,26,11,11,P52430|H3BLB8,MOUSE,39735.6,30.9,181,181.1,145.2,145.2,,355,Serum paraoxonase/arylesterase 1,extracellular space|high-density lipoprotein particle|spherical high-density lipoprotein particle|intracellular membrane-bounded organelle|extracellular exosome|blood microparticle|,blood circulation|cholesterol metabolic process|response to toxic substance|positive regulation of cholesterol efflux|dephosphorylation|aromatic compound catabolic process|response to nutrient levels|positive regulation of transporter activity|carboxylic acid catabolic process|organophosphate catabolic process|phosphatidylcholine metabolic process|positive regulation of binding|response to fatty acid|response to fluoride|,aryldialkylphosphatase activity|arylesterase activity|calcium ion binding|phospholipid binding|high-density lipoprotein particle binding|protein homodimerization activity|,11,26,4720000000,30.9%
Q62009,0.465813872,-0.32725,6.8431712,0.490166667,0.206863029,1.409470321,-0.194,-0.2635,-1.2595,-0.197,-0.092,0.0425,Q62009,Postn,Q62009_Postn,Q62009,Postn,1,18,12,12,Q62009|Q62009-2|Q62009-3|Q62009-5|Q62009-4,MOUSE,93826.5,18.2,182,182.1,144.59,144.59,,838,Periostin,proteinaceous extracellular matrix|extracellular space|trans-Golgi network|extracellular matrix|,cell adhesion|regulation of Notch signaling pathway|tissue development|extracellular matrix organization|,heparin binding|cell adhesion molecule binding|,12,18,1270000000,18.2%
Q07235,0.543702736,0.027416667,5.233937197,0.288166667,0.299644479,1.131724529,-0.008,-0.1915,-0.1505,0.536,0.001,-0.0225,Q07235,Serpine2,Q07235_Serpine2,Q07235,Serpine2,1,20,12,12,Q07235|A2RSF9,MOUSE,44263.6,33.5,183,183.1,141.78,141.78,,397,Glia-derived nexin,extracellular region|extracellular space|cytosol|extracellular matrix|platelet alpha granule|extrinsic component of external side of plasma membrane|neuromuscular junction|neuronal cell body|extracellular vesicle|,"embryo implantation|blood coagulation|negative regulation of cell proliferation|response to radiation|response to wounding|negative regulation of peptidase activity|negative regulation of platelet activation|negative regulation of plasminogen activation|negative regulation of sodium ion transport|negative regulation of endopeptidase activity|negative regulation of protein processing|positive regulation of neuron projection development|negative regulation of phosphatidylinositol 3-kinase signaling|cerebellar granular layer morphogenesis|negative regulation of blood coagulation|negative regulation of cell growth|secretion by cell|secretory granule organization|negative regulation of protein catabolic process|mating plug formation|negative regulation of proteolysis|negative regulation of smoothened signaling pathway|regulation of timing of cell differentiation|positive regulation of astrocyte differentiation|detection of mechanical stimulus involved in sensory perception|regulation of synaptic transmission, glutamatergic|long-term synaptic potentiation|innervation|seminal vesicle epithelium development|dense core granule biogenesis|negative regulation of platelet aggregation|",serine-type endopeptidase inhibitor activity|receptor binding|glycosaminoglycan binding|heparin binding|,12,20,793000000,33.5%
P70428,0.131986627,0.339916667,19.77074398,-0.790833333,0.010542063,-3.616651177,0.796,0.6075,0.8025,0.037,-0.208,0.0045,P70428,Ext2,P70428_Ext2,P70428,Ext2,1,17,11,11,P70428|V9GX32|E9Q1M5,MOUSE,82804.6,20.1,184,184.1,140.78,140.78,,718,Exostosin-2,Golgi membrane|endoplasmic reticulum|endoplasmic reticulum membrane|Golgi apparatus|membrane|integral component of membrane|UDP-N-acetylglucosamine transferase complex|extracellular exosome|,"ossification|mesoderm formation|glycosaminoglycan biosynthetic process|protein glycosylation|heparan sulfate proteoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|cell differentiation|cellular polysaccharide biosynthetic process|","acetylglucosaminyltransferase activity|glucuronosyltransferase activity|transferase activity, transferring glycosyl groups|heparan sulfate N-acetylglucosaminyltransferase activity|protein homodimerization activity|metal ion binding|protein heterodimerization activity|glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity|acetylglucosaminyltransferase activity|",11,17,188000000,20.1%
Q07113,0.924500522,-0.114916667,0.598151609,0.072166667,0.871334358,0.168845087,0.013,0.5625,-1.0285,-0.123,-0.059,-0.0545,Q07113,Igf2r,Q07113_Igf2r,Q07113,Igf2r,1,17,13,13,Q07113,MOUSE,280828.2,5.3,185,185.1,139.66,139.66,,2483,Cation-independent mannose-6-phosphate receptor,nucleus|nuclear envelope lumen|lysosomal membrane|endosome|early endosome|late endosome|trans-Golgi network|focal adhesion|cell surface|membrane|integral component of membrane|endocytic vesicle|trans-Golgi network transport vesicle|extracellular exosome|,transport|,glycoprotein binding|transporter activity|insulin-like growth factor binding|mannose binding|identical protein binding|phosphoprotein binding|,13,17,2010000000,5.3%
Q91WU0,0.739761835,-0.220416667,2.588376207,0.3185,0.551013678,0.630967471,-0.174,0.4895,-1.4545,0.008,-0.108,-0.0835,Q91WU0,Ces1f,Q91WU0_Ces1f,Q91WU0,Ces1f,1,22,11,11,Q91WU0,MOUSE,62010.5,25.3,186,186.1,139.61,139.61,,561,Carboxylesterase 1F,lipid particle|cytosol|,short-chain fatty acid catabolic process|,hydrolase activity|,11,22,1.95E+11,25.3%
P31532,0.282360967,-0.070083333,11.37185261,0.6405,0.072914641,2.157348343,-0.367,-0.0035,-0.8005,0.361,0.416,-0.0265,P31532,Saa4,P31532_Saa4,P31532,Saa4,1,24,9,9,P31532,MOUSE,15144.6,62.3,187,187.1,139.37,139.37,,130,Serum amyloid A-4 protein,extracellular space|high-density lipoprotein particle|,acute-phase response|positive chemotaxis|cell chemotaxis|,chemoattractant activity|,9,24,9930000000,62.3%
Q61805,0.544413282,-0.179416667,5.21569522,0.531166667,0.300905744,1.13031161,-0.087,0.1685,-1.4165,0.437,-0.184,0.0055,Q61805,Lbp,Q61805_Lbp,Q61805,Lbp,1,23,11,11,Q61805|A2AC65,MOUSE,53282.7,21.4,188,188.1,139.1,139.1,,481,Lipopolysaccharide-binding protein,extracellular space|cell surface|extracellular exosome|,"liver development|leukocyte chemotaxis involved in inflammatory response|macrophage activation involved in immune response|acute-phase response|opsonization|lipopolysaccharide transport|lipopolysaccharide-mediated signaling pathway|detection of molecule of bacterial origin|response to lipopolysaccharide|negative regulation of tumor necrosis factor production|positive regulation of chemokine production|positive regulation of interleukin-6 production|positive regulation of interleukin-8 production|positive regulation of tumor necrosis factor production|positive regulation of toll-like receptor 4 signaling pathway|positive regulation of tumor necrosis factor biosynthetic process|positive regulation of macrophage activation|negative regulation of growth of symbiont in host|innate immune response|defense response to Gram-negative bacterium|defense response to Gram-positive bacterium|positive regulation of phagocytosis, engulfment|positive regulation of respiratory burst involved in inflammatory response|cellular response to lipopolysaccharide|cellular response to lipoteichoic acid|positive regulation of neutrophil chemotaxis|regulation of membrane permeability|",lipopolysaccharide binding|receptor binding|lipoteichoic acid binding|,11,23,2590000000,21.4%
P47879,0.812519126,0.121916667,1.751945961,0.1465,0.668044517,0.449976653,0.24,0.4105,-0.5045,0.439,0.211,-0.0645,P47879,Igfbp4,P47879_Igfbp4,P47879,Igfbp4,1,39,11,11,P47879|H3BLB7,MOUSE,28947.5,42.1,189,189.1,137.73,137.73,,254,Insulin-like growth factor-binding protein 4,extracellular space|,regulation of cell growth|inflammatory response|regulation of glucose metabolic process|regulation of growth|positive regulation of MAPK cascade|positive regulation of insulin-like growth factor receptor signaling pathway|type B pancreatic cell proliferation|,insulin-like growth factor binding|insulin-like growth factor I binding|insulin-like growth factor II binding|,11,39,20200000000,42.1%
P12246,0.998029387,0.2966,0.022402444,-0.003583333,0.994854928,-0.006771402,0.724,-0.1265,,-0.179,1.1,-0.0355,P12246,Apcs,P12246_Apcs,P12246,Apcs,1,30,10,10,P12246,MOUSE,26417.6,33.9,190,190.1,132.07,132.07,,224,Serum amyloid P-component,extracellular space|nucleus|protein complex|extracellular exosome|blood microparticle|extracellular matrix|,protein complex assembly|negative regulation by host of viral exo-alpha-sialidase activity|negative regulation by host of viral glycoprotein metabolic process|innate immune response|negative regulation of monocyte differentiation|negative regulation of viral entry into host cell|negative regulation of viral process|negative regulation of exo-alpha-sialidase activity|negative regulation of glycoprotein metabolic process|,complement component C1q binding|calcium ion binding|carbohydrate binding|virion binding|,10,30,14900000000,33.9%
Q8CIT9,0.549465437,0.108916667,5.080115627,-0.376833333,0.310447693,-1.1044198,-0.087,0.0255,0.9535,-0.245,-0.043,0.0495,Q8CIT9,Sbsn,Q8CIT9_Sbsn,Q8CIT9,Sbsn,1,19,9,9,Q8CIT9|E9QPB2|S4R2I1|Q8CIT9-3|A0A0R4J2A5,MOUSE,72446.7,18.2,191,191.1,131.62,131.62,,700,Suprabasin,cytoplasm|extracellular exosome|,,,9,19,357000000,18.2%
P11152,0.156459648,-0.3966,18.13723709,0.92025,0.015355936,3.550590184,-0.861,-1.0365,,-0.11,-0.055,0.0795,P11152,Lpl,P11152_Lpl,P11152,Lpl,1,20,10,10,P11152,MOUSE,53679,25.5,192,192.1,130.51,130.51,,474,Lipoprotein lipase,extracellular space|plasma membrane|cell surface|extracellular matrix|anchored component of membrane|very-low-density lipoprotein particle|chylomicron|extracellular exosome|,fatty acid biosynthetic process|response to cold|positive regulation of macrophage derived foam cell differentiation|positive regulation of cholesterol storage|positive regulation of sequestering of triglyceride|triglyceride biosynthetic process|triglyceride catabolic process|very-low-density lipoprotein particle remodeling|response to drug|triglyceride homeostasis|,lipoprotein lipase activity|triglyceride lipase activity|receptor binding|protein binding|heparin binding|triglyceride binding|apolipoprotein binding|,10,20,3530000000,25.5%
Q60590,0.870244058,0.020583333,1.095214589,0.063833333,0.777102921,0.295724176,0.047,-0.0005,-0.0805,-0.074,0.206,0.0255,Q60590,Orm1,Q60590_Orm1,Q60590,Orm1,1,29,9,4,Q60590|J3JRU4|Q63805,MOUSE,24008.9,34.7,193,193.1,128.84,68.79,,207,Alpha-1-acid glycoprotein 1,extracellular space|,regulation of immune system process|transport|acute-phase response|,,9,29,23100000000,34.7%
P07361,0.91535326,-0.20425,0.709987393,-0.247833333,0.84918294,-0.198475956,2.849,-1.9965,-1.0935,-0.757,-0.444,0.2165,P07361,Orm2,P07361_Orm2,P07361,Orm2,1,10,9,4,P07361,MOUSE,23957.1,29.4,193,193.2,104.23,44.18,,207,Alpha-1-acid glycoprotein 2,extracellular space|,regulation of immune system process|transport|acute-phase response|,,4,10,1900000000,12.5%
Q61406,0.272982869,-0.260083333,12.23718373,0.709166667,0.059742257,2.300019817,-0.534,-0.2495,-1.0605,0.332,-0.219,0.1705,Q61406,Cfhr1,Q61406_Cfhr1,Q61406,Cfhr1,1,21,10,10,Q61406,MOUSE,39640.4,34.6,194,194.1,128.37,128.37,,343,Complement factor H-related 1,extracellular exosome|blood microparticle|,,,10,21,3530000000,34.6%
P06330,0.282360967,-0.22125,11.46284441,0.6755,0.071402852,2.172314809,-0.586,-0.1875,-0.9035,-0.227,0.488,0.0885,P06330,NotFound,P06330_NotFound,P06330,,1,22,9,2,P06330|P01757|P01756|A0A075B5U6,MOUSE,13048.2,72.8,195,195.1,126.98,27.06,,118,Ig heavy chain V region AC38 205.12,,,antigen binding|,10,22,7790000000,72.8%
A0A075B5Y4,0.837468102,0.546583333,1.396067721,-0.1695,0.725092191,-0.368287565,0.981,0.1695,0.7435,0.084,1.361,-0.0595,A0A075B5Y4,NotFound,A0A075B5Y4_NotFound,A0A075B5Y4,Ighv1-81,1,12,8,5,A0A075B5Y4|A0A0A6YVW3,MOUSE,13102.5,64.1,195,195.2,100.95,70.32,,117,Immunoglobulin heavy variable 1-81 (Fragment),,,,5,12,1990000000,47.0%
A0A075B5U4,0.812519126,0.293,1.721946488,-0.142083333,0.672675099,-0.447326193,0.396,0.3605,,0.605,0.193,-0.0895,A0A075B5U4,NotFound,A0A075B5U4_NotFound,A0A075B5U4,Ighv1-18,1,6,7,2,A0A075B5U4,MOUSE,11351.7,58.8,195,195.3,93.02,40.22,,102,Immunoglobulin heavy variable V1-18,,,,2,6,354000000,34.3%
A0A075B5U7,0.598309776,0.3332,4.241520125,0.486583333,0.376571968,0.968175286,0.258,-0.1755,,0.117,1.378,0.0885,A0A075B5U7,NotFound,A0A075B5U7_NotFound,A0A075B5U7,Ighv1-22,1,7,6,3,A0A075B5U7|P01758,MOUSE,13135.6,61.5,195,195.4,83.03,45.15,,117,Immunoglobulin heavy variable 1-22 (Fragment),,,,3,7,129000000,35.8%
A0A075B5V6,0.729414454,0.001916667,2.766555858,0.6765,0.528864498,0.667910905,-1.741,-1.2775,2.0095,-0.168,0.903,0.2855,A0A075B5V6,NotFound,A0A075B5V6_NotFound,A0A075B5V6,Ighv1-42,1,5,6,2,A0A075B5V6|A0A075B5V7,MOUSE,10890,55.1,195,195.5,78.8,18.65,,98,Immunoglobulin heavy variable V1-42,,,,2,5,6680000000,15.3%
A0A075B5U5,,0.211166667,,,,,,,,0.005,0.54,0.0885,A0A075B5U5,NotFound,A0A075B5U5_NotFound,A0A075B5U5,Ighv1-19,1,1,4,1,A0A075B5U5,MOUSE,12970.5,41.3,195,195.6,43.73,11.28,,116,Immunoglobulin heavy variable V1-19,,,,1,1,2660000,17.2%
A0A0A6YXA5,,0.306833333,,,,,,,,0.639,0.193,0.0885,A0A0A6YXA5,NotFound,A0A0A6YXA5_NotFound,A0A0A6YXA5,Ighv1-15,1,1,2,1,A0A0A6YXA5,MOUSE,13066.5,29.9,195,195.7,24.6,12.63,,117,Immunoglobulin heavy variable 1-15 (Fragment),,,,1,1,5640000,21.3%
P01746,0.279130421,0.177,11.80359803,-0.637916667,0.066014631,-2.321018984,0.383,0.7365,,-0.18,0.038,-0.0925,P01746,NotFound,P01746_NotFound,P01746,,1,4,2,1,P01746|P01747,MOUSE,15628.2,17.1,195,195.8,20.7,8.48,,140,Ig heavy chain V region 93G7,,,antigen binding|,1,4,162000000,7.1%
P04202,0.962933411,0.1414,0.269368671,0.021916667,0.939859927,0.0791659,0.258,-0.0015,,0.167,0.314,-0.0305,P04202,Tgfb1,P04202_Tgfb1,P04202,Tgfb1,1,17,10,10,P04202,MOUSE,44993.8,27.6,196,196.1,126.73,126.73,,390,Transforming growth factor beta-1,proteinaceous extracellular matrix|extracellular space|nucleus|cytoplasm|cell surface|secretory granule|axon|neuronal cell body|blood microparticle|microvillus|,"protein import into nucleus, translocation|negative regulation of transcription from RNA polymerase II promoter|MAPK cascade|skeletal system development|ureteric bud development|response to hypoxia|cell activation|epithelial to mesenchymal transition|negative regulation of protein phosphorylation|positive regulation of protein phosphorylation|regulation of sodium ion transport|chondrocyte differentiation|hematopoietic progenitor cell differentiation|CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment|adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains|tolerance induction to self antigen|protein phosphorylation|protein export from nucleus|ATP biosynthetic process|phosphate-containing compound metabolic process|cellular calcium ion homeostasis|defense response|inflammatory response|cell cycle arrest|mitotic cell cycle checkpoint|epidermal growth factor receptor signaling pathway|transforming growth factor beta receptor signaling pathway|common-partner SMAD protein phosphorylation|SMAD protein complex assembly|SMAD protein import into nucleus|Notch signaling pathway|negative regulation of neuroblast proliferation|salivary gland morphogenesis|endoderm development|skeletal muscle tissue development|female pregnancy|aging|negative regulation of DNA replication|cell proliferation|positive regulation of cell proliferation|negative regulation of cell proliferation|germ cell migration|response to radiation|response to wounding|response to glucose|defense response to fungus, incompatible interaction|organ morphogenesis|regulation of gene expression|positive regulation of gene expression|negative regulation of gene expression|positive regulation of epithelial to mesenchymal transition|positive regulation of fibroblast migration|positive regulation of peptidyl-threonine phosphorylation|positive regulation of pathway-restricted SMAD protein phosphorylation|negative regulation of macrophage cytokine production|oligodendrocyte development|cell growth|regulation of striated muscle tissue development|regulation of transforming growth factor beta receptor signaling pathway|evasion or tolerance of host defenses by virus|negative regulation of cell-cell adhesion|hyaluronan catabolic process|T cell differentiation|negative regulation of ossification|negative regulation of cell growth|positive regulation of cell migration|positive regulation of bone mineralization|mammary gland development|positive regulation of histone deacetylation|organ regeneration|positive regulation of protein complex assembly|positive regulation of exit from mitosis|lipopolysaccharide-mediated signaling pathway|positive regulation of cellular protein metabolic process|response to estradiol|response to progesterone|regulation of interleukin-23 production|negative regulation of interleukin-17 production|positive regulation of interleukin-17 production|receptor catabolic process|regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation|positive regulation of superoxide anion generation|mononuclear cell proliferation|positive regulation of collagen biosynthetic process|positive regulation of peptidyl-serine phosphorylation|response to vitamin D|response to laminar fluid shear stress|positive regulation of histone acetylation|positive regulation of protein dephosphorylation|wound healing|T cell activation|regulation of cell proliferation|negative regulation of T cell proliferation|regulation of protein import into nucleus|positive regulation of protein import into nucleus|positive regulation of odontogenesis|response to drug|myelination|regulation of apoptotic process|myeloid dendritic cell differentiation|T cell homeostasis|positive regulation of apoptotic process|positive regulation of MAP kinase activity|regulation of MAPK cascade|protein kinase B signaling|positive regulation of blood vessel endothelial cell migration|negative regulation of blood vessel endothelial cell migration|positive regulation of phosphatidylinositol 3-kinase activity|ossification involved in bone remodeling|regulatory T cell differentiation|cell-cell junction organization|negative regulation of fat cell differentiation|negative regulation of myoblast differentiation|negative regulation of cell cycle|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|negative regulation of mitotic cell cycle|positive regulation of transcription from RNA polymerase II promoter|positive regulation of fibroblast proliferation|positive regulation of isotype switching to IgA isotypes|cell development|lymph node development|digestive tract development|negative regulation of skeletal muscle tissue development|inner ear development|positive regulation of epithelial cell proliferation|negative regulation of epithelial cell proliferation|positive regulation of protein secretion|negative regulation of phagocytosis|negative regulation of T cell activation|positive regulation of chemotaxis|positive regulation of NF-kappaB transcription factor activity|regulation of binding|regulation of DNA binding|positive regulation of smooth muscle cell differentiation|negative regulation of release of sequestered calcium ion into cytosol|positive regulation of protein kinase B signaling|face morphogenesis|frontal suture morphogenesis|pathway-restricted SMAD protein phosphorylation|positive regulation of SMAD protein import into nucleus|SMAD protein signal transduction|mammary gland branching involved in thelarche|branch elongation involved in mammary gland duct branching|regulation of branching involved in mammary gland duct morphogenesis|negative regulation of gene silencing by miRNA|regulation of cartilage development|lens fiber cell differentiation|response to cholesterol|positive regulation of cell cycle arrest|cellular response to growth factor stimulus|cellular response to organic cyclic compound|cellular response to dexamethasone stimulus|cellular response to transforming growth factor beta stimulus|T-helper 17 cell lineage commitment|extracellular matrix assembly|positive regulation of branching involved in ureteric bud morphogenesis|extrinsic apoptotic signaling pathway|negative regulation of hyaluronan biosynthetic process|positive regulation of protein localization to nucleus|positive regulation of NAD+ ADP-ribosyltransferase activity|regulation of actin cytoskeleton reorganization|positive regulation of transcription regulatory region DNA binding|",glycoprotein binding|antigen binding|type II transforming growth factor beta receptor binding|cytokine activity|transforming growth factor beta receptor binding|protein binding|growth factor activity|enzyme binding|type I transforming growth factor beta receptor binding|type III transforming growth factor beta receptor binding|protein homodimerization activity|protein heterodimerization activity|protein N-terminus binding|,10,17,1100000000,27.6%
P11589,0.282360967,-0.091416667,11.28285728,0.665166667,0.074424217,2.142716874,-0.321,-0.3015,-0.6495,-0.062,0.778,0.0075,P11589,NotFound,P11589_NotFound,P11589,Mup2,1,18,9,9,P11589|Q4FZE8|A2BIN1|P04938|A2CEK7|P02762|P11588|A2CEL1|A2AKN8|Q58EV3|A2AKN9|A9R9W0|A9C496|E9PVW0|A2CEL0|E9QA79|A9C497|B5X0G2|A2CEK6|A2BIN0|L7N222|A2AV72|P04939|Q3KQQ2|Q80YX8|A2ANT6|P11591,MOUSE,20948.4,58.8,197,197.1,125.86,125.86,,180,Major urinary protein 2,extracellular space|nucleus|cytosol|,"energy reserve metabolic process|transport|insulin receptor signaling pathway|aerobic respiration|positive regulation of gene expression|negative regulation of lipid storage|positive regulation of glucose metabolic process|heat generation|glucose homeostasis|locomotor rhythm|negative regulation of gluconeogenesis|positive regulation of lipid metabolic process|negative regulation of transcription, DNA-templated|negative regulation of lipid biosynthetic process|positive regulation of protein kinase B signaling|negative regulation of insulin secretion involved in cellular response to glucose stimulus|mitochondrion morphogenesis|cellular response to lipid|",insulin-activated receptor activity|transporter activity|pheromone binding|small molecule binding|,9,18,2000000000,58.8%
Q7TSK7,0.671940248,-0.0288,3.33759931,0.211583333,0.463703174,0.790634317,-0.075,-0.2365,,-0.055,0.235,-0.0125,Q7TSK7,Adamtsl2,Q7TSK7_Adamtsl2,Q7TSK7,Adamtsl2,1,18,12,12,Q7TSK7,MOUSE,109068.3,15.1,198,198.1,124.97,124.97,,957,ADAMTS-like protein 2,extracellular region|proteinaceous extracellular matrix|,proteolysis|negative regulation of transforming growth factor beta receptor signaling pathway|,metalloendopeptidase activity|zinc ion binding|,12,18,1910000000,15.1%
P98063,0.272982869,-0.31325,12.25071797,0.496833333,0.059556368,2.302258228,-0.552,-0.4775,-0.6555,-0.042,-0.202,0.0495,P98063,Bmp1,P98063_Bmp1,P98063,Bmp1,1,14,11,11,P98063|Q9WVM6|E9Q5B9|G3X9F5|Q62381|Q62381-2,MOUSE,113889.4,12.4,199,199.1,124.35,124.35,,991,Bone morphogenetic protein 1,proteinaceous extracellular matrix|extracellular space|Golgi apparatus|membrane-bounded vesicle|,ossification|proteolysis|cell differentiation|cartilage development|positive regulation of cartilage development|,metalloendopeptidase activity|cytokine activity|calcium ion binding|protein binding|growth factor activity|peptidase activity|zinc ion binding|,11,14,1260000000,12.4%
P47877,0.277507267,-0.15575,12.01968711,0.583833333,0.062810361,2.264080806,-0.524,-0.2035,-0.6155,0.441,-0.033,0.0005,P47877,Igfbp2,P47877_Igfbp2,P47877,Igfbp2,1,24,10,10,P47877|D3YU40,MOUSE,33930.2,36.7,200,200.1,124.35,124.35,,305,Insulin-like growth factor-binding protein 2,extracellular region|extracellular space|apical plasma membrane|cytoplasmic vesicle|extracellular exosome|,regulation of cell growth|signal transduction|female pregnancy|aging|response to nutrient|response to mechanical stimulus|response to lithium ion|response to estradiol|response to retinoic acid|cellular response to hormone stimulus|positive regulation of activated T cell proliferation|response to drug|regulation of insulin-like growth factor receptor signaling pathway|response to glucocorticoid|,insulin-like growth factor binding|insulin-like growth factor I binding|insulin-like growth factor II binding|,10,24,2700000000,36.7%
O88968,0.522086579,-0.567083333,5.55085337,0.977166667,0.278557376,1.190381851,-0.099,-0.0575,-3.0105,-0.175,-0.066,0.0055,O88968,Tcn2,O88968_Tcn2,O88968,Tcn2,1,21,10,10,O88968,MOUSE,48041.3,22.3,201,201.1,124.2,124.2,,430,Transcobalamin-2,extracellular space|extracellular exosome|,cobalt ion transport|cobalamin transport|,cobalamin binding|metal ion binding|,10,21,3020000000,22.3%
A0A075B5R6,0.503251182,0.2378,5.937302671,0.642583333,0.254841254,1.282411302,-0.644,0.3485,,0.426,1.108,-0.0495,A0A075B5R6,NotFound,A0A075B5R6_NotFound,A0A075B5R6,Ighv11-1,1,15,9,9,A0A075B5R6|A0A075B5R8,MOUSE,13378.9,51.2,202,202.1,123.19,123.19,,117,Immunoglobulin heavy variable 11-1 (Fragment),,,,9,15,561000000,51.2%
P70274,0.549465437,-0.202083333,4.978803952,0.579833333,0.31777491,1.088750012,0.002,0.2085,-1.6865,0.262,0.055,-0.0535,P70274,Selenop,P70274_Selenop,P70274,Selenop,1,26,9,9,P70274,MOUSE,43595.1,20.7,203,203.1,119.99,119.99,,380,Selenoprotein P,extracellular region|extracellular space|extracellular exosome|,selenium compound metabolic process|brain development|locomotory behavior|post-embryonic development|sexual reproduction|growth|,selenium binding|,9,26,8610000000,20.7%
P14106,0.91535326,0.7918,0.702625027,-0.12575,0.850623736,-0.198212118,1.497,0.2375,,0.791,1.517,-0.0835,P14106,C1qb,P14106_C1qb,P14106,C1qb,1,35,8,8,P14106,MOUSE,26945.1,38.7,204,204.1,118.69,118.69,,253,Complement C1q subcomponent subunit B,collagen trimer|extracellular exosome|blood microparticle|,"complement activation, classical pathway|innate immune response|inner ear development|",protein homodimerization activity|,8,35,1.17E+11,38.7%
Q8CJH3,0.612008945,-0.06325,3.990181489,0.2595,0.399008228,0.905573148,0.272,-0.2745,-0.5765,0.068,0.132,-0.0005,Q8CJH3,Plxnb1,Q8CJH3_Plxnb1,Q8CJH3,Plxnb1,1,17,10,10,Q8CJH3,MOUSE,234738.4,5.6,205,205.1,115.97,115.97,,2119,Plexin-B1,semaphorin receptor complex|integral component of plasma membrane|,negative regulation of cell adhesion|regulation of cell shape|positive regulation of phosphatidylinositol 3-kinase signaling|negative regulation of osteoblast proliferation|positive regulation of GTPase activity|ossification involved in bone maturation|neuron projection morphogenesis|positive regulation of axonogenesis|regulation of cytoskeleton organization|semaphorin-plexin signaling pathway|semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis|,protein binding|semaphorin receptor activity|GTPase activating protein binding|,10,17,646000000,5.6%
P39876,0.623481262,0.144083333,3.847505862,-0.267833333,0.412334253,-0.878716391,0.009,-0.0125,0.8375,0.085,-0.047,-0.0075,P39876,Timp3,P39876_Timp3,P39876,Timp3,1,17,9,9,P39876,MOUSE,24923.3,38.3,206,206.1,113.21,113.21,,211,Metalloproteinase inhibitor 3,proteinaceous extracellular matrix|basement membrane|extracellular space|nucleus|cytoplasm|extracellular exosome|extracellular matrix|,central nervous system development|aging|response to mechanical stimulus|response to hormone|negative regulation of endopeptidase activity|response to cytokine|tissue regeneration|response to estrogen|negative regulation of metalloenzyme activity|negative regulation of membrane protein ectodomain proteolysis|response to folic acid|cellular response to organic substance|,protease binding|metalloendopeptidase inhibitor activity|metal ion binding|,9,17,614000000,38.3%
F8VQJ3,0.482514848,-0.48175,6.425801817,0.889833333,0.227729776,1.342321311,-0.038,-0.2815,-2.4605,0.025,-0.242,0.1065,F8VQJ3,Lamc1,F8VQJ3_Lamc1,F8VQJ3,Lamc1,1,12,10,10,F8VQJ3|P02468,MOUSE,182889.8,8.2,207,207.1,112.69,112.69,,1607,Laminin subunit gamma-1,basement membrane|basal lamina|laminin-1 complex|extracellular matrix|laminin-10 complex|extracellular exosome|basement membrane|extracellular matrix|,protein complex assembly|cell adhesion|cell migration|extracellular matrix disassembly|neuron projection development|hemidesmosome assembly|substrate adhesion-dependent cell spreading|,extracellular matrix structural constituent|protein binding|glycosphingolipid binding|,10,12,284000000,8.2%
P10493,0.282360967,0.183583333,11.33965737,-0.746166667,0.073457182,-2.152054483,0.609,1.1165,-0.0555,-0.303,-0.239,-0.0265,P10493,Nid1,P10493_Nid1,P10493,Nid1,1,14,11,11,P10493,MOUSE,139387.9,9.9,208,208.1,112.58,112.58,,1245,Nidogen-1,extracellular region|proteinaceous extracellular matrix|basement membrane|basal lamina|extracellular matrix|extracellular exosome|cell periphery|extracellular matrix|,cell-matrix adhesion|positive regulation of cell-substrate adhesion|extracellular matrix organization|glomerular basement membrane development|,calcium ion binding|protein binding|collagen binding|laminin binding|laminin-1 binding|proteoglycan binding|extracellular matrix binding|,11,14,146000000,9.9%
Q02257,0.279130421,0.412083333,11.64378556,-2.5765,0.068489098,-2.21364222,1.252,4.2895,-0.4405,-0.946,-1.302,-0.3805,Q02257,Jup,Q02257_Jup,Q02257,Jup,1,16,11,11,Q02257,MOUSE,82541,15.1,209,209.1,110.12,110.12,,745,Junction plakoglobin,nucleus|cytoplasm|cytosol|intermediate filament|plasma membrane|cell-cell junction|cell-cell adherens junction|focal adhesion|intercalated disc|membrane|catenin complex|Z disc|desmosome|protein-DNA complex|extracellular exosome|gamma-catenin-TCF7L2 complex|,desmosome assembly|cell adhesion|signal transduction|single organismal cell-cell adhesion|cell migration|adherens junction assembly|regulation of cell proliferation|positive regulation of protein import into nucleus|regulation of cell fate specification|skin development|detection of mechanical stimulus|positive regulation of sequence-specific DNA binding transcription factor activity|cellular response to indole-3-methanol|bundle of His cell-Purkinje myocyte adhesion involved in cell communication|regulation of heart rate by cardiac conduction|establishment of protein localization to plasma membrane|regulation of ventricular cardiac muscle cell action potential|positive regulation of transcription from RNA polymerase II promoter|,transcription coactivator activity|signal transducer activity|structural molecule activity|protein binding|protein phosphatase binding|alpha-catenin binding|cadherin binding|cell adhesion molecule binding|nuclear hormone receptor binding|,11,16,477000000,15.1%
P51885,0.606693779,-0.335083333,4.072263452,0.445166667,0.391537763,0.922177398,0.305,-0.4255,-1.5525,-0.167,-0.14,-0.0305,P51885,Lum,P51885_Lum,P51885,Lum,1,14,9,9,P51885,MOUSE,38663.6,29.5,210,210.1,108.75,108.75,,338,Lumican,proteinaceous extracellular matrix|fibrillar collagen trimer|extracellular space|extracellular exosome|extracellular matrix|,visual perception|response to organic cyclic compound|collagen fibril organization|positive regulation of transforming growth factor beta1 production|positive regulation of transcription from RNA polymerase II promoter|cartilage development|response to growth factor|,collagen binding|,9,14,2610000000,29.5%
Q02105,0.814495558,0.470583333,1.663543258,0.161833333,0.681782225,0.429954935,0.7,-0.0245,0.4935,0.618,1.087,-0.0505,Q02105,C1qc,Q02105_C1qc,Q02105,C1qc,1,33,8,8,Q02105,MOUSE,26390.5,35.3,211,211.1,107.63,107.63,,246,Complement C1q subcomponent subunit C,collagen trimer|extracellular space|membrane|extracellular exosome|blood microparticle|,"complement activation, classical pathway|negative regulation of granulocyte differentiation|innate immune response|negative regulation of macrophage differentiation|",tumor necrosis factor receptor binding|,8,33,75000000000,35.3%
P22629,0.011676506,0.77725,37.75018905,-2.1495,0.000167873,-8.041240486,2.268,1.6055,1.6825,-0.238,-0.404,-0.2505,P22629,NotFound,P22629_NotFound,P22629,,1,187,6,1,P22629,STRAV,18833.4,43.1,212,212.1,107.4,23.98,,183,Streptavidin,,,,6,187,8.85E+12,43.1%
Q53532,0.01315234,0.811083333,34.67045235,-2.575166667,0.000341157,-7.094362127,2.832,1.6165,1.8475,-0.535,-0.419,-0.4755,Q53532,NotFound,Q53532_NotFound,Q53532,,1,27,6,2,Q53532|Q53533,STRVL,18863.4,43.1,212,212.2,95.68,31.24,,183,Streptavidin-V1,,,,2,27,2.72E+11,20.2%
B2RXS4,0.782114298,-0.03925,2.140388259,0.184166667,0.610887409,0.535632166,0.451,-0.1125,-0.7325,0.038,0.141,-0.0205,B2RXS4,Plxnb2,B2RXS4_Plxnb2,B2RXS4,Plxnb2,1,15,9,9,B2RXS4,MOUSE,209079.3,5.7,213,213.1,106.85,106.85,,1842,Plexin-B2,integral component of plasma membrane|cell surface|extracellular exosome|,neural tube closure|regulation of protein phosphorylation|neuroblast proliferation|brain development|regulation of cell shape|regulation of GTPase activity|positive regulation of axonogenesis|semaphorin-plexin signaling pathway|regulation of neuron migration|,protein binding|semaphorin receptor activity|,9,15,1050000000,5.7%
P52480,0.292566378,0.221583333,11.07633447,-0.822833333,0.078048858,-2.11170435,1.058,1.0095,-0.1685,-0.108,-0.388,-0.0735,P52480,Pkm,P52480_Pkm,P52480,Pkm,1,16,10,10,P52480|P52480-2|P53657|G3X925|E9Q509,MOUSE,58414.4,23.5,214,214.1,106.79,106.79,,531,Pyruvate kinase PKM,nucleus|cytoplasm|mitochondrion|plasma membrane|cilium|extracellular matrix|vesicle|myelin sheath|extracellular exosome|extracellular vesicle|,glycolytic process|programmed cell death|phosphorylation|,magnesium ion binding|pyruvate kinase activity|protein binding|ATP binding|MHC class II protein complex binding|potassium ion binding|poly(A) RNA binding|,12,16,4760000000,23.5%
P16858,0.876686118,0.151416667,1.032218084,-0.1605,0.788457324,-0.280491848,0.755,0.9315,-0.9915,0.52,-0.308,0.0015,P16858,Gapdh,P16858_Gapdh,P16858,Gapdh,1,18,9,9,A0A0A0MQF6|P16858|A0A1D5RLD8|S4R1W1|P10096|V9GXA7|Q64467|S4R2G5|A0A0R4J0X7|V9GX06,MOUSE,36094.6,34.5,215,215.1,106.3,106.3,,333,Glyceraldehyde-3-phosphate dehydrogenase,nucleus|cytoplasm|cytosol|microtubule cytoskeleton|myelin sheath|GAIT complex|,microtubule cytoskeleton organization|glucose metabolic process|glycolytic process|negative regulation of translation|peptidyl-cysteine S-trans-nitrosylation|protein stabilization|neuron apoptotic process|oxidation-reduction process|,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity|protein binding|microtubule binding|enzyme binding|peptidyl-cysteine S-nitrosylase activity|NADP binding|NAD binding|,9,18,686000000,34.5%
Q922D8,0.399101763,0.119083333,8.411579391,-0.423833333,0.1441591,-1.671162779,0.544,-0.0315,0.4805,-0.097,-0.175,-0.0065,Q922D8,Mthfd1,Q922D8_Mthfd1,Q922D8,Mthfd1,1,14,10,10,Q922D8|A0A1W2P733,MOUSE,101882.4,11.1,216,216.1,105.97,105.97,,935,"C-1-tetrahydrofolate synthase, cytoplasmic",mitochondrion|cytosol|membrane|extracellular exosome|,histidine biosynthetic process|neutrophil homeostasis|neural tube closure|purine nucleotide biosynthetic process|methionine metabolic process|one-carbon metabolic process|heart development|serine family amino acid metabolic process|serine family amino acid biosynthetic process|methionine biosynthetic process|10-formyltetrahydrofolate biosynthetic process|transsulfuration|tetrahydrofolate interconversion|oxidation-reduction process|somite development|,formate-tetrahydrofolate ligase activity|methenyltetrahydrofolate cyclohydrolase activity|methylenetetrahydrofolate dehydrogenase (NAD+) activity|methylenetetrahydrofolate dehydrogenase (NADP+) activity|ATP binding|,10,14,758000000,11.1%
P05213,0.573841572,-0.392583333,4.60290526,0.9915,0.346504975,1.020722587,0.516,-0.0065,-3.1745,0.342,-0.273,0.2405,P05213,Tuba1b,P05213_Tuba1b,P05213,Tuba1b,1,9,9,9,P05213|P68369|P68373|P68368|P05214|Q9JJZ2|Q3UX10,MOUSE,50835.4,24.1,217,217.1,105.91,105.91,,451,Tubulin alpha-1B chain,cytosol|microtubule|cytoplasmic microtubule|myelin sheath|extracellular exosome|,microtubule cytoskeleton organization|protein folding|protein polymerization|cellular response to interleukin-4|,double-stranded RNA binding|GTPase activity|structural constituent of cytoskeleton|protein binding|GTP binding|ubiquitin protein ligase binding|,9,9,511000000,24.1%
Q8R1U2,0.812519126,0.10125,1.727933594,-0.1335,0.6717484,-0.44455886,0.675,-0.1845,0.0135,-0.093,0.208,-0.0115,Q8R1U2,Cgref1,Q8R1U2_Cgref1,Q8R1U2,Cgref1,1,16,7,7,E9QPK1|Q8R1U2,MOUSE,30846.9,28.4,218,218.1,103.77,103.77,,281,Cell growth regulator with EF hand domain protein 1,extracellular region|,cell cycle arrest|cell adhesion|,calcium ion binding|,7,16,5080000000,28.4%
Q9Z0M6,0.967717058,0.043416667,0.226575655,0.028833333,0.949166572,0.066400631,-0.795,0.0705,0.8115,-0.068,0.272,-0.0305,Q9Z0M6,Adgre5,Q9Z0M6_Adgre5,Q9Z0M6,Cd97,1,15,7,7,E9QJS7|Q9Z0M6|Q9Z0M6-3|E9QMJ5|Q9Z0M6-2|A0A0D9SEG8|Q9DC42,MOUSE,92922.2,10,219,219.1,103.04,103.04,,818,CD97 antigen,plasma membrane|focal adhesion|membrane|integral component of membrane|extracellular exosome|,cell adhesion|G-protein coupled receptor signaling pathway|positive regulation of synapse assembly|,transmembrane signaling receptor activity|G-protein coupled receptor activity|calcium ion binding|,7,15,274000000,10.0%
Q91VB8,0.657738419,0.19675,3.49111524,-0.5785,0.447598349,-0.811992918,-0.924,0.4565,1.9255,0.093,-0.44,0.0695,Q91VB8,Hba-a1,Q91VB8_Hba-a1,Q91VB8,Hba-a1,1,29,6,6,Q91VB8|P01942|P01966,MOUSE,15169,63.3,220,220.1,102.22,102.22,,142,Alpha globin 1,hemoglobin complex|,oxygen transport|,oxygen transporter activity|iron ion binding|oxygen binding|heme binding|,6,29,64300000000,63.3%
Q91XL1,0.579053364,0.086083333,4.489662075,-0.387166667,0.355658991,-0.998511787,-0.165,-0.0705,1.0745,-0.192,-0.22,0.0895,Q91XL1,Lrg1,Q91XL1_Lrg1,Q91XL1,Lrg1,1,29,8,8,Q91XL1,MOUSE,37829.6,23.9,221,221.1,102.04,102.04,,342,Leucine-rich HEV glycoprotein,extracellular space|extracellular exosome|,positive regulation of endothelial cell proliferation|positive regulation of transforming growth factor beta receptor signaling pathway|positive regulation of angiogenesis|brown fat cell differentiation|,transforming growth factor beta receptor binding|,8,29,9450000000,23.9%
P01592,0.769211152,0.156083333,2.247870224,-0.2265,0.595954327,-0.558931958,-0.091,-0.2055,1.1045,-0.189,0.108,0.2095,P01592,Jchain,P01592_Jchain,P01592,Jchain,1,34,7,7,P01592,MOUSE,18469.7,40.2,222,222.1,100.39,100.39,,159,Immunoglobulin J chain,extracellular space|extracellular exosome|monomeric IgA immunoglobulin complex|dimeric IgA immunoglobulin complex|secretory IgA immunoglobulin complex|secretory dimeric IgA immunoglobulin complex|pentameric IgM immunoglobulin complex|blood microparticle|,adaptive immune response|glomerular filtration|humoral immune response|antibacterial humoral response|positive regulation of protein oligomerization|innate immune response|positive regulation of respiratory burst|,antigen binding|IgA binding|protein homodimerization activity|single-stranded DNA binding|phosphatidylcholine binding|immunoglobulin receptor binding|peptidoglycan binding|,7,34,42600000000,40.2%
P47878,0.859645788,-0.07675,1.171800018,0.1045,0.763519263,0.314423721,0.285,0.0805,-0.7525,-0.176,0.094,0.0085,P47878,Igfbp3,P47878_Igfbp3,P47878,Igfbp3,1,21,8,8,P47878,MOUSE,32713.3,29.1,223,223.1,98.85,98.85,,292,Insulin-like growth factor-binding protein 3,extracellular space|nucleus|insulin-like growth factor ternary complex|extracellular exosome|,regulation of cell growth|osteoblast differentiation|negative regulation of protein phosphorylation|protein phosphorylation|negative regulation of cell proliferation|regulation of glucose metabolic process|negative regulation of smooth muscle cell migration|regulation of growth|positive regulation of apoptotic process|positive regulation of catalytic activity|positive regulation of MAPK cascade|positive regulation of insulin-like growth factor receptor signaling pathway|type B pancreatic cell proliferation|positive regulation of myoblast differentiation|negative regulation of smooth muscle cell proliferation|,fibronectin binding|insulin-like growth factor binding|protein tyrosine phosphatase activator activity|insulin-like growth factor I binding|insulin-like growth factor II binding|,8,21,13300000000,29.1%
A0A0B4J1H7,0.441723111,-0.12475,7.427940016,1.417833333,0.180803152,1.51260713,0.406,0.0005,-2.9075,-0.241,0.838,1.1555,A0A0B4J1H7,NotFound,A0A0B4J1H7_NotFound,A0A0B4J1H7,Igkv1-135,1,20,9,9,A0A0B4J1H7,MOUSE,13419.1,45.8,224,224.1,96.5,96.5,,120,Immunoglobulin kappa variable 1-135 (Fragment),,,,9,20,3910000000,45.8%
A0A0B4J1H9,0.799195719,0.517583333,1.920891879,-0.268166667,0.642555747,-0.488295555,0.861,0.0915,1.0025,-0.094,-0.259,1.5035,A0A0B4J1H9,NotFound,A0A0B4J1H9_NotFound,A0A0B4J1H9,Igkv1-132,1,4,3,3,A0A0B4J1H9,MOUSE,13548.3,33.3,224,224.2,29.1,29.1,,120,Immunoglobulin kappa variable 1-132 (Fragment),,,,3,4,51800000,33.3%
O35664-3,0.334785174,-0.473583333,9.953463127,1.102833333,0.101077313,1.933067396,-0.589,-0.1875,-2.2985,0.307,-0.046,-0.0275,O35664,Ifnar2,O35664-3_Ifnar2,O35664-3,Ifnar2,1,25,7,7,O35664-3|O35664|O35664-2|F6XX07,MOUSE,28268.1,19.3,225,225.1,96.24,96.24,,513,Isoform 3 of Interferon alpha/beta receptor 2,extracellular space|plasma membrane|integral component of plasma membrane|integral component of membrane|,regulation of transcription from RNA polymerase II promoter|cell proliferation|cytokine-mediated signaling pathway|response to interferon-alpha|type I interferon signaling pathway|,type I interferon receptor activity|protein kinase binding|type I interferon binding|,7,25,8130000000,19.3%
Q04857,0.481331214,-0.135583333,6.508406234,0.336833333,0.223439205,1.352677118,-0.578,-0.1355,-0.1985,-0.188,0.098,0.1885,Q04857,Col6a1,Q04857_Col6a1,Q04857,Col6a1,1,10,8,8,Q04857,MOUSE,109628.6,8.8,226,226.1,95.72,95.72,,1025,Collagen alpha-1(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|lysosomal membrane|membrane|extracellular matrix|sarcolemma|protein complex|extracellular exosome|extracellular matrix|,osteoblast differentiation|cell adhesion|endodermal cell differentiation|protein heterotrimerization|cellular response to amino acid stimulus|,platelet-derived growth factor binding|,8,10,569000000,8.8%
Q8C7G5,0.812519126,-0.182416667,1.751444438,0.257166667,0.668121667,0.450416968,0.492,0.1795,-1.6045,0.09,-0.186,-0.0655,Q8C7G5,Apoa5,Q8C7G5_Apoa5,Q8C7G5,Apoa5,1,9,6,6,Q8C7G5|A0A1L1SQP3,MOUSE,41318.5,17.6,227,227.1,92.14,92.14,,368,Apolipoprotein A-V,extracellular region|extracellular space|very-low-density lipoprotein particle|high-density lipoprotein particle|chylomicron|blood microparticle|,triglyceride metabolic process|cholesterol biosynthetic process|lipid transport|response to hormone|positive regulation of cholesterol esterification|positive regulation of triglyceride catabolic process|positive regulation of very-low-density lipoprotein particle remodeling|triglyceride catabolic process|regulation of intestinal cholesterol absorption|organ regeneration|neuron projection regeneration|cholesterol efflux|phospholipid efflux|triglyceride-rich lipoprotein particle remodeling|very-low-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|lipoprotein metabolic process|tissue regeneration|cholesterol homeostasis|reverse cholesterol transport|positive regulation of fatty acid biosynthetic process|phosphatidylcholine metabolic process|positive regulation of lipid catabolic process|positive regulation of lipoprotein lipase activity|acylglycerol homeostasis|triglyceride homeostasis|,phospholipid binding|enzyme activator activity|heparin binding|lipid binding|cholesterol binding|cholesterol transporter activity|enzyme binding|phosphatidylcholine binding|lipase binding|low-density lipoprotein particle receptor binding|phosphatidylcholine-sterol O-acyltransferase activator activity|lipase activator activity|lipoprotein lipase activator activity|lipoprotein particle receptor binding|,6,9,148000000,17.6%
P01843,0.365800695,-1.219083333,9.101482409,2.587166667,0.122984891,1.791909206,-0.819,-0.7025,-6.0165,-0.199,0.22,0.2025,P01843,NotFound,P01843_NotFound,P01843,,1,19,5,5,A0A0G2JE99|P01843,MOUSE,11745.8,69.5,228,228.1,91.87,91.87,,105,Ig lambda-1 chain C region,plasma membrane|,,antigen binding|,5,19,9520000000,69.5%
Q71KU9,0.174302757,0.337583333,16.80208814,-0.7095,0.020882918,-3.076586531,0.829,0.5975,0.6505,-0.247,0.122,0.0735,Q71KU9,Fgl1,Q71KU9_Fgl1,Q71KU9,Fgl1,1,18,7,7,Q71KU9|A0A0R4J0E1|Q3SZZ7,MOUSE,36724.1,24.2,229,229.1,90.96,90.96,,314,Fibrinogen-like protein 1,extracellular exosome|,cholesterol metabolic process|regulation of glucose metabolic process|response to stilbenoid|adipose tissue development|,,7,18,645000000,24.2%
Q8VCS0,0.830200164,0.0896,1.547575958,0.11475,0.700232726,0.407004522,0.011,0.0305,,0.404,0.039,-0.0365,Q8VCS0,Pglyrp2,Q8VCS0_Pglyrp2,Q8VCS0,Pglyrp2,1,14,6,6,Q8VCS0|Q8VCS0-2|Q8VCS0-3,MOUSE,58219.2,15,230,230.1,90.57,90.57,,530,N-acetylmuramoyl-L-alanine amidase,membrane|extracellular exosome|,pattern recognition receptor signaling pathway|peptidoglycan catabolic process|detection of bacterium|negative regulation of interferon-gamma production|negative regulation of natural killer cell differentiation involved in immune response|growth of symbiont in host|regulation of inflammatory response|defense response to Gram-positive bacterium|,zinc ion binding|N-acetylmuramoyl-L-alanine amidase activity|peptidoglycan receptor activity|peptidoglycan binding|,6,14,730000000,15.0%
Q99K41,0.739761835,0.487416667,2.581655307,-0.5965,0.551867056,-0.629826468,2.575,0.8825,-1.1005,0.783,0.379,-0.5945,Q99K41,Emilin1,Q99K41_Emilin1,Q99K41,Emilin1,1,8,8,8,Q99K41,MOUSE,108895,10.1,231,231.1,89.88,89.88,,1017,EMILIN-1,extracellular region|proteinaceous extracellular matrix|collagen trimer|extracellular matrix|extracellular exosome|extracellular matrix|,cell adhesion|positive regulation of cell-substrate adhesion|extracellular matrix organization|,protein binding|extracellular matrix constituent conferring elasticity|identical protein binding|,8,8,101000000,10.1%
O54782,0.384794075,-0.139916667,8.689232756,0.536833333,0.135231145,1.716971155,-0.153,-0.0975,-0.9745,0.091,0.288,0.0065,O54782,Man2b2,O54782_Man2b2,O54782,Man2b2,1,14,9,9,O54782,MOUSE,115835.7,9.6,232,232.1,88.38,88.38,,1018,Epididymis-specific alpha-mannosidase,extracellular exosome|,mannose metabolic process|,alpha-mannosidase activity|zinc ion binding|carbohydrate binding|,9,14,4460000000,9.6%
P43025,0.549465437,-0.32375,5.086192466,0.6125,0.310013605,1.107992538,-0.016,0.0085,-1.8825,-0.215,0.077,0.0855,P43025,NotFound,P43025_NotFound,P43025,Clec3b,1,12,7,7,P43025|Q8CFZ6,MOUSE,22656.5,37.6,233,233.1,88.26,88.26,,202,Tetranectin,granular component|proteinaceous extracellular matrix|extracellular space|cytoplasm|extracellular exosome|,skeletal system development|ossification|positive regulation of plasminogen activation|bone mineralization|,calcium ion binding|protein binding|heparin binding|carbohydrate binding|kringle domain binding|,7,12,466000000,37.6%
P27656,0.519628152,-0.163916667,5.610536678,0.374166667,0.27475546,1.197929491,-0.596,0.2335,-0.6905,-0.014,0.082,0.0015,P27656,Lipc,P27656_Lipc,P27656,Lipc,1,17,7,7,P27656|Q3TYU0,MOUSE,58072.5,14.9,234,234.1,87.43,87.43,,510,Hepatic triacylglycerol lipase,extracellular space|high-density lipoprotein particle|,fatty acid biosynthetic process|cholesterol metabolic process|triglyceride catabolic process|cholesterol transport|very-low-density lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|cholesterol homeostasis|triglyceride homeostasis|,triglyceride lipase activity|protein binding|heparin binding|lipase activity|,7,17,1770000000,14.9%
P55284,0.255274696,-0.24875,13.17684559,0.545833333,0.048118872,2.456081865,-0.661,-0.3085,-0.5955,0.023,0.071,-0.0215,P55284,Cdh5,P55284_Cdh5,P55284,Cdh5,1,12,8,8,P55284,MOUSE,88186.6,11.4,235,235.1,86.98,86.98,,784,Cadherin-5,plasma membrane|cell-cell junction|adherens junction|bicellular tight junction|integral component of membrane|cell junction|cell periphery|,blood vessel maturation|homophilic cell adhesion via plasma membrane adhesion molecules|negative regulation of cell proliferation|single organismal cell-cell adhesion|regulation of establishment of cell polarity|,receptor binding|calcium ion binding|protein binding|beta-catenin binding|protein phosphatase binding|ion channel binding|,8,12,12900000000,11.4%
O88200,0.391017748,0.095416667,8.597006326,-0.361166667,0.138133612,-1.701767009,0.318,0.3415,0.1685,-0.152,-0.122,0.0185,O88200,Clec11a,O88200_Clec11a,O88200,Clec11a,1,12,9,9,O88200,MOUSE,36793.1,34.4,236,236.1,86.48,86.48,,328,C-type lectin domain family 11 member A,extracellular region|extracellular space|cytoplasm|,positive regulation of cell proliferation|,growth factor activity|carbohydrate binding|,9,12,640000000,34.4%
Q02788,0.830935436,-0.154583333,1.48405684,0.090166667,0.710549464,0.388638475,-0.342,-0.0135,-0.2435,-0.199,-0.218,0.0885,Q02788,Col6a2,Q02788_Col6a2,Q02788,Col6a2,1,11,9,9,Q02788|D3Z7D5,MOUSE,111473.4,7.8,237,237.1,85.85,85.85,,1034,Collagen alpha-2(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|extracellular space|extracellular matrix|sarcolemma|protein complex|extracellular exosome|extracellular vesicle|extracellular matrix|,cell adhesion|response to glucose|protein heterotrimerization|,,9,11,370000000,7.8%
E9QKW2,0.384498803,0.450083333,8.732228472,-1.039166667,0.133898944,-1.730609699,0.164,0.3955,2.3495,0.05,-0.184,-0.0745,E9QKW2,Smoc1,E9QKW2_Smoc1,E9QKW2,Smoc1,1,12,7,7,A0A0R4J1E4|E9QKW2|D3Z3A3|Q8BLY1|Q8BLY1-2,MOUSE,51031.9,18.1,238,238.1,84.98,84.98,,452,SPARC-related modular calcium-binding protein 1,basement membrane|,eye development|signal transduction|positive regulation of cell-substrate adhesion|extracellular matrix organization|regulation of osteoblast differentiation|limb development|,calcium ion binding|extracellular matrix binding|,7,12,3040000000,18.1%
A0A075B5S2,0.332238022,-0.612083333,10.04789686,1.841166667,0.098903193,1.948706242,-0.544,-0.3555,-3.6985,-0.082,0.978,0.0295,A0A075B5S2,NotFound,A0A075B5S2_NotFound,A0A075B5S2,Ighv7-1,1,16,7,7,A0A075B5S2|P01791|P01794|P01788|P01787|P01790|P01793|P01792|P01789,MOUSE,13815.5,56.1,239,239.1,84.83,84.83,,121,Immunoglobulin heavy variable 7-1 (Fragment),,,,8,16,3080000000,56.1%
A0A140T8M2,0.399101763,0.1064,8.367784414,0.884416667,0.145620178,1.71701553,-0.979,0.1305,,1.074,0.345,-0.0385,A0A140T8M2,NotFound,A0A140T8M2_NotFound,A0A140T8M2,Igkv12-44,1,20,5,5,A0A140T8M2|P01636,MOUSE,12728.1,43.4,240,240.1,84.6,84.6,,115,Immunoglobulin kappa variable 12-44 (Fragment),,,,5,20,10200000000,43.4%
Q8QZR4,0.376897582,-0.80425,8.858972307,1.8655,0.130047728,1.751663615,-0.629,-0.3155,-4.2665,0.545,-0.165,0.0055,Q8QZR4,Oaf,Q8QZR4_Oaf,Q8QZR4,Oaf,1,8,6,6,Q8QZR4,MOUSE,32151.3,21.9,241,241.1,84.36,84.36,,282,Out at first protein homolog,extracellular exosome|,,,6,8,895000000,21.9%
Q8BI84,0.812519126,0.119416667,1.724966983,-0.223833333,0.672207419,-0.44427929,-0.249,-0.4035,1.3465,-0.063,-0.14,0.2255,Q8BI84,Mia3,Q8BI84_Mia3,Q8BI84,Mia3,1,13,9,9,Q8BI84|Q8BI84-2|J3KMH5|Q8BI84-3,MOUSE,214298.7,5.7,242,242.1,83.76,83.76,,1930,Transport and Golgi organization protein 1 homolog,endoplasmic reticulum membrane|membrane|integral component of membrane|intracellular membrane-bounded organelle|,chondrocyte development|positive regulation of leukocyte migration|exocytosis|negative regulation of cell adhesion|protein transport|collagen fibril organization|negative regulation of cell migration|positive regulation of bone mineralization|wound healing|,,9,13,5760000000,5.7%
P01844,0.449503035,-0.192416667,7.217241327,0.5485,0.189791111,1.472469039,-0.832,0.2335,-0.8015,-0.218,0.363,0.1005,P01844,NotFound,P01844_NotFound,P01844,Iglc2,1,16,5,2,P01844,MOUSE,11425.5,65.3,243,243.1,83.53,37.91,,104,Ig lambda-2 chain C region,plasma membrane|,,,5,16,7980000000,65.3%
P01845,0.468261811,0.194083333,6.746263021,-0.393833333,0.211530842,-1.393072741,0.773,0.0425,0.3575,0.008,-0.22,0.2035,P01845,NotFound,P01845_NotFound,P01845,Iglc3,1,5,4,2,P01845,MOUSE,11541.6,61.5,243,243.2,66.64,25.32,,104,Ig lambda-3 chain C region,plasma membrane|,,antigen binding|,2,5,275000000,37.5%
Q80VA0-2,0.804206729,0.010083333,1.845840067,0.134833333,0.65375646,0.471018091,-0.291,-0.3135,0.4325,0.176,0.063,-0.0065,Q80VA0,Galnt7,Q80VA0-2_Galnt7,Q80VA0-2,Galnt7,1,12,10,10,Q80VA0-2|Q80VA0|Q80VA0-3,MOUSE,76183.4,13,244,244.1,83.24,83.24,,657,Isoform 2 of N-acetylgalactosaminyltransferase 7,Golgi membrane|membrane|integral component of membrane|extracellular exosome|,protein O-linked glycosylation|,polypeptide N-acetylgalactosaminyltransferase activity|carbohydrate binding|metal ion binding|,10,12,399000000,13.0%
Q8VC49,0.231846274,-0.10175,14.80806877,0.617833333,0.033051648,2.731039262,-0.338,-0.5295,-0.3645,0.251,0.368,0.0025,Q8VC49,Ifi27l2b,Q8VC49_Ifi27l2b,Q8VC49,Ifi27l2b,1,8,5,5,Q8VC49,MOUSE,27886.1,20.8,245,245.1,82.73,82.73,,283,Interferon alpha-inducible protein 27-like protein 2B,integral component of membrane|,,,5,8,4160000000,20.8%
O08689,0.612008945,0.18275,3.972743501,-0.361833333,0.400613564,-0.902771685,0.129,-0.2275,1.1895,-0.084,0.108,-0.0185,O08689,Mstn,O08689_Mstn,O08689,Mstn,1,14,7,7,O08689|A0A087WQL8,MOUSE,43662.3,19.9,246,246.1,82.03,82.03,,376,Growth/differentiation factor 8,extracellular space|cytoplasm|,"positive regulation of defense response to virus by host|transforming growth factor beta receptor signaling pathway|response to heat|response to gravity|positive regulation of pathway-restricted SMAD protein phosphorylation|skeletal muscle atrophy|negative regulation of muscle hypertrophy|response to muscle activity|ovulation cycle process|response to testosterone|negative regulation of kinase activity|regulation of apoptotic process|skeletal muscle tissue regeneration|regulation of MAPK cascade|response to estrogen|response to ethanol|negative regulation of myoblast differentiation|positive regulation of transcription, DNA-templated|negative regulation of insulin receptor signaling pathway|muscle cell cellular homeostasis|cell development|negative regulation of skeletal muscle tissue growth|response to electrical stimulus|negative regulation of protein kinase B signaling|SMAD protein signal transduction|cellular response to dexamethasone stimulus|activation of mitophagy in response to mitochondrial depolarization|negative regulation of skeletal muscle satellite cell proliferation|negative regulation of satellite cell differentiation|negative regulation of myoblast proliferation|",receptor binding|cytokine activity|transforming growth factor beta receptor binding|protein binding|growth factor activity|heparin binding|identical protein binding|,7,14,255000000,19.9%
Q91YW3,0.533724271,-0.208,5.369431007,0.327916667,0.290440315,1.176581227,-0.563,-0.2465,,-0.233,-0.08,0.0825,Q91YW3,Dnajc3,Q91YW3_Dnajc3,Q91YW3,Dnajc3,1,10,8,8,Q91YW3,MOUSE,57919.4,14,247,247.1,81.79,81.79,,504,DnaJ homolog subfamily C member 3,cytoplasm|endoplasmic reticulum lumen|smooth endoplasmic reticulum|cytosol|membrane|extracellular exosome|extracellular vesicle|endoplasmic reticulum Sec complex|,negative regulation of protein kinase activity|endoplasmic reticulum unfolded protein response|negative regulation of apoptotic process|proteolysis involved in cellular protein catabolic process|negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation|negative regulation of cyclin-dependent protein kinase activity|,protein binding|chaperone binding|misfolded protein binding|,8,10,305000000,14.0%
A0A075B5R2,0.582508411,0.186083333,4.443380463,-0.445833333,0.359469422,-0.990207741,1.167,-0.4535,0.5135,-0.074,-0.302,0.2655,A0A075B5R2,NotFound,A0A075B5R2_NotFound,A0A075B5R2,Ighv7-3,1,19,5,5,A0A075B5R2|A0A075B5R3|P01786,MOUSE,13628.3,41.6,248,248.1,80.93,80.93,,120,Immunoglobulin heavy variable 7-3 (Fragment),,,,5,19,1280000000,41.6%
A0A075B5R5,0.917768271,0.351583333,0.652031926,-0.142833333,0.860591015,-0.18325787,-1.062,0.2475,2.0835,0.387,0.489,-0.0355,A0A075B5R5,NotFound,A0A075B5R5_NotFound,A0A075B5R5,Ighv4-1,1,20,6,6,A0A075B5R5|P01807|P01808|P01812|P01806|P01809|P01810|A0A075B5Q2|A0A075B5P7|A0A0A6YWG4,MOUSE,13044.9,49.1,249,249.1,80.39,74.92,,116,Immunoglobulin heavy variable 4-1 (Fragment),,,,8,20,2550000000,49.1%
P18524,0.495148757,0.482083333,6.092513839,-0.9405,0.245894387,-1.284873552,0.884,-0.4835,2.4565,-0.323,0.154,0.2045,P18524,NotFound,P18524_NotFound,P18524,,1,2,3,1,P18524,MOUSE,13036.9,23.9,249,249.2,32.57,14.59,,117,Ig heavy chain V region RF,,,antigen binding|,1,2,16100000,9.4%
Q8R0Z6,0.16997749,0.44825,17.39171729,-0.9155,0.018231746,-3.181189342,0.677,0.6325,1.4085,0.044,-0.061,-0.0115,Q8R0Z6,Angptl6,Q8R0Z6_Angptl6,Q8R0Z6,Angptl6,1,10,7,7,Q8R0Z6,MOUSE,51493.9,17.9,250,250.1,79.74,79.74,,457,Angiopoietin-related protein 6,secretory granule|extracellular exosome|,angiogenesis|cell differentiation|,,7,10,329000000,17.9%
Q8R357,0.246733887,-0.331,13.74142548,0.734583333,0.042252991,2.678002341,-0.956,-0.5875,,0.017,-0.143,0.0145,Q8R357,Olfm1,Q8R357_Olfm1,Q8R357,Olfm1,1,8,6,6,Q8R357|O88998|G3X9Q7|O88998-3|A3KGE4|O88998-2|O88998-4,MOUSE,55769.1,14.2,251,251.1,79.52,79.52,,485,Noelin,extracellular space|alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex|synaptic membrane|,atrioventricular valve formation|positive regulation of gene expression|negative regulation of gene expression|positive regulation of epithelial to mesenchymal transition|protein oligomerization|cardiac epithelial to mesenchymal transition|regulation of beta-amyloid formation|negative regulation of beta-amyloid formation|negative regulation of neuron migration|,beta-amyloid binding|protein binding|,6,8,246000000,14.2%
P14847,0.576829565,-0.0016,4.536564026,0.323583333,0.351838692,1.022346911,-0.371,-0.0205,,0.473,-0.049,-0.0405,P14847,Crp,P14847_Crp,P14847,Crp,1,10,6,6,P14847,MOUSE,25530.6,30.6,252,252.1,79.33,79.33,,225,C-reactive protein,extracellular space|extracellular exosome|,acute-phase response|positive regulation of gene expression|negative regulation of macrophage derived foam cell differentiation|negative regulation of lipid storage|positive regulation of superoxide anion generation|negative regulation of vasodilation|regulation of interleukin-8 secretion|,complement component C1q binding|calcium ion binding|low-density lipoprotein particle binding|low-density lipoprotein particle receptor binding|,6,10,436000000,30.6%
P97873,0.562782873,0.35975,4.777800184,-0.637166667,0.332828097,-1.052508885,1.854,0.6945,-0.5135,-0.038,0.356,-0.1945,P97873,Loxl1,P97873_Loxl1,P97873,Loxl1,1,9,7,7,P97873|A0A0R4J0Q4,MOUSE,67189.7,12.8,253,253.1,79.09,79.09,,607,Lysyl oxidase homolog 1,proteinaceous extracellular matrix|extracellular space|extracellular matrix|,oxidation-reduction process|,"copper ion binding|protein binding|oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor|",7,9,656000000,12.8%
P99024,0.969495192,0.093416667,0.211535577,0.026166667,0.952459334,0.062090472,0.465,0.4995,-0.7235,0.291,-0.333,0.3615,P99024,Tubb5,P99024_Tubb5,P99024,Tubb5,1,9,7,4,P99024|Q9CWF2|Q7TMM9|P68372|Q922F4|Q9ERD7|Q9D6F9,MOUSE,50126.4,15.5,254,254.1,78.93,47.71,,444,Tubulin beta-5 chain,nucleus|nuclear envelope lumen|cytosol|microtubule|cytoplasmic ribonucleoprotein granule|cell body|tubulin complex|extracellular exosome|,protein folding|microtubule-based process|cellular process|spindle assembly|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|protein domain specific binding|ubiquitin protein ligase binding|protein complex binding|GTPase activating protein binding|MHC class I protein binding|,7,9,224000000,15.5%
A2AQ07,0.447547975,0.482583333,7.290942293,-0.746166667,0.186597478,-1.488192313,1.333,1.3135,-0.0795,0.244,-0.501,0.5855,A2AQ07,Tubb1,A2AQ07_Tubb1,A2AQ07,Tubb1,1,1,4,1,A2AQ07,MOUSE,51124.7,6.8,254,254.2,44.57,13.35,,451,Tubulin beta-1 chain,cytoplasm|microtubule|extracellular exosome|,microtubule-based process|metabolic process|spindle assembly|protein polymerization|,GTPase activity|structural constituent of cytoskeleton|GTP binding|,1,1,2340000,2.6%
P05366,0.279130421,0.209583333,11.67214528,-2.050166667,0.068043316,-2.218370286,3.389,-0.2895,0.6045,-0.931,-0.729,-0.7865,P05366,Saa1,P05366_Saa1,P05366,Saa1,1,13,6,5,P05366|P04918,MOUSE,13884.1,50,255,255.1,78.71,66.26,,122,Serum amyloid A-1 protein,extracellular space|cytosol|cytoplasmic microtubule|high-density lipoprotein particle|extracellular exosome|,acute-phase response|cholesterol metabolic process|positive chemotaxis|cell chemotaxis|,G-protein coupled receptor binding|protein binding|heparin binding|chemoattractant activity|,6,13,2010000000,50.0%
P05367,0.015036166,1.236916667,33.18407229,-4.338833333,0.000480389,-6.801572182,4.824,3.0945,2.3005,-0.951,-0.929,-0.9175,P05367,Saa2,P05367_Saa2,P05367,Saa2,1,7,4,3,P05367|A0A1B0GQV5,MOUSE,13736,44.2,255,255.2,40.69,28.24,,122,Serum amyloid A-2 protein,extracellular space|cytosol|cytoplasmic microtubule|high-density lipoprotein particle|extracellular exosome|,acute-phase response|response to stilbenoid|positive chemotaxis|cell chemotaxis|,G-protein coupled receptor binding|protein binding|chemoattractant activity|,3,7,227000000,36.0%
A0A075B5N4,0.985417456,0.3426,0.105623923,-0.014416667,0.975972561,-0.031608535,0.243,0.4595,,-0.066,1.105,-0.0285,A0A075B5N4,NotFound,A0A075B5N4_NotFound,A0A075B5N4,Igkv8-27,1,16,6,2,A0A075B5N4,MOUSE,11090.2,60,256,256.1,78.69,28.56,,100,Immunoglobulin kappa chain variable 8-27,,,,6,16,4480000000,60.0%
A0A140T8P5,0.559519208,0.538916667,4.839018998,-0.4515,0.328169413,-1.061934177,1.11,0.6515,0.5325,-0.182,1.168,-0.0465,A0A140T8P5,NotFound,A0A140T8P5_NotFound,A0A140T8P5,Igkv8-24,1,8,5,2,A0A140T8P5,MOUSE,13434.9,35.5,256,256.2,63.99,30.66,,121,Immunoglobulin kappa chain variable 8-24 (Fragment),,,,2,8,1590000000,17.3%
A0A140T8N7,0.441723111,0.0022,7.450171691,0.502416667,0.17987998,1.549036257,-0.307,-0.2915,,-0.222,0.406,0.4255,A0A140T8N7,NotFound,A0A140T8N7_NotFound,A0A140T8N7,Igkv6-25,1,8,5,3,A0A140T8N7|A0A140T8N5,MOUSE,12853.2,40,256,256.3,63.03,41.27,,115,Immunoglobulin kappa chain variable 6-25 (Fragment),,,,3,8,2680000000,32.1%
A0A140T8M3,0.637148916,0.3472,3.726934298,-0.360916667,0.423942123,-0.867696145,0.805,0.3225,,-0.211,0.81,0.0095,A0A140T8M3,NotFound,A0A140T8M3_NotFound,A0A140T8M3,Igkv8-30,1,2,5,1,A0A140T8M3,MOUSE,13506,35.5,256,256.4,62.2,12.07,,121,Immunoglobulin kappa chain variable 8-30 (Fragment),,,,1,2,117000000,9.9%
A0A140T8P7,0.524685888,0.3426,5.464752515,-1.036916667,0.28413501,-1.198134389,2.389,-0.4595,,0.124,0.002,-0.3425,A0A140T8P7,NotFound,A0A140T8P7_NotFound,A0A140T8P7,Igkv8-21,1,1,5,1,A0A140T8P7,MOUSE,13298.8,33.3,256,256.5,59.22,9.09,,120,Immunoglobulin kappa variable 8-21 (Fragment),,,,1,1,13000000,7.5%
A0A140T8M4,0.46334768,-0.400416667,6.952027887,1.6865,0.201742413,1.432140433,0.173,0.1045,-4.0085,-0.214,0.554,0.9885,A0A140T8M4,NotFound,A0A140T8M4_NotFound,A0A140T8M4,Igkv8-19,1,6,4,2,A0A140T8M4,MOUSE,11230.2,42.5,256,256.6,59.04,34.64,,101,Immunoglobulin kappa variable 8-19,,,,2,6,918000000,26.7%
Q9ET66,0.89919911,-0.162583333,0.860115114,0.130166667,0.8203298,0.237213915,0.288,0.4955,-1.4665,0.007,-0.275,-0.0245,Q9ET66,Pi16,Q9ET66_Pi16,Q9ET66,Pi16,1,12,5,5,E9QNE5|Q9ET66|D3Z6T6|Q9ET66-2,MOUSE,53234.3,13.9,257,257.1,78.67,78.67,,489,Peptidase inhibitor 16,extracellular space|integral component of membrane|extracellular exosome|,negative regulation of peptidase activity|negative regulation of cell growth involved in cardiac muscle cell development|,peptidase inhibitor activity|,5,12,909000000,13.9%
E9QPU1,0.765325466,-0.15675,2.323926549,0.4845,0.585608464,0.575696726,0.718,0.4405,-2.3555,-0.284,0.075,0.4655,E9QPU1,Vwf,E9QPU1_Vwf,E9QPU1,Vwf,1,10,8,8,E9QPU1|Q8CIZ8|Q3TPE1|Q3TD35|Q8CIZ8-2,MOUSE,322558.9,2.8,258,258.1,78.58,78.58,,2813,von Willebrand factor,extracellular region|proteinaceous extracellular matrix|endoplasmic reticulum|external side of plasma membrane|extracellular matrix|Weibel-Palade body|extracellular exosome|,liver development|placenta development|cell adhesion|blood coagulation|hemostasis|platelet activation|cell-substrate adhesion|protein homooligomerization|platelet activation|,glycoprotein binding|protease binding|integrin binding|protein binding|collagen binding|immunoglobulin binding|identical protein binding|protein homodimerization activity|protein N-terminus binding|chaperone binding|,9,10,648000000,2.8%
P97464,0.703042167,-0.12675,3.002581007,0.169833333,0.500889467,0.714589405,-0.003,-0.2295,-0.4025,0.101,-0.235,0.0085,P97464,Ext1,P97464_Ext1,P97464,Ext1,1,9,7,7,P97464,MOUSE,87047.9,9.5,259,259.1,77.63,77.63,,746,Exostosin-1,Golgi membrane|endoplasmic reticulum|Golgi apparatus|integral component of endoplasmic reticulum membrane|,"ossification|glycosaminoglycan biosynthetic process|protein glycosylation|gastrulation|axon guidance|brain development|endoderm development|mesoderm development|heparan sulfate proteoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process|olfactory bulb development|cellular polysaccharide biosynthetic process|embryonic skeletal joint development|","acetylglucosaminyltransferase activity|glucuronosyltransferase activity|transferase activity, transferring glycosyl groups|protein homodimerization activity|metal ion binding|protein heterodimerization activity|glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity|",7,9,453000000,9.5%
Q91ZA3,0.054917198,0.854083333,26.09707935,-2.5005,0.00245636,-4.958643454,3.055,1.3525,1.9055,0.004,-0.918,-0.2745,Q91ZA3,Pcca,Q91ZA3_Pcca,Q91ZA3,Pcca,1,10,8,8,Q91ZA3,MOUSE,80547.9,13.1,260,260.1,77.55,77.55,,724,"Propionyl-CoA carboxylase alpha chain, mitochondrial",mitochondrion|mitochondrial matrix|,metabolic process|,biotin carboxylase activity|propionyl-CoA carboxylase activity|ATP binding|enzyme binding|metal ion binding|,8,10,98000000,13.1%
O09159,0.998029387,0.15,0.015509868,-0.00125,0.99643509,-0.004686883,0.19,0.1115,,0.201,0.285,-0.0375,O09159,Man2b1,O09159_Man2b1,O09159,Man2b1,1,7,7,7,O09159,MOUSE,115216.7,8.3,261,261.1,75.15,75.15,,1013,Lysosomal alpha-mannosidase,lysosome|extracellular exosome|,mannose metabolic process|cellular protein modification process|learning or memory|,alpha-mannosidase activity|mannose binding|zinc ion binding|,7,7,79900000,8.3%
A0A075B5N3,0.542293565,-0.369416667,5.283137762,1.431166667,0.296269008,1.143079215,0.741,0.0125,-4.0085,-0.304,0.417,0.9255,A0A075B5N3,NotFound,A0A075B5N3_NotFound,A0A075B5N3,Igkv8-28,1,12,5,5,A0A075B5N3,MOUSE,11017,59.4,262,262.1,75,75,,101,Immunoglobulin kappa variable 8-28,,,,5,12,2450000000,59.4%
Q61646,0.498295882,-0.0002,6.035426979,-1.77325,0.249147941,-1.30223942,3.38,-1.2525,,-0.419,-0.809,-0.9005,Q61646,Hp,Q61646_Hp,Q61646,Hp,1,7,6,6,Q61646,MOUSE,39265.1,18.1,263,263.1,74.99,74.99,,347,Haptoglobin,extracellular space|endoplasmic reticulum|Golgi apparatus|haptoglobin-hemoglobin complex|extracellular exosome|blood microparticle|,response to hypoxia|liver development|immune system process|acute-phase response|Notch signaling pathway|spermatogenesis|response to heat|response to X-ray|response to lead ion|positive regulation of cell death|organ regeneration|response to magnesium ion|response to lipopolysaccharide|response to cobalamin|response to L-ascorbic acid|response to drug|response to hydrogen peroxide|defense response to bacterium|negative regulation of oxidoreductase activity|response to glucocorticoid|response to electrical stimulus|response to growth hormone|negative regulation of hydrogen peroxide catabolic process|,antioxidant activity|hemoglobin binding|protein homodimerization activity|,6,7,275000000,18.1%
Q3U367,0.439067296,0.0908,7.648771594,-0.51575,0.171839437,-1.584074829,0.752,0.0485,,-0.1,-0.243,-0.0035,Q3U367,Aldh9a1,Q3U367_Aldh9a1,Q3U367,Aldh9a1,1,6,6,6,Q3U367|Q9JLJ2,MOUSE,56856.5,12.3,264,264.1,74.02,74.02,,518,4-trimethylaminobutyraldehyde dehydrogenase,mitochondrion|cytosol|extracellular exosome|,cellular aldehyde metabolic process|carnitine metabolic process|neurotransmitter biosynthetic process|oxidation-reduction process|,"aldehyde dehydrogenase (NAD) activity|oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor|aminobutyraldehyde dehydrogenase activity|4-trimethylammoniobutyraldehyde dehydrogenase activity|",6,6,442000000,12.3%
P08003,0.519628152,0.045416667,5.665138812,-0.4345,0.271322693,-1.20745775,0.756,0.4705,-0.4385,-0.186,-0.307,-0.0225,P08003,Pdia4,P08003_Pdia4,P08003,Pdia4,1,9,7,7,A0A0R4J0Z1|P08003,MOUSE,72323.4,9.5,265,265.1,71.51,71.51,,638,Protein disulfide-isomerase A4,endoplasmic reticulum|endoplasmic reticulum lumen|cell surface|endoplasmic reticulum chaperone complex|melanosome|,protein folding|response to endoplasmic reticulum stress|cell redox homeostasis|chaperone-mediated protein folding|,protein disulfide isomerase activity|poly(A) RNA binding|,7,9,224000000,9.5%
P01631,0.231846274,-0.218916667,14.78418891,1.020166667,0.033233885,2.726969484,-1.229,-0.5475,-0.4105,-0.128,0.867,0.1345,P01631,NotFound,P01631_NotFound,P01631,,1,25,4,4,P01631|A0A140T8M0|A0A0B4J1I0|A0A140T8N1|A0A075B5K8|A0A140T8M9|A0A075B5N0,MOUSE,12386.7,38,266,266.1,71.16,71.16,,113,Ig kappa chain V-II region 26-10,,,antigen binding|,6,25,38500000000,38.0%
Q8BYB9,0.502532234,0.14125,5.957233264,-0.6015,0.253674419,-1.260432515,-0.345,0.2415,1.4295,-0.291,-0.257,0.0695,Q8BYB9,Poglut1,Q8BYB9_Poglut1,Q8BYB9,Poglut1,1,8,7,7,Q8BYB9,MOUSE,46892.1,19.3,267,267.1,71.06,71.06,,392,Protein O-glucosyltransferase 1,endoplasmic reticulum lumen|extracellular exosome|,protein O-linked glycosylation|regulation of Notch signaling pathway|cardiovascular system development|,protein xylosyltransferase activity|UDP-glucosyltransferase activity|UDP-xylosyltransferase activity|glucosyltransferase activity|,7,8,617000000,19.3%
Q9Z0L8,0.378897235,-0.0966,8.815931633,0.473583333,0.131342971,1.789516148,-0.499,-0.2625,,0.197,0.104,-0.0225,Q9Z0L8,Ggh,Q9Z0L8_Ggh,Q9Z0L8,Ggh,1,7,5,5,Q9Z0L8|Q9Z0L8-2,MOUSE,35697.1,17.9,268,268.1,70.58,70.58,,317,Gamma-glutamyl hydrolase,extracellular space|nucleus|lysosome|cytosol|melanosome|extracellular exosome|,proteolysis|glutamine metabolic process|response to zinc ion|response to insulin|response to drug|response to ethanol|,gamma-glutamyl-peptidase activity|,5,7,342000000,17.9%
E9QPX1,0.971784399,-0.016083333,0.187192464,-0.018166667,0.957813058,-0.055073613,0.636,-0.2775,-0.3795,0.002,-0.051,-0.0265,E9QPX1,Col18a1,E9QPX1_Col18a1,E9QPX1,Col18a1,1,11,5,5,E9QPX1|P39061|P39061-1|P39061-2,MOUSE,183320.5,3.4,269,269.1,70,70,,1774,Collagen alpha-1(XVIII) chain,collagen trimer|basement membrane|extracellular space|extracellular matrix|extracellular exosome|extracellular matrix|,angiogenesis|endothelial cell morphogenesis|cell adhesion|positive regulation of cell proliferation|extracellular matrix organization|positive regulation of cell migration|positive regulation of endothelial cell apoptotic process|,structural molecule activity|identical protein binding|,5,11,1870000000,3.4%
P16056,0.830935436,-0.05575,1.478422635,0.085166667,0.711471875,0.387326443,-0.238,-0.1425,0.0855,0.065,-0.068,-0.0365,P16056,NotFound,P16056_NotFound,P16056,Met,1,6,6,6,P16056|F8VQL0,MOUSE,155885.1,5.4,270,270.1,69.98,69.98,,1379,Hepatocyte growth factor receptor,basal plasma membrane|cell surface|membrane|integral component of membrane|,activation of MAPK activity|endothelial cell morphogenesis|liver development|placenta development|synaptic transmission|brain development|muscle organ development|skeletal muscle tissue development|positive regulation of glucose transport|muscle cell migration|myotube differentiation|peptidyl-tyrosine phosphorylation|adult behavior|glucose homeostasis|positive regulation of transcription from RNA polymerase II promoter|protein autophosphorylation|hepatocyte growth factor receptor signaling pathway|branching morphogenesis of an epithelial tube|regulation of synaptic transmission|positive chemotaxis|myoblast proliferation|regulation of excitatory postsynaptic membrane potential|regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling|semaphorin-plexin signaling pathway|negative regulation of hydrogen peroxide-mediated programmed cell death|positive regulation of endothelial cell chemotaxis|,protein kinase activity|hepatocyte growth factor-activated receptor activity|protein binding|ATP binding|protein phosphatase binding|,6,6,118000000,5.4%
Q5MJS3,0.962933411,-0.069083333,0.275338201,-0.0275,0.938568944,-0.080248987,0.018,0.4865,-0.6705,-0.103,-0.193,0.0475,Q5MJS3,Fam20c,Q5MJS3_Fam20c,Q5MJS3,Fam20c,1,11,7,7,Q5MJS3|Q8CID3,MOUSE,66392.3,12.6,271,271.1,69.02,69.02,,579,Extracellular serine/threonine protein kinase FAM20C,extracellular space|Golgi apparatus|extracellular exosome|,skeletal system development|protein phosphorylation|positive regulation of bone mineralization|biomineral tissue development|osteoclast maturation|regulation of fibroblast growth factor receptor signaling pathway|positive regulation of osteoblast differentiation|regulation of phosphorus metabolic process|enamel mineralization|odontoblast differentiation|dentinogenesis|,protein serine/threonine kinase activity|calcium ion binding|manganese ion binding|,7,11,712000000,12.6%
A0A140T8M5,0.363785285,-0.011,9.155829185,0.654583333,0.121455471,1.849359512,-0.372,-0.4355,,-0.219,0.664,0.3075,A0A140T8M5,NotFound,A0A140T8M5_NotFound,A0A140T8M5,Igkv6-15,1,16,5,4,A0A140T8M5|A0A140T8P1,MOUSE,12871.1,40,272,272.1,68.54,49.7,,115,Immunoglobulin kappa variable 6-15 (Fragment),,,,6,16,5990000000,40.0%
A0A075B5N7,0.781082551,0.1642,2.163484359,0.204083333,0.607647288,0.54606117,0.456,-0.3725,,0.221,0.525,-0.0085,A0A075B5N7,NotFound,A0A075B5N7_NotFound,A0A075B5N7,Igkv6-13,1,6,5,2,A0A075B5N7,MOUSE,10554.5,47.3,272,272.2,61.31,31.53,,95,Immunoglobulin kappa variable 6-13,,,,2,6,3460000000,30.5%
A0A140T8Q3,0.511564622,-0.012,5.825238526,0.554583333,0.261502682,1.260693317,-0.568,-0.1215,,-0.224,-0.041,0.8945,A0A140T8Q3,NotFound,A0A140T8Q3_NotFound,A0A140T8Q3,Igkv6-17,1,3,5,2,A0A140T8Q3|P01633,MOUSE,12874.2,40,272,272.3,58.48,28.7,,115,Immunoglobulin kappa variable 6-17 (Fragment),,,,2,3,55200000,26.0%
P01645,0.830935436,0.29575,1.48903491,-0.339166667,0.709735468,-0.390255543,-0.808,-0.2655,2.4695,-0.19,0.572,-0.0035,P01645,NotFound,P01645_NotFound,P01645,,1,20,6,5,P01645|P01644|P01646|P01647|A0A140T8M1|P01643|P01648|P01649|A0A075B5L0,MOUSE,12068.2,60.1,273,273.1,68.34,59.44,,108,Ig kappa chain V-V region HP 93G7,,,antigen binding|,7,20,3980000000,60.1%
P01670,0.973172594,-0.101583333,0.166938142,0.030833333,0.962290472,0.049272726,0.541,0.6655,-1.5575,-0.257,0.116,-0.1175,P01670,NotFound,P01670_NotFound,P01670,,1,5,3,1,P01670,MOUSE,12153.4,25.2,273,273.2,35.16,19.59,,111,Ig kappa chain V-III region PC 6684,,,antigen binding|,1,5,243000000,15.3%
Q99P87,0.760764749,-0.1618,2.386303428,0.182416667,0.577257597,0.594282234,0.027,-0.5695,,-0.15,-0.157,0.0405,Q99P87,Retn,Q99P87_Retn,Q99P87,Retn,1,14,5,5,Q99P87,MOUSE,13119,35.9,274,274.1,67.92,67.92,,114,Resistin,extracellular region|extracellular space|extracellular exosome|,,hormone activity|,5,14,4560000000,35.9%
Q8VI78,0.549465437,0.338416667,5.037866105,-0.697166667,0.313482563,-1.099343107,-0.203,0.1165,2.1475,0.136,-0.131,-0.0355,Q8VI78,Pla1a,Q8VI78_Pla1a,Q8VI78,Pla1a,1,9,6,6,Q8VI78,MOUSE,50838.6,15.5,275,275.1,67.73,67.73,,456,Phospholipase A1 member A,acrosomal membrane|extracellular exosome|,lipid catabolic process|,phosphatidylcholine 1-acylhydrolase activity|,6,9,1400000000,15.5%
A0A075B5S9,0.582508411,0.075916667,4.429747209,0.397833333,0.360599632,0.987572999,0.233,-0.1165,-0.4855,-0.178,1.028,-0.0255,A0A075B5S9,NotFound,A0A075B5S9_NotFound,A0A075B5S9,Ighv9-4,1,11,5,4,A0A075B5S9|A0A0B4J1J4|A0A075B5S1,MOUSE,11048.3,60.2,276,276.1,67.46,47.73,,98,Immunoglobulin heavy variable 9-4,,,,6,11,506000000,60.2%
A0A0B4J1J5,0.947121191,0.048916667,0.427419571,0.087833333,0.906270916,0.122770562,1.027,0.5905,-1.6025,-0.148,0.547,-0.1205,A0A0B4J1J5,NotFound,A0A0B4J1J5_NotFound,A0A0B4J1J5,Ighv9-3,1,1,3,1,A0A0B4J1J5,MOUSE,13109.7,26.4,276,276.2,35.16,9.76,,117,Immunoglobulin heavy variable V9-3 (Fragment),,,,1,1,4330000,12.8%
Q9CZT5,0.747751869,-0.20075,2.51643983,0.437833333,0.560216656,0.616248533,-0.092,0.8155,-1.9825,0.235,-0.279,0.0985,Q9CZT5,Vasn,Q9CZT5_Vasn,Q9CZT5,Vasn,1,7,6,6,Q9CZT5,MOUSE,73401,10.8,277,277.1,66.56,66.56,,673,Vasorin,extracellular space|mitochondrion|lysosomal membrane|plasma membrane|cell surface|integral component of membrane|extracellular exosome|,negative regulation of epithelial to mesenchymal transition|negative regulation of transforming growth factor beta receptor signaling pathway|cellular response to hypoxia|cellular response to redox state|,protein binding|transforming growth factor beta binding|,6,7,142000000,10.8%
Q61982,0.221504253,0.528583333,15.32114171,-1.268166667,0.029368775,-2.82594832,1.471,1.8045,0.2125,0.052,-0.313,-0.0555,Q61982,Notch3,Q61982_Notch3,Q61982,Notch3,1,10,6,6,Q61982,MOUSE,257423.3,2.7,278,278.1,66.15,66.15,,2318,Neurogenic locus notch homolog protein 3,nucleoplasm|cytoplasm|plasma membrane|integral component of plasma membrane|actin cytoskeleton|receptor complex|,"negative regulation of transcription from RNA polymerase II promoter|transcription, DNA-templated|Notch signaling pathway|forebrain development|negative regulation of cell differentiation|negative regulation of neuron differentiation|positive regulation of transcription from RNA polymerase II promoter|positive regulation of smooth muscle cell proliferation|neuron fate commitment|artery morphogenesis|glomerular capillary formation|",calcium ion binding|protein binding|enzyme binding|,6,10,159000000,2.7%
A0A075B5K2,0.859645788,0.307916667,1.175628558,0.1725,0.762846476,0.315706507,1.083,0.1765,-0.5945,0.078,1.18,-0.0755,A0A075B5K2,NotFound,A0A075B5K2_NotFound,A0A075B5K2,Igkv9-124,1,11,5,5,A0A075B5K2,MOUSE,10533.4,63.1,279,279.1,65.74,65.74,,95,Immunoglobulin kappa chain variable 9-124,,,,5,11,390000000,63.1%
A0A075B5M7,0.917768271,0.9276,0.666039564,-0.171916667,0.857819755,-0.188523821,1.292,0.7695,,0.063,2.596,-0.0825,A0A075B5M7,NotFound,A0A075B5M7_NotFound,A0A075B5M7,Igkv5-39,1,16,4,4,A0A075B5M7|A0A0B4J1J1|A0A0B4J1J2,MOUSE,10459.3,52.6,280,280.1,65.62,65.62,,95,Immunoglobulin kappa variable 5-39,,,,4,16,6670000000,52.6%
P26618,0.399101763,0.132916667,8.376636288,-0.432166667,0.145323675,-1.665389815,0.722,0.2475,0.0775,-0.121,-0.154,0.0255,P26618,Pdgfra,P26618_Pdgfra,P26618,Pdgfra,1,6,6,6,P26618|P26618-2|A0A0J9YV87,MOUSE,123651.1,6.3,281,281.1,65.62,65.62,,1089,Platelet-derived growth factor receptor alpha,nucleus|cytoplasm|cytosol|integral component of plasma membrane|microvillus|external side of plasma membrane|cell surface|membrane|intrinsic component of plasma membrane|protein complex|,luteinization|in utero embryonic development|hematopoietic progenitor cell differentiation|positive regulation of cytosolic calcium ion concentration|estrogen metabolic process|positive regulation of cell proliferation|female gonad development|anatomical structure morphogenesis|organ morphogenesis|response to inorganic substance|negative regulation of platelet activation|positive regulation of phospholipase C activity|cell migration|peptidyl-tyrosine phosphorylation|signal transduction involved in regulation of gene expression|extracellular matrix organization|lung development|adrenal gland development|positive regulation of cell migration|male genitalia development|response to estradiol|Leydig cell differentiation|response to cytokine|cellular response to reactive oxygen species|platelet-derived growth factor receptor-alpha signaling pathway|positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway|wound healing|gliogenesis|odontogenesis of dentin-containing tooth|positive regulation of phosphatidylinositol 3-kinase activity|positive regulation of DNA replication|protein autophosphorylation|platelet-derived growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|positive regulation of fibroblast proliferation|embryonic digestive tract morphogenesis|embryonic cranial skeleton morphogenesis|skeletal system morphogenesis|inner ear development|regulation of chemotaxis|cardiac myofibril assembly|response to hyperoxia|palate development|face morphogenesis|cell chemotaxis|retina vasculature development in camera-type eye|positive regulation of ERK1 and ERK2 cascade|platelet aggregation|cellular response to amino acid stimulus|metanephric glomerular capillary formation|regulation of mesenchymal stem cell differentiation|,protein kinase activity|transmembrane receptor protein tyrosine kinase activity|platelet-derived growth factor alpha-receptor activity|vascular endothelial growth factor-activated receptor activity|platelet-derived growth factor receptor binding|ATP binding|protein complex binding|vascular endothelial growth factor binding|protein homodimerization activity|phosphatidylinositol 3-kinase binding|platelet-derived growth factor binding|,6,6,134000000,6.3%
P34928,0.279130421,0.0838,11.68911758,0.830916667,0.067777921,2.300311231,-0.641,-0.1885,,0.784,0.481,-0.0165,P34928,Apoc1,P34928_Apoc1,P34928,Apoc1,1,19,5,5,P34928,MOUSE,9696.2,32.9,282,282.1,65.39,65.39,,88,Apolipoprotein C-I,endoplasmic reticulum|very-low-density lipoprotein particle|high-density lipoprotein particle|extracellular exosome|,triglyceride metabolic process|cholesterol metabolic process|negative regulation of phosphatidylcholine catabolic process|negative regulation of very-low-density lipoprotein particle clearance|negative regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|plasma lipoprotein particle remodeling|chylomicron remnant clearance|very-low-density lipoprotein particle clearance|lipoprotein metabolic process|negative regulation of fatty acid biosynthetic process|negative regulation of receptor-mediated endocytosis|negative regulation of lipoprotein lipase activity|,phospholipase inhibitor activity|fatty acid binding|,5,19,16900000000,32.9%
Q9WUB3,0.482514848,-0.402083333,6.365633088,0.597833333,0.230906783,1.329595011,-0.226,-0.1875,-1.6895,-0.135,-0.186,0.0115,Q9WUB3,Pygm,Q9WUB3_Pygm,Q9WUB3,Pygm,1,10,6,6,Q9WUB3|E9PUM3|Q9ET01|Q8CI94|Q3UEJ6,MOUSE,97741,8.3,283,283.1,65.21,65.21,,842,"Glycogen phosphorylase, muscle form",cytoplasm|sarcoplasmic reticulum|Z disc|extracellular exosome|,response to hypoxia|glycogen catabolic process|cellular calcium ion homeostasis|response to cAMP|,drug binding|glycogen phosphorylase activity|AMP binding|pyridoxal phosphate binding|carbohydrate binding|,6,10,97700000,8.3%
E9QP56,0.729414454,0.09475,2.770177416,0.338833333,0.528423664,0.668372651,0.447,0.5045,-1.1755,0.526,0.304,-0.0375,E9QP56,Apoc3,E9QP56_Apoc3,E9QP56,Apoc3,1,21,4,4,E9QP56|P33622|A0A0R4J1N3,MOUSE,15162.8,36.4,284,284.1,63.9,63.9,,137,Apolipoprotein C-III,extracellular region|,triglyceride metabolic process|triglyceride mobilization|lipid transport|cholesterol metabolic process|triglyceride catabolic process|lipoprotein metabolic process|,lipid binding|,4,21,22200000000,36.4%
Q9R100,0.522086579,0.264583333,5.552247297,-0.552166667,0.278467984,-1.18941936,0.259,-0.0985,1.4615,-0.203,-0.243,0.4115,Q9R100,Cdh17,Q9R100_Cdh17,Q9R100,Cdh17,1,5,5,5,Q9R100|A2AKS7,MOUSE,92100.1,7.6,285,285.1,63.57,63.57,,827,Cadherin-17,plasma membrane|integral component of plasma membrane|basolateral plasma membrane|,oligopeptide transport|homophilic cell adhesion via plasma membrane adhesion molecules|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|oligopeptide transmembrane transport|,proton-dependent oligopeptide secondary active transmembrane transporter activity|calcium ion binding|protein binding|,5,5,52300000,7.6%
Q62356,0.366645294,0.43875,9.041993706,-0.9525,0.124681101,-1.782040977,0.489,0.1395,2.1165,-0.096,-0.005,-0.0115,Q62356,Fstl1,Q62356_Fstl1,Q62356,Fstl1,1,8,6,6,Q62356,MOUSE,35694.4,19.6,286,286.1,63.06,63.06,,306,Follistatin-related protein 1,extracellular space|extracellular exosome|,response to starvation|,calcium ion binding|protein binding|heparin binding|,6,8,297000000,19.6%
P09813,0.662037385,0.029916667,3.417317117,0.5525,0.455269219,0.797653715,0.708,0.3525,-1.7995,0.657,0.38,-0.1185,P09813,Apoa2,P09813_Apoa2,P09813,Apoa2,1,15,4,4,P09813,MOUSE,11366,43.1,287,287.1,62.19,62.19,,102,Apolipoprotein A-II,extracellular region|extracellular space|cytosol|very-low-density lipoprotein particle|high-density lipoprotein particle|spherical high-density lipoprotein particle|chylomicron|extracellular exosome|blood microparticle|,acute inflammatory response|negative regulation of cytokine secretion involved in immune response|protein folding|fatty acid metabolic process|phosphatidylcholine biosynthetic process|lipid transport|cholesterol metabolic process|phospholipid catabolic process|response to glucose|positive regulation of cholesterol esterification|negative regulation of very-low-density lipoprotein particle remodeling|beta-glucoside transport|protein oxidation|peptidyl-methionine modification|regulation of intestinal cholesterol absorption|organ regeneration|regulation of protein stability|negative regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|triglyceride-rich lipoprotein particle remodeling|low-density lipoprotein particle remodeling|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|high-density lipoprotein particle clearance|lipoprotein metabolic process|response to drug|cholesterol homeostasis|positive regulation of catalytic activity|response to estrogen|reverse cholesterol transport|positive regulation of interleukin-8 biosynthetic process|diacylglycerol catabolic process|negative regulation of lipid catabolic process|positive regulation of lipid catabolic process|response to glucocorticoid|negative regulation of lipase activity|negative regulation of cholesterol import|negative regulation of cholesterol transporter activity|,lipid transporter activity|phospholipid binding|high-density lipoprotein particle binding|lipid binding|cholesterol binding|phosphatidylcholine binding|apolipoprotein receptor binding|protein homodimerization activity|protein heterodimerization activity|lipase inhibitor activity|phosphatidylcholine-sterol O-acyltransferase activator activity|high-density lipoprotein particle receptor binding|cholesterol transporter activity|,4,15,32800000000,43.1%
Q01705,0.785251911,0.215916667,2.098657079,-0.4515,0.616785694,-0.52728892,1.912,0.9335,-1.5205,0.012,0.107,-0.1485,Q01705,Notch1,Q01705_Notch1,Q01705,Notch1,1,7,5,5,Q01705|Q01705-3|Q01705-4|Q01705-2,MOUSE,284808.6,2.6,288,288.1,62.09,62.09,,2531,Neurogenic locus notch homolog protein 1,Golgi membrane|acrosomal vesicle|ruffle|MAML1-RBP-Jkappa- ICN1 complex|extracellular region|nucleus|nucleoplasm|cytoplasm|endoplasmic reticulum|endoplasmic reticulum membrane|cytosol|cytoskeleton|plasma membrane|integral component of plasma membrane|cell surface|lamellipodium|cytoplasmic vesicle|receptor complex|cell periphery|,"negative regulation of transcription from RNA polymerase II promoter|in utero embryonic development|cell fate specification|epithelial to mesenchymal transition|liver development|heart looping|sprouting angiogenesis|osteoblast fate commitment|positive regulation of neuroblast proliferation|inflammatory response to antigenic stimulus|endocardium development|endocardium morphogenesis|atrioventricular node development|coronary vein morphogenesis|aortic valve morphogenesis|atrioventricular valve morphogenesis|pulmonary valve morphogenesis|mitral valve formation|epithelial to mesenchymal transition involved in endocardial cushion formation|endocardial cushion morphogenesis|cardiac chamber formation|cardiac ventricle morphogenesis|cardiac atrium morphogenesis|cardiac right atrium morphogenesis|cardiac left ventricle morphogenesis|cardiac right ventricle formation|ventricular trabecula myocardium morphogenesis|growth involved in heart morphogenesis|regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation|Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation|cell migration involved in endocardial cushion formation|pericardium morphogenesis|regulation of transcription from RNA polymerase II promoter|transcription from RNA polymerase II promoter|humoral immune response|Notch signaling pathway|positive regulation of transcription of Notch receptor target|spermatogenesis|determination of left/right symmetry|compartment pattern specification|axonogenesis|foregut morphogenesis|endoderm development|heart development|positive regulation of cell proliferation|negative regulation of cell proliferation|epidermis development|regulation of Notch signaling pathway|auditory receptor cell fate commitment|glial cell differentiation|regulation of gene expression|positive regulation of epithelial to mesenchymal transition|negative regulation of cell-substrate adhesion|negative regulation of myotube differentiation|mesenchymal cell development|regulation of somitogenesis|cell differentiation in spinal cord|neural tube development|cell differentiation|neuron differentiation|keratinocyte differentiation|negative regulation of ossification|lung development|embryonic limb morphogenesis|regulation of cell migration|positive regulation of cell migration|positive regulation of BMP signaling pathway|negative regulation of BMP signaling pathway|forebrain development|hair follicle morphogenesis|organ regeneration|response to corticosteroid|response to muramyl dipeptide|response to lipopolysaccharide|embryonic hindlimb morphogenesis|tube formation|skeletal muscle cell differentiation|cellular response to vascular endothelial growth factor stimulus|regulation of cell proliferation|tissue regeneration|positive regulation of apoptotic process|negative regulation of catalytic activity|cell fate commitment|negative regulation of cell differentiation|positive regulation of endothelial cell differentiation|regulation of auditory receptor cell differentiation|negative regulation of auditory receptor cell differentiation|positive regulation of keratinocyte differentiation|negative regulation of myoblast differentiation|negative regulation of neuron differentiation|negative regulation of osteoblast differentiation|positive regulation of Notch signaling pathway|negative regulation of transcription, DNA-templated|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|negative regulation of calcium ion-dependent exocytosis|positive regulation of JAK-STAT cascade|negative regulation of photoreceptor cell differentiation|somatic stem cell division|neuron fate commitment|astrocyte differentiation|oligodendrocyte differentiation|positive regulation of astrocyte differentiation|negative regulation of oligodendrocyte differentiation|branching morphogenesis of an epithelial tube|regulation of epithelial cell proliferation|positive regulation of epithelial cell proliferation|regulation of neurogenesis|negative regulation of neurogenesis|cardiac muscle tissue morphogenesis|cardiac muscle cell proliferation|positive regulation of cardiac muscle cell proliferation|negative regulation of glial cell proliferation|cilium morphogenesis|cardiac epithelial to mesenchymal transition|cardiac septum morphogenesis|ventricular septum morphogenesis|secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development|negative regulation of cell death|prostate gland epithelium morphogenesis|regulation of epithelial cell proliferation involved in prostate gland development|arterial endothelial cell differentiation|venous endothelial cell differentiation|cardiac vascular smooth muscle cell development|endocardial cell differentiation|vasculogenesis involved in coronary vascular morphogenesis|coronary artery morphogenesis|Notch signaling involved in heart development|regulation of cell adhesion involved in heart morphogenesis|heart trabecula morphogenesis|positive regulation of transcription from RNA polymerase II promoter in response to hypoxia|left/right axis specification|cellular response to follicle-stimulating hormone stimulus|distal tubule development|collecting duct development|glomerular mesangial cell development|interleukin-4 secretion|negative regulation of cell migration involved in sprouting angiogenesis|negative regulation of canonical Wnt signaling pathway|neuronal stem cell maintenance|positive regulation of ephrin receptor signaling pathway|regulation of extracellular matrix assembly|apoptotic process involved in embryonic digit morphogenesis|negative regulation of stem cell differentiation|negative regulation of anoikis|negative regulation of pro-B cell differentiation|negative regulation of endothelial cell chemotaxis|",core promoter binding|RNA polymerase II transcription factor binding transcription activator activity|chromatin binding|sequence-specific DNA binding transcription factor activity|enzyme inhibitor activity|receptor activity|Notch binding|calcium ion binding|protein binding|enzyme binding|chromatin DNA binding|sequence-specific DNA binding|protein heterodimerization activity|,5,7,60300000,2.6%
Q09200,0.272956918,0.342916667,12.36628586,-0.9855,0.057992444,-2.32506973,0.561,0.2185,1.7275,-0.126,-0.281,-0.0425,Q09200,B4galnt1,Q09200_B4galnt1,Q09200,B4galnt1,1,10,7,7,Q09200|A0A1W2P6F0,MOUSE,59610.2,12,289,289.1,60.28,60.28,,533,"Beta-1,4 N-acetylgalactosaminyltransferase 1",plasma membrane|integral component of Golgi membrane|,ganglioside biosynthetic process|protein glycosylation|glycosphingolipid metabolic process|spermatogenesis|lipid storage|lipid glycosylation|,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity|,7,10,192000000,12.0%
P01887,0.105134073,-0.4472,21.81560511,1.452583333,0.006583237,4.374029114,-1.696,-0.9415,,0.201,0.177,0.0235,P01887,B2m,P01887_B2m,P01887,B2m,1,22,4,4,P01887,MOUSE,13892.8,22.6,290,290.1,59.99,59.99,,119,Beta-2-microglobulin,extracellular space|cytoplasm|Golgi apparatus|plasma membrane|focal adhesion|external side of plasma membrane|membrane|phagocytic vesicle membrane|MHC class I protein complex|extracellular exosome|,"positive regulation of T cell mediated cytotoxicity|response to molecule of bacterial origin|antigen processing and presentation of peptide antigen via MHC class I|antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent|cellular defense response|T cell differentiation in thymus|protein refolding|response to drug|response to cadmium ion|iron ion homeostasis|negative regulation of receptor binding|",glycoprotein binding|protein binding|identical protein binding|,4,22,33500000000,22.6%
P01639,0.705762664,0.2318,2.975108191,0.317583333,0.504068062,0.717868552,-0.049,0.1315,,0.02,1.096,-0.0395,P01639,NotFound,P01639_NotFound,P01639,Gm5571,1,7,4,4,P01639|A0A140T8N0,MOUSE,14482,33,291,291.1,59.51,59.51,,130,Ig kappa chain V-V region MOPC 41,,,antigen binding|,4,7,506000000,33.0%
Q6P542,0.01315234,0.748583333,34.88894769,-2.668833333,0.000324418,-7.158357604,1.904,1.6205,2.7245,-0.812,-0.767,-0.1785,Q6P542,Abcf1,Q6P542_Abcf1,Q6P542,Abcf1,1,8,6,6,Q6P542,MOUSE,95400.1,6.2,292,292.1,59.23,59.23,,837,ATP-binding cassette sub-family F member 1,nuclear envelope|nucleoplasm|cytoplasm|membrane|polysomal ribosome|,translational initiation|positive regulation of translation|ribosome biogenesis|,ATP binding|translation activator activity|ATPase activity|ribosome binding|poly(A) RNA binding|,6,8,180000000,6.2%
A0A0B4J1J7,0.370892088,0.558916667,8.969129911,-0.7255,0.126790586,-1.765002898,1.124,0.2155,1.4255,-0.233,0.648,0.1735,A0A0B4J1J7,NotFound,A0A0B4J1J7_NotFound,A0A0B4J1J7,Ighv1-82,1,8,6,6,A0A0B4J1J7,MOUSE,10763.9,61.2,293,293.1,57.96,57.96,,98,Immunoglobulin heavy variable 1-82,,,,6,8,2430000000,61.2%
Q8VCC9,0.419651267,-0.1606,7.989374481,0.671083333,0.158877557,1.644080468,-0.044,-1.0825,,-0.168,0.268,0.2235,Q8VCC9,Spon1,Q8VCC9_Spon1,Q8VCC9,Spon1,1,4,4,4,Q8VCC9|Q3UYD7,MOUSE,93444.1,6.1,294,294.1,57.89,57.89,,807,Spondin-1,proteinaceous extracellular matrix|extracellular space|extracellular matrix|,cell adhesion|,,4,4,36000000,6.1%
Q769J6,0.410680076,0.499916667,8.175827142,-1.124166667,0.152200923,-1.637961522,0.392,0.1315,2.6625,-0.214,0.029,-0.0015,Q769J6,Adamts13,Q769J6_Adamts13,Q769J6,Adamts13,1,8,6,6,Q769J6|A2ALB3,MOUSE,160032.5,5.5,295,295.1,57.34,57.34,,1426,A disintegrin and metalloproteinase with thrombospondin motifs 13,proteinaceous extracellular matrix|extracellular space|,proteolysis|blood coagulation|response to toxic substance|response to interferon-gamma|response to tumor necrosis factor|peptide catabolic process|response to interleukin-4|,endopeptidase activity|metalloendopeptidase activity|zinc ion binding|,6,8,98800000,5.5%
A0A0B4J1N0,0.853173903,0.3474,1.254420316,0.173583333,0.749131344,0.337626788,-0.002,0.4885,,0.057,1.28,-0.0865,A0A0B4J1N0,NotFound,A0A0B4J1N0_NotFound,A0A0B4J1N0,Ighv1-76,1,10,5,4,A0A0B4J1N0|A0A075B5Y2|A0A075B5Y5,MOUSE,10993.2,54,296,296.1,57.31,40.54,,98,Immunoglobulin heavy variable 1-76,,,,6,10,3650000000,54.0%
A0A0B4J1M0,0.349133986,0.80875,9.439520397,-0.905833333,0.113775292,-1.845801676,0.735,0.8635,2.1865,-0.243,0.611,0.6995,A0A0B4J1M0,NotFound,A0A0B4J1M0_NotFound,A0A0B4J1M0,Ighv1-77,1,3,4,2,A0A0B4J1M0,MOUSE,10775.9,40.8,296,296.2,51.53,23.63,,98,Immunoglobulin heavy variable 1-77,,,,2,3,1580000000,19.3%
O08538,0.272982869,0.195583333,12.29124137,-0.712166667,0.05900324,-2.308961808,0.657,0.0095,0.9885,-0.121,-0.153,-0.2075,O08538,Angpt1,O08538_Angpt1,O08538,Angpt1,1,6,5,5,O08538,MOUSE,58088.5,10,297,297.1,56.99,56.99,,498,Angiopoietin-1,extracellular space|plasma membrane|microvillus|membrane raft|extracellular exosome|,angiogenesis|patterning of blood vessels|vasculogenesis|in utero embryonic development|negative regulation of protein phosphorylation|sprouting angiogenesis|positive regulation of receptor internalization|negative regulation of cytokine secretion involved in immune response|endocardium morphogenesis|negative regulation of cell adhesion|transmembrane receptor protein tyrosine kinase signaling pathway|activation of transmembrane receptor protein tyrosine kinase activity|endoderm development|positive regulation of endothelial cell migration|positive regulation of phosphatidylinositol 3-kinase signaling|regulation of satellite cell proliferation|hemopoiesis|heparin biosynthetic process|positive regulation of vascular endothelial growth factor receptor signaling pathway|positive regulation of protein ubiquitination|cell-substrate adhesion|regulation of tumor necrosis factor production|positive regulation of peptidyl-serine phosphorylation|protein localization to cell surface|negative regulation of protein import into nucleus|negative regulation of apoptotic process|negative regulation of vascular permeability|regulation of I-kappaB kinase/NF-kappaB signaling|regulation of protein binding|negative regulation of neuron apoptotic process|positive regulation of blood vessel endothelial cell migration|positive regulation of cell adhesion|Tie signaling pathway|positive regulation of peptidyl-tyrosine phosphorylation|positive chemotaxis|positive regulation of protein kinase B signaling|cardiac muscle tissue morphogenesis|vasculogenesis involved in coronary vascular morphogenesis|positive regulation of ERK1 and ERK2 cascade|glomerulus vasculature development|negative regulation of endothelial cell apoptotic process|regulation of macrophage migration inhibitory factor signaling pathway|,receptor binding|vascular endothelial growth factor receptor binding|receptor tyrosine kinase binding|,5,6,247000000,10.0%
G3UX19,0.643086642,-0.558416667,3.646383163,1.1425,0.431878599,0.841940665,0.756,0.2665,-4.4115,0.183,-0.149,0.0045,G3UX19,NotFound,G3UX19_NotFound,G3UX19,Atf6b,1,8,5,5,G3UX19|A0A0A0MQ69|O35451,MOUSE,77389.6,10.4,298,298.1,56.48,56.48,,709,Cyclic AMP-dependent transcription factor ATF-6 beta,intracellular|nucleus|endoplasmic reticulum membrane|protein-DNA complex|,endoplasmic reticulum unfolded protein response|positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress|,sequence-specific DNA binding transcription factor activity|cAMP response element binding|sequence-specific DNA binding|transcription regulatory region DNA binding|,5,8,134000000,10.4%
A0A140T8P6,0.582508411,-0.425916667,4.424404067,0.750833333,0.361043552,0.988020954,-0.994,0.8465,-2.2565,-0.008,-0.114,-0.0295,A0A140T8P6,NotFound,A0A140T8P6_NotFound,A0A140T8P6,Igkv12-46,1,13,3,3,A0A140T8P6,MOUSE,12733.1,40.8,299,299.1,55.7,55.7,,115,Immunoglobulin kappa variable 12-46 (Fragment),,,,3,13,776000000,40.8%
A0A075B680,0.399101763,0.76525,8.405129591,-0.9635,0.144373352,-1.676193052,0.303,1.2515,2.1865,-0.169,1.037,-0.0175,A0A075B680,NotFound,A0A075B680_NotFound,A0A075B680,Ighv1-62-2,1,7,5,3,A0A075B680|A0A0G2JFL3,MOUSE,11338.5,53,300,300.1,54.86,38.72,,100,Immunoglobulin heavy variable 1-62-2,,,,5,7,2170000000,53.0%
A0A075B5V8,0.853173903,0.1672,1.234332428,0.222416667,0.752604407,0.332903373,1.026,-0.9585,,0.748,0.085,-0.0645,A0A075B5V8,NotFound,A0A075B5V8_NotFound,A0A075B5V8,Ighv1-47,1,1,3,1,A0A075B5V8,MOUSE,11197.4,31.6,300,300.2,24.26,8.12,,98,Immunoglobulin heavy variable 1-47,,,,1,1,316000000,13.2%
Q8CBR6,0.946187113,-0.116416667,0.438961206,-0.112833333,0.903865644,-0.125940303,1.023,1.0035,-2.2065,-0.112,-0.21,-0.1965,Q8CBR6,Tsku,Q8CBR6_Tsku,Q8CBR6,Tsku,1,5,3,3,Q8CBR6,MOUSE,38760.8,12.9,301,301.1,54.75,54.75,,354,Tsukushin,extracellular space|,regulation of gene expression|corpus callosum morphogenesis|lateral ventricle development|anterior commissure morphogenesis|negative regulation of Wnt signaling pathway|camera-type eye development|ciliary body morphogenesis|,protein binding|,3,5,117000000,12.9%
Q8BM72,0.399101763,0.26275,8.340898795,-0.367166667,0.146524457,-1.659483629,0.536,0.2805,0.5225,0.218,-0.002,0.0215,Q8BM72,Hspa13,Q8BM72_Hspa13,Q8BM72,Hspa13,1,6,5,5,Q8BM72|D3Z0Y0|Q8BM72-2,MOUSE,51765.4,10.8,302,302.1,54.53,54.53,,471,Heat shock 70 kDa protein 13,endoplasmic reticulum|extracellular exosome|,,ATP binding|,5,6,130000000,10.8%
Q8CG85,0.76064592,0.001083333,2.396134512,-0.149833333,0.575952342,-0.590175268,0.347,0.1105,-0.2295,-0.213,-0.098,0.0895,Q8CG85,Mamdc2,Q8CG85_Mamdc2,Q8CG85,Mamdc2,1,5,5,5,A0A0R4J0J7|Q8CG85,MOUSE,78406.9,8,303,303.1,54.37,54.37,,686,MAM domain-containing protein 2,proteinaceous extracellular matrix|interstitial matrix|endoplasmic reticulum|membrane|,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan|,glycosaminoglycan binding|,5,5,23700000,8.0%
P01723,0.830935436,0.0968,1.490037195,0.170083333,0.709571691,0.393699826,0.528,-0.5385,,-0.204,0.303,0.3955,P01723,NotFound,P01723_NotFound,P01723,,1,17,3,2,P01727|A0A075B663|P01723|P01726|P01729,MOUSE,12335.6,41.8,304,304.1,53.88,38.06,,117,Ig lambda-1 chain V region,plasma membrane|,,antigen binding|,4,17,24600000000,41.8%
P01728,0.424548693,0.032,7.902489236,0.963333333,0.162088079,1.699090482,,-0.6905,,-0.149,0.906,0.0615,P01728,NotFound,P01728_NotFound,P01728,,1,2,3,1,P01728|A0A075B664,MOUSE,12392.7,41.8,304,304.2,50.96,26.26,,117,Ig lambda-2 chain V region,,,antigen binding|,1,2,50400000,28.2%
P01869,0.767593159,0.100416667,2.283230163,0.212166667,0.59112181,0.566263627,0.293,0.1105,-0.4205,-0.259,0.039,0.8395,P01869,NotFound,P01869_NotFound,P01869,Ighg1,1,12,3,3,P01869|P01868,MOUSE,44070.3,12.7,305,305.1,53.65,53.65,,393,"Ig gamma-1 chain C region, membrane-bound form",plasma membrane|integral component of membrane|,,antigen binding|immunoglobulin receptor binding|,3,12,1700000000,12.7%
Q9Z1R3,0.933745622,0.0848,0.535445838,0.03925,0.884006414,0.153210055,0.049,0.0735,,0.225,0.063,0.0135,Q9Z1R3,Apom,Q9Z1R3_Apom,Q9Z1R3,Apom,1,9,4,4,Q9Z1R3,MOUSE,21615.3,16.3,306,306.1,53.25,53.25,,190,Apolipoprotein M,extracellular region|very-low-density lipoprotein particle|low-density lipoprotein particle|high-density lipoprotein particle|discoidal high-density lipoprotein particle|spherical high-density lipoprotein particle|extracellular exosome|,response to glucose|cholesterol efflux|high-density lipoprotein particle remodeling|high-density lipoprotein particle assembly|high-density lipoprotein particle clearance|negative regulation of plasma lipoprotein particle oxidation|lipoprotein metabolic process|reverse cholesterol transport|,lipid transporter activity|phospholipid binding|antioxidant activity|,4,9,387000000,16.3%
O88325,0.830935436,-0.078416667,1.523889772,-0.166833333,0.704062191,-0.398020992,0.284,0.5915,-0.8605,-0.221,-0.317,0.0525,O88325,Naglu,O88325_Naglu,O88325,Naglu,1,6,5,5,O88325,MOUSE,83165.4,8.2,307,307.1,53,53,,739,Alpha-N-acetylglucosaminidase,extracellular exosome|,lysosome organization|cerebellar Purkinje cell layer development|middle ear morphogenesis|locomotor rhythm|retinal rod cell development|inner ear receptor cell development|,,5,6,71000000,8.2%
O09043,0.103361882,-0.619083333,22.50197387,1.4285,0.005620858,4.147692742,-1.855,-0.7225,-1.4225,-0.025,0.302,0.0085,O09043,Napsa,O09043_Napsa,O09043,Napsa,1,7,4,4,O09043,MOUSE,45942.9,13.6,308,308.1,52.55,52.55,,419,Napsin-A,extracellular space|lysosome|extracellular exosome|alveolar lamellar body|,protein catabolic process|membrane protein proteolysis|surfactant homeostasis|,endopeptidase activity|aspartic-type endopeptidase activity|protein binding|peptidase activity|,4,7,625000000,13.6%
O08742,0.439067296,0.172583333,7.676985416,-0.5295,0.170726705,-1.549335141,0.158,0.0595,1.0945,-0.069,-0.258,0.0505,O08742,NotFound,O08742_NotFound,O08742,Gp5,1,7,6,6,O08742,MOUSE,63980.2,7.9,309,309.1,52.06,52.06,,567,Platelet glycoprotein V,integral component of membrane|,cell adhesion|blood coagulation|,,6,7,9280000000,7.9%
A0A075B5K0,0.804206729,0.3548,1.836364543,0.22425,0.655184396,0.473646959,0.189,0.2515,,0.102,1.26,-0.0285,A0A075B5K0,NotFound,A0A075B5K0_NotFound,A0A075B5K0,Igkv14-126,1,19,3,2,A0A075B5K0|P01637,MOUSE,13228.7,36.7,310,310.1,51.71,33.94,,117,Immunoglobulin kappa variable 14-126 (Fragment),,,,4,19,5090000000,36.7%
A0A140T8P9,0.549465437,0.26,5.005656075,0.71125,0.315816192,1.113313353,-0.308,-0.0255,,-0.181,1.708,0.1065,A0A140T8P9,NotFound,A0A140T8P9_NotFound,A0A140T8P9,Igkv14-111,1,4,3,1,A0A140T8P9,MOUSE,13403.1,35,310,310.2,50.65,23.18,,117,Immunoglobulin kappa variable 14-111 (Fragment),,,,1,4,274000000,15.3%
Q9WUU7,0.533724271,0.1474,5.365030016,0.346916667,0.290734787,1.17577682,-0.055,-0.0665,,0.424,0.472,-0.0375,Q9WUU7,Ctsz,Q9WUU7_Ctsz,Q9WUU7,Ctsz,1,8,4,4,Q9WUU7,MOUSE,34680.3,13.3,311,311.1,50.72,50.72,,306,Cathepsin Z,extracellular space|lysosome|endoplasmic reticulum|intracellular membrane-bounded organelle|extracellular exosome|,proteolysis involved in cellular protein catabolic process|epithelial tube branching involved in lung morphogenesis|,cysteine-type endopeptidase activity|,4,8,615000000,13.3%
A0A075B5R9,0.799195719,0.020416667,1.897706678,-0.103166667,0.645995261,-0.482545829,-0.028,0.2155,0.0285,-0.035,-0.092,0.0335,A0A075B5R9,NotFound,A0A075B5R9_NotFound,A0A075B5R9,Ighv14-3,1,8,4,2,A0A075B5R9|A0A075B5R4|A0A075B5S3,MOUSE,13088.7,31.6,312,312.1,50.53,27.75,,117,Immunoglobulin heavy variable V14-3 (Fragment),,,,4,8,884000000,31.6%
A0A075B5R7,0.682286255,0.403,3.191550342,-0.30875,0.479562224,-0.761349288,0.888,0.2885,,0.154,0.81,-0.1255,A0A075B5R7,NotFound,A0A075B5R7_NotFound,A0A075B5R7,Ighv14-2,1,3,4,2,A0A075B5R7,MOUSE,13172.7,30.7,312,312.2,38.76,15.98,,117,Immunoglobulin heavy variable 14-2 (Fragment),,,,2,3,147000000,16.2%
Q04592,0.222975672,0.31875,15.24037565,-0.873833333,0.029920058,-2.804975028,0.783,0.2415,1.2425,-0.088,-0.217,-0.0495,Q04592,Pcsk5,Q04592_Pcsk5,Q04592,Pcsk5,1,8,5,5,Q04592|Q04592-2,MOUSE,220321.6,2.5,313,313.1,50.36,50.36,,1877,Proprotein convertase subtilisin/kexin type 5,extracellular space|endoplasmic reticulum lumen|Golgi apparatus|integral component of membrane|secretory granule|,kidney development|renin secretion into blood stream|signal peptide processing|heart development|embryo implantation|anterior/posterior pattern specification|protein processing|peptide hormone processing|viral life cycle|respiratory tube development|limb morphogenesis|cytokine biosynthetic process|peptide biosynthetic process|embryonic digestive tract development|embryonic skeletal system development|,endopeptidase activity|serine-type endopeptidase activity|peptidase activity|peptide binding|,5,8,174000000,2.5%
A0A0A6YYE7,0.445312347,0.408,7.335978654,-0.70875,0.18467246,-1.530859662,0.215,1.4515,,-0.162,0.442,0.0935,A0A0A6YYE7,NotFound,A0A0A6YYE7_NotFound,A0A0A6YYE7,Igkv4-57,1,8,3,3,A0A0A6YYE7|A0A075B5M4|A0A0B4J1I4|A0A0B4J1I3|A0A0A6YYE5|A0A075B5L8,MOUSE,12803.3,39.3,314,314.1,50.34,38.8,,117,Immunoglobulin kappa variable 4-57 (Fragment),,,,4,8,1830000000,39.3%
A0A0B4J1I9,0.804206729,0.3484,1.837506843,-0.223083333,0.655012089,-0.473882414,0.941,0.0235,,-0.267,0.802,0.2425,A0A0B4J1I9,NotFound,A0A0B4J1I9_NotFound,A0A0B4J1I9,Igkv4-55,1,5,2,1,A0A0B4J1I9|P04945,MOUSE,12850.3,27.3,314,314.2,34.32,16.05,,117,Immunoglobulin kappa variable 4-55 (Fragment),,,,1,5,326000000,13.6%
Q62178,0.549465437,0.1566,4.967273293,0.34225,0.318619734,1.102641944,0.12,-0.2175,,0.368,0.531,-0.0185,Q62178,Sema4a,Q62178_Sema4a,Q62178,Sema4a,1,5,5,5,Q62178|D3YWV5,MOUSE,84389.1,7.1,315,315.1,50.28,50.28,,760,Semaphorin-4A,plasma membrane|integral component of membrane|,angiogenesis|T cell differentiation involved in immune response|axonogenesis|regulation of cell shape|regulation of endothelial cell migration|negative regulation of angiogenesis|T-helper 1 cell differentiation|semaphorin-plexin signaling pathway|,,5,5,64200000,7.1%
Q9JHI0,0.500924078,-0.0872,5.997494232,0.367583333,0.251333614,1.290465438,-0.187,-0.4285,,0.301,-0.111,-0.0105,Q9JHI0,Mmp19,Q9JHI0_Mmp19,Q9JHI0,Mmp19,1,4,4,4,Q9JHI0|Q3UW97,MOUSE,59349.2,9.4,316,316.1,50.1,50.1,,527,Matrix metalloproteinase-19,extracellular region|proteinaceous extracellular matrix|plasma membrane|anchored component of membrane|,angiogenesis|ovarian follicle development|ovulation from ovarian follicle|luteolysis|proteolysis|response to hormone|cell differentiation|collagen catabolic process|response to cAMP|,metalloendopeptidase activity|calcium ion binding|zinc ion binding|,4,4,40400000,9.4%
P01675,0.559519208,0.210916667,4.829115145,0.441833333,0.32891864,1.060150799,-0.408,-0.1915,0.5695,-0.212,0.95,0.5575,P01675,NotFound,P01675_NotFound,P01675,,1,9,4,4,P01675|P01676|P01677|P01678|P01679|A0A075B5L5,MOUSE,11741,36.4,317,317.1,50.02,50.02,,107,Ig kappa chain V-VI region XRPC 44,,,antigen binding|,4,9,2050000000,36.4%
E9Q0F0,0.519628152,0.14125,5.618192592,-1.654833333,0.274271537,-1.202213629,1.863,3.2335,-2.1905,-0.632,-1.384,-0.0425,E9Q0F0,Krt78,E9Q0F0_Krt78,E9Q0F0,Krt78,1,16,3,3,E9Q0F0,MOUSE,114088.5,1.9,318,318.1,49.44,49.44,,1068,Keratin 78,extracellular space|keratin filament|extracellular exosome|,,structural molecule activity|,3,16,15900000000,1.9%
A0A075B5M3,0.576829565,0.0104,4.534634589,0.459416667,0.351995038,1.022839328,-0.655,0.1245,,-0.183,0.803,-0.0375,A0A075B5M3,NotFound,A0A075B5M3_NotFound,A0A075B5M3,Igkv4-58,1,9,4,3,A0A075B5M3|P01680|A0A075B5L2,MOUSE,10407.3,40.2,319,319.1,49.4,32.6,,97,Immunoglobulin kappa variable 4-58,,,,4,9,2400000000,40.2%
A0A075B5M2,0.705987939,0.1718,2.948131839,0.243416667,0.507208842,0.711903411,0.251,-0.1995,,0.153,0.661,-0.0065,A0A075B5M2,NotFound,A0A075B5M2_NotFound,A0A075B5M2,Igkv4-61,1,3,2,1,A0A075B5M2|J3QNZ9|L7N239,MOUSE,10267.2,29.7,319,319.2,38.77,21.97,,94,Immunoglobulin kappa chain variable 4-61,,,,1,3,96300000,18.0%
O54819,0.16997749,-0.3144,17.27640179,1.131416667,0.018722327,3.371332195,-0.743,-1.2435,,-0.113,0.485,0.0425,O54819,Tfpi,O54819_Tfpi,O54819,Tfpi,1,4,3,3,O54819|A2ARA0|O54819-2|A2ARA3|Q8BSB7,MOUSE,36070.2,13.7,320,320.1,49.4,49.4,,306,Tissue factor pathway inhibitor,extracellular space|cell surface|,blood coagulation|negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,3,4,260000000,13.7%
A0A087WPN7,0.544926169,0.0652,5.193889097,0.38075,0.302420405,1.144417417,-0.206,-0.1205,,-0.201,0.567,0.2865,A0A087WPN7,NotFound,A0A087WPN7_NotFound,A0A087WPN7,Ighv13-2,1,9,4,4,A0A087WPN7,MOUSE,11456.7,44,321,321.1,49.37,49.37,,100,Immunoglobulin heavy variable 13-2,,,,4,9,463000000,44.0%
Q922Q9,0.24489781,0.58325,13.86400132,-1.146166667,0.041077109,-2.576943739,1.841,0.3345,1.2935,0.293,-0.418,0.1555,Q922Q9,Chid1,Q922Q9_Chid1,Q922Q9,Chid1,1,5,5,5,A0A0R4J242|Q922Q9|A0A0R4J058|Q922Q9-2|A0A1B0GSH5,MOUSE,45075.9,12.2,322,322.1,49.34,49.34,,393,Chitinase domain-containing protein 1,extracellular region|extracellular space|nucleus|lysosome|late endosome|trans-Golgi network|membrane|extracellular exosome|,carbohydrate metabolic process|chitin catabolic process|innate immune response|negative regulation of cytokine production involved in inflammatory response|,chitinase activity|chitin binding|oligosaccharide binding|,5,5,334000000,12.2%
A0A0A6YXQ0,0.399101763,-0.1146,8.337628505,0.443583333,0.146634833,1.705366132,-0.361,-0.4005,,0.111,-0.09,0.1675,A0A0A6YXQ0,NotFound,A0A0A6YXQ0_NotFound,A0A0A6YXQ0,Ighv8-8,1,11,4,4,A0A0A6YXQ0,MOUSE,13299,26,323,323.1,49.33,49.33,,119,Immunoglobulin heavy variable 8-8 (Fragment),,,,4,11,2020000000,26.0%
O35887,0.277507267,-0.2772,12.00838622,0.693416667,0.062974014,2.35815591,-0.962,-0.4245,,-0.066,0.076,-0.0095,O35887,Calu,O35887_Calu,O35887,Calu,1,4,4,4,O35887|G3UWR0|Q6XLQ8|G3V004|G3UWV3,MOUSE,37177.2,13.3,324,324.1,48.96,48.96,,315,Calumenin,extracellular region|endoplasmic reticulum|endoplasmic reticulum lumen|membrane|sarcoplasmic reticulum lumen|melanosome|,peripheral nervous system axon regeneration|response to organic cyclic compound|negative regulation of catalytic activity|,enzyme inhibitor activity|calcium ion binding|enzyme binding|,4,4,645000000,13.3%
Q62351,0.762754224,-0.189583333,2.34761815,0.2595,0.582422555,0.580208228,0.087,0.2545,-1.2995,-0.135,-0.068,0.0235,Q62351,Tfrc,Q62351_Tfrc,Q62351,Tfrc,1,6,6,6,Q62351|Q8C872,MOUSE,86129.2,8.1,325,325.1,48.23,48.23,,763,Transferrin receptor protein 1,extracellular region|extracellular space|mitochondrion|endosome|plasma membrane|coated pit|external side of plasma membrane|cell surface|membrane|integral component of membrane|cytoplasmic membrane-bounded vesicle|melanosome|intracellular membrane-bounded organelle|perinuclear region of cytoplasm|recycling endosome|recycling endosome membrane|extracellular exosome|blood microparticle|extracellular vesicle|HFE-transferrin receptor complex|,response to hypoxia|cellular iron ion homeostasis|receptor-mediated endocytosis|acute-phase response|aging|response to nutrient|response to manganese ion|osteoclast differentiation|cellular response to extracellular stimulus|response to retinoic acid|transferrin transport|iron ion transmembrane transport|cellular response to drug|positive regulation of bone resorption|response to copper ion|cellular response to iron ion|iron ion import|,glycoprotein binding|double-stranded RNA binding|transferrin receptor activity|iron ion transmembrane transporter activity|protein binding|Hsp70 protein binding|transferrin transmembrane transporter activity|identical protein binding|poly(A) RNA binding|chaperone binding|,6,6,189000000,8.1%
P35454,0.44969573,0.31675,7.171443083,-0.457833333,0.191803131,-1.464779725,1.095,0.0975,0.4445,0.172,0.043,0.0485,P35454,Oxt,P35454_Oxt,P35454,Oxt,1,4,3,3,P35454|P35455,MOUSE,13934.7,36.8,326,326.1,48.18,48.18,,125,Oxytocin-neurophysin 1,extracellular region|extracellular space|cytoplasm|cytosol|secretory granule|terminal bouton|,response to amphetamine|regulation of heart rate|maternal aggressive behavior|positive regulation of cytosolic calcium ion concentration|heart development|female pregnancy|memory|grooming behavior|response to mechanical stimulus|response to sucrose|positive regulation of norepinephrine secretion|response to activity|sleep|response to food|positive regulation of prostaglandin secretion|response to estradiol|response to retinoic acid|response to progesterone|response to prostaglandin E|social behavior|negative regulation of urine volume|positive regulation of renal sodium excretion|response to cocaine|hyperosmotic salinity response|maternal behavior|sperm ejaculation|eating behavior|drinking behavior|response to external biotic stimulus|response to peptide hormone|response to ether|negative regulation of blood pressure|positive regulation of blood pressure|positive regulation of ossification|positive regulation of female receptivity|positive regulation of synaptic transmission|response to glucocorticoid|response to cAMP|response to electrical stimulus|regulation of sensory perception of pain|positive regulation of synapse assembly|male mating behavior|positive regulation of penile erection|positive regulation of hindgut contraction|negative regulation of gastric acid secretion|positive regulation of uterine smooth muscle contraction|,neurohypophyseal hormone activity|oxytocin receptor binding|,3,4,18200000,36.8%
A0A0B4J1J6,0.785251911,0.0026,2.107431734,0.175583333,0.615540774,0.533771311,0.15,-0.3555,,-0.225,0.343,0.1005,A0A0B4J1J6,NotFound,A0A0B4J1J6_NotFound,A0A0B4J1J6,Ighv10-1,1,7,4,4,A0A0B4J1J6,MOUSE,13720.5,35.2,327,327.1,46.99,46.99,,119,Immunoglobulin heavy variable 10-1 (Fragment),,,,4,7,577000000,35.2%
Q91W90,0.021758064,-0.7032,30.72196739,1.82925,0.000846844,6.885175092,-1.966,-1.6355,,0.011,0.02,0.0545,Q91W90,Txndc5,Q91W90_Txndc5,Q91W90,Txndc5,1,6,3,3,Q91W90|E9PXX7|A0A0R4J1Y7,MOUSE,47099.3,10,328,328.1,46.83,46.83,,417,Thioredoxin domain-containing protein 5,endoplasmic reticulum lumen|extracellular exosome|,protein folding|response to endoplasmic reticulum stress|apoptotic cell clearance|cell redox homeostasis|,protein disulfide isomerase activity|,3,6,1370000000,10.0%
Q60805,0.729414454,-0.248916667,2.695171609,0.5635,0.537629189,0.653278137,0.802,0.1665,-2.5605,0.038,0.07,-0.0095,Q60805,Mertk,Q60805_Mertk,Q60805,Mertk,1,8,6,6,Q60805,MOUSE,111239.5,4.6,329,329.1,46.73,46.73,,994,Tyrosine-protein kinase Mer,photoreceptor outer segment|extracellular space|cytoplasm|integral component of membrane|rhabdomere|,natural killer cell differentiation|phagocytosis|spermatogenesis|peptidyl-tyrosine phosphorylation|platelet activation|secretion by cell|substrate adhesion-dependent cell spreading|apoptotic cell clearance|protein kinase B signaling|positive regulation of phagocytosis|negative regulation of lymphocyte activation|retina development in camera-type eye|vagina development|negative regulation of leukocyte apoptotic process|,transmembrane receptor protein tyrosine kinase activity|ATP binding|,6,8,161000000,4.6%
P15116,0.482514848,-0.46825,6.341224672,0.952833333,0.23220819,1.327787828,-0.276,0.0685,-2.6265,-0.008,0.075,-0.0425,P15116,Cdh2,P15116_Cdh2,P15116,Cdh2,1,5,4,4,P15116|D3YYT0,MOUSE,100251,6.4,330,330.1,46.71,46.71,,906,Cadherin-2,cell-cell junction|adherens junction|cell-cell adherens junction|fascia adherens|focal adhesion|intercalated disc|membrane|integral component of membrane|basolateral plasma membrane|apical plasma membrane|catenin complex|lamellipodium|plasma membrane raft|synapse|extracellular exosome|cortical actin cytoskeleton|,cell adhesion|homophilic cell adhesion via plasma membrane adhesion molecules|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|glial cell differentiation|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|cell migration|regulation of myelination|regulation of Rho protein signal transduction|positive regulation of MAPK cascade|cell-cell adhesion mediated by cadherin|blood vessel morphogenesis|regulation of axonogenesis|striated muscle cell differentiation|protein heterooligomerization|establishment of protein localization to plasma membrane|negative regulation of canonical Wnt signaling pathway|neuroligin clustering involved in postsynaptic membrane assembly|neuronal stem cell maintenance|regulation of postsynaptic density protein 95 clustering|positive regulation of synaptic vesicle clustering|,calcium ion binding|protein binding|beta-catenin binding|enzyme binding|protein kinase binding|protein phosphatase binding|protein complex binding|alpha-catenin binding|gamma-catenin binding|nitric-oxide synthase binding|,4,5,170000000,6.4%
Q9EPS3,0.467969953,-1.117583333,6.807521605,2.202833333,0.208568078,1.407572354,-0.253,-0.3745,-6.0295,0.102,-0.199,0.0485,Q9EPS3,Glce,Q9EPS3_Glce,Q9EPS3,Glce,1,7,5,5,Q9EPS3,MOUSE,70429.9,8.5,331,331.1,46.64,46.64,,618,D-glucuronyl C5-epimerase,Golgi membrane|Golgi apparatus|integral component of membrane|,heparan sulfate proteoglycan biosynthetic process|heparin biosynthetic process|,"racemase and epimerase activity, acting on carbohydrates and derivatives|heparosan-N-sulfate-glucuronate 5-epimerase activity|UDP-glucuronate 5'-epimerase activity|",5,7,51400000,8.5%
A0A075B5M1,0.606693779,0.344583333,4.08135766,-0.3675,0.390718733,-0.923112223,-0.027,0.3145,1.2975,0.464,0.042,-0.0235,A0A075B5M1,NotFound,A0A075B5M1_NotFound,A0A075B5M1,Igkv4-63,1,9,4,4,A0A075B5M1,MOUSE,10271.2,41,332,332.1,45.24,45.24,,95,Immunoglobulin kappa variable 4-63,,,,4,9,946000000,41.0%
Q8CF98,0.799195719,-0.0334,1.899064794,0.160583333,0.645793279,0.487480094,-0.466,0.2065,,-0.113,0.235,-0.0295,Q8CF98,Colec10,Q8CF98_Colec10,Q8CF98,Colec10,1,6,4,4,Q8CF98,MOUSE,30922.6,15.1,333,333.1,44.71,44.71,,277,Collectin-10,extracellular region|collagen trimer|nucleus|cytoplasm|cytosol|,defense response|heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|embryo development|,mannose binding|,4,6,190000000,15.1%
Q8CAR0,0.836083189,-0.183916667,1.42736077,0.258833333,0.719886324,0.375829524,0.889,0.0265,-1.8555,-0.069,-0.073,-0.0215,Q8CAR0,Igf1,Q8CAR0_Igf1,Q8CAR0,Igf1,1,7,4,4,Q8CAR0|Q4VJB9|P05017-2|P05017|E9PU89|E9Q138,MOUSE,18872.4,25.4,334,334.1,44.37,44.37,,165,Insulin-like growth factor I,extracellular space|intracellular|insulin-like growth factor ternary complex|,"cell activation|regulation of protein phosphorylation|blood vessel remodeling|nervous system development|cell proliferation|positive regulation of cell proliferation|negative regulation of cell proliferation|response to heat|glial cell differentiation|regulation of gene expression|positive regulation of glycoprotein biosynthetic process|positive regulation of cardiac muscle hypertrophy|phosphatidylinositol 3-kinase signaling|positive regulation of phosphatidylinositol 3-kinase signaling|skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration|muscle hypertrophy|myotube cell development|positive regulation of smooth muscle cell migration|positive regulation of cerebellar granule cell precursor proliferation|water homeostasis|proteoglycan biosynthetic process|lung development|positive regulation of cell migration|mammary gland development|exocrine pancreas development|regulation of establishment or maintenance of cell polarity|positive regulation of protein import into nucleus, translocation|negative regulation of smooth muscle cell apoptotic process|multicellular organism growth|bone mineralization involved in bone maturation|regulation of multicellular organism growth|positive regulation of activated T cell proliferation|positive regulation of tyrosine phosphorylation of Stat5 protein|negative regulation of apoptotic process|positive regulation of DNA binding|positive regulation of MAPK cascade|protein kinase B signaling|positive regulation of insulin-like growth factor receptor signaling pathway|myoblast differentiation|positive regulation of osteoblast differentiation|positive regulation of glycogen biosynthetic process|positive regulation of DNA replication|positive regulation of glycolytic process|positive regulation of mitotic nuclear division|positive regulation of transcription, DNA-templated|positive regulation of transcription from RNA polymerase II promoter|positive regulation of glucose import|positive regulation of Ras protein signal transduction|insulin-like growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|positive regulation of fibroblast proliferation|lung alveolus development|cell development|positive regulation of smooth muscle cell proliferation|branching morphogenesis of an epithelial tube|inner ear development|chondroitin sulfate proteoglycan biosynthetic process|positive regulation of epithelial cell proliferation|positive regulation of protein secretion|positive regulation of peptidyl-tyrosine phosphorylation|protein stabilization|regulation of protein metabolic process|myoblast proliferation|positive regulation of protein kinase B signaling|negative regulation of oocyte development|lung vasculature development|lung lobe morphogenesis|Type I pneumocyte differentiation|Type II pneumocyte differentiation|prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis|prostate gland growth|prostate gland epithelium morphogenesis|prostate gland stromal morphogenesis|negative regulation of androgen receptor signaling pathway|ERK1 and ERK2 cascade|negative regulation of ERK1 and ERK2 cascade|positive regulation of calcineurin-NFAT signaling cascade|extrinsic apoptotic signaling pathway in absence of ligand|positive regulation of trophectodermal cell proliferation|positive regulation of myoblast proliferation|negative regulation of extrinsic apoptotic signaling pathway|",insulin receptor binding|insulin-like growth factor receptor binding|integrin binding|hormone activity|protein binding|growth factor activity|,4,7,610000000,25.4%
P01751,0.662037385,0.1754,3.426514335,-0.27475,0.454306098,-0.808332156,0.172,0.5085,,-0.257,0.475,-0.0215,P01751,NotFound,P01751_NotFound,P01751,Ighv1-72,1,7,5,5,P01751|P01754|P01753,MOUSE,15590.3,23.7,335,335.1,43.91,43.91,,139,Ig heavy chain V region B1-8/186-2,,,,5,7,3440000000,23.7%
P18528,0.91535326,0.1832,0.725534281,0.10075,0.846148467,0.204099257,0.386,-0.1405,,-0.329,1.014,-0.0145,P18528,NotFound,P18528_NotFound,P18528,,1,5,3,1,P18528|P18529|P18527,MOUSE,11121.3,35.7,336,336.1,43.5,22.04,,98,Ig heavy chain V region 6.96,,,antigen binding|,3,5,811000000,35.7%
A0A075B5R1,0.339465731,0.00525,9.710409993,0.5945,0.106895396,1.884772392,-0.179,0.0135,-0.7105,0.164,0.711,0.0325,A0A075B5R1,NotFound,A0A075B5R1_NotFound,A0A075B5R1,Ighv5-17,1,4,3,2,A0A075B5R1,MOUSE,13075.8,35,336,336.2,39.93,25.31,,117,Immunoglobulin heavy variable 5-17 (Fragment),,,,2,4,175000000,25.6%
A0A075B5P9,0.606693779,0.05,4.085211486,0.36625,0.390372172,0.936716568,-0.431,0.0915,,-0.087,0.733,-0.0565,A0A075B5P9,NotFound,A0A075B5P9_NotFound,A0A075B5P9,Ighv5-4,1,3,3,1,A0A075B5P9,MOUSE,13135.8,23.9,336,336.3,38.33,16.87,,117,Immunoglobulin heavy variable 5-4 (Fragment),,,,1,3,40700000,9.4%
P18526,0.495148757,0.482083333,6.092513839,-0.9405,0.245894387,-1.284873552,0.884,-0.4835,2.4565,-0.323,0.154,0.2045,P18526,NotFound,P18526_NotFound,P18526,,1,2,3,1,P18526|A0A075B5Q0|A0A075B5Q6,MOUSE,13072.8,23.9,336,336.4,36.05,14.59,,117,Ig heavy chain V region 345,,,antigen binding|,1,2,16100000,9.4%
A0A075B5Q4,0.958652624,0.14175,0.324404438,-0.043666667,0.928024744,-0.095876892,,0.1745,,0.35,-0.292,0.3345,A0A075B5Q4,NotFound,A0A075B5Q4_NotFound,A0A075B5Q4,Ighv5-12,1,1,3,1,A0A075B5Q4|P18525|A0A075B5Q9,MOUSE,13246,28.2,336,336.5,29.04,7.58,,117,Immunoglobulin heavy variable 5-12 (Fragment),,,,1,1,6370000,13.6%
D3Z4E2,0.277507267,0.0044,12.04144623,0.72275,0.062496454,2.36416272,-0.537,-0.3215,,0.57,0.329,-0.0185,D3Z4E2,NotFound,D3Z4E2_NotFound,D3Z4E2,Nrn1,1,9,3,3,D3Z4E2|A0A286YD56|Q8CFV4,MOUSE,17406.3,20.8,337,337.1,43.2,43.2,,158,Neuritin,alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex|,axonogenesis|,,3,9,3050000000,20.8%
Q9D1Q6,0.748287861,-0.115,2.504077752,0.162083333,0.56181357,0.61938533,-0.092,-0.3325,,0.011,-0.144,-0.0175,Q9D1Q6,Erp44,Q9D1Q6_Erp44,Q9D1Q6,Erp44,1,5,5,5,Q9D1Q6,MOUSE,47251.5,11,338,338.1,42.91,42.91,,406,Endoplasmic reticulum resident protein 44,endoplasmic reticulum lumen|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|cell surface|extracellular exosome|,protein folding|response to unfolded protein|glycoprotein metabolic process|response to endoplasmic reticulum stress|cell redox homeostasis|,protein disulfide isomerase activity|protein binding|,5,5,116000000,11.0%
Q9QUM0,0.416821309,0.4644,8.055565574,-0.556416667,0.156474453,-1.655732503,0.944,0.6525,,0.451,-0.188,0.4625,Q9QUM0,Itga2b,Q9QUM0_Itga2b,Q9QUM0,Itga2b,1,6,4,4,Q9QUM0,MOUSE,113760,6,339,339.1,42.7,42.7,,1033,Integrin alpha-IIb,focal adhesion|integrin complex|external side of plasma membrane|cell surface|extracellular exosome|blood microparticle|,positive regulation of leukocyte migration|cell-matrix adhesion|integrin-mediated signaling pathway|platelet aggregation|,identical protein binding|metal ion binding|extracellular matrix binding|fibrinogen binding|,4,6,152000000,6.0%
P01660,0.917848507,-0.00625,0.644260015,0.1195,0.862132463,0.181205473,0.694,0.6655,-1.5575,-0.304,0.398,0.0665,P01660,NotFound,P01660_NotFound,P01660,,1,11,3,2,P01660|P01659|A0A140T8M6|P01667|P01672|P01669|P01671|P01673,MOUSE,12213.3,31.5,340,340.1,42.18,22.59,,111,Ig kappa chain V-III region PC 3741/TEPC 111,,,antigen binding|,3,11,1300000000,31.5%
P01655,,0.368833333,,,,,,,,0.039,0.788,0.2795,P01655,NotFound,P01655_NotFound,P01655,,1,2,3,2,P01655|P01654|P03977|P01656|A0A075B5P0,MOUSE,12168.4,51.7,340,340.2,37.14,17.55,,112,Ig kappa chain V-III region PC 7132,,,antigen binding|,2,2,148000000,36.6%
A0A075B5N9,0.812519126,-0.0882,1.699929896,0.133416667,0.676093889,0.442279733,-0.411,0.0745,,0.157,-0.201,-0.0605,A0A075B5N9,NotFound,A0A075B5N9_NotFound,A0A075B5N9,Igkv3-7,1,2,2,1,A0A075B5N9|P01674,MOUSE,10969.9,29.2,340,340.3,34.79,15.2,,99,Immunoglobulin kappa variable 3-7,,,,1,2,127000000,12.1%
P01657,0.482514848,-0.091,6.334579671,0.414583333,0.232563756,1.350954248,-0.476,-0.2035,,-0.147,0.4,-0.0285,P01657,NotFound,P01657_NotFound,P01657,,1,5,2,2,P01657|P01634|A0A140T8P2|A0A075B5N1|P01632|A0A075B5N2,MOUSE,12063.3,23.4,340,340.4,32.51,23.86,,111,Ig kappa chain V-III region PC 2413,,,antigen binding|,2,5,1990000000,8.1%
P01665,0.055857691,0.268583333,25.87093359,-1.312166667,0.002587657,-4.858273833,0.614,1.3365,0.8235,-0.453,-0.428,-0.2815,P01665,NotFound,P01665_NotFound,P01665,,1,1,2,1,P01665|P01664|P01666|P01668|A0A140T8Q0|A0A140T8Q4,MOUSE,12116.1,29.7,340,340.5,28.26,8.67,,111,Ig kappa chain V-III region PC 7043,,,antigen binding|,1,1,25900000,14.4%
A0A075B5Y3,0.549465437,0.45575,5.03459114,-0.685833333,0.313719046,-1.098756368,0.264,-0.0545,2.1865,-0.169,0.493,0.0145,A0A075B5Y3,NotFound,A0A075B5Y3_NotFound,A0A075B5Y3,Ighv1-80,1,5,3,3,A0A075B5Y3,MOUSE,12877.4,28.2,341,341.1,42.17,42.17,,117,Immunoglobulin heavy variable 1-80 (Fragment),,,,3,5,2190000000,28.2%
A0A075B674,0.682422874,0.50875,3.180821686,-0.495166667,0.480748382,-0.751216801,-0.133,0.2155,2.1865,-0.217,0.733,0.2675,A0A075B674,NotFound,A0A075B674_NotFound,A0A075B674,Ighv1-78,1,6,4,4,A0A075B674|A0A075B5Y6,MOUSE,11161.3,38.7,342,342.1,41.69,41.69,,98,Immunoglobulin heavy variable 1-78,,,,4,6,2190000000,38.7%
Q6S5C2-2,0.167536967,0.45175,17.73123136,-1.3805,0.016860749,-3.24993881,0.32,1.6965,1.4095,-0.037,-0.633,-0.0455,Q6S5C2,Gnptg,Q6S5C2-2_Gnptg,Q6S5C2-2,Gnptg,1,3,3,3,Q6S5C2-2|A0A140T8R4|Q6S5C2|A0A0R4J0H5,MOUSE,35349.5,7,343,343.1,41.23,41.23,,307,Isoform 2 of N-acetylglucosamine-1-phosphotransferase subunit gamma,Golgi apparatus|extracellular exosome|,carbohydrate phosphorylation|,protein homodimerization activity|,3,3,82300000,7.0%
A0A140T8N3,0.23713653,-0.2224,14.31042178,0.89725,0.037064472,2.785526395,-0.967,-0.5545,,-0.207,0.294,0.3225,A0A140T8N3,NotFound,A0A140T8N3_NotFound,A0A140T8N3,Igkv13-84,1,7,3,3,A0A140T8N3|A0A075B666,MOUSE,12788.3,32.1,344,344.1,41.18,41.18,,115,Immunoglobulin kappa chain variable 13-84 (Fragment),,,,3,7,1640000000,32.1%
Q08879,0.23713653,0.27775,14.17168711,-0.767833333,0.038267606,-2.623064553,1.133,0.5705,0.2815,-0.031,-0.263,-0.0245,Q08879,Fbln1,Q08879_Fbln1,Q08879,Fbln1,1,7,4,4,Q08879|Q08879-2,MOUSE,82139.4,5.9,345,345.1,40.9,40.9,,705,Fibulin-1,proteinaceous extracellular matrix|basement membrane|extracellular space|extracellular exosome|elastic fiber|fibrinogen complex|extracellular matrix|,"negative regulation of protein phosphorylation|negative regulation of cell adhesion|embryo implantation|positive regulation of gene expression|positive regulation of peptidase activity|extracellular matrix organization|positive regulation of fibroblast proliferation|negative regulation of ERK1 and ERK2 cascade|blood coagulation, fibrin clot formation|negative regulation of substrate adhesion-dependent cell spreading|negative regulation of transformation of host cell by virus|positive regulation of substrate-dependent cell migration, cell attachment to substrate|negative regulation of cell motility|negative regulation of stem cell proliferation|negative regulation of transforming growth factor-beta secretion|",fibronectin binding|integrin binding|extracellular matrix structural constituent|calcium ion binding|protein binding|protein C-terminus binding|peptidase activator activity|protein complex binding|identical protein binding|fibrinogen binding|,4,7,230000000,5.9%
P00974,0.000767367,0.977416667,59.1157132,-5.0705,1.22583E-06,-18.37272604,3.864,3.1705,3.5035,-1.69,-1.66,-1.3235,P00974,NotFound,P00974_NotFound,P00974,,1,22,3,3,P00974,BOVIN,11359,26,346,346.1,40.62,40.62,,100,Pancreatic trypsin inhibitor,,,,3,22,3.52E+11,26.0%
Q9R182,0.519628152,-0.1392,5.625763335,0.392583333,0.273793836,1.223270361,-0.065,-0.6845,,-0.152,0.209,-0.0035,Q9R182,Angptl3,Q9R182_Angptl3,Q9R182,Angptl3,1,7,4,4,Q9R182,MOUSE,52770.3,10.3,347,347.1,40.37,40.37,,455,Angiopoietin-related protein 3,extracellular region|extracellular space|early endosome|Golgi apparatus|cell surface|,glycerol metabolic process|fatty acid metabolic process|triglyceride metabolic process|phospholipid metabolic process|cell-matrix adhesion|signal transduction|cholesterol metabolic process|phospholipid catabolic process|response to hormone|negative regulation of phospholipase activity|lipid storage|positive regulation of cell migration|cholesterol homeostasis|positive regulation of angiogenesis|positive regulation of lipid metabolic process|artery morphogenesis|positive regulation of lipid catabolic process|negative regulation of lipoprotein lipase activity|lipid homeostasis|acylglycerol homeostasis|phospholipid homeostasis|triglyceride homeostasis|,enzyme inhibitor activity|phospholipase inhibitor activity|integrin binding|growth factor activity|,4,7,172000000,10.3%
Q9Z222,0.268517745,-0.1974,12.54542444,0.61725,0.055649025,2.456154252,-0.572,-0.5635,,0.127,0.023,-0.0015,Q9Z222,B3gnt2,Q9Z222_B3gnt2,Q9Z222,B3GNT2,1,5,4,4,Q9Z222,MOUSE,46281.5,9.5,348,348.1,40.07,40.07,,397,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2",Golgi membrane|integral component of membrane|extracellular exosome|,protein glycosylation|axon guidance|sensory perception of smell|poly-N-acetyllactosamine biosynthetic process|,"galactosyltransferase activity|N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity|",4,5,201000000,9.5%
Q02596,0.812519126,-0.0354,1.700143907,0.17475,0.676060573,0.442328848,-0.667,0.3865,,0.168,0.027,-0.0915,Q02596,Glycam1,Q02596_Glycam1,Q02596,Glycam1,1,3,3,3,Q02596,MOUSE,16208.6,29.1,349,349.1,39.71,39.71,,151,Glycosylation-dependent cell adhesion molecule 1,extracellular region|plasma membrane|,cell adhesion|,sulfate binding|cell adhesion molecule binding|,3,3,268000000,29.1%
A0A075B5W3,0.812519126,0.4002,1.716422998,0.234916667,0.673531172,0.446621041,0.303,0.2155,,-0.12,1.415,0.1875,A0A075B5W3,NotFound,A0A075B5W3_NotFound,A0A075B5W3,Ighv1-53,1,6,3,3,A0A075B5W3,MOUSE,12962.4,32.4,350,350.1,39.67,39.67,,117,Immunoglobulin heavy variable 1-53 (Fragment),,,,3,6,3330000000,32.4%
Q3UFC6,0.799195719,0.046916667,1.90732382,0.1825,0.644566334,0.48467602,-0.03,0.3105,-0.4135,-0.12,-0.267,0.8015,Q3UFC6,Dsg3,Q3UFC6_Dsg3,Q3UFC6,Dsg3,1,5,5,5,Q3UFC6|O35902|O35902-2,MOUSE,109212.9,6.7,351,351.1,39.36,39.36,,993,Desmoglein-3,plasma membrane|integral component of membrane|extracellular exosome|,homophilic cell adhesion via plasma membrane adhesion molecules|,calcium ion binding|,5,5,166000000,6.7%
Q9EQI5,0.799195719,0.318,1.917206572,-0.199583333,0.643101234,-0.491549931,0.561,0.3145,,0.799,-0.308,0.2235,Q9EQI5,Ppbp,Q9EQI5_Ppbp,Q9EQI5,Ppbp,1,8,3,3,Q9EQI5,MOUSE,12593.7,20.3,352,352.1,39.08,39.08,,113,"Chemokine (C-X-C motif) ligand 7, isoform CRA_b",extracellular space|cell|,leukocyte migration involved in inflammatory response|positive regulation of leukocyte chemotaxis|inflammatory response|immune response|G-protein coupled receptor signaling pathway|neutrophil chemotaxis|response to lipopolysaccharide|regulation of cell proliferation|neutrophil degranulation|chemokine-mediated signaling pathway|,chemokine activity|CXCR chemokine receptor binding|,3,8,7100000000,20.3%
A0A0B4J1I8,0.481331214,0.366416667,6.502373179,0.628166667,0.223749814,1.353863068,-0.027,-0.2725,0.4565,-0.254,1.242,1.0535,A0A0B4J1I8,NotFound,A0A0B4J1I8_NotFound,A0A0B4J1I8,Igkv4-59,1,11,4,4,A0A0B4J1I8|P04944|P04940|P04941|A0A0B4J1I5|P04942|P04943|P70670|Q9JKC6|A0N8I8,MOUSE,12784.1,18.8,353,353.1,38.23,38.23,,117,Immunoglobulin kappa variable 4-59 (Fragment),,,,4,11,10700000000,18.8%
Q9Z2L6,0.598309776,-0.188416667,4.254523838,0.4145,0.375446116,0.955371801,0.413,-0.4505,-1.1495,0.291,-0.225,-0.0095,Q9Z2L6,Minpp1,Q9Z2L6_Minpp1,Q9Z2L6,Minpp1,1,5,4,4,Q9Z2L6,MOUSE,55164,7.4,354,354.1,37.66,37.66,,481,Multiple inositol polyphosphate phosphatase 1,endoplasmic reticulum lumen|plasma membrane|extracellular exosome|,dephosphorylation|,acid phosphatase activity|bisphosphoglycerate 3-phosphatase activity|inositol hexakisphosphate 2-phosphatase activity|,4,5,57400000,7.4%
Q9Z1T2,0.814495558,0.0174,1.663855248,0.14525,0.681733248,0.43398362,0.176,-0.3155,,-0.197,0.414,0.0095,Q9Z1T2,Thbs4,Q9Z1T2_Thbs4,Q9Z1T2,Thbs4,1,3,3,2,Q9Z1T2,MOUSE,109046.1,4,355,355.1,37.44,19.45,,963,Thrombospondin-4,basement membrane|extracellular space|endoplasmic reticulum|sarcoplasmic reticulum|extracellular matrix|extracellular exosome|,positive regulation of endothelial cell proliferation|response to unfolded protein|negative regulation of angiogenesis|regulation of tissue remodeling|response to endoplasmic reticulum stress|behavioral response to pain|tissue remodeling|positive regulation of peptidyl-tyrosine phosphorylation|myoblast migration|positive regulation of cell division|endothelial cell-cell adhesion|positive regulation of neutrophil chemotaxis|,integrin binding|calcium ion binding|protein binding|growth factor activity|heparin binding|,3,3,154000000,4.0%
Q9R0G6,0.22054251,-0.267,15.44597001,1.148666667,0.028536651,3.276138931,,-1.1285,,0.05,-0.018,0.0285,Q9R0G6,Comp,Q9R0G6_Comp,Q9R0G6,Comp,1,1,2,1,Q9R0G6,MOUSE,84965.2,3,355,355.2,36.28,18.29,,755,Cartilage oligomeric matrix protein,proteinaceous extracellular matrix|extracellular space|extracellular exosome|extracellular matrix|,growth plate cartilage development|apoptotic process|cell adhesion|extracellular matrix organization|negative regulation of apoptotic process|limb development|,protease binding|extracellular matrix structural constituent|calcium ion binding|protein binding|collagen binding|heparin binding|heparan sulfate proteoglycan binding|,1,1,9280000,1.7%
Q9EQ21,0.643086642,0.28,3.64022749,-0.260416667,0.432491176,-0.850489731,0.532,0.3405,,0.508,0.1,-0.0805,Q9EQ21,Hamp,Q9EQ21_Hamp,Q9EQ21,Hamp,1,9,2,2,Q9EQ21,MOUSE,9865.4,28.9,356,356.1,37,37,,83,Hepcidin,extracellular region|extracellular space|nucleus|,negative regulation of transcription from RNA polymerase II promoter|myeloid cell homeostasis|cellular iron ion homeostasis|JAK-STAT cascade|cellular response to extracellular stimulus|membrane protein proteolysis|negative regulation of iron ion transmembrane transport|defense response to bacterium|positive regulation of macrophage activation|negative regulation of bone resorption|positive regulation of transcription from RNA polymerase II promoter|negative regulation of inflammatory response|defense response to fungus|iron ion homeostasis|cellular response to iron ion|positive regulation of cellular protein catabolic process|,hormone activity|copper ion binding|,2,9,270000000,28.9%
Q6T5E4,0.46334768,0.0418,6.982659285,0.398416667,0.200324502,1.466336775,-0.182,-0.2125,,0.369,0.246,-0.0115,Q6T5E4,Gcnt2,Q6T5E4_Gcnt2,Q6T5E4,Gcnt2,1,3,3,3,Q6T5E4,MOUSE,46854.9,9.4,357,357.1,36.93,36.93,,401,"Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme",membrane|,protein glycosylation|transforming growth factor beta receptor signaling pathway|posttranscriptional regulation of gene expression|positive regulation of epithelial to mesenchymal transition|negative regulation of cell-substrate adhesion|positive regulation of cell migration|positive regulation of heterotypic cell-cell adhesion|maintenance of lens transparency|positive regulation of protein kinase B signaling|positive regulation of ERK1 and ERK2 cascade|,"N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity|acetylglucosaminyltransferase activity|",3,3,25700000,9.4%
A0A075B697,0.268517745,-0.1218,12.50330047,0.894083333,0.056191413,2.448433974,-0.927,-0.3895,,-0.12,0.651,0.1765,A0A075B697,NotFound,A0A075B697_NotFound,A0A075B697,Ighv2-9-1,1,16,3,2,A0A075B697|P01820|P01819|A0A075B5Q1|P01821|A0A075B6A7|A0A075B5Q5|A0A075B696|A0A075B5Q7,MOUSE,12709.4,22.4,358,358.1,36.47,29.47,,116,Immunoglobulin heavy variable 2-9-1 (Fragment),,,,4,16,11700000000,22.4%
A0A075B5P8,0.87051184,-0.28475,1.070633354,0.2765,0.781513824,0.289997584,1.106,0.2855,-2.6605,-0.062,-0.299,-0.0785,A0A075B5P8,NotFound,A0A075B5P8_NotFound,A0A075B5P8,Ighv2-2,1,1,3,1,A0A075B5P8,MOUSE,12806.4,26.7,358,358.2,33.32,13.94,,116,Immunoglobulin heavy variable 2-2 (Fragment),,,,1,1,59900000,13.7%
A0A075B5R0,0.805367808,-0.022416667,1.821591671,0.147166667,0.657416853,0.465605652,-0.413,0.4715,-0.3465,-0.14,0.191,0.1025,A0A075B5R0,NotFound,A0A075B5R0_NotFound,A0A075B5R0,Ighv5-16,1,4,3,3,A0A075B5R0,MOUSE,13388.1,32.7,359,359.1,36.11,36.11,,116,Immunoglobulin heavy variable 5-16,,,,3,4,249000000,32.7%
Q91V80,0.831619312,0.0683,1.466754815,-0.188666667,0.713385895,-0.388255005,,0.8935,-0.5305,-0.219,0.08,0.1175,Q91V80,Apof,Q91V80_Apof,Q91V80,Apof,1,4,2,2,A0A0R4J0M4|Q91V80,MOUSE,34701.1,10.1,360,360.1,35.9,35.9,,315,Apolipoprotein F,low-density lipoprotein particle|high-density lipoprotein particle|,triglyceride metabolic process|cholesterol metabolic process|cholesterol efflux|,,2,4,176000000,10.1%
A0A075B5U0,0.82112053,0.2018,1.611816785,-0.136583333,0.689951116,-0.421955284,0.37,0.1975,,-0.078,0.558,-0.0385,A0A075B5U0,NotFound,A0A075B5U0_NotFound,A0A075B5U0,Ighv1-12,1,4,3,3,A0A075B5U0,MOUSE,10892,34.6,361,361.1,35.9,35.9,,98,Immunoglobulin heavy variable V1-12,,,,3,4,3290000000,34.6%
A0A075B677,0.556285174,0.113,4.889839831,0.355416667,0.324351579,1.088296944,-0.272,0.0715,,0.171,0.622,-0.0275,A0A075B677,NotFound,A0A075B677_NotFound,A0A075B677,Igkv4-53,1,6,2,2,A0A075B677,MOUSE,10480.4,40.2,362,362.1,35.85,35.85,,97,Immunoglobulin kappa variable 4-53,,,,2,6,255000000,40.2%
P63158,0.003391371,0.893083333,49.6516899,-3.299833333,1.08351E-05,-12.81815866,2.878,2.2595,2.4915,-0.83,-0.839,-0.6015,P63158,Hmgb1,P63158_Hmgb1,P63158,Hmgb1,1,10,4,4,P63158|A0A0J9YUD8|P30681,MOUSE,25064.5,12.5,363,363.1,35.82,35.82,,215,High mobility group protein B1,condensed chromosome|extracellular region|extracellular space|nucleus|cytoplasm|cell surface|transcriptional repressor complex|,"inflammatory response to antigenic stimulus|base-excision repair, DNA ligation|inflammatory response|negative regulation of RNA polymerase II transcriptional preinitiation complex assembly|DNA geometric change|V(D)J recombination|positive regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of DNA binding|negative regulation of blood vessel endothelial cell migration|positive regulation of transcription from RNA polymerase II promoter|negative regulation of apoptotic cell clearance|","four-way junction DNA binding|bubble DNA binding|phosphatidylserine binding|sequence-specific DNA binding transcription factor activity|cytokine activity|protein binding|heparin binding|DNA binding, bending|poly(A) RNA binding|repressing transcription factor binding|supercoiled DNA binding|",4,10,537000000,12.5%
Q8K1I3,0.012313177,0.714583333,36.27022972,-2.532833333,0.000236035,-7.573936677,2.39,2.1955,1.3575,-0.387,-0.712,-0.5565,Q8K1I3,Spp2,Q8K1I3_Spp2,Q8K1I3,Spp2,1,7,3,3,Q8K1I3,MOUSE,23421,14.2,364,364.1,35.69,35.69,,203,Secreted phosphoprotein 24,extracellular exosome|,bone remodeling|,,3,7,547000000,14.2%
A0A075B5T7,0.46334768,0.654916667,6.896044601,-0.8175,0.204359833,-1.422630606,0.303,0.7015,2.1865,-0.128,0.91,-0.0435,A0A075B5T7,NotFound,A0A075B5T7_NotFound,A0A075B5T7,Ighv1-7,1,4,3,3,A0A075B5T7|A0A075B5T4,MOUSE,13273.8,29,365,365.1,35.23,35.23,,117,Immunoglobulin heavy variable V1-7 (Fragment),,,,3,4,2120000000,29.0%
G5E8D6,0.149102391,0.59275,18.59661731,-1.389833333,0.013814599,-3.407658603,0.485,1.4475,1.9305,0.013,-0.326,0.0065,G5E8D6,Efemp2,G5E8D6_Efemp2,G5E8D6,Efemp2,1,7,3,3,G5E8D6|Q9WVJ9|E9Q3N9,MOUSE,53745,6.9,366,366.1,34.89,34.89,,462,EGF-containing fibulin-like extracellular matrix protein 2,proteinaceous extracellular matrix|extracellular exosome|extracellular vesicle|,,calcium ion binding|,3,7,429000000,6.9%
A2AVA0,0.675762207,-0.059,3.274979148,0.25375,0.470437664,0.778111491,-0.305,-0.1175,,-0.12,-0.209,0.4565,A2AVA0,Svep1,A2AVA0_Svep1,A2AVA0,Svep1,1,5,5,5,A2AVA0,MOUSE,402170.3,1.2,367,367.1,34.72,34.72,,3567,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1",extracellular region|cytoplasm|membrane|,cell adhesion|,chromatin binding|calcium ion binding|,5,5,268000000,1.2%
A6H6E2,0.482514848,0.316083333,6.386807095,-0.487833333,0.229783738,-1.331938831,0.916,0.8715,-0.1075,0.111,-0.256,0.3615,A6H6E2,Mmrn2,A6H6E2_Mmrn2,A6H6E2,Mmrn2,1,4,3,3,A6H6E2|A6H6E2-2,MOUSE,105832,4.2,368,368.1,34.61,34.61,,943,Multimerin-2,basement membrane|extracellular space|extracellular exosome|,negative regulation of vascular endothelial growth factor receptor signaling pathway|negative regulation of cell migration involved in sprouting angiogenesis|,,3,4,19400000,4.2%
A0A0B4J1I1,0.677925707,-0.0826,3.229277106,0.233583333,0.475414353,0.768940424,-0.429,-0.0165,,-0.254,0.161,0.1255,A0A0B4J1I1,NotFound,A0A0B4J1I1_NotFound,A0A0B4J1I1,Igkv16-104,1,7,2,2,A0A0B4J1I1,MOUSE,13045.5,23.2,369,369.1,34.02,34.02,,116,Immunoglobulin kappa variable 16-104 (Fragment),,,,2,7,957000000,23.2%
O35452,0.262291975,0.28975,12.77817012,-1.0325,0.052745205,-2.394164269,1.09,1.4425,-0.1145,-0.273,-0.238,-0.1685,O35452,NotFound,O35452_NotFound,O35452,Tnxb,1,6,4,4,O35452|E9Q2T3,MOUSE,442488.3,1.1,370,370.1,33.89,33.89,,4006,Tenascin X,extracellular region|proteinaceous extracellular matrix|extracellular space|intracellular|extracellular exosome|fibrillar collagen trimer|extracellular matrix|,lipid metabolic process|fatty acid metabolic process|triglyceride metabolic process|cell-matrix adhesion|single organismal cell-cell adhesion|extracellular matrix organization|collagen fibril organization|collagen metabolic process|extracellular fibril organization|regulation of JUN kinase activity|elastic fiber assembly|phospholipid metabolic process|positive regulation of cell adhesion|,collagen binding|heparin binding|,4,6,38300000,1.1%
O35622,0.575301274,-0.1802,4.580397875,0.34175,0.348305404,1.030577417,-0.759,-0.0115,,0.052,-0.155,-0.0275,O35622,Fgf15,O35622_Fgf15,O35622,Fgf15,1,5,4,4,O35622,MOUSE,25520.6,25.6,371,371.1,33.86,33.86,,218,Fibroblast growth factor 15,extracellular region|,neural crest cell migration|positive regulation of protein phosphorylation|heart development|positive regulation of cell proliferation|fibroblast growth factor receptor signaling pathway|negative regulation of gene expression|positive regulation of glucose import|positive regulation of JNK cascade|positive regulation of ERK1 and ERK2 cascade|negative regulation of bile acid biosynthetic process|,fibroblast growth factor receptor binding|growth factor activity|,4,5,166000000,25.6%
P54818,0.576829565,0.369583333,4.552738163,-0.8395,0.3505308,-1.011559196,0.055,-0.4365,2.7495,-0.042,-0.063,-0.0455,P54818,Galc,P54818_Galc,P54818,Galc,1,4,4,4,P54818,MOUSE,77483.2,6.8,372,372.1,33.55,33.55,,684,Galactocerebrosidase,mitochondrion|lysosome|extracellular exosome|,carbohydrate metabolic process|galactosylceramide catabolic process|,galactosylceramidase activity|,4,4,432000000,6.8%
P09803,0.787009931,0.096,2.042377321,-0.254583333,0.624830568,-0.519802863,0.962,-0.4645,,0.031,-0.23,0.1815,P09803,Cdh1,P09803_Cdh1,P09803,Cdh1,1,3,3,3,A0A0R4IZW5|P09803,MOUSE,98767.5,4,373,373.1,32.84,32.84,,884,Cadherin-1,cytoplasm|endosome|trans-Golgi network|plasma membrane|cell-cell junction|adherens junction|cell-cell adherens junction|focal adhesion|cytoplasmic side of plasma membrane|cell surface|actin cytoskeleton|integral component of membrane|aggresome|basolateral plasma membrane|lateral plasma membrane|catenin complex|flotillin complex|lamellipodium|cell junction|axon|node of Ranvier|lateral loop|Schmidt-Lanterman incisure|apical junction complex|axon terminus|apical part of cell|perinuclear region of cytoplasm|extracellular exosome|cell periphery|catenin complex|cortical actin cytoskeleton|,"in utero embryonic development|trophectodermal cell differentiation|epithelial cell morphogenesis|homophilic cell adhesion via plasma membrane adhesion molecules|embryo implantation|sensory perception of sound|single organismal cell-cell adhesion|calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules|protein metabolic process|negative regulation of cell-cell adhesion|regulation of protein localization|regulation of water loss via skin|adherens junction organization|uterine epithelium development|positive regulation of transcription factor import into nucleus|regulation of cysteine-type endopeptidase activity involved in apoptotic process|positive regulation of transcription, DNA-templated|decidualization|negative regulation of epithelial cell proliferation|protein homooligomerization|intestinal epithelial cell development|salivary gland cavitation|regulation of branching involved in salivary gland morphogenesis|bicellular tight junction assembly|cellular response to amino acid stimulus|cellular response to lithium ion|cellular response to indole-3-methanol|protein localization to plasma membrane|establishment of protein localization to plasma membrane|negative regulation of canonical Wnt signaling pathway|cochlea development|regulation of protein localization to cell surface|regulation of neuron migration|",glycoprotein binding|calcium ion binding|protein binding|beta-catenin binding|protein phosphatase binding|protein domain specific binding|ankyrin binding|GTPase activating protein binding|gamma-catenin binding|cell adhesion molecule binding|,3,3,58000000,4.0%
D3YTY6,0.662037385,0.413416667,3.439918681,-0.777833333,0.45290606,-0.802052662,-0.381,-0.3325,3.1205,0.156,-0.239,0.1565,D3YTY6,NotFound,D3YTY6_NotFound,D3YTY6,Gm6096,1,15,3,1,D3YTY6,MOUSE,17281.2,13.9,374,374.1,32.83,10.56,,151,Predicted gene 6096,ribosome|,translation|,structural constituent of ribosome|,3,15,2590000000,13.9%
P62751,0.114030488,0.61275,21.26769493,-2.8765,0.00746845,-3.945911933,1.599,1.0055,3.5485,-1.597,-0.326,-0.5535,P62751,Rpl23a,P62751_Rpl23a,P62751,Rpl23a,1,1,3,1,A0A140T8M7|P62751,MOUSE,17694.7,13.4,374,374.2,26.46,4.19,,156,60S ribosomal protein L23a,nucleus|nucleolus|cytosolic large ribosomal subunit|extracellular exosome|TORC2 complex|,translation|cell proliferation|,nucleotide binding|structural constituent of ribosome|protein binding|rRNA binding|poly(A) RNA binding|,1,1,5390000,7.6%
P02662,0.18181008,0.421916667,16.46895566,-1.516833333,0.022547814,-3.035212897,0.898,0.3745,2.2685,-0.311,-0.34,-0.3585,P02662,NotFound,P02662_NotFound,P02662,CSN1S1,1,5,2,2,P02662,BOVIN,24585.5,12.6,375,375.1,32.77,32.77,,214,"Alpha-S1-casein, Michrom mix 6",,,,2,5,291000000,12.6%
P62983,0.16997749,0.419416667,17.15687338,-2.391833333,0.019244767,-3.165601152,1.23,3.2695,0.3465,-0.375,-1.177,-0.7775,P62983,Rps27a,P62983_Rps27a,P62983,Rps27a,1,6,4,4,P62983,MOUSE,18292.9,23,376,376.1,32.33,32.33,,156,Ubiquitin-40S ribosomal protein S27a,nucleoplasm|nucleolus|cytoplasm|cytosol|small ribosomal subunit|membrane|cytosolic small ribosomal subunit|myelin sheath|extracellular exosome|,translation|circadian rhythm|,structural constituent of ribosome|poly(A) RNA binding|metal ion binding|,4,6,131000000,23.0%
Q9DC11,0.799195719,0.258416667,1.921528854,-0.367833333,0.642461511,-0.488436604,-0.715,-0.1535,2.1955,0.169,0.048,0.0065,Q9DC11,Plxdc2,Q9DC11_Plxdc2,Q9DC11,Plxdc2,1,6,3,3,Q9DC11|B1AY85,MOUSE,60185.7,4.7,377,377.1,32.1,32.1,,530,Plexin domain-containing protein 2,plasma membrane|integral component of membrane|extracellular exosome|,,,3,6,151000000,4.7%
Q05144,0.482514848,-0.1948,6.318624549,0.361583333,0.233419721,1.348099503,-0.244,-0.5795,,-0.062,-0.106,0.0175,Q05144,Rac2,Q05144_Rac2,Q05144,Rac2,1,3,3,3,Q05144|Q3TLP8|P63001|P60764,MOUSE,21839.8,16.1,378,378.1,31.98,31.98,,192,Ras-related C3 botulinum toxin substrate 2,nuclear envelope|cytoplasm|cytosol|focal adhesion|membrane|lamellipodium|extracellular exosome|actin filament|,chemotaxis|actin filament organization|G-protein coupled receptor signaling pathway|small GTPase mediated signal transduction|positive regulation of cell proliferation|positive regulation of lamellipodium assembly|regulation of cell-substrate adhesion|cell projection assembly|actin cytoskeleton organization|regulation of T cell proliferation|regulation of mast cell degranulation|bone resorption|regulation of protein kinase activity|regulation of respiratory burst|regulation of mast cell chemotaxis|lymphocyte aggregation|positive regulation of neutrophil chemotaxis|regulation of neutrophil migration|positive regulation of protein targeting to mitochondrion|,GTPase activity|GTP binding|protein kinase regulator activity|,3,3,2210000000,16.1%
P70194,0.524685888,0.0626,5.513490687,-0.30775,0.280964164,-1.202859172,0.332,0.1625,,-0.137,-0.039,-0.0055,P70194,Clec4f,P70194_Clec4f,P70194,Clec4f,1,4,3,3,P70194|A0A0R4IZZ5,MOUSE,61667,6,379,379.1,31.81,31.81,,548,C-type lectin domain family 4 member F,plasma membrane|integral component of membrane|,endocytosis|NK T cell activation|,galactose binding|glycolipid binding|,3,4,670000000,6.0%
P97333,0.282360967,0.686416667,11.4364864,-1.6405,0.071837525,-2.179110316,0.557,0.6965,3.2665,0.097,-0.397,-0.1015,P97333,Nrp1,P97333_Nrp1,P97333,Nrp1,1,6,4,4,P97333,MOUSE,104253.4,4.9,380,380.1,31.35,31.35,,923,Neuropilin-1,extracellular space|early endosome|cytosol|neurofilament|plasma membrane|focal adhesion|integral component of membrane|axon|sorting endosome|,angiogenesis|patterning of blood vessels|neuron migration|sprouting angiogenesis|cell migration involved in sprouting angiogenesis|axon guidance|axonal fasciculation|heart development|motor neuron axon guidance|dendrite development|cell migration|facial nerve structural organization|trigeminal nerve morphogenesis|trigeminal nerve structural organization|vestibulocochlear nerve structural organization|nerve development|branchiomotor neuron axon guidance|gonadotrophin-releasing hormone neuronal migration to the hypothalamus|negative regulation of axon extension|retinal ganglion cell axon guidance|cellular response to hepatocyte growth factor stimulus|endothelial cell chemotaxis|cellular response to vascular endothelial growth factor stimulus|ventral trunk neural crest cell migration|VEGF-activated neuropilin signaling pathway|otic placode formation|negative regulation of neuron apoptotic process|platelet-derived growth factor receptor signaling pathway|vascular endothelial growth factor receptor signaling pathway|hepatocyte growth factor receptor signaling pathway|sympathetic nervous system development|neuron development|regulation of axon extension involved in axon guidance|positive regulation of axon extension involved in axon guidance|negative regulation of axon extension involved in axon guidance|artery morphogenesis|axon extension involved in axon guidance|positive regulation of peptidyl-tyrosine phosphorylation|positive chemotaxis|axonogenesis involved in innervation|dichotomous subdivision of terminal units involved in salivary gland branching|angiogenesis involved in coronary vascular morphogenesis|cell migration involved in coronary vasculogenesis|coronary artery morphogenesis|retina vasculature morphogenesis in camera-type eye|renal artery morphogenesis|sympathetic ganglion development|trigeminal ganglion development|ganglion morphogenesis|positive regulation of ERK1 and ERK2 cascade|semaphorin-plexin signaling pathway|commissural neuron axon guidance|regulation of retinal ganglion cell axon guidance|sensory neuron axon guidance|sympathetic neuron projection extension|sympathetic neuron projection guidance|neural crest cell migration involved in autonomic nervous system development|toxin transport|semaphorin-plexin signaling pathway involved in neuron projection guidance|semaphorin-plexin signaling pathway involved in axon guidance|positive regulation of retinal ganglion cell axon guidance|VEGF-activated neuropilin signaling pathway involved in axon guidance|protein localization to early endosome|facioacoustic ganglion development|negative regulation of extrinsic apoptotic signaling pathway|,vascular endothelial growth factor-activated receptor activity|protein binding|heparin binding|semaphorin receptor activity|growth factor binding|vascular endothelial growth factor binding|metal ion binding|,4,6,56100000,4.9%
Q05D44,0.021758064,0.929916667,30.61014076,-3.1455,0.000868932,-6.082435638,3.004,1.4285,3.0755,-0.364,-1.113,-0.4515,Q05D44,Eif5b,Q05D44_Eif5b,Q05D44,Eif5b,1,4,3,3,Q05D44,MOUSE,138069.9,3.6,381,381.1,31.12,31.12,,1216,Eukaryotic translation initiation factor 5B,cytoplasm|,translational initiation|regulation of translational initiation|,translation initiation factor activity|GTPase activity|GTP binding|poly(A) RNA binding|,3,4,51300000000,3.6%
A0A075B5N6,0.830935436,0.0948,1.503566252,0.17425,0.707364686,0.396882018,-0.526,0.5065,,-0.262,0.445,0.3105,A0A075B5N6,NotFound,A0A075B5N6_NotFound,A0A075B5N6,Igkv8-16,1,4,2,2,A0A075B5N6|A0A0G2JGT0,MOUSE,13623.3,15.8,382,382.1,30.48,30.48,,120,Immunoglobulin kappa variable 8-16,,,,2,4,1640000000,15.8%
Q9QUK9,0.01315234,0.84825,34.471224,-2.780833333,0.000357172,-7.076617303,2.876,1.4815,2.3585,-0.546,-0.705,-0.3755,Q9QUK9,Try5,Q9QUK9_Try5,Q9QUK9,Try5,1,4,3,3,Q9QUK9|Q9R0T7|Q9Z1R9|Q792Y9|Q792Z0|Q792Y8,MOUSE,26961,15.4,383,383.1,29.6,29.6,,246,MCG15083,extracellular space|extracellular exosome|,proteolysis|digestion|,serine-type endopeptidase activity|calcium ion binding|serine-type peptidase activity|,3,4,209000000,15.4%
Q02566,0.441723111,0.89425,7.510684019,-0.962833333,0.177391007,-1.526535343,2.081,1.4005,0.6455,0.226,-0.534,1.5465,Q02566,Myh6,Q02566_Myh6,Q02566,Myh6,1,3,3,3,Q02566|Q91Z83,MOUSE,224360.2,1.7,384,384.1,29.49,29.49,,1938,Myosin-6,stress fiber|nucleoplasm|cytoplasm|mitochondrion|muscle myosin complex|focal adhesion|myosin complex|myofibril|Z disc|myosin filament|,in utero embryonic development|regulation of the force of heart contraction|regulation of heart rate|muscle contraction|striated muscle contraction|adult heart development|visceral muscle development|regulation of heart contraction|regulation of blood pressure|response to heat|actin filament-based movement|muscle filament sliding|myofibril assembly|BMP signaling pathway|regulation of ATPase activity|sarcomere organization|ATP metabolic process|cardiac muscle fiber development|atrial cardiac muscle tissue morphogenesis|ventricular cardiac muscle tissue morphogenesis|cardiac muscle contraction|canonical Wnt signaling pathway|regulation of heart growth|,microfilament motor activity|actin binding|protein binding|calmodulin binding|ATP binding|ATPase activity|protein kinase binding|actin-dependent ATPase activity|calcium-dependent ATPase activity|protein homodimerization activity|protein heterodimerization activity|,3,3,340000000,1.7%
P10404,0.524685888,-0.1554,5.48340231,0.450583333,0.282917472,1.197379098,0.036,-0.8875,,-0.193,0.113,0.1545,P10404,NotFound,P10404_NotFound,P10404,,1,3,2,2,P10404,MOUSE,70752.6,4,385,385.1,29.33,29.33,,641,MLV-related proviral Env polyprotein,plasma membrane|integral component of membrane|viral capsid|viral envelope|virion membrane|,viral life cycle|,metal ion binding|,2,3,55000000,4.0%
Q61495,0.168848446,0.68275,17.62897292,-3.1545,0.017262461,-3.251474179,2.452,4.1785,0.1495,-0.896,-0.916,-0.8715,Q61495,Dsg1a,Q61495_Dsg1a,Q61495,Dsg1a,1,6,4,4,Q61495|Q7TSF1|Q7TSF0,MOUSE,115622,3.9,386,386.1,29.18,29.18,,1057,Desmoglein-1-alpha,plasma membrane|cytoplasmic side of plasma membrane|integral component of membrane|desmosome|extracellular exosome|cell-cell junction|,homophilic cell adhesion via plasma membrane adhesion molecules|,calcium ion binding|protein binding|gamma-catenin binding|,4,6,61600000,3.9%
A0A075B5W6,0.606693779,0.33,4.058884399,0.477083333,0.39274581,0.933439213,0.303,-0.2155,,-0.072,1.35,0.2845,A0A075B5W6,NotFound,A0A075B5W6_NotFound,A0A075B5W6,Ighv1-55,1,2,2,2,A0A075B5W6,MOUSE,12858.3,26.4,387,387.1,29.04,29.04,,117,Immunoglobulin heavy variable 1-55 (Fragment),,,,2,2,560000000,26.4%
Q9DAU1,0.937211904,0.0562,0.48762206,0.039083333,0.893794739,0.1401752,0.223,-0.1575,,0.048,0.2,-0.0325,Q9DAU1,Cnpy3,Q9DAU1_Cnpy3,Q9DAU1,Cnpy3,1,5,3,3,Q9DAU1|Q9DAU1-2,MOUSE,30936.7,10.1,388,388.1,28.74,28.74,,276,Protein canopy homolog 3,endoplasmic reticulum|,innate immune response|,receptor binding|,3,5,187000000,10.1%
P97350,0.065764031,0.9902,25.01464654,-4.305916667,0.003151631,-5.285328596,2.45,4.6975,,-0.058,-1.544,-0.5945,P97350,Pkp1,P97350_Pkp1,P97350,Pkp1,1,5,3,3,P97350|A0A087WS37,MOUSE,82321.1,5,389,389.1,28.55,28.55,,728,Plakophilin-1,nucleus|nucleoplasm|plasma membrane|desmosome|intracellular membrane-bounded organelle|extracellular exosome|,single organismal cell-cell adhesion|intermediate filament bundle assembly|,protein binding|lamin binding|,3,5,90400000,5.0%
E9Q401,0.89919911,-0.07175,0.853224361,0.0765,0.821632413,0.235204179,-0.424,-0.2985,0.3925,-0.223,-0.22,0.3425,E9Q401,Ryr2,E9Q401_Ryr2,E9Q401,Ryr2,1,9,4,4,E9Q401|F6U7V1|Q80ZZ5,MOUSE,570001.1,0.9,390,390.1,28.37,28.37,,4966,Ryanodine receptor 2,smooth endoplasmic reticulum|membrane|integral component of membrane|sarcoplasmic reticulum|sarcomere|Z disc|sarcoplasmic reticulum membrane|calcium channel complex|protein complex|extracellular exosome|,response to hypoxia|regulation of heart rate|embryonic heart tube morphogenesis|left ventricular cardiac muscle tissue morphogenesis|cardiac muscle hypertrophy|detection of calcium ion|calcium ion transport|cellular calcium ion homeostasis|positive regulation of heart rate|regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion|regulation of cardiac muscle contraction by calcium ion signaling|release of sequestered calcium ion into cytosol by sarcoplasmic reticulum|response to muscle activity|calcium-mediated signaling|BMP signaling pathway|response to caffeine|calcium-mediated signaling using intracellular calcium source|response to muscle stretch|release of sequestered calcium ion into cytosol|positive regulation of sequestering of calcium ion|response to redox state|regulation of cardiac muscle contraction|cardiac muscle contraction|canonical Wnt signaling pathway|cytosolic calcium ion transport|calcium ion transport into cytosol|calcium ion transmembrane transport|cellular response to caffeine|cellular response to epinephrine stimulus|establishment of protein localization to endoplasmic reticulum|ventricular cardiac muscle cell action potential|Purkinje myocyte to ventricular cardiac muscle cell signaling|type B pancreatic cell apoptotic process|positive regulation of the force of heart contraction|regulation of AV node cell action potential|regulation of SA node cell action potential|regulation of atrial cardiac muscle cell action potential|regulation of ventricular cardiac muscle cell action potential|positive regulation of calcium-transporting ATPase activity|,intracellular ligand-gated calcium channel activity|ryanodine-sensitive calcium-release channel activity|calcium channel activity|calcium ion binding|protein binding|calmodulin binding|calcium-release channel activity|enzyme binding|protein kinase binding|protein kinase A catalytic subunit binding|protein kinase A regulatory subunit binding|identical protein binding|protein self-association|suramin binding|calcium-induced calcium release activity|organic cyclic compound binding|,4,9,7890000000,0.9%
A6H584,0.039117364,0.511583333,27.89231399,-1.550166667,0.001624683,-5.318992048,1.185,1.7235,0.9515,-0.128,-0.51,-0.1525,A6H584,Col6a5,A6H584_Col6a5,A6H584,Col6a5,1,4,4,4,A0A140T8W1|A6H584|A0A140T8T7|E9Q6A6|Q8C6K9|Q8C6K9-2,MOUSE,291566.4,1.8,391,391.1,28.29,28.29,,2640,Collagen alpha-5(VI) chain,extracellular region|proteinaceous extracellular matrix|collagen trimer|,cell adhesion|,,4,4,38500000,1.8%
P10854,0.115560135,0.85675,21.08954518,-1.919833333,0.00778118,-3.898592787,1.876,2.0955,1.4785,0.918,-0.824,-0.4035,P10854,Hist1h2bm,P10854_Hist1h2bm,P10854,Hist1h2bm,1,10,3,3,P10854|Q64478|Q64525|Q6ZWY9|Q8CGP2-2|Q8CBB6|P70696|Q8CGP2|Q64475|P10853|Q8CGP1|Q9D2U9|Q64524|Q8CGP0,MOUSE,13935.9,18.2,392,392.1,28.26,28.26,,126,Histone H2B type 1-M,nuclear nucleosome|nucleus|nucleoplasm|extracellular exosome|,nucleosome assembly|,DNA binding|protein heterodimerization activity|,3,10,5910000000,18.2%
Q8VCN3,0.739686616,0.0862,2.600736198,0.211583333,0.549447726,0.639801561,0.105,-0.1865,,0.337,-0.239,0.4145,Q8VCN3,Ugt2b37,Q8VCN3_Ugt2b37,Q8VCN3,Ugt2b37,1,4,3,3,Q8VCN3|Q91WH2|Q8K169|P17717|Q8BJL9|Q8R084|Q3UEP4|K9J7B2|Q64435|E9PXN7|P70691|D3Z748|Q63886|B2RT14|Q62452|Q6ZQM8|D3YZE6,MOUSE,61328.4,6.6,393,393.1,27.46,27.46,,530,UDP-glucuronosyltransferase,mitochondrial inner membrane|endoplasmic reticulum|intracellular membrane-bounded organelle|,flavonoid biosynthetic process|cellular response to hormone stimulus|flavonoid glucuronidation|,glucuronosyltransferase activity|,3,4,104000000,6.6%
P09581,0.73776114,0.10925,2.621405769,-0.192166667,0.546838928,-0.637145412,0.127,-0.2295,0.7185,0.028,0.038,-0.0265,P09581,Csf1r,P09581_Csf1r,P09581,Csf1r,1,3,3,3,P09581,MOUSE,110375.4,2.9,394,394.1,27.36,27.36,,977,Macrophage colony-stimulating factor 1 receptor,intracellular|plasma membrane|cell surface|integral component of membrane|CSF1-CSF1R complex|,positive regulation of protein phosphorylation|inflammatory response|transmembrane receptor protein tyrosine kinase signaling pathway|axon guidance|skeletal muscle tissue development|cell proliferation|positive regulation of cell proliferation|negative regulation of cell proliferation|regulation of cell shape|peptidyl-tyrosine phosphorylation|cytokine-mediated signaling pathway|olfactory bulb development|forebrain neuron differentiation|hemopoiesis|osteoclast differentiation|positive regulation of cell migration|ruffle organization|cellular response to macrophage colony-stimulating factor stimulus|macrophage colony-stimulating factor signaling pathway|positive regulation of tyrosine phosphorylation of Stat3 protein|negative regulation of apoptotic process|innate immune response|regulation of bone resorption|cell-cell junction maintenance|positive regulation of osteoclast differentiation|phosphatidylinositol metabolic process|protein autophosphorylation|phosphatidylinositol-mediated signaling|positive regulation of protein tyrosine kinase activity|positive regulation of ERK1 and ERK2 cascade|cellular response to cytokine stimulus|positive regulation of protein serine/threonine kinase activity|positive regulation of chemokine secretion|positive regulation of cell motility|regulation of actin cytoskeleton reorganization|,macrophage colony-stimulating factor receptor activity|protein binding|ATP binding|protein phosphatase binding|cytokine binding|protein homodimerization activity|,3,3,28700000,2.9%
H7BWY6,0.81135046,0.2792,1.780958853,-0.145083333,0.663596543,-0.460791214,0.528,0.2045,,0.565,0.094,0.0045,H7BWY6,Rbp4,H7BWY6_Rbp4,H7BWY6,Rbp4,1,3,3,3,H7BWY6|Q00724,MOUSE,28746.7,8.5,395,395.1,27.33,27.33,,245,Retinol-binding protein 4,extracellular space|protein complex|extracellular exosome|,maintenance of gastrointestinal epithelium|positive regulation of insulin secretion|response to retinoic acid|retinol transport|retinol metabolic process|glucose homeostasis|response to ethanol|,retinol binding|retinol transporter activity|protein heterodimerization activity|,3,3,188000000,8.5%
Q61268,0.251180411,0.017,13.42896143,0.774583333,0.045405019,2.619522627,-0.292,-0.6035,,0.455,0.472,0.0535,Q61268,Apoc4,Q61268_Apoc4,Q61268,Apoc4,1,6,2,2,Q61268,MOUSE,14459.4,16.1,396,396.1,27.2,27.2,,124,Apolipoprotein C-IV,very-low-density lipoprotein particle|high-density lipoprotein particle|,lipid transport|positive regulation of sequestering of triglyceride|triglyceride homeostasis|,,2,6,517000000,16.1%
P35822,0.320477067,-0.2506,10.23605648,0.563583333,0.094709676,2.040266439,-0.403,-0.7745,,-0.144,0.058,0.0105,P35822,Ptprk,P35822_Ptprk,P35822,Ptprk,1,5,4,4,A0A1W2P7Y1|P35822|B2RRF0,MOUSE,166179.6,2.1,397,397.1,26.54,26.54,,1457,Receptor-type tyrosine-protein phosphatase kappa,photoreceptor outer segment|cell-cell junction|cell surface|integral component of membrane|axon|dendrite|leading edge membrane|neuronal cell body|,"protein dephosphorylation|cell adhesion|signal transduction|transforming growth factor beta receptor signaling pathway|negative regulation of cell proliferation|negative regulation of keratinocyte proliferation|cell migration|negative regulation of cell migration|protein localization to cell surface|cellular response to reactive oxygen species|cellular response to UV|peptidyl-tyrosine dephosphorylation|negative regulation of cell cycle|negative regulation of transcription, DNA-templated|focal adhesion assembly|",protein tyrosine phosphatase activity|beta-catenin binding|protein kinase binding|gamma-catenin binding|,4,5,141000000,2.1%
E9QNX4,0.519628152,-0.1398,5.614632017,0.33575,0.274496492,1.221249257,-0.543,-0.1395,,-0.012,-0.054,0.0495,E9QNX4,Alpk1,E9QNX4_Alpk1,E9QNX4,Alpk1,1,10,3,3,E9QNX4|Q9CXB8,MOUSE,137413.2,2.1,398,398.1,26.5,26.5,,1231,Alpha-protein kinase 1,,positive regulation of defense response to virus by host|protein phosphorylation|activation of mitophagy in response to mitochondrial depolarization|,protein serine/threonine kinase activity|ATP binding|,3,10,615000000,2.1%
A0A1Y7VJX7,0.478310449,0.58875,6.604826014,-0.8345,0.218533187,-1.372990825,2.165,0.8105,0.0425,0.442,-0.498,0.5705,A0A1Y7VJX7,NotFound,A0A1Y7VJX7_NotFound,A0A1Y7VJX7,Ighe,1,3,3,3,A0A1Y7VJX7|P06336,MOUSE,55752.3,11.3,399,399.1,26.32,26.32,,486,Immunoglobulin heavy constant epsilon (Fragment),,,,3,3,249000000,11.3%
O89053,0.578818384,0.0104,4.508332432,-0.26975,0.354133292,-1.017038439,0.029,0.3155,,-0.162,-0.124,-0.0065,O89053,Coro1a,O89053_Coro1a,O89053,Coro1a,1,3,3,3,O89053|G3UYK8,MOUSE,51672.9,7.5,400,400.1,25.96,25.96,,461,Coronin-1A,immunological synapse|phagocytic cup|cytoplasm|early endosome|actin filament|plasma membrane|cell-cell junction|membrane|lamellipodium|axon|phagocytic vesicle membrane|cortical actin cytoskeleton|cell leading edge|protein complex|phagocytic vesicle|extracellular exosome|plasma membrane|actin cytoskeleton|cortical actin cytoskeleton|,phagolysosome assembly|calcium ion transport|phagocytosis|actin filament organization|regulation of actin polymerization or depolymerization|regulation of cell shape|cell migration|actin cytoskeleton organization|positive regulation of cell migration|leukocyte chemotaxis|regulation of actin filament polymerization|negative regulation of vesicle fusion|cell-substrate adhesion|uropod organization|regulation of actin cytoskeleton organization|response to cytokine|nerve growth factor signaling pathway|positive regulation of T cell proliferation|T cell homeostasis|natural killer cell degranulation|negative regulation of neuron apoptotic process|homeostasis of number of cells within a tissue|positive regulation of T cell activation|positive chemotaxis|negative regulation of actin nucleation|regulation of release of sequestered calcium ion into cytosol|early endosome to recycling endosome transport|cellular response to interleukin-4|,actin binding|actin monomer binding|protein binding|protein C-terminus binding|cytoskeletal protein binding|myosin heavy chain binding|identical protein binding|protein homodimerization activity|phosphatidylinositol 3-kinase binding|poly(A) RNA binding|actin filament binding|,3,3,6550000,7.5%
Q80T19,0.588783496,0.2752,4.366691037,0.38075,0.365873451,0.990313195,-0.046,0.1395,,0.956,0.388,-0.0615,Q80T19,Hamp2,Q80T19_Hamp2,Q80T19,Hamp2,1,3,2,2,Q5M9M1|Q80T19,MOUSE,9923.4,30.1,401,401.1,25.92,25.92,,83,Hepcidin-2,extracellular region|cell|,cellular iron ion homeostasis|killing of cells of other organism|defense response to bacterium|defense response to fungus|,hormone activity|,2,3,105000000,30.1%
A0A0B4J1H6,0.473752791,-0.199083333,6.677042113,1.0545,0.214929381,1.385328288,0.402,-0.1885,-2.3925,-0.222,0.828,0.3785,A0A0B4J1H6,NotFound,A0A0B4J1H6_NotFound,A0A0B4J1H6,Igkv2-137,1,7,2,2,A0A0B4J1H6|P01630,MOUSE,13302,20,402,402.1,25.91,25.91,,120,Immunoglobulin kappa chain variable 2-137 (Fragment),,,,2,7,13200000000,20.0%
Q8BWP8,0.262605874,-0.2498,12.70059928,0.76075,0.05369577,2.484645457,-0.401,-1.0115,,0.139,0.051,-0.0265,Q8BWP8,B4gat1,Q8BWP8_B4gat1,Q8BWP8,B4gat1,1,3,3,3,Q8BWP8|Q8BWP8-2,MOUSE,47839.9,8.1,403,403.1,25.84,25.84,,415,"Beta-1,4-glucuronyltransferase 1",Golgi membrane|Golgi apparatus|integral component of membrane|extracellular exosome|,protein glycosylation|axon guidance|protein O-linked mannosylation|poly-N-acetyllactosamine biosynthetic process|,"glucuronosyltransferase activity|metal ion binding|N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity|",3,3,67700000,8.1%
Q8K2I4,0.785476623,0.03425,2.0683587,-0.232833333,0.621103719,-0.520252967,1.033,0.0975,-0.6785,-0.107,-0.083,-0.0565,Q8K2I4,Manba,Q8K2I4_Manba,Q8K2I4,Manba,1,3,3,3,A0A0R4J092|Q8K2I4|D6RGR1,MOUSE,101513.6,4.4,404,404.1,25.63,25.63,,879,Beta-mannosidase,lysosome|intracellular membrane-bounded organelle|,carbohydrate metabolic process|glycoprotein catabolic process|mannan catabolic process|,beta-mannosidase activity|,3,3,41500000,4.4%
Q792Z1,0.011676506,0.955083333,37.91992261,-3.053833333,0.000161439,-8.096353958,3.09,1.8425,2.5135,-0.721,-0.747,-0.2475,Q792Z1,Try10,Q792Z1_Try10,Q792Z1,Try10,1,3,2,2,Q792Z1,MOUSE,26905,7.3,405,405.1,25.36,25.36,,246,MCG140784,extracellular space|extracellular exosome|blood microparticle|,proteolysis|digestion|,serine-type endopeptidase activity|,2,3,197000000,7.3%
A0A075B5Q3,0.171160933,-0.294083333,16.93937967,1.2385,0.020233082,3.10795173,-0.493,-0.6855,-1.5615,-0.197,0.462,0.7105,A0A075B5Q3,NotFound,A0A075B5Q3_NotFound,A0A075B5Q3,Ighv2-5,1,6,2,2,A0A075B5Q3,MOUSE,12727.5,16.5,406,406.1,25.26,25.26,,115,Immunoglobulin heavy variable 2-5,,,,2,6,4050000000,16.5%
Q9EPK6,0.439067296,0.25825,7.663020938,-0.6295,0.17127655,-1.548443467,0.8,-0.2325,1.1515,-0.175,-0.212,0.2175,Q9EPK6,Sil1,Q9EPK6_Sil1,Q9EPK6,Sil1,1,3,3,3,Q9EPK6,MOUSE,52771.3,8.1,407,407.1,25.03,25.03,,465,Nucleotide exchange factor SIL1,extracellular space|endoplasmic reticulum|endoplasmic reticulum lumen|,protein transport|,,3,3,45900000,8.1%
A0A075B5V5,0.917768271,0.3974,0.666828242,-0.08225,0.857663989,-0.188530064,0.666,0.2275,,0.125,1.04,-0.0715,A0A075B5V5,NotFound,A0A075B5V5_NotFound,A0A075B5V5,Ighv1-39,1,2,2,2,A0A075B5V5,MOUSE,13044.4,22.2,408,408.1,24.74,24.74,,117,Immunoglobulin heavy variable 1-39 (Fragment),,,,2,2,962000000,22.2%
A0A075B5L4,0.278148384,0.2458,11.939353,-0.636583333,0.063983015,-2.345623488,0.573,0.6825,,-0.156,-0.07,0.1995,A0A075B5L4,NotFound,A0A075B5L4_NotFound,A0A075B5L4,Igkv12-89,1,7,2,2,A0A075B5L4,MOUSE,12138.5,24.3,409,409.1,24.27,24.27,,111,Immunoglobulin kappa chain variable 12-89,,,,2,7,858000000,24.3%
P01627,0.815223461,0.176,1.6513836,-0.235416667,0.683693798,-0.431642293,-0.39,1.0245,,0.114,0.539,-0.4075,P01627,NotFound,P01627_NotFound,P01627,Gm5153,1,2,2,2,P01627|A0A075B5K5|P01628,MOUSE,13451,19.1,410,410.1,24.25,24.25,,120,Ig kappa chain V-II region VKappa167,,,,2,2,40100000,19.1%
P62631,0.549465437,0.0756,5.114645496,-0.34775,0.307989173,-1.129843057,0.556,0.0125,,0.088,-0.249,-0.0295,P62631,Eef1a2,P62631_Eef1a2,P62631,Eef1a2,1,4,2,2,P62631|P10126,MOUSE,50795.6,4.3,411,411.1,23.82,23.82,,463,Elongation factor 1-alpha 2,nucleus|cytoplasm|eukaryotic translation elongation factor 1 complex|neuronal cell body|myelin sheath|,translational elongation|response to inorganic substance|positive regulation of apoptotic process|positive regulation of lipid kinase activity|,translation elongation factor activity|GTPase activity|GTP binding|protein kinase binding|,2,4,144000000,4.3%
A0A075B5T6,0.603623837,0.05,4.192108558,0.37125,0.380880856,0.957150615,0.121,-0.4665,,-0.216,0.654,0.1575,A0A075B5T6,NotFound,A0A075B5T6_NotFound,A0A075B5T6,Ighv10-3,1,4,3,3,A0A075B5T6,MOUSE,13715.5,22.6,412,412.1,23.81,23.81,,119,Immunoglobulin heavy variable V10-3 (Fragment),,,,3,4,369000000,22.6%
Q9ES89,0.399101763,0.28425,8.413455352,-0.462166667,0.144096843,-1.671472654,0.137,0.5975,0.8115,-0.118,0.288,-0.0105,Q9ES89,Extl2,Q9ES89_Extl2,Q9ES89,Extl2,1,6,2,2,Q9ES89|Q3TSR0,MOUSE,37618.1,4.2,413,413.1,23.78,23.78,,330,Exostosin-like 2,endoplasmic reticulum|endoplasmic reticulum membrane|integral component of membrane|extracellular exosome|,glycosaminoglycan biosynthetic process|N-acetylglucosamine metabolic process|heparan sulfate proteoglycan biosynthetic process|UDP-N-acetylgalactosamine metabolic process|,"glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity|alpha-1,4-N-acetylgalactosaminyltransferase activity|metal ion binding|",2,6,271000000,4.2%
P01662,0.89919911,-0.09925,0.862142404,0.2375,0.819946959,0.23773054,1.317,0.5825,-2.5535,-0.328,0.359,0.0275,P01662,NotFound,P01662_NotFound,P01662,,1,3,2,2,P01662|P01663,MOUSE,12155.2,21.6,414,414.1,23.66,23.66,,111,Ig kappa chain V-III region ABPC 22/PC 9245,,,antigen binding|,2,3,127000000,21.6%
A0A075B5T9,0.782114298,0.1792,2.139952489,0.26075,0.610948709,0.541264092,0.255,-0.2095,,-0.195,1.073,-0.0275,A0A075B5T9,NotFound,A0A075B5T9_NotFound,A0A075B5T9,Ighv1-9,1,3,2,2,A0A075B5T9,MOUSE,13045.5,26.7,415,415.1,23.64,23.64,,116,Immunoglobulin heavy variable V1-9,,,,2,3,639000000,26.7%
P62242,0.105134073,0.493083333,21.83236321,-2.513166667,0.006557883,-4.059513757,1.211,0.8895,3.1485,-0.838,-0.972,-0.4805,P62242,Rps8,P62242_Rps8,P62242,Rps8,1,2,2,2,P62242,MOUSE,24490,9.6,416,416.1,23.5,23.5,,208,40S ribosomal protein S8,nucleus|cytoplasm|focal adhesion|membrane|cytosolic small ribosomal subunit|ribonucleoprotein complex|extracellular exosome|,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)|translation|",structural constituent of ribosome|poly(A) RNA binding|,2,2,45800000,9.6%
P12382,0.570201303,-0.2434,4.676745257,0.333083333,0.340663398,1.048619353,-0.126,-0.7605,,-0.204,-0.186,0.0595,P12382,Pfkl,P12382_Pfkl,P12382,Pfkl,1,4,3,2,P12382|Q8C605|Q9WUA3|Q9WUA3-2,MOUSE,86157.1,5.1,417,417.1,23.09,11.49,,780,"ATP-dependent 6-phosphofructokinase, liver type",cytosol|6-phosphofructokinase complex|membrane|extracellular exosome|,"fructose 6-phosphate metabolic process|glycolytic process|response to glucose|fructose 1,6-bisphosphate metabolic process|negative regulation of insulin secretion|carbohydrate phosphorylation|protein oligomerization|protein homotetramerization|",6-phosphofructokinase activity|ATP binding|kinase binding|identical protein binding|metal ion binding|fructose binding|fructose-6-phosphate binding|6-phosphofructokinase activity|,3,4,156000000,5.1%
P47857-3,0.519628152,0.05275,5.650126336,-0.927166667,0.272262211,-1.20781563,-0.065,2.2415,-0.6275,-0.165,-0.901,-0.1665,P47857,Pfkm,P47857-3_Pfkm,P47857-3,Pfkm,1,2,3,2,P47857-3|P47857-2|P47857,MOUSE,103523.5,3.6,417,417.2,22.85,11.25,,780,"Isoform 3 of ATP-dependent 6-phosphofructokinase, muscle type",cytosol|6-phosphofructokinase complex|apical plasma membrane|extracellular exosome|sperm principal piece|,fructose 6-phosphate metabolic process|glycolytic process|positive regulation of insulin secretion|glucose homeostasis|muscle cell cellular homeostasis|carbohydrate phosphorylation|protein oligomerization|glycolytic process through fructose-6-phosphate|,6-phosphofructokinase activity|protein binding|ATP binding|protein C-terminus binding|phosphofructokinase activity|kinase binding|identical protein binding|protein homodimerization activity|metal ion binding|fructose binding|,2,2,5220000,2.6%
A0A1W2P6U8,0.785476623,0.021,2.069372935,0.134583333,0.620958686,0.525388381,-0.092,-0.0275,,-0.003,0.196,0.0315,A0A1W2P6U8,LOC102635990,A0A1W2P6U8_LOC102635990,A0A1W2P6U8,4932415D10Rik,1,4,4,4,A0A1W2P6U8,MOUSE,557033.8,0.7,418,418.1,23.02,23.02,,4986,RIKEN cDNA 4932415D10 gene,,,,4,4,1470000000,0.7%
A0A0A6YWI9,0.958652624,0.0294,0.330549724,-0.033083333,0.926712514,-0.096531001,0.19,-0.0915,,-0.371,0.414,0.0055,A0A0A6YWI9,NotFound,A0A0A6YWI9_NotFound,A0A0A6YWI9,Ighv1-11,1,3,2,2,A0A0A6YWI9,MOUSE,13035.6,17,419,419.1,22.86,22.86,,117,Immunoglobulin heavy variable V1-11 (Fragment),,,,2,3,231000000,17.0%
A0A075B5W1,0.549465437,0.081,5.026441612,0.31625,0.314308292,1.113578386,-0.281,0.0635,,0.085,0.404,0.1335,A0A075B5W1,NotFound,A0A075B5W1_NotFound,A0A075B5W1,Ighv1-50,1,2,2,2,A0A075B5W1|A0A075B5X7,MOUSE,13048.5,26.4,420,420.1,22.62,22.62,,117,Immunoglobulin heavy variable 1-50 (Fragment),,,,2,2,605000000,26.4%
Q02053,0.76783903,-0.0622,2.264587876,-0.181583333,0.593664681,-0.568063749,-0.271,0.3645,,-0.013,-0.315,-0.0765,Q02053,Uba1,Q02053_Uba1,Q02053,Uba1,1,3,3,3,Q02053|P31254,MOUSE,119004.9,3.7,421,421.1,22.54,22.54,,1058,Ubiquitin-like modifier-activating enzyme 1,nucleus|cytoplasm|mitochondrion|cytosol|extracellular exosome|heterochromatin|lysosomal membrane|endosome membrane|desmosome|rough endoplasmic reticulum membrane|,cellular response to DNA damage stimulus|protein ubiquitination|modification-dependent protein catabolic process|,ubiquitin activating enzyme activity|ubiquitin-protein transferase activity|protein binding|ATP binding|poly(A) RNA binding|,3,3,57800000,3.7%
P97467,0.441723111,-0.0894,7.527006461,0.42975,0.176725555,1.5625974,-0.531,-0.1635,,0.131,0.148,-0.0315,P97467,Pam,P97467_Pam,P97467,Pam,1,3,2,2,P97467|F8VQA4|E9Q704,MOUSE,109816.4,2.3,422,422.1,22.27,22.27,,979,Peptidyl-glycine alpha-amidating monooxygenase,cytosol|integral component of plasma membrane|membrane|transport vesicle membrane|extracellular exosome|,peptide amidation|peptide metabolic process|oxidation-reduction process|,peptidylglycine monooxygenase activity|peptidylamidoglycolate lyase activity|copper ion binding|zinc ion binding|L-ascorbic acid binding|,2,3,84100000,2.3%
Q80UM7,0.105134073,0.87025,21.72770851,-2.628833333,0.006717832,-4.038328912,0.973,2.1415,3.4395,-0.251,-0.978,-0.1035,Q80UM7,Mogs,Q80UM7_Mogs,Q80UM7,Mogs,1,3,3,3,Q80UM7,MOUSE,92000.8,3.1,423,423.1,22.18,22.18,,834,Mannosyl-oligosaccharide glucosidase,endoplasmic reticulum membrane|membrane|integral component of membrane|extracellular exosome|,protein N-linked glycosylation|oligosaccharide metabolic process|,mannosyl-oligosaccharide glucosidase activity|,3,3,49600000,3.1%
F8VQD7,0.279130421,0.228,11.66821316,-0.61375,0.068104951,-2.296533896,0.476,0.7165,,0.126,-0.066,-0.1125,F8VQD7,Ptprg,F8VQD7_Ptprg,F8VQD7,Ptprg,1,5,3,3,F8VQD7|Q05909|D6RD11,MOUSE,162430.7,1.9,424,424.1,22.11,22.11,,1442,Receptor-type tyrosine-protein phosphatase gamma,extracellular exosome|,negative regulation of epithelial cell migration|peptidyl-tyrosine dephosphorylation|toxin transport|,protein tyrosine phosphatase activity|identical protein binding|,3,5,70700000,1.9%
Q7TNC4,0.115656065,0.55375,20.80193407,-1.955833333,0.008313934,-3.842021598,1.749,0.4615,2.3845,-0.217,-0.617,-0.4385,Q7TNC4,Luc7l2,Q7TNC4_Luc7l2,Q7TNC4,Luc7l2,1,2,2,2,Q7TNC4|Q7TNC4-4|Q05CX5|Q7TNC4-3|Q7TNC4-2|E9Q715|Q9CYI4|A0A0R4J047|Q9CYI4-2,MOUSE,46981.6,6.3,425,425.1,22.03,22.03,,392,Putative RNA-binding protein Luc7-like 2,U1 snRNP|nuclear speck|,mRNA splice site selection|,mRNA binding|enzyme binding|poly(A) RNA binding|,2,2,40400000,6.3%
Q9DBH5,0.549465437,0.050916667,4.984566458,-0.240166667,0.317353545,-1.087375852,-0.042,0.2675,0.2875,-0.048,-0.083,-0.0765,Q9DBH5,Lman2,Q9DBH5_Lman2,Q9DBH5,Lman2,1,3,3,3,Q9DBH5,MOUSE,40771.4,6.9,426,426.1,21.73,21.73,,358,Vesicular integral-membrane protein VIP36,Golgi membrane|extracellular space|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|integral component of plasma membrane|cell surface|extracellular exosome|,"retrograde vesicle-mediated transport, Golgi to ER|protein transport|positive regulation of phagocytosis|",glycoprotein binding|mannose binding|carbohydrate binding|heat shock protein binding|metal ion binding|,3,3,16500000,6.9%
Q9CQ45,0.561436459,0.0628,4.802473552,0.37675,0.330942577,1.072066067,-0.264,-0.0625,,0.391,-0.274,0.5235,Q9CQ45,Nenf,Q9CQ45_Nenf,Q9CQ45,Nenf,1,2,2,2,Q9CQ45,MOUSE,18904.1,11.6,427,427.1,21.64,21.64,,171,Neudesin,extracellular space|nucleus|nucleoplasm|endomembrane system|membrane|,negative regulation of appetite|positive regulation of MAPK cascade|,growth factor activity|heme binding|metal ion binding|,2,2,35600000,11.6%
Q64700,0.07979453,1.01475,23.7608727,-2.167166667,0.004206421,-4.445345881,2.886,1.0735,2.3355,-0.006,-0.289,0.0885,Q64700,Rbl2,Q64700_Rbl2,Q64700,Rbl2,1,4,4,4,Q64700|A0A1B0GR06|A0A1B0GRM0,MOUSE,128966.4,2.9,428,428.1,20.96,20.96,,1135,Retinoblastoma-like protein 2,nucleus|transcription factor complex|nucleolus|cytoplasm|extracellular exosome|,"transcription, DNA-templated|regulation of transcription from RNA polymerase II promoter|cell cycle|chromatin modification|regulation of lipid kinase activity|regulation of cell cycle|",DNA binding|protein binding|,4,4,3780000000,2.9%
P52431,0.250985566,-0.2378,13.47707564,0.75825,0.044904766,2.628502364,-0.809,-0.5765,,-0.198,0.157,0.2375,P52431,Pold1,P52431_Pold1,P52431,Pold1,1,5,2,2,P52431|D6RFB8,MOUSE,125271.5,2.1,429,429.1,20.89,20.89,,1105,DNA polymerase delta catalytic subunit,nucleotide-excision repair complex|nucleus|nucleoplasm|cytoplasm|membrane|aggresome|delta DNA polymerase complex|,"DNA synthesis involved in DNA repair|DNA replication|DNA-dependent DNA replication|base-excision repair, gap-filling|nucleotide-excision repair, DNA gap filling|cellular response to UV|DNA replication proofreading|fatty acid homeostasis|nucleic acid phosphodiester bond hydrolysis|","nucleotide binding|DNA binding|chromatin binding|damaged DNA binding|DNA-directed DNA polymerase activity|3'-5'-exodeoxyribonuclease activity|3'-5' exonuclease activity|metal ion binding|4 iron, 4 sulfur cluster binding|",2,5,438000000,2.1%
O08807,0.296807957,-0.724083333,10.88570347,1.351833333,0.081551068,2.087570462,-1.495,-0.0615,-2.6435,-0.208,-0.138,0.2015,O08807,Prdx4,O08807_Prdx4,O08807,Prdx4,1,3,2,2,O08807,MOUSE,31280.1,9.1,430,430.1,20.8,20.8,,274,Peroxiredoxin-4,extracellular space|nucleus|cytoplasm|mitochondrion|endoplasmic reticulum|smooth endoplasmic reticulum|cytosol|extracellular exosome|,spermatogenesis|male gonad development|4-hydroxyproline metabolic process|protein maturation by protein folding|extracellular matrix organization|cell redox homeostasis|oxidation-reduction process|reactive oxygen species metabolic process|negative regulation of male germ cell proliferation|,peroxidase activity|protein homodimerization activity|peroxiredoxin activity|,2,3,16800000000,9.1%
Q9Z0J1,0.781082551,-0.188916667,2.164921034,0.192833333,0.607446308,0.540924211,0.062,0.0935,-1.0115,-0.151,-0.066,-0.0605,Q9Z0J1,Reck,Q9Z0J1_Reck,Q9Z0J1,Reck,1,4,3,3,Q9Z0J1,MOUSE,111101,3,431,431.1,20.76,20.76,,971,Reversion-inducing cysteine-rich protein with Kazal motifs,plasma membrane|anchored component of membrane|,blood vessel maturation|embryo implantation|negative regulation of endopeptidase activity|extracellular matrix organization|embryonic forelimb morphogenesis|positive regulation of Notch signaling pathway|,endopeptidase inhibitor activity|serine-type endopeptidase inhibitor activity|,3,4,9510000,3.0%
A0A075B5T5,0.950319883,0.2882,0.405532668,0.04825,0.910849728,0.117529369,0.303,0.2155,,0.97,0.022,-0.0695,A0A075B5T5,NotFound,A0A075B5T5_NotFound,A0A075B5T5,Ighv1-5,1,3,2,2,A0A075B5T5,MOUSE,10960.1,18.3,432,432.1,20.7,20.7,,98,Immunoglobulin heavy variable V1-5,,,,2,3,548000000,18.3%
P47911,0.453091264,0.580083333,7.122538508,-0.7645,0.193975174,-1.46095537,1.373,-0.0325,1.5465,-0.146,0.843,-0.1035,P47911,Rpl6,P47911_Rpl6,P47911,Rpl6,1,2,2,2,P47911,MOUSE,33566.1,6,433,433.1,20.59,20.59,,296,60S ribosomal protein L6,nucleus|nucleolus|cytoplasm|focal adhesion|membrane|cytosolic large ribosomal subunit|cytoplasmic ribonucleoprotein granule|,translation|,structural constituent of ribosome|poly(A) RNA binding|,2,2,28800000,6.0%
Q9D0F3,0.449503035,0.555583333,7.205958307,-1.082833333,0.190284831,-1.475154295,0.154,0.3285,2.8085,-0.198,0.277,-0.0365,Q9D0F3,Lman1,Q9D0F3_Lman1,Q9D0F3,Lman1,1,4,3,3,Q9D0F3,MOUSE,58073,4.8,434,434.1,20.31,20.31,,517,Protein ERGIC-53,Golgi membrane|endoplasmic reticulum membrane|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|membrane|integral component of membrane|sarcomere|ER to Golgi transport vesicle|endoplasmic reticulum-Golgi intermediate compartment membrane|host cell perinuclear region of cytoplasm|extracellular exosome|,ER to Golgi vesicle-mediated transport|endoplasmic reticulum organization|Golgi organization|positive regulation of organelle organization|protein transport|,carbohydrate binding|metal ion binding|,3,4,253000000,4.8%
O08638,0.294783541,0.2268,11.0176182,-0.802416667,0.079111238,-2.179544522,1.164,0.2525,,-0.101,-0.241,0.0595,O08638,NotFound,O08638_NotFound,O08638,Myh11,1,3,3,2,O08638|E9QPE7|O08638-2|Q6URW6-3|Q6URW6|K3W4R2|Q6URW6-2,MOUSE,227879.9,1.6,435,435.1,20.19,11.51,,1972,Myosin-11,stress fiber|muscle myosin complex|brush border|myosin complex|myofibril|smooth muscle contractile fiber|myosin filament|melanosome|extracellular exosome|,smooth muscle contraction|metabolic process|skeletal muscle myosin thick filament assembly|elastic fiber assembly|cardiac muscle fiber development|activation of mitophagy in response to mitochondrial depolarization|,motor activity|actin binding|calmodulin binding|ATP binding|structural constituent of muscle|,3,3,18000000,1.6%
Q8VDD5,0.46334768,0.4024,6.971632637,-0.835583333,0.200833768,-1.470813205,1.743,0.0645,,0.412,-0.036,-0.1715,Q8VDD5,Myh9,Q8VDD5_Myh9,Q8VDD5,Myh9,1,1,2,1,Q8VDD5|F2Z494,MOUSE,227566.2,1.2,435,435.2,17.65,8.97,,1960,Myosin-9,stress fiber|ruffle|uropod|nucleus|cytoplasm|actomyosin contractile ring|cytosol|plasma membrane|brush border|cell-cell adherens junction|cell cortex|actin cytoskeleton|membrane|myosin complex|myosin II complex|cortical cytoskeleton|cell leading edge|cleavage furrow|actomyosin|protein complex|extracellular exosome|myosin II filament|immunological synapse|spindle|plasma membrane|focal adhesion|COP9 signalosome|integrin complex|neuromuscular junction|,"meiotic spindle organization|cell morphogenesis involved in differentiation|cytokinesis|angiogenesis|in utero embryonic development|establishment of T cell polarity|membrane protein ectodomain proteolysis|phagocytosis, engulfment|cell adhesion|myoblast fusion|regulation of cell shape|protein transport|single organismal cell-cell adhesion|actin filament-based movement|platelet formation|monocyte differentiation|actomyosin structure organization|actin cytoskeleton reorganization|uropod organization|blood vessel endothelial cell migration|establishment of meiotic spindle localization|platelet aggregation|negative regulation of actin filament severing|positive regulation of protein processing in phagocytic vesicle|actin filament polymerization|actin filament capping|",microfilament motor activity|actin binding|protein binding|calmodulin binding|ATP binding|ATPase activity|protein domain specific binding|actin-dependent ATPase activity|protein homodimerization activity|protein anchor|ADP binding|poly(A) RNA binding|actin filament binding|,1,1,4970000,0.4%
P55104,0.332238022,-0.2378,10.03283394,0.574916667,0.099246821,2.004234564,-0.354,-0.8115,,0.09,-0.126,0.0125,P55104,Inhbc,P55104_Inhbc,P55104,Inhbc,1,2,2,2,P55104,MOUSE,40085.3,4.5,436,436.1,20.12,20.12,,352,Inhibin beta C chain,extracellular space|extracellular exosome|,positive regulation of pathway-restricted SMAD protein phosphorylation|regulation of apoptotic process|regulation of MAPK cascade|cell development|SMAD protein signal transduction|,cytokine activity|transforming growth factor beta receptor binding|hormone activity|growth factor activity|,2,2,17000000,4.5%
A0A075B5K6,0.824944386,0.6546,1.583390464,0.20725,0.694481935,0.415765688,0.582,0.4785,,0.949,1.367,-0.1035,A0A075B5K6,NotFound,A0A075B5K6_NotFound,A0A075B5K6,Igkv2-109,1,5,1,1,A0A075B5K6|P03976,MOUSE,13170.8,10.8,437,437.1,19.88,19.88,,120,Immunoglobulin kappa variable 2-109 (Fragment),,,,1,5,413000000,10.8%
E9Q1W3,0.46334768,0.398083333,6.881875709,-0.547833333,0.205027648,-1.417118598,0.152,0.3975,1.4665,0.236,0.126,0.0105,E9Q1W3,Neb,E9Q1W3_Neb,E9Q1W3,Neb,1,5,3,3,E9Q1W3|A2AQA9,MOUSE,831956.2,0.5,438,438.1,19.8,19.8,,7152,Nebulin,striated muscle thin filament|Z disc|protein complex|contractile fiber|extracellular exosome|,regulation of actin filament length|sarcomere organization|,actin binding|protein binding|,3,5,9310000000,0.5%
P01626,0.282360967,0.3428,11.40766308,-0.694083333,0.072315883,-2.249552773,0.684,0.8345,,-0.234,0.393,0.0365,P01626,NotFound,P01626_NotFound,P01626,,1,4,3,3,P01626,MOUSE,12462.8,33,439,439.1,19.38,19.38,,112,Ig kappa chain V-II region MOPC 167,,,antigen binding|,3,4,111000000,33.0%
Q8R5K4,0.549465437,0.1324,4.973149684,0.686916667,0.318188905,1.107264422,0.421,-0.9805,,1.143,-0.258,0.3365,Q8R5K4,Nol6,Q8R5K4_Nol6,Q8R5K4,Nol6,1,6,3,3,Q8R5K4|Q8R5K4-2|Q810B6|Q2NKI2|Q2NKI2-2|Q9DCM2|A0A0N4SVE5,MOUSE,130081.4,1.6,440,440.1,19.14,19.14,,1152,Nucleolar protein 6,condensed nuclear chromosome|nucleus|nucleolus|mitochondrion|small-subunit processome|CURI complex|UTP-C complex|,rRNA processing|tRNA export from nucleus|,poly(A) RNA binding|,4,6,1150000000,1.6%
E9Q5P0,0.16997749,0.526583333,17.03529287,-1.076833333,0.019791136,-3.117813945,0.897,0.5785,1.7195,0.017,-0.148,0.0955,E9Q5P0,Hpn,E9Q5P0_Hpn,E9Q5P0,Hpn,1,2,2,2,E9Q5P0|O35453|O35453-2|G3UWE8,MOUSE,48900.6,5.1,441,441.1,18.93,18.93,,445,Serine protease hepsin,endoplasmic reticulum membrane|plasma membrane|integral component of plasma membrane|cell surface|integral component of membrane|extracellular exosome|nuclear membrane|,proteolysis|sensory perception of sound|regulation of cell shape|negative regulation of alkaline phosphatase activity|negative regulation of epithelial to mesenchymal transition|positive regulation of plasminogen activation|positive regulation of cell growth|basement membrane disassembly|cholesterol homeostasis|negative regulation of apoptotic process|positive regulation by host of viral transcription|negative regulation of epithelial cell proliferation|positive regulation of hepatocyte proliferation|,serine-type endopeptidase activity|peptidase activity|serine-type peptidase activity|serine-type exopeptidase activity|,2,2,17500000,5.1%
Q9QZ25,0.334887377,0.37825,9.929219541,-0.928833333,0.101643134,-1.926687192,0.404,0.2595,1.8645,0.125,-0.429,0.0455,Q9QZ25,Vnn3,Q9QZ25_Vnn3,Q9QZ25,Vnn3,1,2,2,2,Q9QZ25,MOUSE,56931.6,3.6,442,442.1,18.61,18.61,,500,Vascular non-inflammatory molecule 3,extracellular space|plasma membrane|anchored component of membrane|,pantothenate metabolic process|,pantetheine hydrolase activity|,2,2,30300000,3.6%
P30412,0.105134073,0.61475,21.99904904,-1.5425,0.006310955,-4.052241473,0.83,1.7845,1.5435,-0.091,-0.67,0.2915,P30412,Ppic,P30412_Ppic,P30412,Ppic,1,3,2,2,P30412,MOUSE,22907.8,10.3,443,443.1,18.41,18.41,,212,Peptidyl-prolyl cis-trans isomerase C,cytoplasm|extracellular exosome|,protein peptidyl-prolyl isomerization|protein folding|,peptidyl-prolyl cis-trans isomerase activity|protein binding|cyclosporin A binding|,2,3,243000000,10.3%
A0A087WRT4,0.272982869,-0.2182,12.28048848,0.742583333,0.05914951,2.407694738,-0.414,-0.9135,,-0.013,-0.064,0.3135,A0A087WRT4,Fat1,A0A087WRT4_Fat1,A0A087WRT4,Fat1,1,2,2,2,A0A1L1SQU7|A0A087WRT4|F2Z4A3,MOUSE,511001.9,0.4,444,444.1,18.14,18.14,,4602,FAT atypical cadherin 1,nucleus|plasma membrane|cell-cell junction|focal adhesion|lamellipodium|cell junction|filopodium|perinuclear region of cytoplasm|extracellular exosome|,actin filament organization|homophilic cell adhesion via plasma membrane adhesion molecules|establishment or maintenance of cell polarity|single organismal cell-cell adhesion|,calcium ion binding|protein binding|,2,2,57500000,0.4%
E9PZQ0,0.339465731,0.31975,9.781664386,-0.5405,0.10515588,-1.896457243,0.705,0.4925,0.5725,-0.141,-0.238,0.5275,E9PZQ0,Ryr1,E9PZQ0_Ryr1,E9PZQ0,Ryr1,1,5,3,3,A0A1L1SQG7|E9PZQ0|K3W4M2|Q5DTZ6|Q5DTZ6-2|Q5DTZ6-3|E9Q7N9|Q99MV7|Q8CFI7|Q99MV7-3|P18293|Q3UFM5|A4Q9F4|Q8K4B0|E9PX23|F8WHY8|A4Q9F4-2|Q9R190|A4Q9F4-3|Q8BKV1|F8WHY9|M0QWK4|H3BLK0|Q3URK1|E0CXM8|Q99N20|E0CZ80,MOUSE,570734.5,0.3,445,445.1,18.14,18.14,,5035,Ryanodine receptor 1,cytoplasm|smooth endoplasmic reticulum|plasma membrane|cell cortex|membrane|integral component of membrane|sarcoplasmic reticulum|junctional membrane complex|T-tubule|I band|sarcoplasmic reticulum membrane|protein complex|extracellular exosome|,response to hypoxia|outflow tract morphogenesis|calcium ion transport|muscle contraction|regulation of muscle contraction|release of sequestered calcium ion into cytosol by sarcoplasmic reticulum|skin development|ossification involved in bone maturation|skeletal muscle fiber development|release of sequestered calcium ion into cytosol|calcium ion transmembrane transport|cellular response to caffeine|,protease binding|ryanodine-sensitive calcium-release channel activity|voltage-gated calcium channel activity|calcium channel activity|protein binding|calmodulin binding|enzyme binding|,4,5,1570000000,0.3%
A0A075B5X8,0.439067296,-0.32425,7.656628817,0.658166667,0.171528827,1.547391361,-0.07,-0.4235,-1.4665,-0.16,-0.227,0.4015,A0A075B5X8,NotFound,A0A075B5X8_NotFound,A0A075B5X8,Ighv8-12,1,6,2,2,A0A075B5X8,MOUSE,11636.9,14.2,446,446.1,18.08,18.08,,105,Immunoglobulin heavy variable V8-12,,,,2,6,1840000000,14.2%
P02663,0.013724449,0.933916667,34.03806915,-3.658166667,0.000394633,-7.044670424,2.133,2.2465,3.9095,-0.625,-1.017,-1.0435,P02663,NotFound,P02663_NotFound,P02663,CSN1S2,1,3,2,2,P02663,BOVIN,26189.4,8.1,447,447.1,17.95,17.95,,222,Alpha-S2-casein,,,,2,3,9280000,8.1%
Q61592,0.253802285,-0.3264,13.27620816,0.68475,0.047030455,2.591072986,-0.829,-0.6455,,0.033,-0.203,0.0125,Q61592,Gas6,Q61592_Gas6,Q61592,Gas6,1,3,2,2,Q61592,MOUSE,76548.1,3.2,448,448.1,17.61,17.61,,674,Growth arrest-specific protein 6,extracellular space|cytoplasm|extracellular exosome|,"neuron migration|positive regulation of protein phosphorylation|positive regulation of cytokine-mediated signaling pathway|positive regulation of glomerular filtration|protein phosphorylation|phagocytosis|signal transduction|enzyme linked receptor protein signaling pathway|blood coagulation|cellular response to starvation|positive regulation of gene expression|negative regulation of tumor necrosis factor-mediated signaling pathway|macrophage cytokine production|peptidyl-serine phosphorylation|fusion of virus membrane with host plasma membrane|viral genome replication|organ regeneration|cell-substrate adhesion|positive regulation of TOR signaling|activation of protein kinase B activity|negative regulation of interferon-gamma production|negative regulation of interleukin-6 production|negative regulation of tumor necrosis factor production|positive regulation of natural killer cell differentiation|positive regulation of peptidyl-serine phosphorylation|negative regulation of protein import into nucleus, translocation|cellular response to interferon-alpha|cellular response to drug|B cell chemotaxis|regulation of growth|negative regulation of apoptotic process|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|apoptotic cell clearance|negative regulation of sequence-specific DNA binding transcription factor activity|protein kinase B signaling|positive regulation of protein kinase activity|negative regulation of transcription, DNA-templated|viral entry into host cell|receptor-mediated virion attachment to host cell|positive regulation of protein export from nucleus|positive regulation of fibroblast proliferation|negative regulation of interleukin-1 secretion|positive regulation of phagocytosis|positive regulation of protein kinase B signaling|positive regulation of protein tyrosine kinase activity|negative regulation of biomineral tissue development|positive regulation of ERK1 and ERK2 cascade|calcium ion transmembrane transport|cellular response to vitamin K|cellular response to glucose stimulus|cellular response to growth factor stimulus|protein targeting to plasma membrane|extracellular matrix assembly|dendritic cell differentiation|hematopoietic stem cell migration to bone marrow|negative regulation of oligodendrocyte apoptotic process|negative regulation of interleukin-6 secretion|negative regulation of fibroblast apoptotic process|negative regulation of endothelial cell apoptotic process|positive regulation of dendritic cell chemotaxis|negative regulation of renal albumin absorption|negative regulation of dendritic cell apoptotic process|","phosphatidylserine binding|receptor binding|voltage-gated calcium channel activity|calcium ion binding|protein tyrosine kinase activator activity|receptor tyrosine kinase binding|cysteine-type endopeptidase inhibitor activity involved in apoptotic process|receptor agonist activity|binding, bridging|",2,3,14200000,3.2%
P07214,0.830935436,-0.1008,1.510488367,0.099916667,0.706238133,0.398320524,-0.111,-0.2105,,-0.105,-0.042,-0.0355,P07214,Sparc,P07214_Sparc,P07214,Sparc,1,2,2,2,A0A1L1SSH9|P07214|Q5NCU4,MOUSE,35305.2,5.2,449,449.1,17.59,17.59,,302,SPARC,proteinaceous extracellular matrix|basement membrane|extracellular space|cell surface|nuclear matrix|platelet alpha granule|platelet alpha granule membrane|,negative regulation of endothelial cell proliferation|signal transduction|heart development|response to gravity|response to lead ion|positive regulation of endothelial cell migration|negative regulation of angiogenesis|regulation of cell morphogenesis|lung development|response to lipopolysaccharide|response to L-ascorbic acid|response to cytokine|wound healing|regulation of cell proliferation|response to peptide hormone|response to ethanol|response to cadmium ion|inner ear development|response to glucocorticoid|response to cAMP|response to calcium ion|bone development|cellular response to growth factor stimulus|,calcium ion binding|collagen binding|extracellular matrix binding|,2,2,101000000,5.2%
Q99MN9,0.116943374,0.559083333,20.6584088,-1.6445,0.008593283,-3.798039028,2.177,1.3585,0.6085,-0.056,-0.536,-0.1975,Q99MN9,Pccb,Q99MN9_Pccb,Q99MN9,Pccb,1,2,2,2,Q99MN9|E9Q1J7,MOUSE,59035.6,4.6,450,450.1,17.58,17.58,,541,"Propionyl-CoA carboxylase beta chain, mitochondrial",mitochondrion|mitochondrial matrix|,metabolic process|,propionyl-CoA carboxylase activity|ATP binding|,2,2,6580000,4.6%
Q8BYC6,0.246733887,-0.973583333,13.70650613,2.0195,0.042594094,2.560893248,-1.829,-0.4435,-3.6775,-0.024,0.129,0.0035,Q8BYC6,Taok3,Q8BYC6_Taok3,Q8BYC6,Taok3,1,12,2,2,Q8BYC6|Q3V3K3,MOUSE,105790.3,2.8,451,451.1,17.5,17.5,,898,Serine/threonine-protein kinase TAO3,nucleus|cytoplasm|,MAPK cascade|activation of MAPKK activity|DNA repair|protein phosphorylation|cellular response to DNA damage stimulus|mitotic G2 DNA damage checkpoint|regulation of mitotic cell cycle|signal transduction by protein phosphorylation|stress-activated protein kinase signaling cascade|positive regulation of stress-activated MAPK cascade|regulation of apoptotic process|positive regulation of JUN kinase activity|negative regulation of JNK cascade|positive regulation of JNK cascade|protein autophosphorylation|,protein serine/threonine kinase activity|MAP kinase kinase kinase activity|ATP binding|transferase activity|,2,12,30000000000,2.8%
E9Q3P4,0.630479413,0.662,3.788553264,-1.25125,0.417969579,-0.881729566,3.44,-0.6145,,-0.472,1.704,-0.7475,E9Q3P4,Cenpf,E9Q3P4_Cenpf,E9Q3P4,Cenpf,1,8,2,2,E9Q3P4,MOUSE,345546.7,0.9,452,452.1,17.44,17.44,,2997,Centromere protein F,"chromosome, centromeric region|spindle pole|condensed chromosome outer kinetochore|nucleus|nuclear envelope|nucleoplasm|cytoplasm|spindle|nuclear matrix|midbody|pronucleus|kinetochore|","mitotic cell cycle|chromosome segregation|regulation of G2/M transition of mitotic cell cycle|protein transport|regulation of striated muscle tissue development|negative regulation of transcription, DNA-templated|metaphase plate congression|",protein C-terminus binding|transcription factor binding|protein homodimerization activity|dynein binding|,2,8,11600000000,0.9%
P62827,0.16997749,0.568916667,17.3889061,-1.3215,0.018243552,-3.188308394,1.101,0.6095,1.9785,0.098,-0.497,0.1235,P62827,Ran,P62827_Ran,P62827,Ran,1,2,2,2,P62827|Q14AA6,MOUSE,24593.8,9.7,453,453.1,17.4,17.4,,216,GTP-binding nuclear protein Ran,nucleus|nuclear envelope|nucleoplasm|nucleolus|cytoplasm|centriole|membrane|midbody|melanosome|RNA nuclear export complex|recycling endosome|extracellular exosome|chromatin|,"ribosomal subunit export from nucleus|ribosomal large subunit export from nucleus|ribosomal small subunit export from nucleus|protein import into nucleus, translocation|protein import into nucleus|protein export from nucleus|mitotic nuclear division|small GTPase mediated signal transduction|metabolic process|actin cytoskeleton organization|positive regulation of protein binding|cellular protein localization|cellular protein complex localization|cell division|protein localization to nucleolus|",GTPase activity|protein binding|GTP binding|GDP binding|poly(A) RNA binding|pre-miRNA binding|,2,2,16700000,9.7%
A2ASS6,0.12645791,-0.4548,20.13387098,1.02325,0.009696453,3.985192189,-1.116,-1.0215,,-0.165,-0.005,0.0335,A2ASS6,NotFound,A2ASS6_NotFound,A2ASS6,Ttn,1,7,3,3,A2ASS6|E9Q8K5|E9Q8N1,MOUSE,3935740.7,0,454,454.1,17.37,17.37,,35213,Titin,nucleus|cytoplasm|,somitogenesis|protein phosphorylation|heart development|regulation of relaxation of cardiac muscle|,protein serine/threonine kinase activity|protein binding|calmodulin binding|ATP binding|ankyrin binding|metal ion binding|,3,7,52100000000,0.0%
Q9CPN9,0.673666325,-0.26925,3.316415981,0.6575,0.465970477,0.777933854,0.741,0.0345,-2.5695,0.193,0.063,-0.0775,Q9CPN9,2210010C04Rik,Q9CPN9_2210010C04Rik,Q9CPN9,2210010C04Rik,1,5,1,1,Q9CPN9,MOUSE,27106.2,4.8,455,455.1,17.31,17.31,,247,RIKEN cDNA 2210010C04 gene,extracellular space|,proteolysis|,serine-type endopeptidase activity|,1,5,1180000000,4.8%
A0A075B5L7,0.861748197,0.6738,1.153387547,-0.18825,0.766763172,-0.313071638,1.321,0.2525,,-0.31,0.95,1.1555,A0A075B5L7,NotFound,A0A075B5L7_NotFound,A0A075B5L7,Igkv4-80,1,3,2,2,A0A075B5L7,MOUSE,12676,18.9,456,456.1,17.23,17.23,,116,Immunoglobulin kappa variable 4-80 (Fragment),,,,2,3,492000000,18.9%
P07743,0.478310449,-0.0624,6.573012476,0.623083333,0.220139894,1.395153511,0.109,-0.9815,,-0.052,0.603,0.0095,P07743,Bpifa2,P07743_Bpifa2,P07743,Bpifa2,1,1,1,1,P07743,MOUSE,24923.6,6.8,457,457.1,17.19,17.19,,235,BPI fold-containing family A member 2,extracellular region|secretory granule|extracellular exosome|,defense response to bacterium|,lipopolysaccharide binding|,1,1,13200000,6.8%
Q9EPL0,0.277507267,0.25825,12.08635822,-0.942166667,0.061853486,-2.278610189,0.795,1.4065,-0.0135,-0.196,-0.526,0.0835,Q9EPL0,Xylt2,Q9EPL0_Xylt2,Q9EPL0,Xylt2,1,2,2,2,Q9EPL0,MOUSE,97608.3,3.1,458,458.1,17.18,17.18,,865,Xylosyltransferase 2,Golgi membrane|endoplasmic reticulum membrane|integral component of membrane|,glycosaminoglycan biosynthetic process|heparan sulfate proteoglycan biosynthetic process|proteoglycan biosynthetic process|chondroitin sulfate biosynthetic process|heparin biosynthetic process|,acetylglucosaminyltransferase activity|protein xylosyltransferase activity|,2,2,13600000,3.1%
E9PUU4,0.16997749,-0.2234,17.02860062,1.108083333,0.019821656,3.320565401,-0.992,-0.7845,,0.556,-0.192,0.2955,E9PUU4,Gemin5,E9PUU4_Gemin5,E9PUU4,Gemin5,1,5,3,3,E9PUU4|Q8BX17|A2AFQ9,MOUSE,169370,2.2,459,459.1,17.15,17.15,,1503,Gem-associated protein 5,nucleus|nucleoplasm|cytoplasm|cytosol|membrane|nuclear body|SMN complex|SMN-Sm protein complex|,spliceosomal snRNP assembly|,snRNA binding|poly(A) RNA binding|,3,5,2360000000,2.2%
Q3U492,0.270557177,0.272416667,12.43741343,-1.153833333,0.057050395,-2.342648077,1.631,1.1105,-0.1935,-0.412,-0.431,-0.0705,Q3U492,Kcp,Q3U492_Kcp,Q3U492,Kcp,1,2,2,2,Q3U492|Q3U492-2|E9QNB3,MOUSE,178777.4,1.5,460,460.1,17.14,17.14,,1550,Kielin/chordin-like protein,extracellular space|,hematopoietic progenitor cell differentiation|positive regulation of BMP signaling pathway|,protein binding|,2,2,5160000,1.5%
A0A087WQT1,0.305538902,0.181,10.55358535,-0.808666667,0.088032182,-2.214362267,,0.7875,,-0.022,0.112,-0.1535,A0A087WQT1,NotFound,A0A087WQT1_NotFound,A0A087WQT1,BC025446,1,1,1,1,A0A087WQT1|Q8R155,MOUSE,15147.2,18.6,461,461.1,17.03,17.03,,134,cDNA sequence BC025446,,,,1,1,14500000,18.6%
A0A075B5L3,0.014426602,0.507583333,33.58656668,-2.122833333,0.000437868,-6.783673912,1.629,2.0005,1.0775,-0.539,-0.778,-0.3445,A0A075B5L3,NotFound,A0A075B5L3_NotFound,A0A075B5L3,Igkv4-90,1,1,1,1,A0A075B5L3,MOUSE,12723.1,13.6,462,462.1,16.85,16.85,,117,Immunoglobulin kappa chain variable 4-90 (Fragment),,,,1,1,1210000,13.6%
Q8BYY9,0.648286631,0.16925,3.574414108,-0.4535,0.439095099,-0.828095973,1.282,0.7115,-0.8055,0.089,-0.121,-0.1405,Q8BYY9,Serpina3b,Q8BYY9_Serpina3b,Q8BYY9,Serpina3b,1,1,1,1,Q8BYY9,MOUSE,47642.2,2.6,463,463.1,16.85,16.85,,420,Serine protease inhibitor A3B,extracellular space|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,1,1,4760000,2.6%
P43274,0.021262869,0.79325,31.26529795,-2.2855,0.000747257,-6.154308931,2.039,1.3995,2.3695,0.122,-0.782,-0.3885,P43274,Hist1h1e,P43274_Hist1h1e,P43274,Hist1h1e,1,2,2,2,P43274|P43277|P43275|P15864,MOUSE,21976.9,11.8,464,464.1,16.61,16.61,,219,Histone H1.4,nucleosome|nucleus|nuclear heterochromatin|extracellular exosome|nucleolus|,negative regulation of transcription from RNA polymerase II promoter|nucleosome assembly|nucleosome positioning|,DNA binding|protein binding|chromatin DNA binding|poly(A) RNA binding|,2,2,35000000,11.8%
Q3UHI0-2,0.729414454,-0.113,2.689579925,0.189583333,0.53832185,0.658425735,-0.234,-0.2195,,-0.16,-0.21,0.2585,Q3UHI0,Ccser2,Q3UHI0-2_Ccser2,Q3UHI0-2,Ccser2,1,10,2,2,Q3UHI0-2|Q3UHI0,MOUSE,115944.3,1.9,465,465.1,16.59,16.59,,833,Isoform 2 of Serine-rich coiled-coil domain-containing protein 2,microtubule cytoskeleton|,,microtubule binding|,2,10,5.48E+11,1.9%
Q9ER39,0.70868614,0.2142,2.919438524,0.42075,0.510571005,0.707567818,-0.808,0.7315,,0.947,0.344,-0.1435,Q9ER39,Tor1a,Q9ER39_Tor1a,Q9ER39,Tor1a,1,1,1,1,Q9ER39,MOUSE,38228.6,3.3,466,466.1,16.57,16.57,,333,Torsin-1A,nucleus|nuclear envelope|cytoplasm|endoplasmic reticulum|endoplasmic reticulum lumen|cytoskeleton|synaptic vesicle|membrane|cell junction|transport vesicle|secretory granule|growth cone|cytoplasmic vesicle membrane|nuclear membrane|extrinsic component of endoplasmic reticulum membrane|intracellular membrane-bounded organelle|extracellular exosome|,"protein deneddylation|response to oxidative stress|organelle organization|nuclear envelope organization|cell adhesion|neuron projection development|protein localization to nucleus|wound healing, spreading of cells|intermediate filament cytoskeleton organization|synaptic vesicle transport|chaperone mediated protein folding requiring cofactor|protein homooligomerization|regulation of dopamine uptake involved in synaptic transmission|chaperone-mediated protein folding|ER-associated misfolded protein catabolic process|nuclear membrane organization|chaperone-mediated protein transport|positive regulation of synaptic vesicle endocytosis|regulation of protein localization to cell surface|",protein binding|ATP binding|cytoskeletal protein binding|ATPase activity|kinesin binding|unfolded protein binding|misfolded protein binding|,1,1,5670000,3.3%
Q9Z0J4-5,0.117753043,-0.293,20.53504335,1.31375,0.008840883,4.075952416,-0.765,-1.3975,,0.307,0.361,0.0295,Q9Z0J4,Nos1,Q9Z0J4-5_Nos1,Q9Z0J4-5,Nos1,1,4,3,3,Q9Z0J4-5|F8WGF2|Q9Z0J4|S4R255|Q9Z0J4-3|Q9Z0J4-4|Q9Z0J4-2,MOUSE,165708.8,2,467,467.1,16.56,16.56,,1429,"Isoform NNOS Mu of Nitric oxide synthase, brain",mitochondrion|mitochondrial outer membrane|cytosol|cytoskeleton|vesicle membrane|postsynaptic density|sarcoplasmic reticulum|Z disc|T-tubule|nuclear membrane|sarcoplasmic reticulum membrane|sarcolemma|azurophil granule|dendritic spine|membrane raft|synapse|caveola|,"response to hypoxia|regulation of sodium ion transport|nitric oxide biosynthetic process|striated muscle contraction|nitric oxide mediated signal transduction|female pregnancy|aging|negative regulation of cell proliferation|response to heat|response to lead ion|response to activity|peptidyl-cysteine S-nitrosylation|positive regulation of guanylate cyclase activity|response to lipopolysaccharide|response to vitamin E|multicellular organismal response to stress|positive regulation of histone acetylation|response to nicotine|exogenous drug catabolic process|negative regulation of apoptotic process|negative regulation of potassium ion transport|response to peptide hormone|response to estrogen|response to ethanol|negative regulation of blood pressure|negative regulation of heart contraction|positive regulation of transcription, DNA-templated|negative regulation of vasoconstriction|positive regulation of vasodilation|positive regulation of transcription from RNA polymerase II promoter|negative regulation of insulin secretion|behavioral response to cocaine|regulation of neurogenesis|negative regulation of hydrolase activity|negative regulation of cytosolic calcium ion concentration|negative regulation of serotonin uptake|negative regulation of calcium ion transport|regulation of sensory perception of pain|oxidation-reduction process|cellular response to mechanical stimulus|cellular response to growth factor stimulus|response to nitric oxide|positive regulation of the force of heart contraction|positive regulation of long-term synaptic potentiation|positive regulation of adrenergic receptor signaling pathway involved in heart process|positive regulation of neuron death|",NADPH-hemoprotein reductase activity|nitric-oxide synthase activity|iron ion binding|protein binding|calmodulin binding|FMN binding|enzyme binding|heme binding|protein homodimerization activity|flavin adenine dinucleotide binding|NADP binding|,3,4,7010000000,2.0%
P02668,0.519628152,0.479416667,5.743439584,-0.613166667,0.266474737,-1.223292517,0.545,0.0225,1.7905,0.378,0.398,-0.2575,P02668,NotFound,P02668_NotFound,P02668,CSN3,1,2,2,2,P02668,BOVIN,21383.1,14.7,468,468.1,16.45,16.45,,190,Kappa-casein,,,,2,2,6120000,14.7%
P12804,0.131006626,-0.4992,19.8908499,1.04175,0.010254512,3.930794349,-1.234,-1.0145,,-0.084,-0.203,0.0395,P12804,Fgl2,P12804_Fgl2,P12804,Fgl2,1,1,1,1,P12804,MOUSE,49634.7,2.3,469,469.1,16.41,16.41,,432,Fibroleukin,extracellular exosome|,cytolysis|,,1,1,29700000,2.3%
D3YZ61,0.156459648,0.45325,18.09780295,-1.190833333,0.015496003,-3.308098074,1.626,1.0155,0.5045,0.171,-0.444,-0.1535,D3YZ61,C1qtnf3,D3YZ61_C1qtnf3,D3YZ61,C1qtnf3,1,2,1,1,D3YZ61|Q9ES30,MOUSE,35268.9,2.8,470,470.1,16.4,16.4,,319,Complement C1q tumor necrosis factor-related protein 3,extracellular region|collagen trimer|extracellular space|cell|membrane|extracellular exosome|,negative regulation of gene expression|cellular triglyceride homeostasis|negative regulation of NF-kappaB import into nucleus|glucose homeostasis|negative regulation of gluconeogenesis|positive regulation of cytokine secretion|negative regulation of inflammatory response|protein oligomerization|positive regulation of protein kinase B signaling|positive regulation of adiponectin secretion|protein trimerization|positive regulation of ERK1 and ERK2 cascade|negative regulation of monocyte chemotactic protein-1 production|negative regulation of interleukin-6 secretion|,identical protein binding|,1,2,39100000,2.8%
P16014,0.478310449,0.19925,6.559666224,-1.0935,0.220817444,-1.365265881,0.708,2.3185,-0.7885,-0.072,-0.992,0.0215,P16014,Chgb,P16014_Chgb,P16014,Chgb,1,3,2,2,P16014,MOUSE,78081.7,3.6,471,471.1,16.24,16.24,,677,Secretogranin-1,extracellular region|secretory granule|,,protein binding|,2,3,33600000,3.6%
P01642,,0.3485,,,,,,,,-0.12,0.242,0.9235,P01642,NotFound,P01642_NotFound,P01642,Gm10881,1,1,1,1,P01642,MOUSE,12729,10.4,472,472.1,16.23,16.23,,115,Ig kappa chain V-V region L7 (Fragment),,,,1,1,370000000,10.4%
A0A075B6D5,0.740804438,1.0628,2.566249049,-0.54325,0.553828238,-0.633831807,1.022,1.7555,,-0.643,2.087,1.0925,A0A075B6D5,NotFound,A0A075B6D5_NotFound,A0A075B6D5,Igkv19-93,1,4,2,2,A0A075B6D5,MOUSE,12905.5,13.1,473,473.1,16.14,16.14,,114,Immunoglobulin kappa chain variable 19-93,,,,2,4,440000000,13.1%
P48356,0.335630756,-0.2278,9.896792152,0.541583333,0.102404911,1.980149222,-0.53,-0.5755,,0.092,-0.243,0.1175,P48356,Lepr,P48356_Lepr,P48356,Lepr,1,2,2,2,P48356|P48356-4|P48356-2|P48356-3|P48356-5,MOUSE,132954.3,1.2,474,474.1,15.88,15.88,,1162,Leptin receptor,extracellular region|plasma membrane|integral component of plasma membrane|receptor complex|,signal transduction|cholesterol metabolic process|cytokine-mediated signaling pathway|regulation of metabolic process|negative regulation of gluconeogenesis|negative regulation of hydrolase activity|,transmembrane signaling receptor activity|cytokine receptor activity|protein binding|identical protein binding|,2,2,310000000,1.2%
P27046,0.26133403,0.0075,13.00197122,1.101333333,0.05009598,2.72435735,,-0.8185,,0.315,0.52,0.0135,P27046,Man2a1,P27046_Man2a1,P27046,Man2a1,1,1,1,1,P27046,MOUSE,132370.8,0.9,475,475.1,15.85,15.85,,1150,Alpha-mannosidase 2,Golgi membrane|Golgi apparatus|cis-Golgi network|membrane|integral component of membrane|extracellular exosome|,in utero embryonic development|liver development|mannose metabolic process|N-glycan processing|mitochondrion organization|vacuole organization|respiratory gaseous exchange|lung alveolus development|positive regulation of neurogenesis|retina morphogenesis in camera-type eye|,"mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity|zinc ion binding|mannosidase activity|hydrolase activity, hydrolyzing N-glycosyl compounds|carbohydrate binding|",1,1,7400000,0.9%
P97927,0.917768271,-0.21425,0.655415441,-0.235166667,0.859920804,-0.184150516,1.278,1.6055,-3.1735,-0.607,-0.029,-0.3595,P97927,Lama4,P97927_Lama4,P97927,Lama4,1,2,1,1,P97927,MOUSE,204497.2,0.8,476,476.1,15.85,15.85,,1816,Laminin subunit alpha-4,extracellular region|basement membrane|basal lamina|extracellular exosome|,blood vessel development|cell adhesion|regulation of cell adhesion|regulation of cell migration|regulation of embryonic development|brown fat cell differentiation|,receptor binding|,1,2,9990000,0.8%
A2ARZ3,0.01315234,0.926416667,34.87914305,-3.221166667,0.000325151,-7.207068001,1.753,2.9115,2.9465,-0.098,-1.094,-0.8605,A2ARZ3,NotFound,A2ARZ3_NotFound,A2ARZ3,Fsip2,1,4,2,2,A2ARZ3,MOUSE,790434.4,0.1,477,477.1,15.66,15.66,,6995,Fibrous sheath-interacting protein 2,mitochondrion|motile cilium|,,protein binding|,2,4,163000000,0.1%
Q05020,0.279130421,-0.1092,11.63174718,0.880083333,0.068679209,2.289947541,-0.16,-1.1145,,0.258,0.436,0.0345,Q05020,Apoc2,Q05020_Apoc2,Q05020,Apoc2,1,3,2,2,Q05020,MOUSE,10741.1,14.4,478,478.1,15.65,15.65,,97,Apolipoprotein C-II,extracellular region|extracellular space|cytosol|very-low-density lipoprotein particle|low-density lipoprotein particle|intermediate-density lipoprotein particle|spherical high-density lipoprotein particle|chylomicron|extracellular exosome|,positive regulation of phospholipase activity|positive regulation of triglyceride catabolic process|negative regulation of very-low-density lipoprotein particle clearance|lipid catabolic process|negative regulation of cholesterol transport|cholesterol efflux|phospholipid efflux|chylomicron remnant clearance|high-density lipoprotein particle clearance|response to drug|lipoprotein transport|negative regulation of catalytic activity|positive regulation of fatty acid biosynthetic process|negative regulation of lipid metabolic process|negative regulation of receptor-mediated endocytosis|positive regulation of lipoprotein lipase activity|positive regulation of phospholipid catabolic process|triglyceride homeostasis|,lipid binding|phospholipase activator activity|protein homodimerization activity|phospholipase binding|lipase inhibitor activity|lipoprotein lipase activator activity|,2,3,226000000,14.4%
Q9CYA0,0.282360967,-0.3528,11.38913708,0.712416667,0.072625025,2.24621906,-1.125,-0.4355,,-0.104,-0.089,-0.0105,Q9CYA0,Creld2,Q9CYA0_Creld2,Q9CYA0,Creld2,1,2,1,1,Q9CYA0,MOUSE,40386.9,4.2,479,479.1,15.63,15.63,,350,Cysteine-rich with EGF-like domain protein 2,extracellular space|endoplasmic reticulum|Golgi apparatus|,,calcium ion binding|,1,2,11100000,4.2%
E9QLL8,0.135921833,0.571583333,19.30891352,-1.938833333,0.011724887,-3.564488227,0.84,1.1605,2.6225,-0.489,-0.855,0.1505,E9QLL8,Serpina11,E9QLL8_Serpina11,E9QLL8,Serpina11,1,2,2,2,E9QLL8|E9QK54|Q8CIE0,MOUSE,47783.4,4.4,480,480.1,15.46,15.46,,427,Serpin A11,extracellular space|,negative regulation of endopeptidase activity|,serine-type endopeptidase inhibitor activity|,2,2,17200000,4.4%
E9Q616,0.262291975,-0.1244,12.75697585,1.040583333,0.05300324,2.497400961,-1.147,-0.3505,,0.795,0.055,0.0255,E9Q616,Ahnak,E9Q616_Ahnak,E9Q616,Ahnak,1,3,3,3,E9Q616,MOUSE,605040.9,0.9,481,481.1,15.29,15.29,,5656,AHNAK nucleoprotein (desmoyokin),nucleus|cytoplasm|lysosomal membrane|cytosol|plasma membrane|cell-cell junction|focal adhesion|actin cytoskeleton|membrane|vesicle|sarcolemma|costamere|cell-cell contact zone|extracellular exosome|T-tubule|membrane raft|,regulation of RNA splicing|protein oligomerization|regulation of voltage-gated calcium channel activity|,S100 protein binding|poly(A) RNA binding|structural molecule activity conferring elasticity|,3,3,845000000,0.9%
A0A140T8N8,0.960183899,0.808,0.303163349,0.057916667,0.932574777,0.088913297,0.777,0.7695,,0.709,1.938,-0.1535,A0A140T8N8,NotFound,A0A140T8N8_NotFound,A0A140T8N8,Igkv9-123,1,4,2,2,A0A140T8N8,MOUSE,12986.4,17.9,482,482.1,15.27,15.27,,117,Immunoglobulin kappa variable 9-123 (Fragment),,,,2,4,246000000,17.9%
B99906,0.039474858,1.148416667,27.6888999,-2.911833333,0.00170259,-5.352554685,2.156,2.5215,3.1355,0.377,-1.402,0.1025,B99906,NotFound,B99906_NotFound,B99906,,1,6,2,2,B99906|B99902|B99903,PromTArt6,4855.8,34.7,483,483.1,15.25,15.25,,46,VATVSLPR-like Promega trypsin artifact 1-5 concatentated (871.1) xATVSLPR [Sus scrofa],,,,2,6,12000000000,34.7%
P01725,0.804206729,0.2466,1.837484051,-0.221916667,0.655015527,-0.473877258,0.975,-0.2155,,-0.254,0.276,0.4515,P01725,NotFound,P01725_NotFound,P01725,,1,4,2,2,P01725,MOUSE,11767.9,26.3,484,484.1,15.23,15.23,,110,Ig lambda-1 chain V region S178,,,antigen binding|,2,4,6410000000,26.3%
Q9Z126,0.998029387,-0.0698,0.027782869,0.002416667,0.993623177,0.008383863,0.11,-0.2525,,-0.073,-0.251,0.1175,Q9Z126,Pf4,Q9Z126_Pf4,Q9Z126,Pf4,1,3,1,1,Q9Z126,MOUSE,11471.5,11.4,485,485.1,15.18,15.18,,105,Platelet factor 4,extracellular space|platelet alpha granule|protein complex|,positive regulation of leukocyte chemotaxis|protein complex assembly|inflammatory response|immune response|G-protein coupled receptor signaling pathway|positive regulation of gene expression|positive regulation of macrophage derived foam cell differentiation|negative regulation of angiogenesis|cytokine-mediated signaling pathway|platelet activation|leukocyte chemotaxis|positive regulation of cAMP metabolic process|response to lipopolysaccharide|positive regulation of tumor necrosis factor production|regulation of cell proliferation|positive regulation of cAMP-mediated signaling|negative regulation of MHC class II biosynthetic process|positive regulation of macrophage differentiation|negative regulation of megakaryocyte differentiation|negative regulation of cytolysis|positive regulation of transcription from RNA polymerase II promoter|chemokine-mediated signaling pathway|negative regulation of extrinsic apoptotic signaling pathway in absence of ligand|,chemokine activity|heparin binding|CXCR chemokine receptor binding|CXCR3 chemokine receptor binding|,1,3,62500000,11.4%
Q59IW6,0.011676506,0.54225,37.85575088,-1.766833333,0.000163842,-8.075479462,1.351,1.4875,1.4385,-0.307,-0.515,-0.2015,Q59IW6,Abi3bp,Q59IW6_Abi3bp,Q59IW6,Abi3bp,1,3,1,1,Q59IW6|Q59IW5|Q59IW9|E9Q8E3,MOUSE,130163.5,0.5,486,486.1,15.1,15.1,,1179,"ABI gene family, member 3 (NESH)-binding protein",proteinaceous extracellular matrix|interstitial matrix|extracellular space|,positive regulation of cell-substrate adhesion|extracellular matrix organization|,collagen binding|glycosaminoglycan binding|heparin binding|,1,3,80500000,0.5%
A2AFG3,0.16997749,-0.3502,17.44673523,1.94675,0.018002237,3.448812745,-2.209,-0.8275,,-0.167,0.932,0.5205,A2AFG3,Pdzd4,A2AFG3_Pdzd4,A2AFG3,Pdzd4,1,3,2,2,A2AFG3,MOUSE,74414.1,2.4,487,487.1,15.01,15.01,,657,PDZ domain-containing protein 4,,protein ubiquitination|,ubiquitin protein ligase activity|,2,3,1430000000,2.4%
P68433,0.015496083,0.901083333,32.84133098,-2.4725,0.000519837,-6.576408976,2.697,1.6985,2.0165,0.157,-0.732,-0.4305,P68433,Hist1h3g,P68433_Hist1h3g,P68433,Hist1h3a,1,2,2,2,A0A1W2P768|P68433|P84228|P84244|P02301|F8WI35,MOUSE,15517.9,10.2,488,488.1,14.9,14.9,,136,Histone H3.1,nuclear nucleosome|nucleoplasm|membrane|extracellular exosome|,chromatin silencing at rDNA|DNA replication-dependent nucleosome assembly|protein heterotetramerization|regulation of gene silencing|,DNA binding|protein binding|histone binding|protein heterodimerization activity|,2,2,53100000,10.2%
F6R7E8,0.012313177,0.825916667,36.61182725,-2.792833333,0.000218181,-7.679725425,2.859,1.5755,2.2325,-0.646,-0.611,-0.4545,F6R7E8,Gm2663,F6R7E8_Gm2663,F6R7E8,Gm2663,1,6,1,1,F6R7E8|Q9CPN7,MOUSE,27260.6,8,489,489.1,14.87,14.87,,247,Predicted gene 2663,extracellular space|,proteolysis|,serine-type endopeptidase activity|,1,6,663000000,8.0%
Q9CZB2,,0.852166667,,,,,,,,1.019,-0.138,1.6755,Q9CZB2,Pmel,Q9CZB2_Pmel,Q9CZB2,Pmel,1,1,1,1,Q9CZB2|Q60696,MOUSE,66927.6,2.7,490,490.1,14.85,14.85,,626,Melanocyte protein PMEL,endoplasmic reticulum membrane|Golgi apparatus|multivesicular body membrane|melanosome|,melanosome organization|melanin biosynthetic process|,,1,1,2810000,2.7%
Q8R1L8,0.926068831,-0.08025,0.583435851,0.220166667,0.87429182,0.165045765,1.766,1.0345,-3.3715,0.31,-0.43,0.2095,Q8R1L8,Angptl8,Q8R1L8_Angptl8,Q8R1L8,Angptl8,1,1,1,1,Q8R1L8,MOUSE,22119.7,8,491,491.1,14.84,14.84,,198,Angiopoietin-like protein 8,extracellular region|,glucose metabolic process|positive regulation of protein processing|regulation of lipid metabolic process|cellular lipid metabolic process|type B pancreatic cell proliferation|fat cell differentiation|cell maturation|regulation of lipoprotein metabolic process|negative regulation of lipoprotein lipase activity|triglyceride homeostasis|glucose metabolic process|type B pancreatic cell proliferation|,hormone activity|,1,1,8620000,8.0%
Q69ZS0,0.468261811,0.2282,6.742991569,0.376583333,0.211690244,1.423785683,-0.116,0.1205,,0.323,0.309,0.5045,Q69ZS0,Pdzrn3,Q69ZS0_Pdzrn3,Q69ZS0,Pdzrn3,1,4,2,2,Q69ZS0|Q69ZS0-3|Q69ZS0-2,MOUSE,120996.6,1.6,492,492.1,14.81,14.81,,1063,E3 ubiquitin-protein ligase PDZRN3,neuromuscular junction|,neuromuscular junction development|protein ubiquitination|,ubiquitin-protein transferase activity|protein binding|zinc ion binding|ligase activity|ubiquitin protein ligase activity|,2,4,1350000000,1.6%
P62806,0.012313177,0.857416667,36.55301758,-2.6885,0.000221156,-7.661425598,2.834,1.7575,2.0135,-0.266,-0.762,-0.4325,P62806,Hist1h4h,P62806_Hist1h4h,P62806,Hist1h4a,1,1,1,1,P62806,MOUSE,11367.1,9.7,493,493.1,14.74,14.74,,103,Histone H4,nuclear chromosome|nucleosome|nucleoplasm|membrane|extracellular exosome|,chromatin silencing at rDNA|nucleosome assembly|DNA replication-dependent nucleosome assembly|DNA replication-independent nucleosome assembly|negative regulation of megakaryocyte differentiation|protein heterotetramerization|,DNA binding|protein binding|histone binding|poly(A) RNA binding|protein heterodimerization activity|,1,1,79700000,9.7%
Q8K3F2,0.767593159,-0.1402,2.282173989,0.372583333,0.591265585,0.572979315,0.668,-1.3955,,0.213,-0.161,-0.0255,Q8K3F2,Mmp21,Q8K3F2_Mmp21,Q8K3F2,Mmp21,1,6,2,2,Q8K3F2,MOUSE,65738.1,3.8,494,494.1,14.72,14.72,,568,Matrix metalloproteinase-21,extracellular region|extracellular matrix|,hematopoietic progenitor cell differentiation|proteolysis|,metalloendopeptidase activity|calcium ion binding|metallopeptidase activity|zinc ion binding|,2,6,10800000000,3.8%
Q8K426,0.223574057,0.767416667,15.17734,-2.0705,0.0303575,-2.814233669,2.948,0.4175,2.0425,-0.616,-0.828,0.6405,Q8K426,Retnlg,Q8K426_Retnlg,Q8K426,Retnlg,1,2,1,1,Q8K426,MOUSE,13276.1,10.2,495,495.1,14.7,14.7,,117,Resistin-like gamma,extracellular space|,myeloid dendritic cell chemotaxis|,hormone activity|,1,2,38800000,10.2%
Q91X17,0.557519683,-0.1728,4.868330434,0.284083333,0.325961987,1.084305505,-0.311,-0.3755,,-0.081,-0.191,0.0945,Q91X17,Umod,Q91X17_Umod,Q91X17,Umod,1,2,2,2,Q91X17,MOUSE,73582.4,2.8,496,496.1,14.69,14.69,,642,Uromodulin,spindle pole|basolateral plasma membrane|apical plasma membrane|anchored component of membrane|ciliary membrane|extracellular exosome|primary cilium|,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules|leukocyte cell-cell adhesion|excretion|chemical homeostasis|metanephric ascending thin limb development|metanephric distal convoluted tubule development|metanephric thick ascending limb development|neutrophil migration|regulation of ion homeostasis|,calcium ion binding|IgG binding|,2,2,162000000,2.8%
S4R1P5,0.853173903,0.162,1.266800633,-0.24875,0.746998856,-0.340797019,1.45,-0.8275,,0.226,-0.36,0.3215,S4R1P5,Dst,S4R1P5_Dst,S4R1P5,Dst,1,4,3,3,S4R1P5|E9Q9X1|Q91ZU6-4|Q91ZU6-3|Q91ZU6|Q91ZU6-2|A0A087WSP0,MOUSE,876109,0.3,497,497.1,14.68,14.68,,7717,Dystonin,actin cytoskeleton|cytoplasmic membrane-bounded vesicle|hemidesmosome|neuronal postsynaptic density|,cytoskeleton organization|cell cycle arrest|axonogenesis|retrograde axon cargo transport|,actin binding|calcium ion binding|protein binding|,3,4,1970000000,0.3%
E9QA60,0.612008945,-0.1358,3.968074199,0.244916667,0.401044514,0.914206335,-0.207,-0.3585,,-0.223,0.046,0.0635,E9QA60,NotFound,E9QA60_NotFound,E9QA60,Zfp626,1,5,2,2,A0A0U1RQ84|E9QA60,MOUSE,32071.4,9.1,498,498.1,14.66,14.66,,272,Zinc finger protein 626,,"regulation of transcription, DNA-templated|",nucleic acid binding|sequence-specific DNA binding transcription factor activity|metal ion binding|,2,5,3710000000,9.1%
B2RQ80,0.02172221,0.849416667,30.97942492,-2.3885,0.0007981,-6.110204369,1.509,2.7965,1.8255,-0.047,-0.493,-0.4945,B2RQ80,Tnik,B2RQ80_Tnik,B2RQ80,Tnik,1,2,2,2,B2RQ80|B9EKN8|E9PUL9|P83510|E0CY98|E0CXD6|P83510-2|E0CZD7|E0CZF8|Q9JM52-3|G3X9G2|Q5SXG3|Q5SXG1|Q9JM52|E9PVG7|A0A0A6YW53|Q9JM52-2|A0A0A6YWM8|F8VPL5|A0A0A6YWR8|P97820|B2RUE8|B7ZNR9,MOUSE,155455.9,1.4,499,499.1,14.66,14.66,,1360,Tnik protein,nucleus|nucleoplasm|cytoplasm|cytoskeleton|apical plasma membrane|perinuclear region of cytoplasm|recycling endosome|extracellular exosome|,MAPK cascade|positive regulation of protein phosphorylation|positive regulation of defense response to virus by host|protein phosphorylation|cytoskeleton organization|activation of JNKK activity|regulation of mitotic cell cycle|microvillus assembly|stress-activated protein kinase signaling cascade|actin cytoskeleton reorganization|activation of protein kinase activity|intracellular signal transduction|regulation of apoptotic process|protein autophosphorylation|neuron projection morphogenesis|regulation of dendrite morphogenesis|protein localization to plasma membrane|,protein kinase activity|protein serine/threonine kinase activity|ATP binding|MAP kinase kinase kinase kinase activity|,2,2,162000000,1.4%
O89051,,0.115833333,,,,,,,,-0.12,0.327,0.1405,O89051,Itm2b,O89051_Itm2b,O89051,Itm2b,1,1,1,1,O89051,MOUSE,30772.9,7.1,500,500.1,14.57,14.57,,266,Integral membrane protein 2B,extracellular space|Golgi apparatus|plasma membrane|endosome membrane|membrane|Golgi-associated vesicle membrane|integral component of organelle membrane|intracellular membrane-bounded organelle|extracellular exosome|,negative regulation of amyloid precursor protein biosynthetic process|,beta-amyloid binding|ATP binding|,1,1,24900000,7.1%
Q8CE64,0.135921833,0.77625,19.33646409,-1.740833333,0.011650742,-3.560044704,1.032,2.4535,1.4545,0.055,-0.768,0.4305,Q8CE64,Zfp276,Q8CE64_Zfp276,Q8CE64,Znf276,1,2,2,2,Q8CE64,MOUSE,68935.4,2.4,501,501.1,14.56,14.56,,614,Zinc finger protein 276,nucleus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|",DNA binding|zinc ion binding|,2,2,56600000,2.4%
Q61884,0.011676506,0.801916667,40.54710513,-2.7815,8.81636E-05,-8.991694091,2.724,1.7815,2.0725,-0.73,-0.586,-0.4505,Q61884,Mns1,Q61884_Mns1,Q61884,Mns1,1,4,2,2,Q61884,MOUSE,60291.8,2.8,502,502.1,14.45,14.45,,491,Meiosis-specific nuclear structural protein 1,nuclear envelope|intermediate filament|axoneme|sperm flagellum|,spermatogenesis|cilium organization|positive regulation of cilium assembly|meiotic cell cycle|left/right axis specification|,identical protein binding|,2,4,474000000,2.8%
Q9WV54,0.115560135,0.328416667,20.93240328,-1.727833333,0.008067885,-3.85234677,1.48,1.8505,0.2465,-0.568,-0.701,-0.3375,Q9WV54,Asah1,Q9WV54_Asah1,Q9WV54,Asah1,1,1,1,1,Q9WV54,MOUSE,45068.1,2,503,503.1,14.4,14.4,,394,Acid ceramidase,lysosome|extracellular exosome|,lipid metabolic process|,ceramidase activity|,1,1,21200000,2.0%
Q6DFZ1,0.566520262,0.1094,4.728159461,0.429416667,0.336654213,1.058220436,0.257,-0.5535,,-0.11,0.682,0.2715,Q6DFZ1,Gbf1,Q6DFZ1_Gbf1,Q6DFZ1,Gbf1,1,4,2,2,Q6DFZ1,MOUSE,208832.4,1,504,504.1,14.4,14.4,,1861,Golgi-specific brefeldin A-resistance factor 1,Golgi membrane|mitochondrion|peroxisome|endoplasmic reticulum lumen|endoplasmic reticulum-Golgi intermediate compartment|Golgi apparatus|Golgi stack|cis-Golgi network|trans-Golgi network|plasma membrane|membrane|cell leading edge|trans-Golgi network|,"cell activation involved in immune response|retrograde vesicle-mediated transport, Golgi to ER|Golgi to endosome transport|Golgi organization|regulation of mitotic cell cycle|regulation of cell adhesion|neutrophil chemotaxis|regulation of ARF protein signal transduction|protein localization to Golgi apparatus|retrograde transport, endosome to Golgi|positive regulation of GTPase activity|COPI coating of Golgi vesicle|establishment of monopolar cell polarity|protein localization to endoplasmic reticulum exit site|Golgi disassembly|endoplasmic reticulum-Golgi intermediate compartment organization|reactive oxygen species biosynthetic process|protein localization to endoplasmic reticulum tubular network|regulation of protein localization to cell surface|vesicle-mediated transport|","ARF guanyl-nucleotide exchange factor activity|protein binding|phosphatidylinositol-3,4,5-trisphosphate binding|phosphatidylinositol-3,5-bisphosphate binding|",2,4,1040000000,1.0%
P97821,0.869131757,0.071625,1.108545155,-0.1085,0.774721278,-0.305254753,0.153,,,-0.038,0.124,0.0475,P97821,Ctsc,P97821_Ctsc,P97821,Ctsc,1,2,1,1,P97821,MOUSE,53174.2,2.5,505,505.1,14.35,14.35,,462,Dipeptidyl peptidase 1,extracellular space|lysosome|endoplasmic reticulum|Golgi apparatus|membrane|extracellular exosome|,T cell mediated cytotoxicity|proteolysis|apoptotic process|activation of cysteine-type endopeptidase activity involved in apoptotic process|aging|response to organic substance|proteolysis involved in cellular protein catabolic process|positive regulation of proteolysis involved in cellular protein catabolic process|positive regulation of apoptotic signaling pathway|,cysteine-type endopeptidase activity|serine-type endopeptidase activity|cysteine-type peptidase activity|cysteine-type endopeptidase activator activity involved in apoptotic process|peptidase activator activity involved in apoptotic process|phosphatase binding|chloride ion binding|identical protein binding|protein self-association|chaperone binding|,1,2,16300000,2.5%
Q8C341-2,0.597774545,1.366,4.278601586,-1.439583333,0.373370363,-0.976370756,3.933,0.5265,,2.39,1.246,-1.2655,Q8C341,Suco,Q8C341-2_Suco,Q8C341-2,Suco,1,2,2,2,Q8C341-2|Q8C341,MOUSE,140779.6,1.5,506,506.1,14.3,14.3,,1250,Isoform 2 of SUN domain-containing ossification factor,rough endoplasmic reticulum|membrane|integral component of membrane|rough endoplasmic reticulum membrane|,multicellular organismal development|positive regulation of collagen biosynthetic process|positive regulation of osteoblast differentiation|regulation of bone remodeling|,,2,2,89000000,1.5%
E9Q328,0.07979453,0.44075,23.81149699,-2.877166667,0.004157673,-4.471899244,3.349,1.3795,0.9095,-1.001,-1.144,-0.8485,E9Q328,5430401F13Rik,E9Q328_5430401F13Rik,E9Q328,5430401F13Rik,1,1,1,1,E9Q328|F6URP1,MOUSE,18977.3,6.8,507,507.1,14.19,14.19,,175,RIKEN cDNA 5430401F13 gene,,,,1,1,226000000,6.8%
Q60963,0.268517745,0.287083333,12.50829735,-0.9105,0.056126798,-2.348418281,0.968,1.3075,-0.0485,-0.267,-0.114,-0.1235,Q60963,Pla2g7,Q60963_Pla2g7,Q60963,Pla2g7,1,2,1,1,Q60963,MOUSE,49599.7,2.7,508,508.1,14.18,14.18,,440,Platelet-activating factor acetylhydrolase,cytoplasm|low-density lipoprotein particle|,inflammatory response|lipid catabolic process|low-density lipoprotein particle remodeling|lipid oxidation|plasma lipoprotein particle oxidation|positive regulation of monocyte chemotaxis|,1-alkyl-2-acetylglycerophosphocholine esterase activity|phospholipid binding|calcium-independent phospholipase A2 activity|,1,2,19600000,2.7%
Q6P9P0,0.231846274,-0.08425,14.81387661,0.6835,0.033007478,2.732029296,-0.207,-0.5945,-0.4765,0.261,0.499,0.0125,Q6P9P0,Slf2,Q6P9P0_Slf2,Q6P9P0,Slf2,1,8,2,2,Q6P9P0|E9Q839|K4JR88|K4JBS4|K4JR71,MOUSE,144937.3,1,509,509.1,14.12,14.12,,1278,SMC5-SMC6 complex localization factor protein 2,chromatin|extracellular space|nucleus|intracellular membrane-bounded organelle|,,,2,8,1.05E+11,1.0%
A0A075B5K3,0.606693779,-0.1378,4.109816803,0.30825,0.38816674,0.941429003,-0.645,-0.0005,,-0.24,0.094,0.1025,A0A075B5K3,NotFound,A0A075B5K3_NotFound,A0A075B5K3,Igkv17-121,1,2,1,1,A0A075B5K3|A0A075B5J9,MOUSE,12863.4,13.7,510,510.1,14.1,14.1,,116,Immunoglobulin kappa variable 17-121,,,,1,2,156000000,13.7%
Q70FJ1,0.231846274,-0.1206,14.67586384,1.326083333,0.034073254,2.863524763,-1.335,-0.4975,,-0.179,0.902,0.5065,Q70FJ1,Akap9,Q70FJ1_Akap9,Q70FJ1,Akap9,1,4,2,2,Q70FJ1|Q70FJ1-2|E9QQ10|Q70FJ1-3,MOUSE,439405.6,0.4,511,511.1,13.96,13.96,,3797,A-kinase anchor protein 9,pericentriolar material|cytoplasm|Golgi apparatus|centrosome|ciliary basal body|,signal transduction|spermatogenesis|Sertoli cell development|,protein binding|protein complex scaffold|,2,4,1460000000,0.4%
E9PZ36,0.573841572,-0.0044,4.611905853,0.33225,0.3457876,1.03648488,-0.216,-0.1915,,-0.12,-0.033,0.5385,E9PZ36,Pkhd1,E9PZ36_Pkhd1,E9PZ36,Pkhd1,1,3,2,2,E9PZ36,MOUSE,450351.1,0.6,512,512.1,13.92,13.92,,4059,Polycystic kidney and hepatic disease 1,cytoplasm|centrosome|apical plasma membrane|ciliary basal body|perinuclear region of cytoplasm|extracellular exosome|primary cilium|mitotic spindle|,kidney development|cellular calcium ion homeostasis|positive regulation of cell proliferation|regulation of centrosome duplication|regulation of TOR signaling|negative regulation of NF-kappaB transcription factor activity|cilium assembly|negative regulation of apoptotic process|negative regulation of protein kinase B signaling|regulation of ERK1 and ERK2 cascade|,protein binding|,2,3,4050000000,0.6%
P14576,0.786464912,0.489916667,2.054133051,-0.600833333,0.623141528,-0.517590785,-1.505,0.9615,2.9145,0.417,-0.916,1.0675,P14576,Srp54a,P14576_Srp54a,P14576,Srp54,1,2,2,2,P14576,MOUSE,56005.1,3.5,513,513.1,13.85,13.85,,504,Signal recognition particle 54 kDa protein,"signal recognition particle, endoplasmic reticulum targeting|nuclear speck|",SRP-dependent cotranslational protein targeting to membrane|metabolic process|,GTPase activity|GTP binding|7S RNA binding|,2,2,73400000,3.5%
Q9WVB3,0.302878103,0.33875,10.62453425,-0.6565,0.08660572,-2.034643379,0.385,0.5605,1.0555,-0.397,0.429,-0.0005,Q9WVB3,Tle6,Q9WVB3_Tle6,Q9WVB3,Tle6,1,2,2,2,Q9WVB3|D3Z5E1,MOUSE,65970.1,4.4,514,514.1,13.69,13.69,,581,Transducin-like enhancer protein 6,nucleus|cell cortex|protein complex|,positive regulation of neuron differentiation|positive regulation of neurogenesis|,protein binding|,2,2,226000000,4.4%
P26040,0.277507267,0.19325,12.08769551,-0.770833333,0.061834442,-2.27531206,0.532,0.0295,1.1745,-0.141,-0.119,-0.3165,P26040,Ezr,P26040_Ezr,P26040,Ezr,1,5,2,2,P26040|P26041|P26043|Q7TSG6,MOUSE,69519.7,4,515,515.1,13.63,13.63,,586,Ezrin,ruffle|uropod|extracellular space|intracellular|nucleolus|cytoplasm|endosome|cytosol|actin filament|plasma membrane|microvillus|brush border|focal adhesion|cell cortex|actin cytoskeleton|membrane|basolateral plasma membrane|apical plasma membrane|extrinsic component of membrane|filopodium|T-tubule|microvillus membrane|vesicle|ruffle membrane|ciliary basal body|myelin sheath|cell body|microspike|membrane raft|apical part of cell|cell tip|extracellular exosome|cell periphery|astrocyte projection|Schwann cell microvillus|cytoplasmic side of apical plasma membrane|focal adhesion|,intestinal D-glucose absorption|sphingosine-1-phosphate signaling pathway|leukocyte cell-cell adhesion|regulation of cell shape|positive regulation of gene expression|membrane to membrane docking|actin cytoskeleton reorganization|receptor internalization|regulation of microvillus length|establishment or maintenance of apical/basal cell polarity|positive regulation of multicellular organism growth|filopodium assembly|phosphatidylinositol-mediated signaling|positive regulation of protein secretion|actin filament bundle assembly|establishment of endothelial barrier|positive regulation of establishment of protein localization to plasma membrane|regulation of organelle assembly|terminal web assembly|positive regulation of protein localization to early endosome|positive regulation of cellular protein catabolic process|positive regulation of early endosome to late endosome transport|microvillus assembly|,protein binding|protein domain specific binding|poly(A) RNA binding|cell adhesion molecule binding|actin filament binding|,3,5,170000000,4.0%
E9Q9F7,0.46334768,-1.702583333,6.89856944,4.0195,0.20424106,1.423059716,-0.374,-0.1485,-10.6145,-0.246,0.558,0.6095,E9Q9F7,Ccdc146,E9Q9F7_Ccdc146,E9Q9F7,Ccdc146,1,2,2,2,E9Q9F7|Q8R422|Q6P1H4|Q9WVL6|G3X8Z3|Q9R0S0|Q9Z111,MOUSE,115632.1,1.2,516,516.1,13.43,13.43,,977,Coiled-coil domain-containing 146,centriole|,,,2,2,197000000,1.2%
A0A1Y7VLS3,0.16997749,-0.14,17.23280813,0.925416667,0.018911204,3.362374841,-0.756,-0.6345,,0.381,0.307,0.0025,A0A1Y7VLS3,Togaram1,A0A1Y7VLS3_Togaram1,A0A1Y7VLS3,Togaram1,1,4,2,2,A0A1Y7VLS3|Q6A070|Q6A070-2,MOUSE,201882.1,1.1,517,517.1,13.4,13.4,,1826,TOG array regulator of axonemal microtubules protein 1,,,,2,4,990000000,1.1%
Q6ZPY7,0.853173903,0.29525,1.251354656,-0.288833333,0.749660338,-0.334010793,-1.12,0.1035,2.3355,0.258,-0.265,0.4595,Q6ZPY7,NotFound,Q6ZPY7_NotFound,Q6ZPY7,Kdm3b,1,11,2,2,B9EKS2|Q6ZPY7,MOUSE,172583.6,1.2,518,518.1,13.39,13.39,,1562,Lysine-specific demethylase 3B,nucleus|,"transcription, DNA-templated|regulation of transcription, DNA-templated|chromatin modification|oxidation-reduction process|",metal ion binding|dioxygenase activity|,2,11,9730000000,1.2%
P10166,0.900997634,0.086583333,0.829387902,-0.122166667,0.82615438,-0.229362846,-0.763,-0.0555,1.2615,0.106,-0.23,0.2005,P10166,Mycl,P10166_Mycl,P10166,Mycl,1,6,2,2,P10166,MOUSE,41361,2.9,519,519.1,13.39,13.39,,368,Protein L-Myc,nucleus|,"regulation of transcription, DNA-templated|",DNA binding|sequence-specific DNA binding transcription factor activity|protein binding|protein dimerization activity|,2,6,3620000000,2.9%
Q0VBK2,0.23713653,0.529083333,14.32646179,-2.9505,0.036927833,-2.666980177,2.184,4.1765,-0.3475,-0.719,-1.493,-0.6265,Q0VBK2,Krt80,Q0VBK2_Krt80,Q0VBK2,Krt80,1,1,1,1,Q0VBK2,MOUSE,51173.1,2.2,520,520.1,13.39,13.39,,452,"Keratin, type II cytoskeletal 80",cytoplasm|intermediate filament|keratin filament|,,structural molecule activity|,1,1,38000000,2.2%